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Abstract 
Protein kinases are important mediators of cell signalling that are often implicated in 
disease when deregulation occurs. The catalytic kinase domain is highly conserved 
with 518 identified members in the super family. Kinase structural studies are mainly 
based on relatively static crystal structures. However protein kinases are inherently 
dynamic entities in solution. Several Ser/Thr protein kinases were evaluated by NMR 
in order to obtain an amenable target for solution structure and functional 
characterisation. Subsequently a calcium calmodulin dependent protein kinase 
dubbed CaMK1D was identified as the optimal system. CaMK1D normally mediates 
intracellular signalling downstream of chemokines. It is amplified in breast cancer, 
and induces cell proliferation, migration and invasion. Here we report the backbone 
resonance assignments for the 38 kDa human autoinhibited CaMK1D in its free 
state, encompassing a canonical bi-lobed kinase fold and autoinhibitory and 
calmodulin binding domains. These assignments allowed us to probe the binding 
mode of CaMK1D with small molecule ligands and refine the crystal structure via 
dihedral angle restraints for a more complete structure. Furthermore we investigated 
the solution structure of the CaMK1D∙Ca2+/CaM complex and propose a model of the 
activation mechanism and establish a key residue implicated in complex formation. 
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Amino Acids 
Ala, A,  Alanine 
Arg, R,  Arginine 
Asn, N,  Asparagine 
Asp, D,   Aspartic acid 
Cys, C  Cysteine 
Gln, Q,  Glutamine 
Glu, E,  Glutamic acid 
Gly, G,  Glycine 
His, H   Histidine 
Ile, I,   Isoleucine 
Lys, K,  Lysine 
Leu L,   Leucine 
Met, M  Methionine 
Phe, F,  Phenylalanine 
Pro, P,  Proline 
Ser, S,  Serine 
Thr, T,  Threonine 
Trp, W,  Tryptophan 
Tyr, Y,  Tyrosine 
Val, V,  Val 
 
 
Abbreviations 
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Kinase Groups 
AGC Named after cAMP dependent kinase, cGMP dependent kinase, 
and protein kinase C families. This group includes kinases that 
are typically modulated by cyclic nucleotides, phospholipids, and 
calcium. 
Atypical Named atypical because this group represents kinases which 
lack sequence similarity to the eukaryotic protein kinase domain 
but exhibit kinase actitivity. 
CAMK Named after the Ca2+/CaM dependent kinase family. Consists of 
kinases that are regulated by Ca2+/CaM dependent but also 
those that not. 
CK1 Named after cell kinase 1, although originally named after 
casein kinase 1. This is a small ancient group of kinases that are 
highly similar to each other but are the most divergent of the 
groups related to the eukaryotic protein KD.  
CMGC Named after the cyclin dependent protein kinase, mitogen 
dependent kinase, gylocgen synthase kinase, and cyclin 
dependent like kinase families. This group includes kinases 
involved in cell cycle control, MAPK signalling, metabolic control 
splicing, stress response and other unknown functions. 
Other This group is named other because it consists of several kinase 
families that include unique kinases which are have sequence 
similarity to the conserved eukaryotic protein KD but do not fit 
into any of the other groups. 
PKL Named after protein kinase-like because these kinases have a 
protein kinase-like fold and catalytic mechanism but lack 
substantial sequence similarity. 
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RGC Named after Receptor guanylate cyclises. This group consists of 
kinases that feature an active guanylate cyclase domain that 
produces cGMP. Furthermore these kinases have a catalytically 
inactive KD. However the KD appears to have a regulatory 
function instead.  
STE Named after homologs of yeast sterile 7, sterile 11, sterile 20 
genes. These kinases are involved in the MAPK cascade. 
TK Named after tyrosine kinase, because this group consists of 
families of kinases that phosphorylate almost exclusively on 
tyrosine residues. 
TKL Named after tyrosine kinase-like because this group is most 
similar to the TK group but instead typically phosphorylate on 
Ser/Thr residues. 
 
Domains, Genes, Motifs and Proteins 
AD   Association domain 
AID   Autoinhibitory domain 
APE motif  Alanine, Proline, Glutamic acid, motif 
A-loop   Activation loop 
CAAX motif  Cysteine, Alanine, Alanine, any amino acid, motif 
CaM   Calmodulin 
CAMK/CaMK Ca2+/CaM dependent protein kinase 
CaMK1A  Calcium/calmodulin dependent protein kinase α 
CaMK1B/Pnck Calcium/calmodulin dependent protein kinase β/pregnancy up-
regulated non-uqbuitiously expressed CaM kinase 
Abbreviations 
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CaMK1G/CLICK-III Calcium/calmodulin dependent protein kinase γ/ CaMK-like 
CREB like kinase 3 
CaMK1D  Calcium/calmodulin dependent protein kinase δ 
CaMKK  Calcium/calmodulin dependent protein kinase kinase 
CBD  Calmodulin binding domain 
CDK   Cyclin-dependent kinases  
CK1   Cell kinase 1 
CKLiK   Calcium/calmodulin dependent protein kinase kinase 
CLK   Cyclin-dependent-like kinases 
C-lobe  C-terminal lobe 
CREB   cAMP response binding protein 1 
CRIB   Cdc42/Rac1 interactive binding domain 
CSNK1  Casein kinase 1    
CSNK1G3  Casein kinase 1 γ isoform 3 
DFG motif  Aspartic acid, Phenylalanine, Glycine, motif 
GSK   Glycogen synthase kinases  
KD   Kinase domain 
MAPK   Mitogen-dependent kinase or mitogen activated protein kinase 
N-lobe  N-terminal lobe 
PAK4   p21-activated kinase 4 
PAK5   p21-activated kinase 5 
PBD   p21-binding domain 
PKA   protein kinase A or cAMP dependent kinase 
Abbreviations 
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PKB    protein kinase B  
PKC/Akt  protein kinase C/retovirus strain Ak thymoma  
PKG   Protein kinase G or cGMP dependent kinase 
Pim1   Proviral insertion site of Maloney murine virus leukemia induced 1 
p-loop   Phosphate binding loop/Gly rich loop 
RD   Regulatory domain 
RGC/GYC  Receptor guanylate cyclases 
TK   Tyrosine kinase 
TKL   Tyrosine kinase-like 
TOPK/PBK  T-cell originated protein kinase/PDZ binding kinase 
STE   Homologs of yeast sterile 7, sterile 11, sterile 20 genes 
VRK   Vaccinia related kinase 
 
Biological metabolites and reagents 
ADP   Adenosine 5’-diphosphate 
AMP   Adenosine 5’-monophosphate 
AMPPNP  Adenosine 5’-(β,γ-imido)triphosphate  
ATP   Adenosine 5’-triphosphate 
BIM-1   Bisindolylmaleimide I, hydrochloride 
2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-
yl)maleimide, HCl 
cAMP   cyclic adenosine monophosphate 
cGMP   cyclic guanosine monophosphate 
Abbreviations 
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DMSO  Dimethly sulfoxide 
GSK-3 XIII  Glycogen synthase kinase 3 XIII inhibitor 
   (5-methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine 
GTP   Guanosine triphosphate 
2H2O   Deuterium oxide 
HEPES  4-(2-hydroxethyl)piperazine-1-ethanesulfonic acid 
IPTG   Isopropyl-β-D-1-thiogalactopyranoside 
LB   Luria broth 
MES   2-(N-morpholino)ethanesulfonic acid 
MOPS  3-(N-morpholino)propanesulfonic acid 
Na2HPO4  Sodium phosphate 
NaN3   Sodium azide 
TCEP   Tris(2-caroboxyethyl)phosphine hydrochloride 
TMAO   Trimethylamine N-oxide 
Tris   2-Amino-2-(hydroxymethyl)-1,3-propanediol  
 
Methods 
BLAST  Basic alignment search tool 
HSQC   Heteronuclear single quantum coherence 
ITC   Isothermal titration calorimetry 
RT-PCR  Real time polymerase chain reaction 
SAXS   Small angle x-ray scattering 
SEC   Size exclusion chromatography 
Abbreviations 
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SDM   Site directed mutagenesis 
SDS PAGE  Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TROSY  Transverse Relaxation Optimised Spectroscopy 
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Chapter I Introduction 
Objectives 
Protein function is governed by its structure and dynamics,all  these phenomena are 
inherently connected. Protein kinases can interconvert between multiple states 
reflecting distinct conformations along their reaction trajectory. Despite a highly 
conserved ATP binding site and global protein kinase domain fold, specific inhibition 
and differential modes of regulation and activation has been demonstrated across 
many protein kinases. Due to their dynamic behaviour often a ligand is required to 
stabiliize a particular conformation inorder to promote crystallization for structural 
study by protein crystallography. In collaboration with the Structural Genomics 
Consortium (SGC) the aim of this thesis is to determine the structure, mechanism of 
regulation, activation, and small molecule ligand mediated inhibition of a protein by 
solution NMR. The initial target dubbed TOPK/PBK, a cancer relevant protein kinase 
that has to date proven to be unreceptive to crystallisation. Structure determination 
of TOPK/PBK will help to elucidate the mechanism of its regulation and activation 
because a high throughput screen against a library of kinase ligands conducted by 
the SGC did not indicate any binders suggesting an unknown mode of autoinhibition. 
The requirements for activation and relief of autoinhibition will be investigated 
inaddition to the discovery and characterisation of ligand binding sites that modulate 
activity. In a wider context, a kinase by NMR approach will complement the wealth of 
data available on kinase crystal structures by yielding structural, functional, binding, 
and dynamic information in solution. Furthermore an advantage of NMR over 
crystallography is its application as a ligand screening tool that can readily identify 
low affinity substrates, inhibitor fragments, and novel allosteric binding sites, thus 
providing a foundation for the rational design of more specific inhibitors.  
 
In parallel with TOPK/PBK, several different Ser/Thr protein kinase clones whose 
structures have been solved by the SGC will be evaluated to establish their 
amenability to solution NMR. Here a similar general principle of study to TOPK/PBK 
will be applied in terms of characterising the structure, its mechanism of regulation 
and activation, and interactions in solution. Since crystal structures of these 
 19 
 
alternative kinases are already available only a backbone solution structure will be 
necessary initially as a basis for solution NMR interaction studies.  
 
The general criteria for an optimised kinase target includes: expression of 
iostopically labeled soluble monomeric folded protein at high yields (typically 5-10 
mg quantites or more of protein), long term solubility and stability of atleast several 
days to one week preferably at room temperature or higher (>25°C) for triple 
resonance data acquisition. Spectral quality must also be met sufficiently in terms of 
high peak intensity, peak count, and resolution. Evaluating a kinase that satisfies 
these criteria will likely require optimisation of its solution conditions and construct 
design.  
 
Once optimal conditions are established, appropriate isotope labelling methods will 
be implemented in order to acquire relevant experiments for straightforward 
sequential backbone assignment. As a minimum requirement the backbone 
assignment of a protein kinase will be necessary in order to characterise its 
backbone solution structure which can then be used as a reference spectrum for 
binding studies and probing its regulation and activation. Perturbation of the 
reference state via interactions with ligands, proteins, or mutagenesis will be 
monitored in solution by 1H-15N HSQC TROSY experiments.  
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Phosphorylation and the kinase superfamily 
Protein kinases by definition are enzymes which modify other proteins through 
covalent attachment of a gamma phosphate group from adenosine triphosphate 
(ATP) to the hydroxyl group on a protein substrate. This post translational 
modification is described as protein phosphorylation and is reversible by 
dephosphorylation, a separate, counteractive, process mediated by protein 
phosphatases (Figure 1). Studies of kinase mediated phosphorylation can be traced 
back to 1954, when casein was found to be phosphorylated by a liver enzyme 
(Burnett and Kennedy 1954; Cohen 2002). Shortly after in 1955, it became evident 
that phosphorylation and dephosphorylation were implicated in the interconversion of 
glycogen phosphorylase b and glycogen phosphorylase a and was dependent on 
ATP, Mg2+ and an enzyme termed phosphorylase kinase (Fischer and Krebs 1955; 
Krebs and Fischer 1956; Fischer, Graves et al. 1959; Cohen 2002). During this 
period it was incorrectly thought that phosphorylation was limited to the regulation of 
glycogenolysis. However, studies on protein kinase A (PKA) and the discovery of 
various phosphorylated substrates including both enzymes and proteins in the 1970s 
and 1980s revealed that phosphorylation was actually a widespread regulatory 
mechanism that affected many cellular processes (Langan 1969; Linn, Pettit et al. 
1969; Cohen 2002).  
 
Research on protein kinases has advanced progressively since the 1950s such that 
protein phosphorylation is now recognised as a major signalling and regulatory 
mechanism that can modulate protein activity, stability, protein-protein interactions 
and cellular localisation. Phosphorylation occurs extensively throughout the cell with 
approximately 30 % of all human proteins being phosphorylated (Cohen 2001). 
Regulated kinase activity is therefore critical for normal cellular function because 
kinases can orchestrate many diverse cellular processes such as cell proliferation, 
gene expression, apoptosis and metabolism. Therefore deregulation of kinase 
activity often contributes to cancer and many other diseases and is a major focus of 
drug discovery efforts through the desgine of kinase inhibitors (Cohen 2002; 
Vlahovic and Crawford 2003; Melnikova and Golden 2004; Paul and Mukhopadhyay 
2004; Baselga 2006; Fedorov, Marsden et al. 2007; Marsden and Knapp 2008). 
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Figure 1.0. Reversible phosphorylation. 
Protein kinases catalyse the phosphorylation of substrate proteins by transferring the 
gamma phosphate group from ATP to the hydroxyl group of the substrate protein 
whilst generating ADP in the process. The reaction usually requires ATP in complex 
with Mg2+ although certain kinases have evolved to acquire Mg2+ independent kinase 
activity (Mukherjee, Sharma et al. 2008). Protein phosphatases catalyse the 
dephosphorylation of phosphorylated proteins via hydrolysis of the phosphoric acid 
monoester bond to produce the hydroxyl group of the substrate protein and a free 
phosphate ion. 
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Currently, 518 protein kinase members have been identified in the human kinase 
superfamily dubbed the human kinome, and based on their ability to phosphorylate 
Ser/Thr or Tyr substrates they can be broadly sub divided into two main catagories: 
protein Ser/Thr kinases and the protein Tyr kinases. These can be further classified 
into ten groups with distinct sequences based on sequence alignments and 
phylogenetic trees using the conserved eukaryotic protein kinase domain (KD) as a 
reference whilst also supported by knowledge of sequence similarity and domain 
structure outside of the KD, known biological function, and the classification of yeast, 
worm, and fly kinomes (Manning, Whyte et al. 2002). Nine of the defined groups 
including: AGC, CAMK, CK1, CMGC, STE, other, TK, TKL, and RGC/GYC, classify 
the 478 kinases that are related to the eukaryotic protein KD (Figure 3). The 40 
kinases which lack sequence similarity to the KD but show kinase activity and 
structural similarity are classified under the atypical group. Most of the groups are 
further subdivided into a heirachy of families and subfamilies (Manning, Whyte et al. 
2002).  
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Figure 1.1. Human kinome. 
A dendogram of the human kinase superfamily illustrates the classification and 
evolutionary relationship of 478 protein kinases which show homology to the 
conserved eukaryotic protein KD. Classification for these particular protein kinases is 
defined by nine major groups: AGC, CAMK, CK1, CMGC, other RGC/GYC, STE, TK 
and TKL. Only the other group is not labelled but is represented by branches 
separate from the main branch of the other eight groups. Here distances along the 
branch between two kinases is proportional to the divergence between their 
sequences. The atypical group, representing 40 divergent human protein kinases 
lacking sequence homology to the conserved eukaryotic KD is not shown. Kinases 
that were evaluated for NMR studies in this thesis are circled in red. This figure was 
taken from cellsignal.com. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 25 
 
The Protein Kinase Domain  
The structure of the first KD to be determined was murine PKA (Knighton, Zheng et 
al. 1991; Knighton, Zheng et al. 1991), revealing a bilobal fold that comprised of a 
small ATP binding β-sheet N-terminal lobe (N-lobe) and a large substrate binding α-
helical C-terminal lobe (C-lobe). Both lobes are linked together by a short loop 
dubbed the hinge which also allows inter lobe movment (Figure 1.2). Furthermore it 
revealed the structure of a protein kinase in an active conformation poised  function 
of the many key conserved residues and motifs first identified and described by 
Hanks et al in their kinase classification (Hanks, Quinn et al. 1988; Hanks and 
Hunter 1995). These functional motifs implicated in binding and catalysis of ATP-
Mg2+ are described below 
 
Within the N-lobe there is a conserved motif, known as the p-loop or Gly rich loop 
whose consensus sequence is: GXGXXG. This loop behaves as a flexible clamp at 
the front of the active site cleft to cover and anchor the phosphates of ATP serving to 
position the nucleotide for catalysis. Capable of adopting open and closed 
conformations the distance of the p-loop relative to the catalytic loop has been 
described as a way to gauge the open and closed conformations of the loop. For 
example in the presence of nucleotide the tip of the p-loop is brought closer to the 
catalytic loop indicative of a closed conformation but in the absence of nucleotide the 
p-loop is further away and often disordered.  
 
A pair of invariant residues found in the N-lobe of most kinases is the catalytic Lys 
and αC helix associated Glu, together these residues form a salt bridge that is an 
archetypal hallmark for the kinase active conformation. The catalytic Lys interacts 
with the α and β phosphates of ATP, helping to neutralise these negative charges, 
but it is only optimially configured to achieve this when the αC helix Glu forms the 
conserved salt bridge with the catalytic Lys. The αC helix is therefore a key 
regulatory element in many kinases because it can adopt an active  in inactive 
conformation ( in which the αC helix Glu is oritentated away from the catalytic Lys 
 26 
 
hence kinase activation will require rearrangement of the αC helix (Huse and Kuriyan 
2002). 
In the upper region of the C-lobe several important loops are found that include the 
catalytic loop described by the consensus sequence: DXXXXN. Here the conserved 
Asp acts as a catalytic base via its carboxylic acid side chain nucleophilic attack of 
the substrate hydroxyl group. Another significant region that encompasses several 
motifs is the activation segment which includes the DFG, activation loop, and P+1 
loop. The magnesium coordinating DFG, in particular its conformation is critical for 
catalytic activity whereas the activation loop is often disordered but typically features 
a phosphoryalation site which can stabilize the segment. Phosphoryaltion promotes 
kinase activation by coordinating several key catalytic residues into their catalytically 
competetant conformation (Figure 1.3). At the C-terminus of this segment is the P+1 
loop, a short stretch of residues that contribute towards substrate binding near the 
phosphoylation site. 
 
Situated between the lobes is the active site cleft also known as the catalytic cleft. 
Here the native phosphate donating substrate ATP-Mg2+ binds. Typically the 
catalytic cleft can be described in terms of six main features known as the 
hydrophobic pocket, hydrophobic channel, and adenosine, sugar, hinge and 
phosphate binding regions (Figure 1.4). ATP-Mg2+ binds with its adenosine moiety 
facing towards the hinge and engages in hydrogen bonding with this flexible loop 
whilst the ribose and phosphate moieties are orientated into their respective sugar 
and phosphate regions of the cleft (Fabbro, Ruetz et al. 2002).  
 
Active and inactive conformations 
Kinases can adopt multiple conformations but are often described simply as inactive 
or active depending on the hallmarks of the DFG conformation and catalytic Lys αC 
helix Glu salt bridge formation. Another model has been proposed to describe the 
active and inactive conformation interms of their dynamic assembly of internal 
hydrophobic spines (Taylor and Kornev ; Kornev, Taylor et al. 2008). Key conserved 
internal residues that constitute two spines dubbed the regulatory (R-spine) and 
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catalytic (C-spine) span from the N-lobe to the C-lobe have been identified as being 
central to the dynamic interconversion between active and inactive kinase state 
(Figure 1.5). In the active conformation of many kinase structures the R-spine is 
assembled satisfying the classic hallmarks of the active state. However the active 
conformation poised for competent catalysis is also dependent on the complete 
assembly of the C-spine which requires ATP to be bound in the catalytic cleft. Here 
the adenosine moiety becomes part of the spine. 
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Figure 1.2. The eukaryotic catalytic kinase domain.  
PKA (PDB ID: 1ATP) the archetypal KD illustrates canonical bilobal fold consists of a 
small N-lobe (black) and a large C-lobe (gray). Here PKA adopts an active and 
catalytically competent conformation poised for catalysis. Key functional motifs that 
contribute to substrate binding and catalysis are highlighted in colour. The p-loop, 
hinge, DFG, catalytic Lys, and catalytic loop interact with ATP-Mg2+. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 30 
 
 
Figure 1.3. Key residues in the catalytic cleft.  
PKA is itself regulated by phosphorylation, which increases its activity. Residues are 
shown in the PKA active conformation of the catalytic cleft poised for catalysis. In the 
activation loop phospho Thr 197 forms a network of interactions that coordinates and 
stabilizes the catalytic loop, DFG motif, and αC helix in their catalytically competent 
confirguation. 
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Figure 1.4. Key regions within the catalytic cleft.  
Binding of ATP-Mg2+ to a protein kinase active site cleft can be described in terms of 
several specific regions dubbed the hinge, adenine, sugar, and phosphate binding 
regions, the hydrophobic channel, and the hydrophobic pocket. 
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Figure 1.5. Internal hydrophobic spines.  
The conformation of an active kinase poised for competent catalysis can be 
described in terms of conserved R-spine (orange) and C-spine (cyan) assembly. 
Here the both spines are completely assembled. Notable hallmarks of a catalytically 
competent conformation such as the conserved Lys-Glu salt bridge and DFG-in 
conformation are satisfied. 
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TOPK 
T-cell originated protein kinase (TOPK) also known as PDZ-binding kinase (PBK), is 
a 36 kDa Ser/Thr kinase  classified under the other group and was first identified in a 
yeast two hybrid screen interacting with a tumor suppressor protein termed the PDZ2 
domain of human homologue of the drosophila discs-large (hDlg). Subsequent 
analysis of TOPK revealed that it features a KD followed by a C-terminal T/S-X-V 
PDZ interacting motif (Gaudet, Branton et al. 2000). Shortly after its discovery, TOPK 
was also identified in lymphokine-activated killer T (T-LAK) cells and testis. BLAST 
(basic local alignment search tool) homology searching and phylogenetic tree 
analysis revealed that TOPK is related to the dual specific kinase mitogen activated 
protein kinase kinase (MAPKK) whilst sequence analysis revealed divergence in 
some conserved functional motifs (Abe, Matsumoto et al. 2000).  
 
Studies have indicated that TOPK is up-regulated during mitosis, meiosis, and is 
involved in the promotion of cell proliferation and cytokinesis. This is coupled with 
phosphorylation by cdk1/cyclin B at the T9 position to form a complex that 
associates with protein regulator of cytokinesis (PRC1) which interacts with 
microtubules and enhances cytokinesis. Interesringly the suppression of TOPK 
disrupts cytokinesis (Matsumoto, Abe et al. 2004; Abe, Takeuchi et al. 2007; Park, 
Nishidate et al. 2009). Furthermore a role for TOPK in spermatogenesis has also 
been described (Fujibuchi, Abe et al. 2005). Activation of TOPK requires 
phosphorylation on T198 but the kinase that mediates this is unknown, although 
TOPK activity is believed to be down-regulated by protein phosphatase 1α (PP1α) 
(Abe, Matsumoto et al. 2000; Matsumoto, Abe et al. 2004; Fujibuchi, Abe et al. 2005; 
Park, Nishidate et al. 2009).   
 
Up-regulated TOPK expression is evident in T-LAK cells, activated lymphoid cells 
and tumors (Abe, Matsumoto et al. 2000), and hematologic tumors that include 
leukemia, lymphoma, and myeloma. Furthermore, TOPK up-regulation correlates 
with the malignancy of these tumors (Simons-Evelyn, Bailey-Dell et al. 2001; Cote, 
Simard et al. 2002; Nandi, Tidwell et al. 2004). A role for TOPK is suggested in UVB-
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mediated skin carcinogenesis (Oh, Zhu et al. 2007), colorectoral cancer (Zhu, 
Zykova et al. 2007), and HeLa cervical cancer cells (Kwon, Lee et al. 2010). In 
melanoma cells TOPK phosphorylation of histone H2AX prevents apoptosis induced 
by arsenite (Zykova, Zhu et al. 2006). TOPK is highly expressed in breast cancer 
and promotes cell growth via Histone H3 phosphorylation but siRNA mediated gene 
silencing of TOPK inhibits breast cancer cell growth (Park, Lin et al. 2006).  
 
Downstream phosphorylation targets of TOPK include Leu-Gly-Asn repeat enriched 
protein/G-protein signalling modulator 2 (LGN/GSM2) whose activation mediates cell 
division in breast cancer cells (Fukukawa, Ueda et al. 2010) Moreover, activated 
TOPK can phosphorylate p38 MAPK (Abe, Matsumoto et al. 2000). Downstream of 
the insulin-like growth factor 1/insulin-like growth factor receptor 1 (IGF/IGF-IR) 
signalling pathway TOPK mediates tumor cell proliferation via p38 MAPK (Herrero-
Martin, Osuna et al. 2009). Additional TOPK interacting proteins include the tumor 
suppression protein p53, adapter protein p47 of the p97 AAA ATPase, and ERK2 
which TOPK can phosphorylate and vice versa (Zhu, Zykova et al. 2007; Park, 
Nishidate et al. 2009; Hu, Gartenhaus et al. 2010).  
 
Pim1 
First discovered as the preferential proviral integration site in Maloney murine 
leukemia virus (MoMuLV) induced T-cell lymphoma (Cuypers, Selten et al. 1984), 
Pim1 is a member of the Ser/Thr Pim kinase family that also constitutes Pim2 and 
Pim3. The Pim kinases are catagorized under the CAMK group. Pim1 is expressed 
predominantly as a 33 kDa protein although a 44 kDa isoform also exists in human 
prostate cancer cells and contains an N-terminal proline-rich motif that binds to the 
SH3 domain of tyrosine kinase Etk. The 33 kDa Pim1 is found within the cytosol and 
nucleus whereas the 44 kDa Pim1 localises around the plasma membrane (Xie, Xu 
et al. 2006). Due to different upstream initiation codons in the gene, murine Pim1 
also exists as 33 and 44 kDa isoforms (Padma and Nagarajan 1991). Pim1 (1XWS) 
adopts a constitutively active conformation and contains a Pro insertion in its hinge 
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region resulting in novel hydrogen-bonding patterns and an expanded ATP binding 
pocket (Qian, Wang et al. 2005). 
 
Tissue specificity of Pim1 is wide spread, with PIm1 occurring in hematopoietic cells, 
lymphoid cells, prostate, testis, thymus, and bone marrow. Regulation of Pim1 
activity occurs at transcriptional, post transcriptional, translational and post 
translational levels but is predominantly transcriptional. Pim1 activity correlates with 
its protein levels (Zhu, Ramirez et al. 2002). Physiologically Pim1 is implicated in the 
proliferation and survival of cells (Wang, Bhattacharya et al. 2001; Wang, 
Bhattacharya et al. 2002). Expression of Pim1 is induced by cytokines, mitogens, 
and growth factors (Bachmann and Moroy 2005). Pim1, 2 and 3 deficient mice 
exhibit reduced body size at birth and during the postnatal period (Mikkers, Nawijn et 
al. 2004). Transgenic mice over expressing Pim1 become more susceptible to tumor 
incidence, carcinogens and MoMuLV induced lymphomagenesis (Domen, van der 
Lugt et al. 1993). Activation of Pim1 is co-operative with the oncogene c-myc (van 
Lohuizen, Verbeek et al. 1989). Double transgenic mice over expressing both Pim1 
and c-myc display pre-B-cell leukemia in utero (Verbeek, van Lohuizen et al. 1991).  
 
Abberant over expression of Pim1 is associated with human lymphomas, acute 
leukemia, and neoplastic prostate cancer (Amson, Sigaux et al. 1989; 
Dhanasekaran, Barrette et al. 2001). Furthermore Pim1 over expression due to 
chromosomal translocation occurs in the common form of non-Hodgkin‘s lymphoma 
known as diffuse large cell lymphoma (DLCL) (Akasaka, Akasaka et al. 2000). 
Aberrant somatic hypermutations associated with Pim1 have also been identified in 
DLCL (Pasqualucci, Neumeister et al. 2001).  
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PAK5 
p21-activated kinase 5 (PAK5) is a member of the PAK family of Ser/Thr kinases 
which are catagorised under the STE group. PAKs are downstream effectors of the 
small GTPases Cdc42 and Rac1. Six isoforms constitute the PAK family and are 
classified into group 1 (PAK1, 2, 3) and 2 (PAK 4, 5, 6) based on their domain 
architecture and regulation. Both groups feature a C-terminal KD, a central domain 
containing Proline-rich motifs which act as docking sites for SH3 domain containing 
proteins, and a N-terminal regulatory domain (RD) composed of a p21-binding 
domain (PBD) also known as Cdc42/Rac1 interactive binding domain (CRIB). Group 
1 members have an additional autoinhibitory domain (AID) that overlaps the PBD 
and require GTP•Cdc42/Rac1 binding to the PDB/CRIB to relieve inhibition and 
initiate activation. In contrast group 2 PAKs are constitutively active and do not 
require GTP•Cdc42/Rac1 binding (Jaffer and Chernoff 2002; Wells and Jones 2010). 
Instead binding of small GTPases regulates their subcellular localisation (Abo, Qu et 
al. 1998). Group 2 PAKs express a high level of domain plasticity and experience 
many conformational changes during catalysis suggesting that their mechanism of 
transition from a catalytically non-productive to productive conformation is different 
from group 1 members (Eswaran, Lee et al. 2007). 
 
PAK5 was first identified from an RT-PCR screen using degenerate primers based 
on PAK4 and found to express predominantly in the brain as an 80 kDa protein. The 
KD features a Ste20 motif that is highly conserved in all Ste20 kinases. PAK5 is 
closely related to its other group II members, showing 85 % and 80 % sequence 
identity with PAK4 and PAK6 respectively but only about 50 % sequence identity 
with group I members. Unlike group I PAKs which bind both GTP-Cdc42/Rac1, 
PAK5 can only bind to GTP-Cdc42 (Pandey, Dan et al. 2002). Similarly PAK4 
preferentially binds GTP-Cdc42 but only weakly to Rac1 (Abo, Qu et al. 1998). 
Interestingly although PAK5 is constitutively active it is reported to contain an AID in 
the N-terminal domain (Ching, Leong et al. 2003).  
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Physiologically the PAK kinases are implicated in cell motility, morphology, cell 
survival, hormone signalling, and gene transcription (Wells and Jones 2010). Current 
evidence suggests that PAK5 is implicated in cell survival and neurite extension. 
Localisation of PAK5 to the mitochondria from the nucleus and its activatiion of anti-
apoptotic pathways involving Raf1 and BAD promote cell survival (Cotteret, Jaffer et 
al. 2003; Cotteret and Chernoff 2006; Wu, Carr et al. 2008). Over expression of 
PAK5 in neuronal cells promote neurite outgrowth (Dan, Nath et al. 2002).  
 
CSNK1G3 
Casein kinase 1 γ isoform 3 (CSNK1G3) is one of 7 known human isoforms that 
constitute the Casein kinase 1 (CK1) family of Ser/Thr kinases. CSNK1G3 is 51 kDa 
in size and is the largest CK1 isoform. CK1 kinases are monomeric and constitutively 
active and highly conserved across the kinase catalytic domain. They possess 
variable N-terminal and C-terminal domains. CK1 kinases phosphorylate a wide 
spectrum of substrate targets that include for example transcription factors, splice 
factors, translation factors, cytoskeletal proteins, and vesicle associated proteins 
(Knippschild, Gocht et al. 2005). Splice variants of the CK1 isoforms result in the 
modulation of their activities, subcellular localisation, function, and biochemical 
properties. The rat homolog of CSNK1G3 is highly expressed in brain, heart, liver, 
kidney, and lung (Zhai, Graves et al. 1995). In kidney cancer cells the activity of CK1 
γ isoforms is elevated (Elias, Li et al. 1981).  
 
CK1 kinases have a substrate consensus sequence that to some extent requires a 
priming phosphorylation step involving another kinase phopsphorylating a Ser/Thr 
near the substrate consensus sequence (Flotow, Graves et al. 1990; Meggio, Perich 
et al. 1991; Meggio, Perich et al. 1992). CSNK1G3 has a large regulatory C-terminal 
domain that features an inhibitory domain. Autophosphorylation of the inhibitory 
domain results in autoinhibition via a pseudosubstrate mechanism (Graves, Haas et 
al. 1993; Fish, Cegielska et al. 1995; Graves and Roach 1995; Zhai, Graves et al. 
1995; Longenecker, Roach et al. 1998). Truncation of the C-terminal domain 
increases kinase activity (Carmel, Leichus et al. 1994; Zhai, Graves et al. 1995). A 
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CK1 kinase inhibited homodimer model has been postulated (Longenecker, Roach 
et al. 1998). Another described mechanism of regulating the constitutively active 
CK1 kinases involves changing its subcellular localisation and compartmentalisation 
(Ho, Mason et al. 1997).  
 
multifunctional or restricted. Multifunctional types exhibit broad substrate specificity 
and include CaMKK, CaMK1, CaMK2, and CaMK4. Restricted types exhibit single 
substrate specificity and include CaMK3 (also known as eEF-2K, or elongation factor 
2), myosin-light chain kinase (MLCK), and phoshorylase kinase (Hook and Means 
2001; Soderling and Stull 2001).  
 
With the exception of CaMK3, all CaMK family members a share similar domain 
organisation (Figure 1.6), comprising of an N-terminal catalytic KD followed by a C-
terminal RD which maintains the kinase in an autoinhibited and inactive state via the 
AID component. A calmodulin binding domain (CBD) overlaps the C-terminal end of 
the AID. CaMK2 and phosphorylase kinase feature an additional association domain 
(AD) C-terminal of RD which enables multimerization. All CaMK members regulated 
by the RD are activated by the binding of Ca2+/Calmodulin (Ca2+/CaM) to the CBD 
which relieves autoinhibition and exposes the substrate binding site and activates 
the catalytic KD. Once activated CaMKs can phosphorylate Ser/Thr residues in 
protein substrates to alter their functionality (Hook and Means 2001; Soderling and 
Stull 2001).  
 
Some CaMKs are further regulated by phosphorylation within their activation loop by 
another upstream CaMK. For example CaMKK can phosphorylate CaMK1 and 
CaMK4. Both CaMK2 and CaMK4 are capable of autophosphorylation after 
Ca2+/CaM dependent activation. CaMK2 autophosphorylation can occur at two sites 
within the AID. Depending on which site and the sequential order of 
autophosphorylation, CaMK2 can undergo autonomous activity or inhibition (Figure 
1.7). Likewise CaMK4 exhibits Ca2+/CaM independent activity if autophosphorylation 
occurs within the N-terminus. If autophosphorylation is within the AID then this 
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causes CaMKIV inhibition. Phosphorylation can therefore lead to activation and  
inactivation (Swulius and Waxham 2008).  
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Figure 1.6. Domain organisation of the CaMK family.  
A common feature for all the members of the CaMK family except for CaMK3 is a C-
termina regulatory domain comprised of the AID which imparts autoinhibition on the 
kinase, and the CBD whic relieves autoinhibition upon Ca2+/CaM binding. The KD of 
CaMK3 lacks sequence homology to the conserved eukaryotic KD and its 12 
conserved subdomains and is defined as the αKD (Swulius and Waxham 2008). 
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Figure 1.7. Domain organisation of CaMK2 subfamily members.  
Amongst the CaMK2 isoforms the linker region between the CBD and the AD 
exhibits the most sequence diversity as a result of splice variants. CaMK2 regulation 
is also modulated by autophosphorylation in the AID or CBD, an intermolercular 
event that occurs within the same oligomeric holoenzyme dependent on the 
association domain. Both the activating and substrate CaMK2 require Ca2+/CaM. 
Autophosphorylation of T286/287 site enables autonomous activity by permitting 
Ca2+ independence dubbed CaM trapping. Conversely autophosphorylation of 
T305/306/307 is inhibitory, abolishing Ca2+/CaM binding. 
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 (Figure 1.8). Sequence diversity is most evident in the C-terminal stretch of residues 
after the RD. In CaMK1A (also known as CaMK1 because it was the first CaMK1 
studied), CaMK1B (also known as PncK) and CaMK1D isoforms, this stretch 
comprises of 30-60 C-terminal residues of unknown function. However, with 
CaMK1G (also known as CLICK-III) the C-terminal stretch of residues extends 92 
residues after AID and terminates with a CAAX (where C is Cys, A is any aliphatic 
residue, and X is any residue) motif. Prenylation occurs on this motif and mediates 
CaMK1G targeting to the membranes of the sarcoplasmic reticulum and golgi 
(Takemoto-Kimura, Terai et al. 2003). Initial activation of CaMK1 members requires 
Ca2+/CaM and maximal activity requires phosphorylation of a Thr residue within the 
activation loop that is mediated by CaMKK. The latter process requires the binding of 
Ca2+/CaM to both CaMKI and the upstream CaMKK (Haribabu, Hook et al. 1995). 
 
CaMK1D 
Calcium calmodulin dependent protein kinase I δ (CaMK1D) is a 43 kDa Ser/Thr 
protein kinase that belongs to the CaMK1 subfamily from the CaMK family consisting 
of four isoforms (α, β, γ, δ) which are expressed from four different genes and can 
produce splice variants.  all exhibit the canonical domain organisation of the CaMK 
family. CaMK1D was originally isolated from a HeLa cDNA library and found to share 
80% sequence identity with CaMK1A (Ishikawa, Tokumitsu et al. 2003). A splice of 
CaMK1D dubbed CKLiK variant atory domains of both are identical in sequence 
showing diversity only after Leu 348 of CaMK1D. Therefore CKLiK is believed to be 
a splice variant of CaMK1D (Ishikawa, Tokumitsu et al. 2003). CKLiK is a 
granulocyte specific kinase (Verploegen, Lammers et al. 2000; Verploegen, Ulfman 
et al. 2005)  
Expression of CaMK1D is widespread in other tissues including brain, liver, 
pancreas, spleen, thymus, prostate, testis, ovary, and colon (Ishikawa, Tokumitsu et 
al. 2003). CKLiK is specifically expressed in polymorphonuclear leukocytes including 
neutrophilic and eosinophilic granulocytes (Verploegen, Lammers et al. 2000). 
CaMK1B exhibits similar tissue specificity to CaMK1D, whereas CaMK1G 
expression   appears highest in neurons but is low in skeletal muscle, kidney, liver 
and spleen. In contrast CaMK1A expression is ubiquitous. Heterogeneous 
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expression of CaMKI isoforms occurs in different parts of the brain (Haribabu, Hook 
et al. 1995; Takemoto-Kimura, Terai et al. 2003; Colomer and Means 2007). CaMKI 
isoforms are predominantly cytosolic. Although mouse CaMKI homologs and splice 
variants demonstrate translocation to the nucleus after cell stimulation (Ueda, 
Sakagami et al. 1999; Rina, Jusuf et al. 2001; Sakagami, Kamata et al. 2005).  
 
In neurons CaMK1D exhibits a two-fold increase in translocation following neuron 
activation with Ca2+ mobilizing stimuli. CaMK1D nuclear translocation is dependent 
on its activation because two inactive forms of CaMK1D, K52A and T180A abolish 
translocation. K52A renders CaMK1D catalytically inactive within the ATP binding 
site whereas T180A prevents activation loop phosphorylation by CaMKK. 
Furthermore nuclear translocation of CaMK1D is blocked in stimulated neurons 
preincubated with STO-609, a CaMKK inhibitor (Sakagami, Kamata et al. 2005). 
Interestingly a constitutively active construct of CKLiK identical in sequence to the 
CaMK1D kinase catalytic domain demonstrates localisation to the nucleus 
(Verploegen, Lammers et al. 2000). 
 
Activation of CaMKI members requires Ca2+/CaM and enhanced activity requires 
activation loop phosphorylation by CaMKK. Ishikawa et al assessed the activity of 
fully active CaMK1D in vitro by incubating CaMK1D with CaMKK and Ca2+/CaM and 
found CaMK1D to be active. Activation of CaMK1D by Ca2+/CaM alone produces 30-
fold less activity due to the absence of Thr 180 phosphorylation mediated by 
CaMKK. Furthermore CaMK1D could not be phosphorylated by either CaMKKα or 
the autonomously active isoform CaMKKβ3 in the absence of Ca2+/CaM. This 
suggested that the activation loop is not accessible to CaMKKs unless Ca2+/CaM is 
present (Ishikawa, Tokumitsu et al. 2003). CaMK1D can also be activated using 
HeLa cell extract suggesting that CaMKK is expressed in the extract. A GST-
CaMK1D fusion exhibited Ca2+/CaM dependent autophosphorylation but curiously 
had no impact on CaMk1D activity (Ishikawa, Tokumitsu et al. 2003). Evidence of 
CaMKI activation loop autophosphorylation or autophosphorylation of another 
residue was lacking but may have occurred on GST or on an unidentified residue 
that does not directly modulate CaMK1D activity.  
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In further experiments, an increase in the intracellular Ca2+ concentration was 
induced with inomycin and produced a 1.5-fold increase in CaMK1D activity in HeLa 
cells compared to the absence of inomycin. Their data suggested that CaMK1D in 
HeLa cells exhibit high activity even without increasing the intracellular Ca2+ 
concentration. A high level of sustained CaMK1D activity was presumed to be due to 
the upstream activating CaMKK even at resting Ca2+ concentrations. Consequently 
CaMK1D activity in resting HeLa cells was found to be reduced when the CaMKK 
inhibitor STO-609 was applied. In summary the HeLa cells contained CaMKK that 
could activate CaMK1D in both the presence and absence of inomycin and that 
sustained CaMK1D activity was due in part to the Ca2+ independent activity of 
CaMKK (Ishikawa, Tokumitsu et al. 2003). Interestingly Ca2+ independent activation 
of CaMKIs is demonstrated in human T lymphocyte cells under conditions of 
oxidative stress suggesting a novel mechanism of CaMK1 activation (Howe, LaHair 
et al. 2002). 
 
CaMK1D and other CaMK1 iosforms are currently not well characterised in terms of 
their biological role but in vitro studies have shown CaMK1 activity towards 
substrates such as CREB (cyclic AMP response element binding protein 1), 
synapsin, cystic fibrosis transmembrane regulator (CFTR), and eukaryotic translation 
initiation factor 4 gamma 2 (eIF4GII). Perhaps the best characterised and 
physiologically relevant substrates are CREB and eIF4GII (Picciotto, Cohn et al. 
1992; Picciotto, Czernik et al. 1993; Sun, Lou et al. 1996; Qin, Raught et al. 2003). 
CKLiK is better characterised and shown to be expressed in human 
polymorphonuclear leukocytes (PMNs) that include neutrophilic and eosinophilic 
granulocytes. PMNs are implicated in defending the host from foreign invading 
microorganisms, damaged cells and cellular debris. During inflammation, PMNs are 
recruited to the site of inflammation through the release of chemokines at the site of 
inflammation and upon activation PMNs mediate functions such as phagocytosis. 
CKLiK is therefore proposed to play a major role in signalling such cellular responses 
in PMNs (Verploegen, Lammers et al. 2000; Verploegen, Ulfman et al. 2005). 
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CaMK1G 
Calcium calmodulin dependent protein kinase I γ (CaMK1G) is the largest isoform of 
the CaMK1 subfamily and was first identified in a screen for novel putative CaMK-
like CREB kinases (CLICKs) using degenerate PCR strategies and subsequently 
showed high sequence homology to CLICK I and II (Takemoto-Kimura, Terai et al. 
2003). In vivo studies demonstrate that CaMK1G has the ability to anchor to the 
golgi and plasma membrane in a CAAX motif and prenylation dependent manner. 
Mutagenesis of the CAAX motif Cys prenylation site abolished the recruitment of 
CaMK1G to the golgi and plasma membrane. Likewise reduction of prenylation via 
inhibition of HMG-CoA produced a similar effect (Takemoto-Kimura, Terai et al. 
2003). CaMK1G mRNA transcripts express predominantly in the brain with lower 
amounts evident in skeletal muscle, spleen, liver and kidney. Furthermore 
expression is particularly high in neurons with CaMK1G implicated in dendrite 
formation via lipid raft association. Actin polymerisation is also promoted by 
CaMK1G via downstream activation of the MEK/erk pathway (Takemoto-Kimura, 
Terai et al. 2003; Takemoto-Kimura, Ageta-Ishihara et al. 2007) 
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Figure 1.8. CaMK1 domain organisation. 
This schematic illustrates the domain organisation of the CaMK1 subfamily 
members. They consist of a KD and C-terminal RD composed of the AID and 
overlapping CBD. Additional C-terminal residues after the RD are undefined in terms 
of function except in CaMK1G, which features a CAAX motif for membrane targeting. 
Ca2+/CaM binding to the CBD relieves autoinhibition. Further activation can follow via 
activation loop phosphorylation by CaMKK as indicated by the phosphorylated 
residues.  
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Figure 1.9. Sequence alignment of CaMK1 isoforms. 
The KD and RD of the CaMK1 isoforms show high sequence homology. Non-
homologous regions arise mainly in the C-terminal end after the RD. Conserved 
residues, partially conserved, and similar residues are coloured in red, yellow and 
green respectively. The alignment and was generated using ClustalW (Thompson, 
Higgins et al. 1994), whilst colouring was done using TEXSHADE (Beitz 2000) from 
the biology workbench software (Subramaniam 1998). The gray, brown, and blue 
bars above the sequence alignment correspond to the KD, regulatory AID, and CBD 
respectively. Important loop regions such as the p-loop, hinge, catalytic loop, and 
activation loop are shown by the denoted by text whilst the illustrated secondary 
structure elements correspond to CaMK1D determined from its crystal structure 
(PDB: 2JC6). The arrow denotes the activating phosphorylation site. 
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The CaMK cascade 
CaMKK can modulate the activities of CaMK1, and CaMK4 via phosphorylation. 
These multifunctional CaMKs constitute the CaMK cascade, with CaMKK as the 
upstream kinase component. CaMKK can promote maximal activity and modulation 
of substrate specificity and affinity of CaMK1 and CaMK4 provided all CaMK 
cascade members are already Ca2+/CaM activated. It is postulated that the activation 
loop of CaMK1s and CaMK4s is only accessible to CaMKK when bound to 
Ca2+/CaM (Soderling 1999; Means 2000; Means 2008). The CaMK cascade is a 
physiological Ca2+/CaM dependent signalling cascade that is involved in many 
cellular processes. Established findings indicate that the cascade exhibits cross talk 
with other kinases (Figure 1.10). For example, CaMKK can also interact with PKA, 
PKB, and AMPK. PKA inhibits CaMKK whilst CaMKK can active PKB and AMPK, 
suggesting that the CaMK cascade is implicated in regulating cell survival and levels 
cellular ATP. Also illustrated is the indirect activation of MAPKs such as ERK, JNK 
and p38 mediated by CaMKIV (Soderling 1999; Means 2000; Means 2008). 
Physiological substrates of CaMKI are not well characterised due to limited evidence 
and uncertainty associated with its translocation to the nucleus, although studies 
suggest CaMK1 interacts with CREB, a substrate that is also common to CaMK4. A 
more detailed introduction to CaMKK, CaMK1, and CaMK4 is discussed in their 
respective sections with particular emphasis on CaMK1 as the bulk of this thesis 
focuses on the CaMK1D isoform. 
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Figure 1.10. The CaMK cascade and putative signalling pathways. 
The CaMK cascade is implicated in many signalling pathways and cellular processes 
such as gene expression but in this simplified schematic only a few of the best 
characterised examples are illustrated. For example it is shown that CaMKK can also 
activate PKB and AMPK in addition to its CaMK cascade members. CaMK1 resides 
predominantly within the cytosol although limited evidence suggests CaMK1 might 
translocate to the nucleus. With CaMKK and CaMK4 it is well established that both 
localise in the cytosol and nucleus. Blue arrows represent activation/phosphorylation, 
purple represents indirect activation, red represents inhibition, yellow represents 
translocation, and black represents formation/conversion. 
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CaMKK 
Calcium calmodulin dependent protein kinase kinase, also known as CaMKK is a 
monomeric 55-65kDa protein kinase that exists as two isoforms (Figure 1.11), 
CaMKKα and CaMKKβ (Tokumitsu, Enslen et al. 1995; Kitani, Okuno et al. 1997; 
Anderson, Means et al. 1998). CaMKK isoforms are expressed from different genes 
with CaMKKα and CaMKKβ comprised of 505 and 587 residues respectively. 
CaMKKβ can also produce splice variants depending on the cell type. One unique 
splice variant in Hela cells exhibits Ca2+/CaM independent activity completely (Hsu 
2001(Ishikawa, Tokumitsu et al. 2003). In addition to regulation via the AID and 
Ca2+/CaM, CaMKK is inhibited by PKA mediated phosphorylation at ser 458 of 
CaMKKα and ser 495 of CaMKKβ, a mechanism of inhibition equivalent to CaMK2 
(Wayman, Tokumitsu et al. 1997; Matsushita and Nairn 1999). CaMKK contains a 
putative phosphorylation site in its activation loop and it is speculated that an 
upstream kinase yet to be identified might active CaMKK. Curiously CaMKK can 
autophosphorylate but without any effect on catalytic activity. Differences between 
the two CaMKK isoforms arise in the N-terminal region in which CaMKKβ features an 
N-terminal 23 residue sequence (residues 129-151) that imparts Ca2+/CaM 
independent activity after activation by Ca2+/CaM. This enables autonomous activity 
beyond transient increases in Ca2+ concentration (Tokumitsu, Iwabu et al. 2001). 
Both CaMK2 and CaMK4 are also capable of autonomous activity although via 
different mechanisms involving autophosphorylation. 
  
Notably the KD of CaMKK lacks conserved acidic residues from subdomains V and 
VI which are generally required for the recognition of basic residues near the 
phosphorylation site of substrates. Instead CaMKK contains an Arg, Pro, rich 
insertion (RP insert) located between subdomain II and III. This insert allows CaMKK 
recognition of CaMK1s and CaMK4s. Deletion of the insert abolishes the ability of 
CaMKK to phosphorylate CaMKIs and CaMKIVs but not protein kinase B (PKB) 
(Tokumitsu, Takahashi et al. 1999). Despite deletion of the RP insert, CaMKK 
activity is retained against PKB and involves different substrate recognition 
determinants with PKB compared to CaMK1 and CaMK4. Generally kinase 
recognition of substrates is dependent on the primary sequence around the 
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phosphorylation site. However, with CaMKK, the tertiary structure of its substrate 
appears to be paramount because it cannot phosphorylate unfolded CaMK1s and 
CaMK4 (Hook and Means 2001). 
 
CaMKK is expressed mainly in the brain, neurons, thymus, testis, and spleen. On a 
cellular level CaMKK localises in both the cytosol and nucleus (Nakamura, Okuno et 
al. 1996; Sakagami, Saito et al. 1998) sakagami). Expression of CaMKK seems to 
parallel CaMK4 unlike CaMK1 which is more broadly expressed. It is suggested that 
in cell types where CaMKK is not expressed, CaMK1 may exhibit substrate 
recognition that is independent of its activation by CaMKK or there are further 
isoforms of CaMKK yet to be identified. Over expression studies of CaMKK show an 
increase in CaMK1 and CaMK4 activity coupled with an increase in CREB mediated 
transcription. This correlates positively with evidence of CaMK4 residing within the 
nucleus. However CaMK1 localises predominantly in the cytosol. Evidence of 
CaMK1 residing in the nucleus is limited. Examples of CaMK1 nuclear localisation 
are discussed in the following CaMK1 section. Thus the mechanism in which CaMK1 
phosphorylates CREB remains unresolved. 
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Figure 1.11. CaMKK domain organisation.  
Two main isoforms of CaMKK both possess a canonical KD followed by a C-terminal 
RD representative of the CaMK family. CaMKK activation occurs through Ca2+/CaM 
binding to the CBD. An active splice variant independent of Ca2+/CaM also exists. 
CaMMKβ contains additional stretch of N-terminal residues (orange) that facilitates 
Ca2+/CaM independent activity after Ca2+/CaM activation. Inhibitory phosphorylation 
sites are indicated within the RD (Swulius and Waxham 2008).  
 
 
 
 
 
 
 
 
 
 54 
 
CaMK4 
Another member of the CaMK cascade is CaMK4, which is expressed as two 
isoforms from a single gene. Both CaMK4α and β isoforms are monomeric with 
molecular weights of 65 and 67 kDa respectively. CaMKIVβ is larger due to an 
additional 28 N-terminal residues (Figure 1.12). Like all CaMKs, the CaMK4s are 
activated by Ca2+/CaM but possess a second activation step analogous to CaMK1s. 
Maximal activation occurs in a Ca2+/CaM dependent manner when CaMK4s are 
phosphorylated within their activation loop by CaMKK. In contrast to CaMK1s 
maximally activated CaMK4 can then undergo autophosphorylation of its N-terminus 
at residues Ser 12 and 13 enabling Ca2+/CaM independent activity. Mutatagenesis of 
these phosphorylation sites abolish activation by CaMKK but deletion of 20 N-
terminal residues permits activation by CaMKK. The N-terminal region is suspected 
to function as a secondary AID that is relieved upon phosphorylation or truncation 
(Hook and Means 2001). Additional regulation can occur with autophosphorylation 
occurring on a Ser within the AID that prevents Ca2+/CaM binding and activation. 
This inhibitory mechanism is comparable with CaMKK and CaMK2. 
Dephosphorylation of CaMK4s is mediated by protein phosphatase 2A (PP2A).  
 
CaMK4 is predominantly expressed in the brain but is also expressed in 
hematopoietic stem cells, progenitor T cells, testis, and the ovaries (Hook and 
Means 2001). Within the cell CaMK4 resides in the cytosol and nucleus but 
information about its targets within the cytosol is limited (Jensen, Ohmstede et al. 
1991). Contrastingly, CaMK4 nuclear substrates are better characterised. For 
example it is well established that CaMK4 is involved in Ca2+ dependent gene 
transcription and demonstrates activity towards CREB and CREB binding protein 
(CBP) (Enslen, Sun et al. 1994; Matthews, Guthrie et al. 1994). Other transcription 
factors that CaMK4 can phosphorylate include serum response factor (SRF) and 
histone deactylase 4 (HDAC4). 
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Figure 1.12. CaMK4 domain organisation.  
CaMK4 isoforms feature a KD adjacent to a C-terminal RD characteristic of CaMKs. 
In the RD an inhibitory phosphorylation site prevents Ca2+/CaM binding therefore 
down regulating activity whereas activation loop phosphorylation promotes activity. 
CaMKIVβ activation loop phosphorylation leads to autophosphorylation within the N-
terminus and results in Ca2+/CaM independent activity (Swulius and Waxham 2008). 
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The autoinhibitory domain 
All CaMK1 members are maintained in an inactive state due to the regulatory AID. 
The domain boundaries of the AID and the overlapping CBD for CaMKIs were first 
defined through serial C-terminal truncations of CaMK1A which decreased the ability 
of CaMK1A to bind to Ca2+/CaM and decreased Ca2+/CaM dependent activity (Hook 
and Means 2001). Deletion analysis beyond the CBD boundary up to residue Phe 
298 (CaMK1A_1-298), revealed that this construct was still autoinhibited, however 
an additional single residue truncation of Phe 298 up to Asn 297 (CaMK1A1-297), 
generated a constitutively active construct, thereby suggesting the importance of 
Phe 298 in mediating autoinhibition (Hook and Means 2001). Although this construct 
exhibited Ca2+/CaM independent activity it was reported to be only 70% active in 
comparison to the activated wild type CaMK1A suggesting that residues N-terminal 
of Asn 297 remained that could potentially exert an autoinhibitory effect. Similarly 
truncation of another construct up to Val 294 was also found to be constitutively 
active (Hook and Means 2001). However, in the context of full length CaMK1A, 
mutagenesis of Phe 298, and Val 294 to Ala only resulted in a small increase in 
basal levels of Ca2+/CaM independent activity, thus implying the role of other 
residues mediating autoinhibitory contacts. For example, Phe 307 was found to 
impart an autoinhibitory effect because mutagenesis of this residue to Ala resulted in 
Ca2+/CaM independent activity that was 30% active in comparison to the activated 
wild type (Hook and Means 2001).  
 
The pseudosubstrate hypothesis 
The general model for the autoinhibition of CaMK family members was based on a 
pseudosubstrate hypothesis derived from the observation that Myosin light chain 
kinase (MYLK) possessed a sequence within its AID with similarity to the recognition 
motif in its substrate Myosin light chain. From the pseudosubstrate hypothesis, it was 
postulated that in the absence of Ca2+/CaM, the AID would occupy the substrate 
binding site. Upon cleavage of the AID, MYLK was found to exhibit Ca2+/CaM 
independent activity (Kemp, Pearson et al. 1987; Pearson, Wettenhall et al. 1988). 
Autoinhibition of MLCK was restored upon addition of a peptide corresponding to the 
AID of MYLK. This peptide could also bind to Ca2+/CaM thus reinforcing the concept 
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of an overlapping AID and CBD within the regulatory domain. Other evidence 
consistent with the pseudosubstrate hypothesis was exemplified by the crystal 
structure of Twitchin, which had a 60 residue AID segment comprised of a helix and 
loop that blocked the substrate binding site and active site (Hu, Parker et al. 1994).   
 
In the context of CaMK1s, Yokokura et al demonstrated that a peptide corresponding 
to the AID of CaMK1A could competitively inhibit CaMK1A with respect to Ca2+/CaM. 
Similarly a constitutively active CaMK1A construct was also inhibited by the peptide 
AID and showed competitive inhibition with respect to the substrate peptide syntide-2 
but was non-competitive with ATP, thus implying that the peptide AID bound to the 
substrate binding site of the constitutively active CaMK1A. Sequence analysis and 
alignment of the CaMK1A AID and CaMK1A substrates such as synapsin-1, syntide-
2, and CREB reveals key basic and hydrophobic residues within the AID that satisfy 
the substrate consensus sequence of CaMK1s of Hyd-X-R-X-X-S/T-X-X-X-Hyd 
(where Hyd is any hydrophobic residue and X is any residue). Collectively the results 
suggested that CaMK1A was regulated by a pseudosubstrate mechanism 
(Yokokura, Picciotto et al. 1995). 
 
Prior to the first structure determination of a CaMK1 member, it was presumed that 
the pseudosubstrate model of autoinhibition observed in other CaMKs held true for 
CaMK1s, however the structural basis for CaMK1 autoinhibition was not as simple 
as this.  Back in 1996 the first apo CaMK1 structure to be solved was the rat form of 
CaMK1A, a construct which included the kinase catalytic domain and the AID 
(Goldberg, Nairn et al. 1996).  Autoinhibited rat CaMK1A exhibited the typical bilobal 
kinase fold comprising of an N-terminal β-sheet lobe and a larger C-terminal α-
helical lobe and significantly revealed the structure of the AID to be composed of a 
helix-loop-helix segment that folded over both the C-terminal and N-terminal lobes 
(Figure 1.13). The first and second helices of the AID were designated as αR1 and 
αR2 respectively and shown to mediate CaMK1A autoinhibition through distinct 
mechanisms. Helix αR1 and some parts of the AID loop occupy and occlude the 
substrate binding site through intramolecular interactions characteristic of a 
pseudosubstrate mechanism.  
 58 
 
This pseudosubstrate interaction is mainly driven by hydrophobic packing with 
residues from α helix D. Notably near the C-terminal end of helix αR1 the side chain 
of Phe 298 which mimics the P-5 position, appears buried inside a hydrophobic 
pocket formed by Phe 104, Ile 210, and Pro-216 within the substrate binding site. N-
terminal of Phe 298, further extensive hydrophobic packing is evident with helix αR1 
residues Ile 286, Val 290, and Ile 294, all packing against a hydrophobic interface 
from the C-terminal lobe of the kinase catalytic domain (Goldberg, Nairn et al. 1996). 
Interestingly these autoinhibitory contacts mediated by Ile 286, Val 290, and Val 294 
have been mutated by Matsushita and co-workers which resulted in an increased 
basal level of Ca2+/CaM independent activity (Matsushita and Nairn 1998). Although 
the pseudosubstrate contacts in CaMK1A are predominantly hydrophobic, 
electrostatic interactions are also evident. The electrostatic contribution to the 
pseudosubstrate mechanism is mediated by Lys 300, a residue located in the loop 
region of the helix-loop-helix segment. This residue interacts with Glu 102 most likely 
by mimicking the P-3 position because mutation of Glu 102 reportedly alters the P-3 
specificity of CaMK1A (Goldberg, Nairn et al. 1996).  
 
The first mechanism of autoinhibtion described in CaMK1A satisfies the 
pseudosubstrate hypothesis that was predicted to occur in CaMK1s. A second 
mechanism is also exemplified in CaMK1A by the latter part of the AID which imparts 
additional autoinhibitiory effects beyond the substrate binding site of the C-terminal 
lobe. Notably helix αR2 forms autoinhibitory interactions with the N-terminal ATP 
binding lobe resulting in the disruption of its conformation and ability to bind ATP. 
This intramolecular interaction is mediated by hydrophobic contacts between 
hydrophobic residues that span helix αR2 and the interacting interface on the N-
terminal lobe. Residues from helix αR2 which are implicated in this include Ala 306, 
Phe 307, Ala 309, Ala 312, Val 313, and Met 316, whilst those which contribute to 
the N-terminal lobe hydrophobic interface include Leu 26, Gly 27, Phe 31, Leu 36, 
Leu 45, Leu 97, Ser 99, and Gly 101 (Goldberg, Nairn et al. 1996).  
 
Due to the interactions between helix αR2 and the N-terminal ATP binding lobe, 
conformational changes occur within the ATP binding loop (also known as the p-
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loop) associated with the N-terminal lobe. One notable localised contribution to this 
is attributed to a conserved Phe 31 within the respective loop which engages in van 
der vaal interactions with Phe 307 from helix αR2. Structural comparison of this loop 
region in autoinhibited CaMK1A with active PKA indicates that the side chain of Phe 
31 occludes the position normally occupied by the ribose moiety of bound ATP as 
exemplified in PKA.  Phe 54, the equivalent residue in PKA functions to cap the β 
and γ phosphate groups of bound ATP from solvent exposure but due to the inactive 
conformation of the CaMK1A N-terminal lobe induced by helix αR2, Phe 31 is unable 
to facilitate this. Moreover, Phe 54 is part of a group of hydrophobic residues 
suggested to play a role in maintaining the active state of PKA that includes an 
active activation loop (Goldberg, Nairn et al. 1996). The AID thus mediates 
autoinhibition on CaMK1A and presumeably other CaMK1s by inducing the ATP 
binding site into an inactive open conformation and occludes substrate binding via 
the pseudosubstrate mechanism. 
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Figure 1.13. Surface and cartoon representation of the AID pseudosubstrate 
model in rCaMK1A.  
The AID (cyan) mediates autoinhibition of rat CaMK1A by occupying the substrate 
binding site in the C-terminal lobe (light gray) via the αR1 helix and by interacting 
with the N-terminal ATP binding lobe (dark gray) via the αR2 helix. The 
pseudosubstrate interactions are predominantly hydrophobic (orange). An 
electrostatic interaction in the AID loop is also highlighted between (blue) and red 
(red). The figure was adapted from the rat CaMK1A structure determined by 
Goldberg and co-workers (Goldberg, Nairn et al. 1996).  
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CaMK1s and Ca2+/CaM in the cell cycle  
Cell proliferation is associated with an increase in intracellular Ca2+ concentration 
and Ca2+/CaM is implicated in the cell cycle via the activation of downstream CaMKs 
(Kahl and Means 2003). The involvement of CaMK1s in cell cycle progression has 
been demonstrated in various studies. For example, treatment of fibroblasts 
expressing CaMK1 and CaMK2 with KN-93, a specific inhibitor of CaMK1, CaMK2, 
and CaMK4 caused cells to arrest in the late G1 phase, preventing activation of the 
cell cycle regulator cyclin D1/Cdk4 and phosphorylation of pRB. Both are necessary 
for cell cycle progression from G1 to S (synthesis) phase. A CaMK1 deficient cell line 
confirmed that cell cycle arrest was due to the inhibition and inactivation of CaMK1 
and not CaMK2. Moreover CaMK2 deficient cells did not arrest (Kahl and Means 
2003). Human or mouse cells cultured in media containing low Ca2+ concentrations 
cease cell division and accumulate in the G1 phase. CaM inhibitors W-7 and W-13 
inhibit proliferation and colony formation in breast cancer cells and other cell lines.  
 
CaMK1s in disease 
Deregulation of the cell cycle can result in uncontrolled cell proliferation and 
therefore cancer. Rodriguez-Mora et al using the tumorgenic breast cancer cell line 
MCF-7 tested the effects of CaMK inhibition on its cell cycle progression and 
proliferation. Results from this study indicated that CaMKK and CaMK1 are required 
for cell cycle progression in the MCF-7 cell line. In this case KN-93 inhibited MCF-7 
cell proliferation by arresting cells in the G1 phase but did not induce apoptosis. A 
similar result was acquired using CaMK1 siRNA and CaMKK siRNA. Interestingly 
expression levels of cyclin D1 exhibited reduced expression in MCF-7 following 
treatment with KN-93 suggesting that CaMK1 inhibition also causes an inhibition in 
cyclin D1 expression. The effect of CaMK1 inhibition on cell proliferation in the non-
turmogenic cell line MCF-10 showed a reduced inhibitory effect on cell proliferation 
in comparison to the tumorgenic MCF-7. This difference was accounted for in terms 
of the differential expression of CaMK1 between the cell lines, with expression of 
CaMK1 being greater in MCF-7 than MCF-10 (Rodriguez-Mora, LaHair et al. 2005; 
Rodriguez-Mora, Lahair et al. 2006).  
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The role of CaMKs in cancer also has been highlighted in endometrial carcinomas in 
which over expression of CaMK1, CaMK2, and CaMK4 was found to correlate with 
the malignant potential of endometrial carcinomas. Their results demonstrated that 
endometrial carcinomas treated with KN-93 induced cell cycle arrest and down 
regulated expression of cyclin D1 as exemplified in previous reports by Rodriguez-
Mora et al with MCF-7. Moreover it also induced apoptosis which correlated with the 
down regulation of the anti-apoptotic bcl-2 and up regulation of the pro-apoptotic 
caspase-3. Sub cellular localisation of CaMKI in endometrial carcinomas is 
predominantly cytosolic with some presence in the nucleus. 
 
Interestingly CaMK1D has been implicated in breast cancer (Bergamaschi, Kim et al. 
2008) in which it was found to be up regulated from a microarray of breast cancer 
tumors defined as a basal-like subtype. This cancer type exhibited an epithelial-
mesenchymal transition phenotype which is characterised by increased cell 
proliferation, loss of cell-cell adhesion, and increased migration and invasion 
indicative of metastasis. Engineered CaMK1D expression in the immortalised but 
non-turmorgenic cell line MCF-10A demonstrated increased cell growth versus the 
vector-alone control cells. In addition, CaMK1D increased the S phase fraction 
therefore suggesting increased cell cycle progression. Evidence of CaMK1D 
promoting metastasis was suggested from decreased expression levels of E-
cadherin and increased levels of Vimentin in the MCF-10A cell line. 
Imunofluorescence studies illustrated a positive correlation between the expression 
of CaMK1D and Vimentin in the cell line. Furthermore, a wound healing assay 
revealed that CaMK1D expression enhanced cell migration. 
 
Calcium signalling  
Ca2+ is one of the most important and widely used secondary messengers within the 
cell being implicated in many cellular processes such as cell cycle regulation, cell 
proliferation, apoptosis, gene expression, cell differentiation, muscle contraction and 
hormone signalling. However, Ca2+ is also highly toxic to the cell if the intracellular 
concentration is high and exposure is abnormally prolonged. Regulation of 
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intracellular Ca2+ concentrations is therefore essential for normal cellular function 
(Berridge, Bootman et al. 1998). The signalling effects of Ca2+ are mediated through 
controlled increases in its cytosolic concentration in a temporal and spatial manner. 
Cells utilise Ca2+ derived from the extracellular environment and from intracellular 
stores such as the endoplasmic reticulum, sarcoplasmic reticulum, mitochondria and 
perinuclear space (Berridge, Bootman et al. 1998). Typically the cytosolic Ca2+ 
concentration is kept low around 100 nM during the basal state of the cell to prevent 
constitutively aberrant signalling and to ensure that a Ca2+ concentration gradient is 
maintained across the cytosol and the intracellular and extracellular Ca2+ stores. 
ATPase transporters actively pump cytosolic Ca2+ into the extracellular and 
intracellular stores to maintain a Ca2+ concentration gradient. Exchangers and 
buffers also help maintain a low cytosolic Ca2+ concentration (Figure 1.14). Upon cell 
stimulation this gradient permits a rapid influx of Ca2+ into the cytosol whereby the 
cytosolic Ca2+ concentration can increase up to 1 – 2 µM (Clapham 2007). 
 
In excitable cell types like neurons and muscle, Ca2+ can enter the cell and into the 
cytosol from the extracellular store through voltage operated channels (VOCs or 
voltage gated channels) and receptor operated channels (ROCs or ligand gated  
channels). In non excitable cells, Ca2+ entry from the extracellular store is facilitated 
via store operated channels (SOCs), which are opened following the depletion of 
intracellular Ca2+ stores. Entry of Ca2+ from intracellular stores into the cytosol is 
mediated by activation of the IP3 and Ryanodine receptors. The IP3 receptor is 
activated by inositol 1,4,5 triphosphate (IP3) which is produced by Phospholipase C 
(PLC) as a cleavage product from phosphatidylinositol 4,5 bisphosphate (PIP2). 
Activation of PLC itself is mediated by the activation of upstream G-protein coupled 
receptors (GPCRs) or receptor tyrosine kinases (RTKs) by external stimuli such as 
growth factors or GPCR agonists (Figure 1.14).  
 
Activation of the Ryanodine receptor is mediated by an increase in the cytosolic Ca2+ 
concentration in a process known as Ca2+ induced Ca2+ release (CICR). 
Subsequently more Ca2+ is released via the Ryanodine receptor from the 
intracellular store into the cytosol which initiates a positive feedback response with 
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the Ryanodine receptor. Activation of the Ryanodine receptor is thus coupled to the 
activation of VOCs, ROCs, SOCs, and the IP3 receptor because these channels and 
receptors can mediate an increase in the cytosolic Ca2+ concentration. 
 
Influxes of Ca2+ into the cytosol occurs in transient aliquots described as sparks, 
waves, or puffs, depending on the intracellular area covered. Ca2+ waves can also 
occur in an intercellular manner as means of coordinating the signalling effect 
globally. Moreover cells can initiate repetitive Ca2+ signalling termed oscillations and 
by modulation of the amplitude and frequency of the Ca2+ oscillations it allows cells 
to encode diverse signalling information and therefore activate a variety of signalling 
responses. It has been reported for example that the expression efficiency and 
specificity of some genes are dependent on an optimal intracellular Ca2+ frequency 
(Dolmetsch, Xu et al. 1998). 
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Figure 1.14. Calcium signalling and concentration gradients.  
Upstream signalling events of GPCRs and RTKs can initiate downstream Ca2+ 
signalling. Transporters and exchangers help to maintain the concentration gradient 
(Clapham 2007). 
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Calmodulin 
Ca2+ secondary messenger effects are mediated through Ca2+ binding proteins that 
can either directly or indirectly initiate downstream signalling effects and cellular 
processes. Protein kinase C (PKC) for example is a direct mediator of Ca2+ signalling 
by binding to Ca2+ via its C2 domain. Indirect mediators of Ca2+ signalling include 
proteins that constitute the E-F hand motif family, a structural motif that enables Ca2+ 
binding. Generally there are two main types of the E-F hand motif proteins. One type 
binds to Ca2+ but do not undergo any significant conformational changes and are 
considered to function as Ca2+ buffers or transporters. The second type bind Ca2+ 
and experience conformational changes and are known as Ca2+ sensors. These 
sensor proteins couple Ca2+ signalling to many biological processes via modulation 
of downstream substrate proteins. 
 
One of the main decoders of Ca2+ signalling is calmodulin (CaM), a highly conserved 
and ubiquitous Ca2+ sensor protein with a molecular weight of approximately 17k Da. 
In a Ca2+ dependent manner is an allosteric activator of many proteins that possess 
the CBD. In terms of structure, CaM comprises of an N-terminal and C-terminal 
globular domain connected by a flexible helical linker with an overall fold that 
ressembles a dumbell (Figure 1.15). Each globular domain contains two E-F hand 
motifs that feature a helix-loop-helix motif and are capable of binding Ca2+.  In total 
CaM can bind up to four Ca2+ ions with one Ca2+ associated with each of the four E-
F hand motifs (Chin and Means 2000). Six to seven negatively charged oxygen 
atoms of the carbonyl and carboxyl groups within the motif coordinate Ca2+. 
 
The N-terminal Ca2+ binding sites are denoted as sites I and II, whilst the C-terminal 
sites are III and IV. Although the N-terminal and C-terminal globular domains are 
homologous, the C-terminal pair of E-F hand motifs have 10-fold higher affinity for 
Ca2+ (Hook and Means 2001). As a Ca2+ sensor protein, the affinity of CaM for Ca2+ 
is within the cytosolic concentration range (10-6M to 10-7M) thus enabling it to 
respond to the relevant changes in cytosolic Ca2+ concentrations. Ca2+ binding is a 
cooperative event. It has been suggested that Ca2+ might bind preferentially to site III 
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first. However, have also shown that Ca2+ binds to sites III and IV simultaneously 
(Hook and Means 2001).  
 
Upon transient increases in the intracellular Ca2+ concentration, Ca2+ binds to one of 
the CaM E-F hand motifs and causes the helices of the E-F hand motif to become 
pulled closer together. This Ca2+ induced conformational change initiates a 
cooperative binding event that is transduced through a β-sheet connected to the 
neighbouring E-F hand motif. Consequently there is an increase in its Ca2+ binding 
affinity (Hook and Means 2001). Subsequent binding of another Ca2+ ion at the 
neighbouring E-F hand motif causes both E-F hand motifs to pull further apart and 
induce the exposure of a hydrophobic pocket within the globular domain. This 
enables CaM to bind to the CBD of its substrate targets. Furthermore, the presence 
of a substrate target peptide can enhance the cooperative binding event whilst the 
presence of substrate proteins has also been reported to increase its affinity for Ca2+ 
by up to 10-fold (Peersen, Madsen et al. 1997).  
 
Global conformational changes also occur in which the helical content of CaM is 
increased. Most notably this involves the formation of an eight turn α helix denoted 
as helix IV (Chin and Means 2000; Hook and Means 2001) from the previously 
flexible linker connecting the globular domains of the CaM apo state. This helical 
linker facilitates the binding of CaM to many diverse substrates harbouring the CBD 
via its conformational plasticity. In the Ca2+ bound state, the globular domains adopt 
open conformations which results in the exposure of hydrophobic groups that form a 
hydrophobic crevice. Four conserved Met residues are contained within these 
hydrophobic crevices and contribute towards important interactions with substrates. 
Both the N-terminal and C-terminal crevices form a hydrophobic tunnel in which the 
CDB of substrates traverse. Generally the CBD region of substrates exhibits an 
amphipathic helix conformation that traverses the hydrophobic tunnel (Hook and 
Means 2001). Each of the globular domains can also adopt a different conformation 
in the absence of Ca2+ with the N-terminal domain forming a closed conformation 
whilst the C-terminal domain takes on a semi open conformation which results in the 
partial solvent exposure of a hydrophobic patch. It has been suggested that this 
 68 
 
enables CaM to interact with some substrate targets whilst in its apo state at resting 
Ca2+ concentrations (Swindells and Ikura 1996). CaM substrate targets are capable 
of exhibiting various binding modes with CaM. 
 
CaM binding proteins can be categorised into six groups according to their mode of 
regulation by CaM in the presence and absence of Ca2+ (Chin and Means 2000). 
One group are capable of binding to CaM irreversibly regardless of the Ca2+ 
concentration and are typified by phoshporylase kinase. A second group describes 
proteins that bind to CaM in the absence of Ca2+ but dissociate in the presence of 
Ca2+. Such proteins are exemplified by neuromodulin and neurogranin which are 
considered to function as intracellular reservoirs for CaM at the basal Ca2+ 
concentration until transient increases in the Ca2+ concentration causes the 
intracellular reservoir proteins to liberate Ca2+ bound CaM. A third group represents 
proteins that can interact weakly with apo CaM or CaM that is only partially bound to 
Ca2+ to form an inactive complex with CaM. However, upon an increasing Ca2+ 
concentration, the low affinity complex becomes a high affinity active complex as 
CaM becomes saturated with Ca2+. Some proteins that bind to Ca2+ saturated CaM 
form an inactive complex and this represents the forth group of CaM regulation. 
Proteins of this group include for example, GPCRs, and the IP3 receptor type 1. 
Conversely there are proteins that interact with Ca2+ saturated CaM and 
subsequently form an active high affinity complex as demonstrated by the CaMKs. 
This describes the most conventional CaM mode of regulation and is categorised as 
the fifth group. Lastly the sixth group of CaM regulated proteins describes those such 
as CaMKs which exhibit the same mode of regulation as the previous fifth group but 
also includes further indirect activation of the protein via phosphorylation by an 
upstream CaMK which is also activated by Ca2+ saturated CaM. In the case of 
CaMKII, phosphorylation is mediated by autophosphorylation upon Ca2+/CaM 
binding. 
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Figure 1.15. The structure of apo CaM and Ca2+ bound CaM.  
The cartoon structure of CaM is represented by α helices, loops, and β strands 
shown in red, yellow, and cyan respectively. On the left side showing apo CaM the 
N-terminal globular domain adopts a closed conformation with the E-F hand motifs 
packed close together whilst the C-terminal CaM globular domain takes on a semi 
open conformation. On the right hand side showing Ca2+/CaM both globular domains 
adopt the open conformationand coupled with the exposure of their respective 
hydrophobic pockets and the formation of a helical linker.  
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Isothermal Titration Calorimetry 
 
Binding constants and thermodynamic parameters 
Isothermal titration calorimetry (ITC) is a technique that enables determination of the 
binding affinity (association constant, Ka), enthalpy change (ΔH), entropy change 
(ΔS), and stoichiometry (N) associated with a chemical reaction at a constant 
temperature. Typically this involves an interaction between ligand L and 
macromolecule M to form complex ML. Both ΔH and ΔS are two thermodynamic 
parameters which can be used to define Ka and are related to the Gibbs free energy 
of binding (ΔG) according to equations [1], [2], and [3], shown below and using these 
terms the KA can be deduced (Wiseman, Williston et al. 1989; Leavitt and Freire 
2001). 
 
[1] ΔG = -RTlnKa = ΔH-TΔS,  
[2]  Ka = e 
(-ΔG/RT),  
[3] Ka = e 
(-ΔH-TΔS/RT),  
(R= gas constant, T = temperature) 
 
ΔH reflects the strength of non-covalent interactions between L and M relative to 
those existing with the solvent and describes the heat changes associated with 
processes that are coupled with the interaction. These processes include binding, 
protonation, ionisation, and conformational changes for example. ΔS reflects the 
changes in solvation entropy and changes in conformational entropy associated with 
the interaction. ΔG describes whether a reaction is a spontaneous (when ΔG is 
negative, reaction occurs without the addition of energy into the system from 
surroundings) or non spontaneous (when ΔG is positive, system requires addition of 
energy from surroundings in order for reaction to occur) process and can indicate the 
affinity of binding (Leavitt and Freire 2001).  
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Ka describes the binding affinity for a binding interaction between L and M. Whereas 
the inverse of Ka, the dissociation constant (Kd) describes the strength of binding 
between L and M in terms of the tendency for the ML complex to separate and is 
defined as the concentration of L at which half of the M bindings sites are occupied 
by L to form ML. When L binds reversibly to a macromolecule M with a single binding 
site as shown by equation [4], the association and dissociation constants can be 
described by equations [5] and [6] respectively. Current ITC instruments can 
determine Kd values that range from 0.01-100 µM (Ladbury and Chowdhry 1996; 
Ladbury 2007). 
 
[4] [M] + [L] ↔ [ML],  
[5] Ka = [ML] / [M] [L],  
[6] Kd = [M] [L] / [ML],  
 
Principle of the ITC experiment 
The ITC instrument is comprised of a sample cell and reference cell contained in an 
adiabatic jacket (Figure 1.15). Both cells are electronically linked to each other and 
to the jacket via thermopile circuits which detect temperature differences between 
the cells and with respect to the jacket. A feedback system ensures that any 
detected temperature difference between the cells is minimised and that they are 
maintained at the experiment temperature. The feedback system in ITC operates on 
a heat compensation principle in which the directly observed feedback signal in an 
experiment is the heat energy per unit time (µcal s-1) which must be added or 
removed from the sample cell in order to maintain zero temperature difference 
between the sample cell and reference cell at the designated experiment 
temperature. The temperature of the jacket is typically cooled 5-10 K below the 
experiment temperature therefore the cells are heated in order to maintain the cells 
at the experiment temperature. Prior to the experiment this serves as the baseline 
signal. During an ITC experiment a specified volume of ligand L (i.e. Ca2+/CaM) is 
injected from the syringe into the sample cell containing the macromolecule M (i.e. 
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CaMK1D) and is constantly mixed (Pierce, Raman et al. 1999; Ladbury 2007). Each 
injection results in either a release or absorption of heat energy (qi) proportional to 
the amount of L (VΔLi, where V is the cell volume and ΔLi the increase in 
concentration of bound ligand after ith injection) that binds to M for that injection and 
the ΔH for the interaction as described below in equation [7] (Leavitt and Freire 
2001). 
 
[7] qi = VΔLiΔH 
 
In response to each injection the heat change is measured with respect to the 
reference cell temperature and the feedback signal indicates the power (µcal s-1) that 
is added (if the heat change is endothermic) or removed (if the heat change is 
exothermic) from the sample cell in order to maintain the zero temperature difference 
between the sample and reference cell at the designated experiment temperature. 
The area under each peak that the feedback signal produces correlates with the heat 
change associated for that particular injection. During the first few injections, L is 
completely bound to M thus producing large heat changes but subsequent injections 
result in fewer available M binding sites with smaller heat changes. Eventually M 
binding sites are saturated and the heat changes that follow are caused by dilution 
and mixing effects. If titrations are repeated at different temperatures it is possible to 
obtain the heat capacity (ΔCp) for the interaction which describes the temperature 
dependence of ΔH (Pierce, Raman et al. 1999; Ladbury 2007). 
 
The c value  
When designing an ITC experiment an important parameter that must be considered 
is the c value which has no units and is related to the product of stoichiometry N, 
association constant Ka, and the total macromolecule concentration [M]T as shown 
below in equation [8]. 
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[8]  c =  NKa[M]T  
 
In order for an accurate determination of the Ka, the c value should be between 1 
and 1000 in order to produce an ideal sigmoid shaped binding isotherm (Wiseman, 
Williston et al. 1989; Pierce, Raman et al. 1999). However, if the c value is too large 
because the concentration of MT binding sites is much greater than 1/Ka then all of L 
will be bound to M until saturation which results in a binding isotherm rectangular in 
shape with a sharp slope that has few points. Conversely if the c value is too small 
because the concentration of MT binding sites is much lower than 1/Ka then full 
saturation of M is difficult to achieve and consequently the binding isotherm appears 
shallow. In both cases where the c value is not optimal determination of the Ka 
therefore becomes difficult, but by adjusting the MT concentration, the c value can 
also be adjusted.  
 
In the case of weak interactions where Ka is small this will require a higher 
concentration of MT and 10 to 20-fold excess concentration of L with respect to MT in 
order to achieve saturation of MT but this will depend on the availability and solubility 
of MT and L at their respective higher concentrations. For strong interactions where 
Ka is large and the saturation of MT is easier to achieve (i.e. CaMK1D and 
Ca2+/CaM), this requires a lower concentration of MT but will depend on how large 
the heat change is at lower concentrations of MT because if the measured heat 
changes are smaller than the sensitivity limits of the ITC instrument then the real 
heat changes associated with the interaction cannot be distinguished from unreal 
heat changes due to dilution and mechanical effects of stirring. 
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Figure 1.15. ITC instrument. 
 The ITC instrument setup is made up of several components. A sample cell 
containing the macromolecule M, and a reference cell containing buffer or water. 
Both cells are housed inside an adiabatic jacket that is maintained at the chosen 
experiment temperature. The syringe contains the ligand L, and also functions as a 
stirrer. The cells are cooled 5-10 K below the chosen experiment temperature 
therefore an input of heat energy is used to maintain the cells at this temperature.  
Thermopile circuits detect changes in heat energy between the cells and also within 
the jacket then convert the changes into electrical energy and convey them to the 
computer in order to operate a feedback system that minimises the changes in heat 
energy between the sample cell and reference cell and also ensure that the jacket 
temperature is maintained at the experiment temperature. The output signal from the 
ITC instrument displays the increase or decrease in power (µcal s-1) that is 
necessary to maintain the zero temperature difference between the sample and 
reference cell at the designated experiment temperature (Velazquez-Campoy, 
Ohtaka et al. 2004). 
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Figure 1.16. Binding isotherms for different C values.  
The binding isotherms for different c values are shown to illustrate the how the shape 
of the curve is dependent on the c value which is related to the product of Ka, [M]T 
and N. To determine the Ka, the c value should be between 1 and 1000 by adjusting, 
[M]T. The y axis and x axis correspond to (1/V0)dq/dx (kcal mol
-1) and [LT]/[MT]. V0 
denotes the volume of the sample cell (Wiseman, Williston et al. 1989). 
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Nuclear Magenetic Resonance 
Nuclear magnetic resonance (NMR) spectroscopy is a technique that can determine 
the solution structure of proteins at atomic resolution using isotope labelled proteins. 
In addition NMR can provide information about interactions, conformational changes 
and dynamics (Wuthrich 2003). NMR is complementary to protein crystallography 
which is another technique for high resolution structure determination. However 
protein crystallography requires proteins that are receptive to crystallisation which 
can present a major limiting step. In contrast NMR requires isotope labelled proteins 
in solution. An advantage with protein crystallography is that any protein size can be 
studied whereas NMR is often limited to proteins no greater than 30 kDa due to 
resonance line shape broadening and overlap. Protein structures that are 
determined by protein crystallography only represent a snap shot of a particular 
conformation that is amenable to crystallisation and may not be reflective of the 
native protein conformation. This can be due to the influence of crystallisation 
artefacts such as crystal contacts which can exert bias towards certain protein 
conformations.  Protein structures determined by NMR represent an ensemble of the 
conformations that the protein can sample in solution and there are no artificial 
contacts, consequently the NMR protein structure is more likely to resemble the 
native conformation. To appreciate the application of protein NMR and its 
advantages and disadvantages, the relevant NMR theory will be discussed in the 
subsequent sections. 
 
Nuclear spin 
Atomic nuclei possess an intrinsic property termed spin that can give rise to angular 
momentum (P). Spin is characterised by the nuclear spin quantum number (I), also 
termed spin I, which describes the shape of the magnetic field and can adopt either 
zero, integral (i.e. 1, 2, 3 etc) or half integral (i.e.1/2, 3/2, 5/2 etc) values depending 
on the proton and neutron content of the nucleus. Only integral and half integral 
values result in nuclei with a net spin and an associated magnetic field. These types 
of nuclei are termed spin active because they are amenable to NMR. Spin active 
nuclei are associated with a magnetic field described as the magnetic moment (µ) 
because nuclei have charge and in combination with the motion of net spin this 
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generates a local magnetic field. Both the µ and P of a spin active nucleus are 
related to each other by the magnetogyric ratio (γ), a constant that describes the 
ratio between µ and P for a particular nucleus and is an indicator of its magnetic 
strength. In addition µ can be parallel (when γ is positive) or anti-parallel (when γ is 
negative) to P. The relationship between these terms is: µ = γP. 
 
Spin 1/2 nuclei  
P is a vector quantity and therefore has both magnitude and direction. Consequently 
the P of a nucleus characterised by spin I has direction defined in terms of 2I+1 
number of possible orientations which it can adopt with respect to an arbitrary 
chosen axis. By convention this is defined as the z-axis, thus the z-component of P 
is denoted as Pz and is quantized as: Pz = ħm, where ħ is planks constant in terms of 
Joules radians-1.Furthermore the direction of the 2I+1 allowed orientations are 
described by the magnetic quantum number (m) which has 2I+1 values that are 
between +I and -I. For example nuclei of interest in protein NMR include 1H, 15N and 
13C, which are spin 1/2 nuclei and therefore restricted to two orientations (2*1/2+1 = 
2) described by m as spin +1/2 and spin -1/2. Permitted directions of the Pz 
component for spin 1/2 nuclei can thus be represented as: Pz = +1/2ħ, Pz = -1/2ħ, or 
Pz = ±1/2ħ  
 
α and β states 
In the absence of an external magnetic field (B0), the P of spin I nucleus has no 
preference for any of its allowed orientations. Moreover, these orientations are 
energetically equivalent but when B0 is applied this degeneracy is removed because 
the associated µ of a spin I nucleus enables it to interact with B0 in 2I+1 ways and 
possess different energy states. Spin 1/2 nuclei for example can align in two allowed 
orientations that have distinct energy states depending on the alignment of spin 1/2 
nuclei with respect to B0. Alignment of spin 1/2 nuclei can be parallel (denoted +1/2) 
or anti-parallel (denoted -1/2) to B0 which correlates to a lower energy state (denoted 
α) and higher energy state (denoted β) respectively. Spectroscopy effectively 
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involves measuring ΔE = hv (h is planks constant, v is frequency) associated with the 
transition between distinct energy states. Therefore in NMR the transitions between 
α and β states of spin 1/2 nuclei can be induced by applying an appropriate v of 
radiation that corresponds to the precession v of spin 1/2 nuclei also known as the 
Larmor v. Since ΔE and v are related by h, Larmor v therefore correlates to the ΔE of 
the α and β transition, whilst Larmor v itself is determined by the nuclei γ and B0, 
therefore: ΔE = hv = hγB0 / 2π = ħγB0 
 
Boltzmann distribution and sensitivity 
Low frequency radiation is used in NMR to induce transitions because the ΔE 
between α and β energy states is small (since ΔE = hv). At thermal equilibrium the 
population difference between the α and β states is described by the Boltzmann 
equation: Nα / Nβ = e(ΔE / RT) which indicates that ΔE for the transition is small due to 
the small population difference between α and β states. Given that the net 
absorption of ΔE correlates to the intensity of the transitions, the sensitivity of NMR 
is thus relatively low because the ΔE of the transitions studied is also low. However 
due to the relationship: ΔE= ħγB0, increasing the B0 strength will increase the 
transition ΔE and improve sensitivity (Figure 1.18).   
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Figure 1.17. Space quantization of spin 1/2 nuclei.  
The magnetic quantum number (m) describes the direction of the 2I+1 allowed 
orientations for the angular momentum (P) of a spin I nucleus. This schematic 
represents a space quantization of m for a spin 1/2 nucleus showing the two possible 
directions m = +1/2 and m = -1/2. 
 
 
Figure 1.18. Energy state of allowed orientations for spin 1/2 nuclei and 
dependence on B0.  
Spin 1/2 nuclei can align in a high (α) and low (β) energy state in the presence of B0. 
The sensitivity of NMR depends on the transition ΔE. Due to the relationship ΔE= 
ħγB0, the transition ΔE and thus NMR sensitivity can increase with increasing B0.  
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The vector model of NMR 
At thermal equilibrium and in the presence of B0 the Boltzmann distribution describes 
a slight excess of the low energy α state which results in a net magnetization vector 
(M) along the z-axis (parallel to B0) termed longitudinal magnetization. When a 
second magnetic field B1 is applied perpendicular to B0 via a transmitter coil, this 
forces M into the xy plane termed transverse magnetization which precesses at the 
Larmor v. Subsequently this induces into the receiver coil an oscillating voltage that 
decays over time to produce the free induction decay (FID) which is Fourier 
transformed into an NMR spectrum. Mean while a concomitant relaxation processes 
reduce transverse M and increase longitudinal M until it is parallel to the z-axis 
again. 
 
Longitudinal Relaxation  
There are two relaxation processes known to occur in NMR termed longitudinal 
relaxation (denoted T1) and transverse relaxation (denoted T2) with both contributing 
to the decay of the FID. Firstly longitudinal relaxation is the process that restores the 
equilibrium population difference between the high and low energy spin states. In 
terms of the vector model this corresponds to a restoration of M to the +z-axis. 
Longitudinal relaxation occurs because spin active nuclei exhibit vibrational and 
rotational motion which changes their associated magnetic field and their respective 
interactions with the magnetic field of the surroundings termed the lattice. These 
magnetic interactions are mediated directly through space defined as dipolar 
interactions. Magnetic fields associated with the lattice contain components that are 
identical in Larmor v to the spin active nuclei and can thus interact with high energy 
state spin active nuclei. Subsequently the energy associated with such spin active 
nuclei is subsequently dissipated into the lattice causing an increase in the 
vibrational and rotational energy of the lattice. Hence longitudinal relaxation is also 
termed spin-lattice relaxation. 
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Transverse relaxation 
T2 relaxation describes the loss of transverse M predominantly due to a loss of 
phase coherence in the xy plane. This arises because spin active nuclei when 
initially in the xy plane experience slightly different local magnetic fields due to 
fluctuations in local magnetic fields and a non-homogenous static magnetic field. As 
a result these nuclei exhibit different Lamor v causing a loss of phase coherence and 
therefore no resultant M in the xy plane. Accordingly the broad distribution of Larmor 
v correlates to a spread of frequencies in the NMR spectrum that are defined by a 
line shape with line width described in terms of: ΔV1/2 = 1 / πT2. Another mechanism 
that contributes to transverse relaxation is the transfer of energy between interacting 
spin active nuclei that have identical Larmor v but different m states. Such nuclei 
exchange m states and thus undergo spin flipping i.e. spin 1/2 nuclei interchange 
between β state and α state. Effectively no net change in the population of energy 
states occurs although the average life time of the spin active nuclei in the excited  
state is reduced which can cause line shape broadening. 
 
Transverse Relaxation Optimised Spectroscopy and large proteins 
A major limitation of NMR is protein size because large proteins give rise to a greater 
number of resonances that results in resonance overlap. Furthermore resonance 
signals broaden out due to slow tumbling of proteins in solution and fast transverse 
relaxation rates (T2). Tumbling is described by the rotational correlation time (τc) 
which is proportional to 1/T2. Therefore large proteins have large τc and short T2 and 
vice versa. At high magnetic field strengths the two main types of relaxation that 
occur are to due to chemical shift anisotropy (CSA) and dipole dipole (DD) 
interactions (Pervushin, Riek et al. 1997; Pervushin 2000; Riek, Pervushin et al. 
2000; Fernandez and Wider 2003). 
  
The CSA interaction arises because nuclei can have different local magnetic fields 
depending on their orientation with respect to the external magnetic field hence they 
are anisotropic. CSA mediated relaxation can be described by a CSA rate constant 
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which increases with the square of the magnetic field. DD interactions originate from 
nuclei being able to generate an instantaneous magnetic dipolar field that is 
proportional to µ. The effectiveness of DD mediated relaxation is dependent on µ 
associated with the nucleus and the inverse sixth power of the distance between the 
nuclei (1/r6) (Pervushin 2000).  
 
In proteins the main source of DD mediated relaxation is from 1H. Significantly 
relaxation via DD can be reduced with the introduction of 2H at non-labile positions 
within a large protein. The TROSY effect (Figure 1.19) can reduce the rate of 
transverse relaxation rate (T2) (describes the dephasing of transverse components 
of the precessing magnetization) by exploiting interference between CSA and DD to 
effectively suppress the transverse relaxation. In a TROSY experiment the slowest 
relaxing component is independent of T2 and is therefore selected to produce a well 
resolved peak (Pervushin 2000). 
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Figure  1.19. TROSY effect.  
The FID decays less rapidly when TROSY is applied and corresponds to sharper 
resonance line shapes and an improvement in resolution. 
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Chemical shift 
It is known that the larmor v for a given nucleus is proportional to the applied external 
magnetic field B0 but for nuclei within molecules such as proteins the situation is 
slightly different because these nuclei are surrounded by moving electrons. A 
consequence of this is that the local magnetic field around the nucleus is altered due 
to an opposing magnetic field produced by the surrounding electron. Basically the 
external magnetic field experienced by the nucleus is reduced which in turn changes 
its larmor v. This effect is described as shielding and its extent is depedent on the 
density and distribution of the electron which surrounds the nucleus. The chemical 
shift (δ) therefore describes the dependence of NMR energy levels (ΔE =hv) on the 
electronic environment. Identical nuclei in different chemical environments can thus 
possess different larmor v. For any resonance, δ can be defined as: 
 
δ = v - vRef / vRef 
 
Chemical shift perturbation 
Chemical shift perturbations (CSPs) are a property used in NMR to indicate changes 
in the local environment of nuclei. CSPs associated with 15N nuclei are greater than 
1H therefore weighting is required to address this imbalance and described as 
normalisation of the CSP. Thus standard formula used to account for this is: Δδ total 
= ((ΔδH)
2 + (ΔδN)
2)0.5 
 
HSQC 
Heteronuclear single quantum coherence (HSQC) is a 2D NMR experiment that 
resolves protein 1H peaks via the 1H and 15N dimensions. It is commonly used to 
assess the suitability of a protein for NMR backbone assignment. The transverse 
relaxation optimised spectroscopy (TROSY) HSQC is the same experiment as a 
standard HSQC but is designed for large molecular weight proteins that exhibit broad 
lineshapes and overlap. TROSY does not utilise decoupling, selecting only the 
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narrowest lineshape resonance and is often combined with deuterated proteins to 
improve signal intensity and lineshape leading to an improvement in resolution. 
These experiments can also be used to test for ligand or protein binding against a 
1H, 15N labelled protein along with characterisation of binding affinities. The amide 1H 
is sensitive to changes in its local chemical environment therefore the HSCQ is a 
sensitive method for the detection of ligand and protein-protein interactions. 
 
Backbone assignment strategy 
Sequential assignment of the backbone amide resonances in a protein can be 
achieved by acquiring a set of triple resonance experiments using a 15N, and 13C 
uniformly labelled protein. Proteins of large molecular weight (i.e. > 25 kDa) may 
require deuteration or perdeuteration. All the subsequent experiments to be 
described provide carbon resonance information which are correlated to the 
backbone 1HN (amide proton) and 15N (amide nitrogen) resonances evident in a 
HSQC spectrum. Provided the primary sequence is known a backbone assignment 
is accomplished by establishing the connectivity between residues where possible 
via their 13CO (carbonyl carbon), 13CA (α carbon) and 13CB (β carbon) resonances. 
Certain residue types have unique 13CA and 13CB resonances thus the identification 
of residues in the primary sequence for building a sequential assignment relies on 
this aspect.  
 
HN(CA)CO and HNCO 
A backbone assignment process begins with the HNCO experiment which correlates 
the backbone amide resonance of residue i to the 13CO (carbonyl carbon) resonance 
of the preceding residue termed residue i-1 (Figure 1.20). Each backbone amide 
resonance therefore produces one inter (residue i-1) 13CO resonance in the HNCO 
spectrum.  In terms of signal to noise ratio, the HNCO is the most sensitive 
experiment which helps to confirm the number of real backbone amide resonances 
observed in the HSQC particularly in overlapped regions. However the HNCO alone 
cannot determine the connectivity of backbone amide resonances via 13CO 
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resonances and therefore requires the HN(CA)CO (brackets around the nuclei 
denotes that the magnetization is transferred via the nuclei but its resonance is not 
observed). This complementary experiment correlates the backbone amide 
resonance of residue i to its intra (residue i) 13CO and to the inter (residue i-1) 13CO. 
Thus for each backbone amide resonance correlated to the HN(CA)CO spectrum 
two 13CO resonances are produced. Superimposing HNCO and HN(CA)CO spectra 
therefore helps to confirm the intra  13CO  and inter 13CO resonance of residue i and 
i-1. 
 
HNCA and HN(CO)CA 
Another pair of experiments required for sequential backbone assignment includes 
the HNCA and HN(CO)CA, with the former experiment correlating the backbone 
amide resonance of residue i to its intra (residue i) 13CA  and to the inter (residue i-1) 
13CA . Subsequently two 13CA resonances are produced for each backbone amide 
resonance correlated to the HNCA. However the 13CA resonance information 
provided by the HNCA needs to be complemented by the HN(CO)CA  because this 
experiment correlates the backbone amide resonance of residue i to the inter 
(residue i-1) 13CA resonance. In this case one inter (residue i-1) 13CA resonance is 
produced for each backbone amide resonance correlated to the HN(CO)CA. 
Combining the HNCA and HN(CO)CA spectra therefore confirms the intra 13CA  and 
inter 13CA resonance of residue i and i-1. 
 
HNCACB and HN(COCA)CB 
In order to increase confidence in identifying residue types and establishment of 
unambiguous sequential assignments it is necessary to acquire 13CB resonance 
information. Hence the HNCACB is acquired because this experiment correlates the 
backbone amide resonance of residue i to the intra (residue i) and inter (residue i-1) 
13CA and 13CB resonances (Figure 1.20). Potentially four, three or two peaks maybe 
produced for each backbone amide resonance correlated to the HNCACB depending 
on whether both residues i and -1 are Gly or if one of them is Gly because only Gly 
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residues lack a CB side chain. Exploiting the HNCACB requires combining it with 
experiments that help to distinguish between the intra (residue i) and inter (residue i-
1) 13CA and 13CB resonances. Identifying the inter (residue i-1) 13CB in a HNCACB 
spectrum depends on the HN(COCA)CB because this experiment correlates the 
backbone amide resonance of residue i to the inter (residue i-1) 13CB resonance. 
Therefore the HN(COCA)CB produces one inter (residue i-1) 13CB resonance for 
each backbone amide resonance correlated to the HN(COCA)CB assuming that 
residue i-1 is not a Gly. A combination of the HNCACB, HNCA and HN(CO)CA will 
also help confirm the intra (residue i) and inter (residue i-1) 13CA resonances. 
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Figure 1.20. Triple resonance experiments HN(CA)CO, HNCO, HNCA, 
HN(CO)CA, HNCACB and HN(COCA)CB.  
Magnetization transfer pathways of the experiments are shown denoted by an arrow. 
Nuclei highlighted in red indicate that resonances for these are observable in the 
experiment. Nuclei highlighted in gray participate in he magnetization transfer but are 
not observable in the experiment. 
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Chapter II Materials and Methods 
 
All chemicals, reagents, and equipment purchased or used came from Alta 
Biocience, Beckman, Biorad, Calbiochem, Expedeon, Fisher scientific, GE 
healthcare, Invitrogen, Merck, Roche, Stratagene, and Sigma-Aldrich. 
 
cDNA clones 
All cDNA clones shown in table1 were provided by our collaborators the Structural 
Genomics Consortium (SGC). Both pLIC-SGC1 and pNIC-Bsa4 expression vectors 
encode an N-terminal His6-tag and an adjacent TEV protease cleavage site for His6-
tag removal. The pGEX-6p-2 encodes an N-terminal GST-tag, followed by a 
prescissionTM protease (GE healthcare) cleavage site to allow removal of the GST-
tag.  
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cDNA clone Default 
Cell line 
Antibiotic resistance Expression 
vector 
Affinity Tag 
TOPK3-322 BL21 (DE3) 
 
50 µg/ml Kanamycin 
 
pNIC28-Bsa4 His6 
TOPK10-322 BL21 (DE3) 
 
50 µg/ml Kanamycin 
 
pNIC28-Bsa4 His6 
Pim1 BL21 (DE3) 
 
100 µg/ml Ampicillin 
 
pLIC-SGC1 His6 
CSNK1G3 
 
BL21 (DE3) 
 
50 µg/ml Kanamycin 
 
pNIC28-Bsa4 His6 
CAMK1D 
 
Rosetta 
(DE3) 
 
50 µg/ml Kanamycin         
34 µg/ml 
chloramphenicol 
 
pNIC28-Bsa4 His6 
CaMK1G 
 
BL21 (DE3) 
R3-
p2RARE 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
VRK2A 
 
Rosetta 
(DE3) 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
PAK4 
 
BL21 (DE3) 
 
100 µg/ml Ampicillin 
 
pGEX-6p-2 GST 
PAK5 
 
BL21 (DE3) 
 
50 µg/ml Kanamycin 
 
pNIC28-Bsa4 His6 
PAK6 
 
BL21 (DE3) 
 
50 µg/ml Kanamycin 
 
pNIC28-Bsa4 His6 
Calmodulin BL21 (DE3) 
 
50 µg/ml Kanamycin 
 
pNIC28-Bsa4 His6 
 
Table1. SGC cDNA clone details. The pNIC28-Bsa4 and pLIC-SGC1 are 
customised pET vectors created by the SGC. All subsequent media used in the 
protocols described were supplemented with the relevant antibiotics shown in this 
table. See appendix for vector maps. 
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cDNA clone Optimised 
Cell line 
Antibiotic 
resistance 
Expression 
vector 
Affinity 
Tag 
CaMK1D BL21 (DE3) 
RIPL codon 
plus 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
CaMK1D1-298 
 
BL21 (DE3) 
RIPL codon 
plus 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
CAMK1D1-280 
 
BL21 (DE3) 
RIPL codon 
plus 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
CaMK1D_T180E 
 
BL21 (DE3) 
RIPL codon 
plus 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
CaMK1D_T180E1-
298 
 
BL21 (DE3) 
RIPL codon 
plus 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
CaMK1D_T180E1-
280 
 
 
BL21 (DE3) 
RIPL codon 
plus 
 
50 µg/ml Kanamycin         
34 µg/ml 
Chloramphenicol 
 
pNIC28-Bsa4 His6 
 
Table2. Expression construct details of CaMK1D and CaMK1D mutants after 
cell line optimisation. Listed are details of the CaMK1D constructs that were used 
in this thesis. All subsequent media used in the protocols described were 
supplemented with the relevant antibiotics shown in this table. 
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Vector Maps 
 
Figure.2.0. pNIC-28-Bsa4 vector. 
 
 
Figure.2.1. pLIC-SGC1 vector. 
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Figure 2.2. pGEX-6P-2 vector. 
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Transformations 
 
Rosetta (DE3) and BL21 (DE3) 
The concentration of cDNA stocks used in transformation typically ranged from 20-
200 ng µL-1.The cDNA plasmids were transformed into their respective default E. coli 
cell lines by adding 1 µL of cDNA plasmid to 20 µL of competent cells (Novagen) 
pre-thawed on ice and incubating them on ice for 5 minutes. The cells were then 
subjected to a 30 second heat shock at 42 °C and transferred back on ice for 2 
minutes. Subsequently 80 µL SOC or LB media equilibrated at room temperature 
was added to the cells which were then incubated at 37 °C with shaking at 200 RPM 
for 1 hour. Finally 50 µL of cells were plated out on an LB agar plate supplemented 
with the appropriate antibiotic resistance, then inverted and incubated at 37 °C 
overnight. 
 
BL21 (DE3) RIPL codon plus 
cDNA plasmids of CaMK1D and its mutants plasmids (cDNA stock concentrations 
typically ranged from 20-200 ng µL-1) were into BL21 (DE3) RIPL codon plus 
(Stratagene) by adding 1 µL of 10-fold dilute β-mercaptoethanol mix (stratagene) to 
20 µL of competent cells on ice for 10 minutes. Subsequently 1 µL of cDNA plasmid 
was added to the cells and incubated on ice for 30 minutes. Cells were then heat 
shocked for 20 seconds at 42 °C and transferred back on ice for 2 minutes followed 
by the addition of 180 µL of SOC or LB pre-heated at 42 °C and incubation at 37 °C, 
200 RPM, for 1 hour. Finally 50 µL of cells were plated out on an LB agar plate 
supplemented with the appropriate antibiotic resistance, then inverted and incubated 
at 37 °C overnight. 
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Protein expression 
 
Expression tests in LB 
Small scale expression tests were conducted by inoculating 5 mL of LB culture 
containing the appropriate antiobiotic(s) with a single cDNA plasmid transformed 
colony then incubated at 37 °C, 200 RPM, overnight. 0.5 mL of this start up culture 
was then used to inoculate 100 ml of LB culture the next morning. All the kinase 
proteins were grown at 37 °C then cooled to 18 °C when O.D600nm was 0.3, whilst 
CaM was grown at 37 °C. When cultures reached O.D600nm equal to 0.6-0.7, a 1 mL 
sample was taken as a pre-induction sample then 0.5 mM IPTG was added to the 
main culture and left to grow overnight. 1 mL post induction samples were taken for 
expression test comparison i.e. after 4, 8, 16 post induction hours. Normalised pre 
and post induction samples from whole cell lysates were prepared for SDS PAGE 
(BioRad, Tris HCl, 15% gel: 15% resolving gel, 4% stacking gel) and stained with 
comassie blue or instant blueTM (Expedeon) 
 
Solubility tests 
100 µL of post-induction sample were sonicated on ice at 20 second intervals. 
Sonicated samples were then centrifuged at 18000xg for 3 minutes. The supernatant 
was transferred to a new eppendorf. An equal volume of SDS sample buffer was 
added to the supernatant (soluble fraction) whilst the pellet (insoluble fraction) was 
made up to the same final volume in SDS sample buffer and resuspended. 
 
CaMK1D Cell line and deuterated M9 minimal media expression tests 
Expression tests of CaMK1D in BL21 (DE3), BL21 DE3 RIPL codon plus, and 
Rosetta (DE3), in deuterated M9 minimal media (see appendix) was conducted as 
follows. Single transformed colonies of BL21 (DE3), BL21 DE3 RIPL codon plus, and 
Rosetta (DE3) were selected for inoculation of 2 ml of LB  and grown at 37 °C, 200 
RPM for 6-8 hours. 0.5 ml of LB start up was then used to inoculate 10 ml of M9 
minimal media containing 70% (v/v) 2H2O then grown at 37 °C, 200 RPM overnight. 
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The next morning 2 ml of the M9 minimal media start up was then used to inoculate 
100 ml of M9 minimal media containing 70 % and 99 % (v/v) 2H2O in 250 ml flasks 
then grown at 37 °C, 200 RPM until the O.D600nm was 0.2, at which point the 
temperature was lowered to 18 °C. When cultures reached an O.D600nm of 0.4, a 1 ml 
sample was taken as a pre induction sample then 1mM IPTG was added to the main 
culture and left to grow overnight at 18 °C, 200 RPM. 1 ml post induction samples 
were taken the following morning. 
 
Expression of unlabelled kinases and CaM in LB 
This protocol describes the expression of protein kinases and CaM. A single colony 
transformed with the cDNA plasmid of interest was used to inoculate 20 ml of LB and 
incubated overnight at 37 °C, 200 RPM. In the following morning the 20 ml LB start 
up culture was used to inoculate 1 L of LB in a 5 L flask and incubated at 37°C, 180 
RPM. For kinases at an O.D600nm of 0.4, the culture was cooled to 18 °C and induced 
with 1 mM IPTG at an O.D600nm of 0.6 and grown overnight with shaking at 180 RPM. 
For CaM, the temperature was maintained at 37 °C and at an O.D600nm of 0.6 cells 
were induced with 1 mM IPTG and grown overnight at 37 °C, 180 RPM. 
 
Expression of isotope and deuterium labelled proteins 
Preliminary 1H, 15N labelled kinase samples, 2H CaM and other deuterated proteins 
were expressed in their default cell lines. All 2H, 15N CaMK1D constructs, and 2H, 
15N, 13C CaMK1D were expressed in either Rosetta or BL21 (DE3) RIPL codon plus. 
These proteins were expressed as described below.  
 
2 ml of LB was inoculated with a single colony transformed with the cDNA plasmid of 
interest and grown at 37 °C, 200 RPM for 6-8 hours. After this, 50 ml of M9 minimal 
media start up was inoculated with 0.5 ml (1ml for CaM) of the LB start up and 
incubated at 37 °C, 200 RPM overnight. In the case of 2H, 15N CaMK1D constructs, 
2H CaM, 2H, 15N, 13C CaMK1D and other deuterated proteins, 0.5 ml was used to 
 97 
 
inoculate 50 ml M9 minimal media containing 70 % (v/v) 2H2O in a  and grown 
overnight at 37 °C, 200 RPM. 
 
Following overnight growth of non-deuterated cultures the 50 ml M9 start up was 
then used to inoculate 1 L of M9 minimal media in a 5 L flask in the morning and 
incubated at 37 °C, 180 RPM until the O.D600nm was 0.3, at which point the 
temperature was lowered to 18 °C. At an O.D600nm equal to 0.6, the 1 L culture was 
induced with 1 mM ITPG and grown overnight.  
 
After overnight growth of deuterated cultures the 50 ml M9 start up was used to 
inoculate 1 L (as a final volume) of M9 minimal media containing 99 % (v/v) 2H2O for 
in a 5 L baffled flask in the morning and incubated at 37 °C, 120 RPM until the 
O.D600nm was 0.2. At this point the temperature was cooled to 18 °C and at an 
O.D600nm of 0.4, the cells induced with 1 mM IPTG and grown overnight. In the case 
of deuterated CaM, cells were maintained at 37 °C and induced at an O.D600nm of 0.4 
and grown overnight. For the inoculation step a slight dilution effect of the final 2H2O 
content can result when adding the M9 start up containing 70 % (v/v) 2H2O. An 
alternative method to ensure 99 % (v/v) 2H2O or perdeuterated growths was to spin 
down the cells at 4000 RPM (Beckman centrifuge) and resuspend in 1 L (as a final 
volume) of M9 minimal media containing 99 % (v/v) 2H2O. When high levels 
deuterium incorporation were not desired the amount of deuterium oxide in the final 
1 L culture was adjusted accordingly i.e. to 70 % (v/v) 2H2O. 
2H CaM was expressed 
in the same manner as CaMK1D in 99% deuterium oxide but without any 15N, 13C 
labelling and induction was conducted at 37°C. 
 
Primary Ni2+ NTA-affinity protein purification 
After overnight expression, cells were centrifuged at 7000xg (Beckman centrifuge) 
for 15 minutes and resuspended on ice in equilibration buffer (50 mM HEPES pH 
7.5, 500 mM NaCl, 0.5 mM TCEP, 5 mM imidazole, 0.02 % NaN3) supplemented 
with an EDTA-free complete protease inhibitor cocktail (Roche). The cells were lysed 
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on ice by using either the French press or the EmulsiflexTM cell disruptor with the 
resulting cell lysate centrifuged at 75000g for 45 minutes (Beckman centrifuge). The 
supernatant was filtered through a 0.45 µM filter and His6-tagged protein was purified 
by Ni2+NTA-affinity chromatography (GE Healthcare). This involved the filtered cell 
lysate being applied to the Ni2+NTA-affinity column via a peristaltic pump, followed by 
a wash with 5 column volumes of wash buffer (50 mM HEPES pH 7.5, 500 mM 
NaCl, 0.5 mM TCEP, 20 mM imidazole, 0.02 % NaN3) to remove non-specifically 
bound proteins. His6-tagged protein i.e. CaMK1D was eluted with elution buffer (50 
mM HEPES pH 7.5, 500 mM NaCl, 0.5 mM TCEP, 250 mM imidazole, 0.02 % NaN3) 
and His6-tagged CaMK1D containing fractions were pooled together as determined 
from SDS PAGE. 
 
His6-tag cleavage and dialysis  
Pooled His6-tagged CaMK1D (~20 mg/ml, ~ 520 µM) was transferred to a dialysis 
tube to which 0.5-1 mg/ml TEV protease (expressed with a His6-tag and purified 
inhouse from a cDNA plasmid provided by the SGC) was added to remove the His6-
tag, and dialyse out the imidazole at 4 °C overnight in dialysis buffer (50 mM HEPES 
pH 7.5, 500 mM NaCl, 0.5 mM TCEP, 0.02 % NaN3).  
 
Secondary Ni2+ NTA-affinity purification 
After overnight dialysis, CaMK1D was again purified on the Ni2+NTA-affinity column 
by loading the sample on with a peristaltic pump. The flow through was collected 
then 5 column volumes of equilibration buffer and wash buffer was passed through 
respectively and each collected separately. Finally 5 column volumes of elution 
buffer was passed through and collected. Fractions containing CaMK1D were 
determined by SDS PAGE and pooled together. TEV protease co-elutes in the 
CaMK1D fractions but is removed in the following size exclusion step. 
 
Buffer compatibility for CaMK1D•Ca2+/CaM- HEPES buffer 
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For the binding studies and activity assays involving CaMK1D, CaMK1D_T180E, 
CaMK1D_W306S, CaMK1D_M319A and the C-terminal truncation constructs the 
running buffer for the superdex S75 size exclusion was 50 mM HEPES pH7.5, 150 
NaCl, 0.5 mM TCEP, 0.02 % NaN3. HEPES was used instead of Na phosphate 
because CaMK1D, CaMK1D_T180E, CaMK1D_W306S, and CaMK1D_M319A all 
require Ca2+/CaM for activation but Ca2+ when combined with Na phosphate (default 
kinase buffer) results in precipitate of Ca2+ phosphate. Although the C-terminal 
truncation constructs have Ca2+/CaM independent activity, the same HEPES buffer 
system was used for these to maintain consistency with the other CaMK1D 
constructs for binding and activity studies. 
 
Size exclusion chromatography 
Post his6-tag cleavage and second Ni2+ NTa affinity purification proteins were 
pooled and concentrated to 1 mL in a 10 K MWCO concentrator (Vivaspin or Amicon 
Ultra-15 centrifugal device (Millipore)). This sample was then centrifuged at 18000xg 
for 10 minutes to remove aggregate and precipitate. The resulting supernatant was 
then extracted into a syringe and loaded on to the superdex S75 (GE Healthcare) 
size exclusion column in 50 mM Na phosphate or HEPES pH 7.5, 150 mM NaCl, 0.5 
mM TCEP, 0.02% NaN3. The size exclusion elution profile was monitored at 280 nM 
and the elution profile indicated that the protein was monomeric.  CaM was purified 
by size exclusion using 300 mM NaCl. The absorbance of CaM is also a lot lower 
because CaM does not contain any Trp residues. Fractions containing CaMK1D 
according to SDS PAGE were pooled and the sample was concentrated and 
exchanged into 50 mM Trizma pH 9.5, 150 mM NaCl, 0.5 mM TCEP and left at room 
temperature (25 °C) for 24 hours in order to facilitate the exchange of amide 2H with 
1H. After complete exchange the sample was exchanged back into buffer containing 
50 mM Na phosphate or HEPES pH 7.0, 150 mM, NaCl, 0.5 mM TCEP, 0.02 % 
NaN3 using a 10 K MWCO concentrator (Vivaspin or Amicon Ultra-15 centrifugal 
device (Millipore). The 2H, 15N, 13C labelled CaMK1D sample used for triple 
resonance backbone experiments was buffer exchanged into the Na phosphate 
buffer previously described but with 75 mM NaCl. All NMR samples were prepared in 
600 µl final volume containing 10 % 2H2O. 
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Anion exchange  
CaM was purified in the same manner as described for CaMK1D but with an 
additional anion exchange (Resource Q column) purification step after size 
exclusion. Pooled CaM fractions from the Superdex-75 size exclusion purification 
were concentrated to 1 ml in a 5 K MWCO concentrator (Vivaspin or Amicon Ultra-15 
centrifugal device (Millipore) then diluted 10-fold with resource buffer A (50 mM 
Hepes pH 8, 0.5mM TCEP, 0.02 % NaN3) and concentrated to 5 ml. Alternatively a 
superloop can also be used with CaM diluted 10-fold in resource buffer A. CaM was 
then loaded onto the ResourceQ via a 5 ml loop and eluted over a linear gradient 
with resource buffer B (50 mM Hepes pH 8.8, 1 M NaCl, 0.5mM TCEP, 0.02 % 
NaN3) from 0 % buffer B to 100 % buffer B concentration. CaM containing fractions 
were pooled as determined from SDS PAGE. For deuterated CaM the amide 2H 
exchange with 1H procedure was not necessary. TOPK was also purified by anion 
exchange as a final step with the buffer pH adjusted accordingly to the predicted pI 
of TOPK 
 
Beer Lambert law 
Except for CaM, all the concentrations of all proteins were estimated via UV 
absorbance at 280nM and calculated using the beer-lambert law.  
 
A = cεl 
Where A = absorbance, c = concentration, ε = extinction coefficient, l = path length 
 
The concentration of CaM was determined via the Bradford assay because CaM 
does not contain any Trp residues necessary for estimation of its concentration with 
<10% error by UV absorbance at 280nM.  
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Bradford assay 
Purified CaM was diluted 20-100 fold (final concentration of 10-100 μM) with 50 mM 
Hepes pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 0.02 % NaN3 (CaM storage buffer), in a 
final volume of 20 µL. A blank sample was prepared using 980 µl of Bradford reagent 
(Biorad) and 20 µl of CaM storage buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 0.5 
mM TCEP, 0.02 % NaN3) in a cuvette. The diluted CaM sample was then added to 
980 µL of Bradford reagent. After 5 minutes a UV absorbance reading at 595 nM 
was measured and the concentration of CaM was calculated. 
 
ThermofluorTM (Thermal shift assay) 
Stock protein was diluted to 20-100 μM with 50 mM HEPES pH 7.5, 150 mM NaCl, 
0.5 mM TCEP and mixed with SYPRO orange dye (Invitrogen) to a final 
concentration of 10x. 2 uL Samples were then dispensed to a 96-well plate at a final 
protein concentration of 2-10 µM including the relevant buffer or soluble ligand of 
interest to a final volume of 20 µl. Thermal shift assay (ThermofluorTM) experiments 
was conducted over 20-90 C using an Mx3005P RT-PCR machine (stratagene).  
 
Site directed mutagenesis  
In order to create an activation loop phosphorylation mimic in CaMK1D, a T180E 
mutation was engineered into the native phosphorylation site using the Quikchange 
lighting mutagenesis kit (stratagene). This mutant was dubbed CaMK1D_T180E. In 
order to generate C-terminal truncated CaMK1D: CaMK1D1-298 and CaMK1D1-
280, stop codons were introduced after residue Arg 298 and Ala 280. Site directed 
mutagenesis was conducted using the Quikchange lightning kit (stratagene) to 
generate the mutated cDNA plasmids. Mutagensis reactions were confirmed by DNA 
sequencing. All primers were ordered from Invitrogen or Alta biosciences.  
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Oligonucleotide Primer 
length 
GC 
content 
Tm  Mismatch Mutation 
Forward primer 
5’-GGC AAA GGA GAT GTG 
ATG TCC GAG GCC TGT 
GGA ACT CCA GGC TAT 
GTC-3’ 
48 bp 56% 84.5°C 6.25% Thr 180 > Glu 
Reverse primer 
5’-GAC ATA GCC TGG AGT 
TCC ACA GGC CTC GGA 
CAT CAC ATC TCC TTT 
GCC-3’ 
48 bp 56% 84.5°C 6.25% Thr 180 > Glu 
Foward primer 
5’-CAC GAG TCC GTC AGC 
GCC CAG ATC CGG TGA 
AAC TTT GCC AAG AGC-3’ 
45 bp 56% 84.4°C 6.7% Lys 299 > stop 
codon 
Reverse primer 
5’-GCT CTT GGC AAA GTT 
TCA CCG GAT CTG GGC 
GCT GAC GGA CTC GTG-3’ 
45 bp 56% 84.4°C 6.7% Lys 299 > stop 
codon 
Foward primer 
5’-GCA GCT CGG CAC CCA 
TGG ATC GCT TGA GAC 
ACA GCC CTC AAC-3’ 
42 bp 56% 83.7°C 7.14% Gly 281 > stop 
codon 
Reverse primer 
5’-GTT GAG GGC TGT GTC 
TCA AGC GAT CCA TGG 
GTG CCG AGC TGC-3’ 
 
42 bp 56% 83.7°C 7.14% Gly 281 > stop 
codon 
Forward pimer 
5’-AGA TCC GGA AAA ACT 
TTG CCA AGA GCA AAT 
CAA GAC AAG CAT TTA 
ATG CC-3’ 
 
50 bp 40% 78.4°C 4% Trp 306 > Ser  
Reverse primer 
5’-GG CAT TAA ATG CTT G 
TC TTG ATT TGC TCT TGG 
CAA AGT TTT TCC GGA 
TCT-3’ 
 
50 bp 40% 78.4°C 4% Trp 306 > Ser  
Reverse primer 
5’-GCC ACG GCC GTC GTG 
AGA CAT GCT AGA AAA 
CTA CAC CTC G-3’ 
 
40 bp 58% 78.7°C 7.5% Met 319 > Ala 
Reverse primer 
5’-C GAG GTG TAG TTT TCT 
AGC ATG TCT CAC GAC 
GGC CGT GGC-3’ 
 
40 bp 58% 78.7°C 7.5% Met 319 > Ala 
 
Table 3. Primer designed for site directed mutagenesis. The primer sequence 
highlight in bold and underlined indicates the engineered mutation. 
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Isothermal titration calorimetry  
CaMK1D and CaM samples for ITC were prepared by dialysing into 1 L of ITC buffer 
(50 mM HEPES pH 7.5, 150 mM NaCl, 0.5 TCEP, 10 mM CaCl2) overnight at 4 °C 
using D-tube dialyzers (Novagen) with 12-14 and 6-8 kDa MWCO for CaMK1D and 
CaM respectively. Following dialysis, CaMK1D was diluted to a final concentration of 
10 µM in a final volume of 2.2 mL (required volume for the cell sample to fill the 1.4 
mL cell), whereas CaM was diluted to 150 µM in a final volume of 0.5 mL (required 
volume for syringe sample). Both samples were diluted using the same ITC buffer 
that they were dialysed into. These concentrations were used to produce a c value of 
333.33, which corresponds to an appropriate binding isotherm for a tight binding 
interaction and enable determination of the Kd. ITC experiments were conducted 
using a VP-ITC MicroCalorimeter instrument at 25 °C. Each experiment consisted of 
an initial 2 L injection followed by 29 injections of 10 L injected during 20 seconds 
and a spacing of 280 seconds between injections. Data were processed and 
analysed using the program Origin. 
 
Small angle x-ray scattering  
Protein samples for SAXS were prepared by dialysing CaMK1D and CaM into SAXS 
buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 10 mM CaCl2) 
overnight at 4 °C using D-tube dialyzers (Novagen) with 12-14 and 6-8 kDa MWCO 
for CaMK1D and CaM respectively. Following dialysis, samples were prepared to 
their appropriate final concentration and volume using the same SAXS buffer used in 
dialysis. SAXS data were collected at the X33 beam line using a MAR345 image 
plate detector (MarResearch, Norderstedt, Germany) located at the EMBL Hamburg 
outstation on a bending magnet (sector D) on the storage ring DORIS III of the 
Deustches Elektronen Synchotron (DESY). A single photon counting pixel detector 
was used as a detector. A sample detector distance of 2675 mm was used, covering 
the range of 0.06-6 nm (where q = 4πsinθ / λ, θ is the scattering angle and λ is the 
wavelength of the x-ray). The x-ray λ used was 0.15 nm. Scattering curves were 
collected at room temperature using 22, 11, 5.5 mg ml-1 for CaMK1D and 10, 5, 2.5 
mg ml-1 for CaM. 
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SAXS data anaylsis was performed using the PRIMUS software (P. V. Konarev 
2003). Values for the radius of gyration (Rg) and maximum particle size were 
deduced using GNOM (Svergun 1992).  Ten low resolution ab initio bead models 
were generated with DAMMIF (Svergun 2009). Spatial discrepancy between the 
models was minimized with SUPCOMB (Svergun 2001), then averaged using 
DAMAVER (Svergun 2003) and filtered by DAMFILT to create a final bead model. All 
programs mentioned were available in the ATSAS suite. Manual fitting of the bead 
models and crystal structures and models were performed using Pymol (Schrodinger 
2010). 
 
Kinase radioactivity assay 
E. coli expressed TOPK/PBK and Pim1 were assessed for activity using a 
radioactivity assay based on a protocol described by Park and co-workers (Park, Lin 
et al. 2006). The assay buffer was 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM 
MgCl2, 10 mM NaF, 1 mM Na3VO4, 1 mM EDTA, 1 mM DTT, and 50 μM ATP which 
was supplemented with 5 μCi of [32P-γ]ATP (GE healthcare). A commercial source of 
active human full length TOPK/PBK (Invitrogen) expressed from the Sf9 insect cell 
line was used as a positive control. Histone H3 was used as a generic substrate. 
Activity was confirmed via transfer of the assay reaction to SDS PAGE and then 
analysed by autoradiography. 
 
NADH coupled activity assay 
Samples for assaying kinase activity with the NADH coupled assay were prepared in 
a final 600 µL volume of assay buffer (50 mM Hepes pH7.5, 150 mM NaCl, 0.5 mM 
TCEP, 10 mM CaCl2, 20 mM MgCl2), 400 µM NADH, 2 mM PEP, 2 mM ATP, 2U mL
-
1 LDH, 1.5U mL-1 PK, 50-100 µM (Sigma Aldrich) substrate peptide (camtide2, 
Altabioscience) and 500 nM Calmodulin. 50 nM of CaMK1D were used. Assay 
reactions were conducted at room temperature and monitored by measuring the 
change in NADH (ε = 6220 M-1) absorbance at 340 nM over five minutes. Specific 
activity was determined from initial reaction rates.  
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Nuclear Magnetic Resonance Experiments 
 
Triple resonance 
All triple resonance experiments were performed at 25 °C (298 K) on the Varian 
Inova 800 and 900 MHz NMR spectrometers equipped with triple resonance 
cryogenic probes with Z-axis pulse field gradients. Backbone assignments were 
accomplised from TROSY versions of 1H,15N-HSQC, HNCO, HN(CA)CO, 
HN(CO)CA, HNCA, HNCACB and HN(COCA)CB (Gardner and Kay 1998). Spectra 
were processed with NMRPipe (Delaglio, Grzesiek et al. 1995) and analysed using 
CCPNMR analysis (Vranken, Boucher et al. 2005). 2H, 15N, 13C, labelled CaMK1D 
was buffer exchanged into in 50 mM Na phosphate pH 7.0, 75 mM NaCl, 0.5 mM 
TCEP, 0.02 % NaN3 and 10 % 
2H2O. 
 
1D 1H and ePHOGSY  
One dimensional 1H spectra were acquired on a Varian 800 MHz at 25 °C (298K) 
using the standard water sequence from the Varian biopack. Parameters such as the 
90° pulse and T.O.F (transmitter offset) value were calibrated for each 1H NMR 
experiment. The ePHOGSY experiments were conducted by Dr Christian Ludwid 
and Dr Sundaresan Rajesh using a final protein concentration of 10 μM TOPK in 
buffer containing 25 mM HEPES pH 7.5, 150 NaCl, 10 mM MgCl2. A final AMPPNP 
concentration of 1 mM was titrated into 10 μM TOPK to test for binding. Spectra 
were processed and analysed using NMRLab (Gunther, Ludwig et al. 2000). 
 
2D 1H, 15N HSQC and 1H, 15N TROSY-HSQC 
Two dimensional 1H, 15N HSQC and 1H, 15N TROSY-HSQC experiments were 
acquired on a Varian 800 MHz at 25 °C using the gNhsqc sequence from the Varian 
biopack. The 90° pulse, T.O.F value, and PwN were calibrated for each 1H, 15N 
HSQC and TROSY-HSQC experiment. All CaMK1D titrations conducted by 1H, 15N 
TROSY-HSQC experiments were performed in 50 mM HEPES pH 7.5, 150 mM 
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NaCl, 0.5 mM TCEP, 0.02 % NaN3 and 10 % 2H2O. Spectra were acquired with 16 
scans and 128 increments.   
 
Crystallography and NMR system (CNS) 
The crystal structure of CaMK1D (2JC6) was used as the starting point for structural 
refinement. For the initial structure residues defined in the crystal structure were kept 
rigid (residues 11-58, 64-164, and 185-313). Loops which were not defined by the 
crystal structure were created and given random coil orientation. Restraints derived 
from TALOS (Shen, Delaglio et al. 2009), were in-putted as  and  dihedral angle 
constraints. A modified simulated annealing protocol from CNS (Brunger, Adams et 
al. 1998; Brunger 2007) was used to refine the structure generating ten structures. 
This consisted of two slow cooling steps, the first consisting of 1000 steps cooling 
from 5000 K and the second consisting of 3000 steps cooling from 2000 K, followed 
by a final energy minimisation step. The simulated annealing protocol was repeated 
four times using the structure from the previous run as the starting structure for the 
next.
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Chapter III Results 
Evaluation of TOPK for NMR studies 
 
TOPK purified as a monomer by size exclusion  
The TOPK SGC cDNA clone that was used to evaluate its potential for NMR studies 
was 99 % identical to wild type TOPK dubbed TOPK full length. The only difference 
between the clones is the deletion of residue E2 (Figure 3.0). This construct was 
designed by the SGC with the E2 deletion to aid crystallization by either alleviating 
electrostatic repulsions that could hinder ordered protein-protein interactions during 
crystallization or to reduce the entropic cost of forming ordered intermolecular 
contacts. In terms of structure and function, this deletion is unlikely to have any 
impact as it is located at the N-terminus and not within the KD. 1H, 15N and 2H, 15N 
labelled TOPK were expressed and purified to 95 % purity based on SDS PAGE. 
Purification step involving SEC revealed two peaks. SDS PAGE confirmed that the 
larger second elution peak corresponded to TOPK and was estimated to be 
monomeric by SEC based on comparison to known protein standards (Figure 3.2). 
followed by a sharp peak in anion exchange (Figure 3.3). Exchange of amide 2H for 
1H was facilitated by buffer exchanging into TRIZMA buffer at pH 9.0.  
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Figure 3.0. TOPK domain architechture.  
Full length TOPK consists of an unstructured N-terminus featuring a regulatory 
phosphorylation site, T9, KD that includes C-terminal T/S-X-V PDZ interaction motif, 
cdk1 interaction, cyclin B1, PRC1, and microtubule interaction sites. An unstructured 
N-terminus Two TOPK cDNA clones were engineered by the SGC dubbed TOPK 
and TOPK10-322 length is shown for comparison with TOPK and TOPK10-322. Both 
TOPK and TOPK10-322 constructs encodes the ePK catalytic domain and the C-
terminal T/S-X-V PDZ interacting motif represented by the white and yellow boxes 
respectively. Our TOPK construct is almost identical to TOPK full length except for 
the deletion of E2. However it does retain T9, which is a phosphorylation site 
reported to modulate the activity of TOPK. In TOPK10-322, T9 is absent due to N-
terminal deletion of the first 9 residues. Phosphorylation of Thr 198 is also required 
for activity. Within the ePK catalytic domain the gray box highlights the substrate 
binding region with known substrate targets mapped below. The total number of 
residues shown in brackets includes residues resulting from the TEV protease 
cleavage site i.e. residues Gly and His shown figure. The gray boxes indicate cdk1, 
cyclin B1, PRC1,and microtubule interaction sites. 
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        10         20         30         40         50 
M-GISNFKTP SKLSEKKKSV LCSTPTINIP ASPFMQKLGF GTGVNVYLMK 
        60         70         80         90        100 
RSPRGLSHSP WAVKKINPIC NDHYRSVYQK RLMDEAKILK SLHHPNIVGY 
       110        120        130        140        150 
RAFTEANDGS LCLAMEYGGE KSLNDLIEER YKASQDPFPA AIILKVALNM 
       160        170        180        190        200 
ARGLKYLHQE KKLLHGDIKS SNVVIKGDFE TIKICDVGVS LPLDENMTVT 
       210        220        230        240        250 
DPEACYIGTE PWKPKEAVEE NGVITDKADI FAFGLTLWEM MTLSIPHINL 
       260        270        280        290        300 
SNDDDDEDKT FDESDFDDEA YYAALGTRPP INMEELDESY QKVIELFSVC 
       310        320 
TNEDPKDRPS AAHIVEALET DV 
 
Predicted pI = 5.0  
 
Figure 3.1. TOPK primary sequence. 
Active TOPK requires phosphorylation of residues T9 and T198 which are 
highlighted in red. An unusual aspartic acid rich region located within the substrate 
binding region is underlined. Residue E2 was deleted by the SGC to aid 
crystallisation.  
 
 
 
 110 
 
 
Figure 3.2. TOPK SEC elution profile. 
On a superdex 75 26/60 column, TOPK elutes as the second large elution peak 
between 140-165 mL as confirmed by SDS PAGE. By comparison with protein 
standards, the peak suggests a monomeric species corresponding to the 36 kDa 
TOPK 
 
 Figure 3.3. TOPK anion exchange elution profile.  
On a resource Q column, TOPK was eluted over a 0-100% NaCl gradient. A single 
elution peak at 25% (250 mM) NaCl corresponds to TOPK.  
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1H, 15N HSQC of TOPK shows only 70 % of the expected backbone 
amide resonance peaks  
A 1H, 15N HSQC spectrum of 1H, 15N TOPK was acquired to assess its backbone 
structure and backbone amide resonance peak count (Figure 3.4). The spectrum 
reveals that E. coli expressed TOPK is folded due to the observation of downfield 
amide resonance peakdispersion within the amide region (8.5-11.5 ppm 1H 
dimension). Furthermore amide resonance peaks with strong intensities are evident 
suggesting a stable backbone, although a small subset of resonance peaks with 
weak intensity are also present, suggesting that the backbone also has some 
intrinsic dynamic behaviour. The backbone amide resonance peak count was 
approximately 70 % of the expected total (215/303). At least 90 % is expected for a 
straight forward amide directed backbone assignment. Peak overlap also was 
evident in the centre of the spectrum.  
 
2H labelling did not increase the amide resonance peak count 
Due to the lower than expected peak count and overlap it was necessary to improve 
the spectrum before pursuing a feasible backbone assignment. ttempts to improve 
the 1H, 15N HSQC spectrum were first made by acquiring a 1H, 15H TROSY-HSQC 
(Figure 3.5) on a 2H, 15N TOPK sample (expressed using M9 minimal media 
containing 99% 2H2O) which improved the resolution and intensity of peaks but did 
not increase the amide peak count. The lack of additional amide peaks with 2H 
labelled TOPK suggests that the missing peaks (broadened beyond detection) was 
not due to increased T2 relaxation associated with large molecular weight proteins. 
Instead we suspect that broadening was due to intermediate exchange phenomena. 
A comparison of the TOPK 1H, 15N HSQC and 1H, 15N TROSY HSQC spectra by 
superimposition (Figure 3.6) indicates that the peak counts are similar but highlights 
the improved line shape produced by the TROSY spectrum. 
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Figure 3.4. TOPK 1H, 15N HSQC.  
Backbone amide resonance peak dispersion in the 1H, 15N HSQC spectrum 
illustrates that expression of 15N TOPK in E. coli is folded. Approximately 215 out of 
303 expected amide peaks were observable. Considerable amide resonance overlap 
is apparent in the centre of the spectrum. Three Trp side chain amide 1Hε 
resonances appear to be present (10.0-10.5 ppm 1H dimension, 129-131 ppm 15N 
dimension). The spectrum was acquired with 200 µM 1H 15N TOPK in 50 mM 
HEPES pH 7.5, 100 mM NaCl, 2.0 mM TCEP, 100 µM AEBSF, 10 % 2H2O, on a 
Varian 800 MHZ at 30 °C. 
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Figure 3.5. 2H, 15N TOPK TROSY-HSQC.  
Amide resonance dispersion in the spectrum reveals that 2H, 15N TOPK is folded. 
Due to the TROSY effect the line shapes appear narrower when compared to the 
TOPK HSQC (Figure 3.4). However, 2H labelling does not increase the peak count 
suggesting that the missing peaks are not due to increased T2 relaxation associated 
with the large molecular weight of TOPK but because of intrinsic intermediate 
exchange broadening. The spectrum was acquired with 200 µM 2H, 15N TOPK in 50 
mM HEPES pH 7.5, 100 mM NaCl, 2.0 mM TCEP, 100 µM AEBSF, 10 % 2H2O on a 
Varian 800 MHZ at 30 °C. 
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Figure 3.6. TOPK 1H, 15N HSQC and TROSY-HSQC. 
Superimposition of the 1H, 15N HSQC (black) of 1H, 15N TOPK and 1H, 15N TROSY-
HSQC (red) of 2H 15N TOPK indicates that they are nearly identical. Differences are 
evident in the Asn and Gln side chain amide region (6.2-8.0ppm 1H dimension, 110-
115 ppm 15N dimension) in which the intensity of these amide resonances appear 
weaker in the 1H, 15N TROSY-HSQC compared to the 1H, 15N HSQC. Moreover the 
TROSY-HSQC spectrum of 2H, 15N TOPK exhibits narrower lineshapes and stronger 
signal intensity resulting in greater resolution compared to the HSQC spectrum. Both 
spectra were acquired as previously described for the TOPK 1H, 15N HSQC and 1H, 
15N TROSY-HSQC using 200 µM TOPK in 50 mM HEPES pH 7.5, 100 mM NaCl, 2.0 
mM TCEP, 100 µM AEBSF, 10 % 2H2O at 30 °C. 
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ThermofluorTM suggests that TOPK exhibits low-moderate thermal stability in 
buffers that range from pH 6-8 
From our initial 1H, 15N HSQC spectrum of TOPK it became apparent that the amide 
peak count was insufficient for an informative backbone assignment. In order to 
improve on the TOPK amide peak count we screened different buffer solution 
conditions that improved TOPK stability using thermofluorTM, a thermal denaturing 
assay that can estimate the melting temperature (Tm) of a protein and therefore 
indicate protein stability. Sigmoidal melting curves are produced by thermofluorTM for 
a protein that undergoes a transition from a folded to unfolded state. The Tm can be 
estimated from the midpoint of the sigmoidal thermal melting curve. Our buffer 
screen contained buffer solution conditions that varied in buffer type, pH, and 
stabilizers.  
 
Improving the stability of TOPK and other protein kinases was of interest because 
we wanted to validate whether an increase in stability could also conceivably 
translate into significantly improved NMR spectra. Since most protein kinases are 
highly dynamic entities we believe that the stability and dynamics of a kinase are 
inherently related thus a kinase with high stability should possess limited dynamics 
and vice versa. By increasing the stability of a kinase we aim to reduce its mobility 
and alter the dynamics of its backbone amide resonances. Consequently residues 
that are stabilized become more rigid which translates to backbone amide 
resonances with stronger signal intensity. Amide resonances that have broadened 
out due to dynamics on an intermediate exchange timescale should therefore 
produce an observable resonance signal assuming their dynamic properties can be 
changed by stabilization.  
 
Assessing the Tm of TOPK in different buffer conditions was therefore necessary to 
find an optimal condition that increased protein stability whilst improving its NMR 
spectra. Figure 3.7 presents the melting curves for TOPK in the different buffers and 
pH that range from 6.0-8.0. These results indicate that TOPK has Tm values that 
range from 42.0-51.0 °C, although the higher Tm values do not appear to correlate 
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with a higher pH. For example our default buffer of 50 mM HEPES pH 7.5, produced 
a Tm of 47.5 °C, whereas, 50 mM Na cocadylate pH 6.5, mM Na phosphate pH 7.0 
and 50 mM Tris pH 8.0 produced a Tm of 48.2, 51.0 and 50.3 °C respectively. Based 
on our experience with thermofluorTM and other kinases, we define a ΔTm > 2.0 °C 
as being a significant change in stability. Furthermore we consider the range of 
TOPK Tm values to fall within a range that is typical of low-moderate protein stability 
(<45 °C is low, 45-55 °C is moderate stability, >55 °C is high stability). This 
approximate correlation between Tm and actual protein stability was established by 
comparing thermofluorTM data with microdrop screening, another method for 
validation of protein stability by visually monitoring precipition over time (Lepre 
1998). 
 
Thus the ΔTm of Tris pH 8.0 and Na phosphate pH 7.5 with respect to HEPES pH 
7.5 were considered to be significant with ΔTm of +2.8 and +3.0 °C respectively, 
whereas the ΔTm between HEPES pH 7.5 and Na cocadylate pH 6.5 was +0.7 °C 
suggesting an insignificant change in stability. We expected the stability of TOPK to 
increase at higher pH because the predicted isoelectric point (pI) of TOPK is 5.0, 
hence there was an increase in Tm for Tris pH 8.0 but with Na phosphate pH 7.0 we 
suspect that the Tm increase maybe due to the presence of phosphate. This 
suggests a buffer type effect that can impart stability despite the pH being slightly 
lower than our default pH. It is possible that the mechanism behind this is due to the 
phosphate ions binding to the active site cleft and stabilizing it.  
 
ThermofluorTM suggests that NaCl increases TOPK stability 
In the context of NMR, a high pH is not ideal for observing the maximum number of 
amide peaks in a 1H, 15N HSQC because the exchange rate of the amide 1H with the 
solvent is base catalysed. At basic pH, the average lifetime of the protonated amide 
will be shorter, having greater propensity to be deprotonated, which results in amides 
resonances with weaker intensity. Hence the pH we selected for studying kinases 
was typically within the 6.5-7.5 range depending on the stability of the kinase and its 
predicted pI. Stabilizers in our buffer screen were therefore important in increasing 
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kinase stability. For example, 150 mM NaCl was often associated with an increase in 
the Tm by 2 °C or more (data not shown).  
 
The amide peak count for TOPK did not improve at pH 7.0 
Considering our thermofluorTM results for the buffer, pH and stabilizer effects on the 
Tm of TOPK, we decided to lower the default buffer pH and validate any potential 
improvements in the TOPK 1H, 15N HSQC. Thus TOPK was prepared in 50 mM 
HEPES pH 7.0, 150 mM NaCl, 2.0 mM TCEP, 100 µM AEBSF and 10 % 2H2O. 
Another buffer solution was prepared as described but with Na phosphate pH 7.0 
subsituted for HEPES pH 7.0 because thermofluorTM results implied an increase in 
Tm with Na phosphate pH 7.0. Subsequent 1H, 15N HSQC spectra in the new buffer 
solutions showed no significant improvements in the peak count (data not shown). 
Despite changing buffer conditions via buffer type, pH and stabilizers to increase 
TOPK stability in terms of Tm this did not correlate with a significant improvement in 
NMR spectra. 
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Figure 3.7. TOPK thermofluor.pH screen  
TOPK thermal stability was assessed in various buffer types and pH by 
thermofluorTM. In the buffers that were tested, the highest Tm that TOPK displayed 
was 51.0 °C in 50 mM Na phosphate pH 7.0. Conversely Bis-Tris pH 6.0 produced 
the lowest Tm most likely because the pH is near the TOPK predicted pI of 5.0. 
Results could not be obtained for 50 mM MOPS pH 7.0 because the buffer was not 
available. 
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Bacterially expressed TOPK is inactive and the active site is occluded 
Although the TOPK spectra confirmed that it was folded, the functional state of the 
protein was unknown. Therefore TOPK activity was assessed using a kinase 
radioactivity assay (Park, Lin et al. 2006). Phosphorylation of the substrate Histone 
H3 was not observed for TOPK thus indicating inactivity (Figure). However activity 
was evident with our positive control, TOPK-Invitrogen. This suggests that our 
bacterially expressed TOPK is inactive whereas TOPK-Invitrogen expressed from an 
insect cell line exhibited kinase activity. We presume that bacterially expressed 
TOPK is lacking the necessary post translational modifications necessary for TOPK 
activation. Presumably TOPK-Invitrogen is active because in insect cells it is able to 
receive the necessary post translational modifications from activating kinases that 
phosphorylate Thr 9 and Thr 198 (Invitrogen 2007). Active TOPK has been produced 
by Abe et al using cell lysates as a bulk activation method. Cdk1 is known to 
phoshorylate TOPK Thr 9 but the kinase which phosphorylates Thr 198 remains 
undetermined (Abe, Matsumoto et al. 2000; Matsumoto, Abe et al. 2004; Abe, 
Takeuchi et al. 2007). Sequence analysis of TOPK reveals that Thr 198 is located 
within the activation loop suggesting that this residue is implicated in up-regulating 
kinase activity in a phosphorylation dependent mechanism analogous to PKA and 
the tyrosine kinase domain of the insulin receptor (InRK) aswell as many other 
kinases (Adams 2003). 
 
Furthermore, we hypothesised that TOPK inactivity might correlate with inhibition of 
the active site cleft. Therefore binding of Mg2+-AMPPNP to the active site was 
assessed by the 1D NMR ePHOGSY experiment. Results indicates that TOPK does 
not exhibit any binding to Mg2+-AMPPNP (Figure 3.8 A, B, C) because summation of 
the two spectra (1H spectrum and presaturated 1H spectrum) show no overall 
difference, thus suggesting that TOPK active site cleft is occluded. Our collaborators 
the SGC (data not shown) performed high throughput ligand screening against 
TOPK using thermofluorTM with their library of kinase inhibitors but found no hits 
reinforcing the idea that the ATP binding site was somehow occluded. PDZ, a known 
substrate of TOPK also failed to indicate any obvious interactions (data not shown) 
suggesting that the substrate binding site was also inhibited. 
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Figure 3.8 A and B. ePHOGSY individual spectra of Mg2+-AMPPNP in the 
presence and absence of TOPK.  
The upper spectrum illustrates the control experiment: 1H spectrum of Mg2+-
AMPPNP (black) and its pre-saturated equivalent (red) .The lower spectrum is the 
actual binding experiment: 1H spectrum of TOPK+ Mg2+-AMPPNP (blue) and its pre-
saturated equivalent (green).  
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Figure 3.8 C. ePHOGSY difference spectra of Mg2+-AMPPNP, and TOPK + Mg2+-
AMPPNP.  
The summation of the Mg2+-AMPPNP (red) and TOPK + Mg2+-AMPPNP (green) 
ePHOGSY spectra illustrates that there is no significant difference between them 
therefore suggesting that TOPK did not bind AMPPNP. If binding were to occur then 
this would be indicated by negative AMPPNP resonances in the spectrum after 
summation of the apo ligand and bound ligand spectra. The 1H resonances occurring 
near 2 ppm are due to buffer contamination in the TOPK + Mg2+-AMPPNP sample.  
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Evalution of TOPK10-322 for NMR studies 
 
A putative TOPK N-terminal AID 
The mechanism behind TOPK inactivity is unknown but we suspect that the TOPK 
N-terminus has a putative autoinhibitory role. Therefore nine N-terminal residues of 
TOPK were deleted (TOPKΔ1-9) and we termed this construct TOPK10-322. Our 
deletion includes Thr 9, a phosphorylation site believed to up-regulate TOPK activity. 
It is known that once Thr 9 is phosphorylated by cdk1, the affinity of TOPK for 
cdk1/cyclin B1 increases (Matsumoto, Abe et al. 2004). We hypothesise that 
phosphorylation on Thr 9 and binding of cdk1cyclin B1 relieves autoinhibiton 
imparted by the N-terminus through local and possibly allosteric conformational 
changes resulting in TOPK activation. Moreover we anticipate that conformational 
changes associated with activation could improve on the TOPK 1H, 15N HSQC 
spectrum. This is because conformational changes correlate with changes in 
dynamics therefore if the backbone amides peaks under intermediate exchange in 
inactive TOPK experience conformational changes upon activation then this may 
shift them towards fast or slow exchange, phenomena which are observable.    
 
TOPK10-322 purified to 95 % purity and is monomeric 
TOPK10-322 was expressed and purified to 95 % purity based on SDS PAGE. 
Deletion of TOPKΔ1-9 had negligible effects on TOPK10-322 expression and 
purification when compared to TOPK. Size exclusion purification of TOPK10-322 
produced a single monomeric peak corresponding to a 36 kDa protein (Figure 3.9). 
In the subsequent anion exchange purification, TOPK10-322 eluted as a sharp peak 
(Figure 3.10). Exchange of amide 2H for 1H was facilitated by buffer exchanging into 
TRIZMA buffer at pH 9.0.  
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Figure 3.9. TOPK10-322 Size exclusion elution profile.  
TOPK10-322 is 35 kDa and appears monomeric by size exclusion purification (S75 
column) because it elutes between 150–165 ml. This is a position that corresponds 
to a 35 kDa species based on comparison with the elution of protein standards. 
 
 
Figure 3.10. TOPK10-322 anion exchange elution profile. 
TOPK10-322 elutes as a single sharp peak by anion exchange purification 
(Resource Q column) at approximately 25% of 1M NaCl (250 mM) with 95 % purity 
by SDS PAGE. 
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TOPK10-322 is folded but only an estimated 66 % of expected backbone amide 
resonances are observable in its 1H, 15N HSQC 
A 1H, 15N HSQC spectrum of 1H, 15N labelled TOPK10-322 (Figure 3.11) revealed 
amide resonance dispersion indicative of a folded protein. Most of the amide 
resonances showed moderate signal intensity. A minority of weaker amide 
resonances were also evident suggesting that they corresponded to the dynamic 
regions of TOPK10-322. In the centre of the spectrum resonance overlap is 
apparent. The peak count was estimated to be 194 out of 295 expected backbone 
amide peaks which equates to approximately 66 % of the total. This is a lower than 
the total backbone amide peak count in TOPK which had 70 % of its expected amide 
resonances visible. Thus TOPK10-322 did not improve on the TOPK peak count and 
indicates that TOPKΔ1-9 has made 4 % more peaks enter intermediate exchange 
and become unobservable. Furthermore it suggests that in TOPK the backbone 
amide peaks in intermediate exchange are not due to the N-terminal segment. It is 
possible that relief of autoinhibition imparted by TOPKΔ1-9 and subsequent 
activation has caused parts of TOPK to become more dynamic on an intermediate 
exchange time scale. An alternative possibility is that deletion of TOPKΔ1-9 
destabilizes TOPK and therefore increases its dynamic behaviour in the intermediate 
exchange regime. 
 
2H labelling did not improve the TOPK peak count 
A 1H, 15N TROSY-HSQC spectrum of 2H, 15N labelled TOPK10-322 (Figure 3.12) did 
not exhibit any significant improvement in the peak count suggesting that the 
unobserved backbone amide resonances was due to intrinsic dynamics on an 
intermediate exchange timescale. However, notable spectral improvements were 
evident in the line shapes which were finer and the peak intensities were stronger 
relative to the HSQC spectrum (Figure 3.13). 
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The backbone solution conformations of TOPK10-322 and TOPK are similar 
We compared the backbone conformation of TOPK10-322 with TOPK by 
superimposing their spectra (Figure 3.14). This revealed that their global backbone 
conformations are similar with only a few slight CSPs. Deletion of TOPKΔ1-9 
therefore does not significantly alter the backbone conformation of TOPK. 
Differences are evident in the central region of the superimposed spectra where 
there appears to be less amide resonance overlap with TOPK10-322 presumably 
because some peaks have undergone CSP, intermediate exchange, or have simply 
been removed as they are part of the TOPKΔ1-9 segment.  
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Figure 3.11. TOPK10-322 
1H, 15N HSQC.  
Amide resonance dispersion in the 1H, 15N HSQC spectrum of 1H, 15N labelled 
TOPK10-322 illustrates that the construct is folded. An approximate peak count of 
backbone amides was estimated to be 211 out of 295 expected peaks (72% of the 
total). The spectrum was acquired with 200 µM TOPK10-322 in 50 mM HEPES pH 
7.5, 100 mM NaCl, 2.0 mM TCEP, 100 µM AEBSF, 10 % 2H2O at 30°C on a Varian 
800 MHZ.  
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Figure 3.12. TOPK10-322 
1H, 15N TROSY-HSQC.  
Only a slight improvement in the line shape is evident in the 1H, 15N TROSY-HSQC 
of 2H, 15N labelled TOPK10-322 when compared to the 1H, 15N HSQC of 1H, 15N 
labelled TOPK10-322. No additional backbone amide peaks were evident. The 
TROSY spectrum was acquired under the same conditions as described for the 1H, 
15N HSQC of TOPK10-322 with 200 µM TOPK10-322 in 50 mM HEPES pH 7.5, 100 
mM NaCl, 2.0 mM TCEP, 100 µM AEBSF, 10 % 2H2O on a Varian 800 MHZ at 30°C.  
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Figure 3.13. TOPK10-322 1H, 15N HSQC and TROSY-HSQC.  
A comparison of the 1H, 15N TOPK10-322 1H, 15N HSQC (black) and 2H, 15N 
TOPK10-322 1H, 15N TROSY-HSQC (red) by superimposition illustrates that they are 
both identical in peak count. The line shapes of backbone amide resonances in the 
1H, 15N TROSY-HSQC are sharper due to the TROSY effect and resonance 
intensities are slightly stronger due to 2H labelling. Both spectra were acquired with 
200 µM TOPK10-322 in 50 mM HEPES pH 7.5, 100 mM NaCl, 2.0 mM TCEP, 100 
µM AEBSF, 10 % 2H2O on a Varian 800 MHZ at 30 °C.  
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Figure 3.14. TOPK 1H, 15N HSQC and TOPK10-322 1H, 15N HSQC 
 Superimposition of the 1H, 15N HSQC spectra for 1H, 15N TOPK (black) and 1H, 15N 
TOPK10-322 (red) reveals that their backbone conformations are similar. Many of 
the peaks superimpose with minimal difference in chemical shift, indicating that 
deletion of TOPKΔ1-9 has not significantly altered the TOPK backbone 
conformation. However differences are apparent in the central region of the 
superimposed spectra with the TOPK10-322 displaying less resonance overlap. 
Each respective spectrum was acquired as previously described. 
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ThermofluorTM suggests that TOPK10-322 exhibits low-moderate thermal 
stability in buffers that range from pH 6-8 
Buffer screening was conducted on TOPK10-322 by thermofluorTM (Figure 3.15) to 
find an optimal buffer pH for NMR without compromising stability. As a result of this 
TOPK10-322 produced Tm values that ranged from 41.6-46.6 °C, which suggested a 
kinase with low-moderate stability. Results indicated that TOPK10-322 was most 
stable in 50 mM Tris pH 8.0 with an average Tm of 46.6 °C. Unfortunately its 
average Tm in HEPES pH 7.5 could not be determined due to non-sigmoidal melting 
curves. In 50 mM Na phosphate pH 7.0, 50 mM Na cocadylate pH 6.5, 50 mM MES 
pH 6.5 and 50 mM Bis-Tris pH 6.5, TOPK10-322 produced Tm values corresponding 
to 46.0, 44.0, 41.6 and 41.7 °C respectively. A comparison of these Tm values for 
TOPK10-322 with the Tm values of TOPK acquired in the equivalent buffer type and 
pH reveals that TOPK has greater thermal stability. This suggests that the 
differences in Tm between TOPK10-322 and TOPK are due to TOPKΔ1-9 causing 
destabilization. For example, there is a ΔTm of 4 °C between TOPK and TOPK10-
322 in 50 mM Na phosphate pH 7.0. Moreover with the exception of MES pH 6.5, 
there appears to be a correlation between increasing Tm and increasing pH. In 
contrast TOPK does not exhibit this correlation despite having the same pI as 
TOPK10-322 because TOPKΔ1-9 does not have any effect on the pI. The lack of 
correlation in TOPK maybe an artefact associated with sample aggregation, 
precipitation or degradation. Screening of stabilizers indicated that 150 mM NaCl 
increased the Tm of TOPK10-322 in a similar extent to TOPK (data not shown). 
 
The amide peak count for TOPK10-322 did not improve at pH 6.5 
In order to improve the NMR spectra of TOPK10-322 in terms of its amide peak 
count we decided to lower the buffer pH from 7.5 to 6.5 based on our evaluation of 
Tm data for TOPK10-322 whilst considering that TOPK did not improve its peak 
count that at pH 7.0. A comparison of the 1H, 15N labelled TOPK10-322 1H, 15N 
HSQC at pH 7.5 and 6.5 showed that lowering the pH to 6.5 had no significant effect 
on the peak count therefore there was no change in the number of observable 
backbone amide resonances. Only a few pH dependent CSPs were evident when 
lowering the pH (Figure 3.16).  
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Figure 3.15. TOPK10-322 thermofluor pH screen. 
The thermal stability of TOPK10-322 was assessed in different buffer types and pH 
by thermofluorTM to estimate its optimal pH for stability. Of the buffers that were 
tested 50 mM TRIS pH 8.0 appeared to produce the highest Tm of 46.6 °C. At lower 
pH the Tm of TOPK is significantly lower, for example 50 mM Bis-Tris pH 6.0 and 50 
mM MES pH 6.5 produce Tm values of 41.7 and 41.6 °C respectively. However in 50 
mM Na cocadylate pH 6.5, the Tm is 44.0 °C which is higher than the Tm produced 
by 50 mM MES pH 6.5 suggesting the difference in stability could be a buffer type 
effect. Results for 50 mM HEPES pH 7.5 was omitted due to non-sigmoidal melting 
curves. 50 mM MOPS pH 7.0 was not available for testing. 
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Figure 3.16. TOPK10-322 1H, 15N HSQC pH 7.5 and 6.5.  
In order to increase the peak count of TOPK10-322 the pH of the buffer was lowered 
from 7.5 (blue) to 6.5 (red). However an overlay of the 1H, 15N HSQC of TOPK10-
322 at pH 7.0 and pH 6.5 revealed that additional peaks were not evident at pH 6.5. 
Only a few pH dependent CSPs were notable as indicated by the arrows. The 
spectra were acquired with 0.2 mM TOPK10-322 buffer in 50 mM HEPES pH 7.5 
(blue), pH 6.5 (red), 100 mM NaCl, 2.0 mM TCEP, 100 µM AEBSF, 10 % 2H2O at 30 
°C on a Varian 800 MHz. 
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TOPK10-322 and TOPK_D9_D198 are inactive  
Bacterially expressed TOPK10-322 was shown by its 1H, 15N HSQC spectrum to be 
folded although its functional state was unknown. TOPK10-322 was tested for 
activity in a kinase radioactivity assay (Park, Lin et al. 2006) which revealed it to be 
inactive because phosphorylation of the substrate Histone H3 was not observed 
(Figure). This suggests that TOPKΔ1-9 is not sufficient in activating TOPK. It is 
possible that residues imparting autoinhibition on TOPK may extend beyond Thr 9 
because the beginning of the kinase boundary is defined from Ser 32 based on 
primary sequence databases (kinbase ; uniprot). Alternatively our hypothesis of an 
N-terminal autoinhibitory segment could be wrong. Both TOPK and TOPK10-322 
lack Thr 198 phosphorylation which could also explain the inactivity of our TOPK 
constructs. Consequently we produced single and double phosphorylation mimics by 
mutating Thr 9 and Thr 198 to Asp 9 and Asp 198, respectively to try and active 
TOPK. However these constructs did not display any activity when tested with the 
NADH coupled activity assay (data not shown). 
 
ThermofluorTM assay suggests TOPK_T9D_T198D is folded and exhibits low-
moderate thermal stability in buffers range from pH 6-8  
Kinase activity was not detected for TOPK_T9D_T198D and we were unsure of its 
folded state. Due to time constraints a 1H, 15N labelled sample of TOPK_T9D_T198D 
could not be prepared for structural analysis. Instead thermofluorTM was used to 
quickly gain insight into the stability of the double mutant. Buffer screening by 
thermofluorTM suggested that TOPK_T9D_T198D was folded because it exhibited 
sigmoidal melting curves characteristic of a folded protein (Figure 3.17). Tm values 
for TOPK_T9D_T198D ranged from 42.9-46.6 °C, suggesting low-moderate stability. 
The highest Tm corresponded to 50 mM TRIS pH 8.0. TOPK_T9D_T198D stability 
appears to increase with pH although the ΔTm with increasing pH starting from pH 
6.5 was less than 2.0 °C. This suggests that the change in stability within the pH 
range of 6.5-8.0 was not significant. ThermofluorTM results also indicate that 
TOPK_T9D_T198D was less stable in 50 mM MES pH 6.5 compared to 50 mM 
MOPS pH 6.5 with a ΔTm = 2.3 °C, which suggests a potential buffer type effect. 
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Figure 3.17. TOPK_T9D_T198D thermofluor pH screen. 
Characterisation of TOPK_T9D_T198D thermal stability in different buffer types and 
pH was conducted by thermofluorTM. Sigmoidal melting curves typical of a folded 
protein were produced suggesting that the double mutation has not unfolded the 
protein. Stability of TOPK_T9D_T198D appears to correlate positively with high pH. 
Both 50 mM Bis-Tris pH 6.0 and 50 mM Na cocadylate pH 6.5 were omitted as they 
produced non-sigmoidal melting curves.  
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Evalutation of Pim1 for NMR studies 
 
Pim1 purified to 90 % purity despite His6-tag cleavage issues 
Another kinase target provided by the SGC for NMR analysis was Pim1, a well 
characterised therapeutic target. Pim1 (Figure 3.18, 3.19) was initially expressed and 
purified to 90 % purity based on SDS PAGE but at half the expected yield due to 
difficulty encountered with Pim1 His6-tag cleavage mediated by TEV protease. Only 
50 % cleavage was observed by SDS PAGE which meant that 50 % of Pim1 
retained its N-terminal His6 tag and could not be further purified. Despite attempts to 
optimise the cleavage efficiency of TEV protease, it was discovered that due to the 
constitutive activity of Pim1 (Qian, Wang et al. 2005), the N-terminal His6-tag was 
phosphorylated by Pim1 (Jacobs, Black et al. 2005). This interfered with the ability of 
TEV protease to cleave the TEV site adjacent to the His6-tag but the issue was 
resolved by adding alkaline phosphatase. Purified Pim1 produced a peak with a 
slight shoulder suggesting the presence of contaminants that co elute at a similar 
size (Figure 3.22) although SDS PAGE indicates 90% purity. 
 
Pim1 is constitutively active  
A radioactive kinase activity assay (Park, Lin et al. 2006) was used to assess the  
activity of Pim1 and confirmed it to be constitutively active because phosphorylation 
of the generic substrate Histone H3 was detected in the autoradiograph. However 
Pim1 did not exhibit autophosphorylation (Figure 3.28). It is believed that because 
Pim1 is constitutively active, undergoing autophosphorylation during expression but 
not dephosphorylation (Bullock, Debreczeni et al. 2005). Therefore we postulate that 
all Pim1 autophosphorylation sites were already phosphorylated which would 
account for the lack of autophosphorylation with Pim1 in the radioactive assay. 
Elucidation of the Pim1 phosphorylation state was not confirmed. 
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Figure 3.18. Pim1 full length 44kDa and 34kDa variants. 
Our Pim1 construct is 99% identical to the Pim1 full length 34kDa shorter variant. 
Residue Gly 250 in the 34kDa Pim1 variant however is replaced by Arg 250 in our 
construct due to a single residue polymorphism. 
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       100        110        120        130        140 
 MLLSKINSL AHLRAAPCND LHATKLAPGK EKEPLESQYQ VGPLLGSGGF 
       150        160        170        180        190 
GSVYSGIRVS DNLPVAIKHV EKDRISDWGE LPNGTRVPME VVLLKKVSSG 
       200        210        220        230        240 
FSGVIRLLDW FERPDSFVLI LERPEPVQDL FDFITERGAL QEELARSFFW 
       250        260        270        280        290 
QVLEAVRHCH NCGVLHRDIK DENILIDLNR GELKLIDFGS GALLKDTVYT 
       300        310        320        330        340 
DFDGTRVYSP PEWIRYHRYH GRSAAVWSLG ILLYDMVCGD IPFEHDEEII 
       350        360        370        380        390 
RGQVFFRQRV SSECQHLIRW CLALRPSDRP TFEEIQNHPW MQDVLLPQET 
       400   
AEIHLHSLSP GPSK 
 
Predicted pI = 5.7 
 
Figure 3.19. Pim1 primary sequence. 
The primary sequence encoded for our Pim1 construct and its predicted pI are 
shown. Pim1 is constitutively active and does not require phosphorylation for 
activation but it can undergo autophosphorylation. 
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Figure 3.20. SDS PAGE of His6-Pim1 Ni
2+ NTA purification. 
Elution fractions were pooled from fraction number 3-9. 
 
Figure 3.21. SDS PAGE of Pim1 post His6-tag cleavage. 
Pim in the FT and Eq fractions were pooled after overnight incubation with TEV 
followed by Ni2+ NTA purification to purify from incomplete His6-tag cleavage, free 
His6-tag, and other protein contaminants. 
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Figure 3.22. Pim1 size exclusion elution profile and SDS PAGE.  
Pim1 purified by size exclusion purification (S75 26/60 column) elutes approximately 
between 145–165 ml. A slight shoulder in the peak is due to a large molecular weight 
contaminant that elutes at a similar size and shape. Pim1 is 34 kDa and elutes at a 
position that correlates to a 34 kDa species based on comparison with protein 
standards eluted by size exclusion. Pim1 therefore appears to be monomeric. 
Fractions highlighted by the red box were pooled together. 
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Pim1 is folded but the majority of expected backbone amide resonances are 
unobservable in its 1H, 15N HSQC 
Having deduced that purified Pim1 is constitutively actively we decided to analyse its 
backbone solution structure. A 1H, 15N HSQC spectrum of 1H, 15N labelled Pim1 
(Figure 3.23) reveals that a significant number of backbone amide resonances are 
missing thus yielding a very low peak count for a protein expected to have 302 
backbone amide peaks. Most of the observable backbone amide resonances appear 
near the centre of the spectrum with limited dispersion. They also display non-
uniform resonance intensities suggesting that Pim1 is dynamic in solution. Only four 
out of six Trp side chain amide Hε resonances are visible but their presence 
indicates a folded protein. Many of the expected backbone amide resonances that 
were not observed were likely undergoing intermediate exchange phenomena but 
also the large number resonances that broaden out suggests possible aggregation 
resulting in a larger molecular weight species and thus a slower tumbling rate. 
Another potential issue that might have contributed to the low spectral quality of 
Pim1 was sample heterogeneity arising from multiple phosphorylated Pim1 species. 
Precipitation of Pim1 after acquisition of its 1H, 15N HSQC at 25 °C was also evident 
thus indicating low stability. This would contribute towards the uniform reduction in 
amide peak intensity. Considering all these difficulties associated with Pim1 we 
conclude that a backbone assignment of Pim1 is not feasible without further 
extensive optimisation. 
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Figure 3.23. Pim1 1H, 15N HSQC.  
Pim1 exhibits a significantly lower than expected amide peak count for a 34k Da 
protein composed of 313 residues. Backbone amide resonance dispersion appears 
to be narrow and clustered around the center of the spectrum. Dispersed Trp side 
chain amide 1Hε resonances are evident  in the 1H, 15N HSQC spectrum (9.8-10.3 
ppm 1H dimension, 128-130 ppm 15N dimension) suggesting that Pim1 is folded. 
Most of the amide resonances are unobservable because they are suspected to be 
in intermediate exchange or broadened out due to intrinsic intermediate dynamics 
and aggregation respectively. To confirm the folded state of Pim1 an activity assay 
was conducted and demonstrated that Pim1 is constitutively active indicating that it 
is folded. The spectrum was acquired with 200µM 1H, 15N Pim1 at 25°C in 50 mM 
HEPES pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 0.02 % Na azide, 10 % 2H2O on a 
Varian 800 MHZ. 
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Pim1 is intrinsically dynamic and is conformationally unstable 
In order to further understand the dynamic behaviour of Pim1 we examined the B-
factors (also known as the temperature factor) associated with the crystal structure 
of Pim1 in complex with the bisindolymaleimide I, hydrochloride (BIM-1) inhibitor 
because B-factors describe the thermal motion about each atom and indicate 
mobility (Willis 1975; Ringe and Petsko 1986). Figure 3.24 reveals that intermediate 
and high B-factors (based on the B-factor scale) span the Pim1 structure thus 
indicating that Pim1 exhibits intermediate and high levels of mobility over many parts 
of both Pim1 kinase lobes even with Bim-1 bound to the active site cleft. Evidently 
the B-factors support the notion previously inferred from the Pim1 1H, 15N HSQC that 
Pim1 is a dynamic entity but it is likely that the true extent of Pim1 dynamics is 
greater in apo form because there would be no constraints imposed by the inhibitor 
on Pim1.  
 
However, a potential caveat associated with the B-factors is the influence of crystal 
lattice contacts which can mask or reduce regions of mobility. Even so, intermediate 
and high levels of mobility are still apparent in the Pim1 B-factors. Considering the B-
factors, 1H, 15N HSQC and activity data presented for Pim1, we postulate that the 
dynamic properties of Pim1 are inherently linked to its constitutively active nature. 
The rationale for this is based on the notion that the active site cleft of constitutively 
active Pim1 dynamically interconverts between an ensemble of catalytically 
productive and non-productive conformations. Therefore we expect such 
conformational changes around the active site cleft to convey mobility across both 
Pim1 kinase lobes and about the connecting hinge since the hinge and interface 
between the lobes define the active site cleft. 
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Figure 3.24 Pim1-BIM1 inhibitor crystal structure and B-factors. 
Pim1 in complex with the BIM-1 inhibitor (PDB: 1XWS) exhibits a canonical kinase 
fold comprised of an N-terminal ATP binding lobe and a larger C-terminal substrate 
binding lobe. Notably the activation loop is well defined. B-factors describe the 
dynamic and rigid regions of Pim1 which displays high (red and orange), 
intermediate (green and yellow) and low (blue) B-factors across both the N-terminal 
and C-terminal lobes.  
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ThermofluorTM suggests that Pim1 exhibits low-moderate stability in buffers 
that range from pH 6-8 
Optimisation of the default Pim1 NMR buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 
0.5 mM TCEP, 0.02% Na Azide, 10 % 2H2O) was necessary in order to try and 
improve its stability and amide peak count. Different buffer conditions were screened 
using the thermofluorTM assay although evaluation of Pim1 stability was difficult 
because Pim1 often produced atypical sigmoidal melting curves with a high initial 
fluorescence suggesting that the protein sample was precipitated, unfolded and 
aggregated. Extensive efforts to resolve this required high speed centrifugation and 
re-purification by size exclusion to remove precipitation and aggregation 
respectively. 
 
Figure 3.25 presents the thermofluorTM results for Pim1 in different buffer types in 
which the effect of pH on Pim1 stability was assessed. Our data shows that the Tm 
of Pim1 ranges from 43.5-46.5 °C for the tested buffer types with pH varying from 
6.0-8.0 and suggests that Pim1 has low-moderate stability. In addition, the Tm of 
Pim1 does not vary significantly with pH and there is no apparent correlation 
between Tm and pH with the lowest Tm produced by 50 mM Na phosphate pH 7.0 
and the highest Tm produced by 50 mM MES pH 6.5. Compared to the default buffer 
type of 50 mM HEPES pH 7.5, which produced a Tm of 44.7 °C, the Tm of Pim1 in 
50 mM MES pH 6.5 was 46.5 °C, corresponding to a ΔTm of 1.8 °C. This suggests 
an increase in stability even though MES pH 6.5 is closer than HEPES pH 7.5 to the 
Pim1 predicted pI of 5.7. It is possible that this result is an artefact or the predicted pI 
is not 5.7. 
 
The amide peak count for Pim1 did not improve at pH 6.5 
Despite this we substituted 50 mM MES pH 6.5 for 50 mM HEPES pH 7.5 in our 
default NMR buffer in order to try and improve the amide peak count because 
thermofluorTM results suggested that there was an insignificant change in the stability 
of Pim1 at pH 6.5 compared to the default pH 7.5. Subsequently the effect of 
lowering the pH on Pim1 in terms of its amide peak count and stability was validated 
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by acquiring a 1H, 15N HSQC at 25 °C. Disappointingly the resulting spectrum (data 
not shown) did not yield any significant improvement in the amide peak count 
compared to Pim1 in its default NMR buffer. Likewise no improvement in stability 
was apparent because precipitation was evident after acquiring the 1H, 15N HSQC 
spectrum, thus suggesting that an increase in Tm of 1.8 °C at pH 6.5 versus pH 7.5 
was not sufficient for a significant change in Pim1 stability or the thermofluorTM data 
was a false estimate. The lack of correlation between buffer pH and stability made it 
difficult to predict an optimal pH for NMR studies without significantly compromising 
protein stability. 
 
Lowering the pH did not improve the amide peak count of Pim1 and given that Pim1 
produces a low quality 1H, 15N HSQC and exhibits low stability suggests that the 
spectrum and stability of Pim1 are intrinsically correlated to some extent. It was 
therefore important to try and address this as a potential means of improving the 
spectral quality of Pim1. Further estimates of the Tm for Pim1 in different buffers 
even in the presence of 150 mM NaCl as a stabiliser proved difficult due to 
thermofluorTM data yielding non-sigmoidal melting curves. Optimisation of Pim1 NMR 
spectra in terms of its buffer conditions was therefore not pursued any further.  
 
BIM-1 binds to Pim1 and increases its stability 
Our previous efforts to screen different buffer conditions with varying pH and 
additives to find an optimal condition that improved the NMR spectra and stability of 
Pim1 proved unsuccessful. Therefore we explored an alternative strategy for 
optimising the stability of Pim1 involving the use of ligands that promote stabilization 
of Pim1. The rationale behind this was to suppress the constitutive activity of Pim1 
and thus change its dynamic properties so that Pim1 adopts a single stable 
conformation as opposed to the multiple conformations that we suspect it samples 
when constitutively active. With a reduction in Pim1 mobility we expect a 
concomitant increase in amide peak intensity, CSPs and a change in the dynamics 
of its backbone amide resonances. 
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Before proceeding with the ligand mediated stabilization strategy by NMR we first 
assessed Pim1 ligand binding using thermofluorTM by starting with a known tight 
binding inhibitor termed Bisindolymaleimide I, Hydrochloride (BIM-1), a water soluble 
reversible ATP competitive inhibitor that binds and inhibits PKC with a Ki of 10 nM 
and PKA with a Ki of 2 µM. However a Ki for Pim1 binding to BIM-1 is not known but 
the interaction is presumed to be relatively tight because it was co-crystallised with 
Pim1 by the SGC (PDB: 1XWS). AMPPNP was a weak binding Pim1 ligand that we 
also assessed by thermofluorTM for comparison with BIM-1. The resulting ΔTm 
induced by each ligand was determined to infer the change in Pim1 stability. In the 
presence of BIM-1 the Tm of Pim1 increases with increasing concentrations of BIM-1 
suggesting that the BIM-1 binds to Pim1 in a stabilizing manner (Figure 3.26). For 
example it is evident that at 1, 10 and 100 µM BIM-1 the ΔTm relative to apo Pim1 
increases by 2.3, 4.7, and 8.3 °C respectively suggesting a tight binding and stable 
interaction. In contrast, addition of AMPPNP up to 1 mM exhibited a ΔTm = -0.6 °C 
indicating a decrease in Tm but because the ΔTm < 2 °C we considered this to be an 
insignificant. It also suggests that the interaction is very weak (Figure 43). We 
believe that there is at least a weak interaction because Pim1 is constitutively active 
and therefore receptive to nucleotide binding.  
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Figure 3.25. Pim1 thermofluor pH screening. 
Pim1 thermal stability was characterised in various buffer types and pH. No apparent 
correlation is evident between the Tm of Pim1 and buffer pH. Our thermofluorTM data 
suggests that Pim1 has a maximum Tm of 45.6 °C when the buffer type and pH is 50 
mM MES pH 6.5. An average Tm for 50 mM MOPS pH 7.0 was not determined due 
non-sigmoidal melting curves. 
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Figure 3.26. Pim1 ligand binding by thermofluor. 
Binding of BIM-1 and AMPPNP to Pim1 were tested by thermofluorTM. An 
insignificant ΔTm is associated with Pim1 in the presence of 0.25, 0.5, and 1.0 mM 
AMPPNP indicative of a weak interaction. However in the presence of 1.0, 10.0, and 
100.0 µM BIM-1 there is a significant increase in the Tm of Pim1 by 2.3, 4.7 and 8.3 
°C respectively suggesting that a high affinity thermally stable complex is formed 
with BIM-1. 
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Pim1-BIM-1 inhibitor complex did not improve the 1H, 15N HSQC spectrum 
Pim1 binding to the BIM-1 inhibitor was previously validated by thermofluorTM and 
suggested to bind tightly. For NMR analysis 1 mM BIM-1 was added to Pim1 to 
ensure complete saturation and this inhibition of Pim1. Figure 3.27 illustrates the 1H, 
15N HSQC of the Pim1-BIM-1 complex and reveals that the strategy of forming a 
single stable complex did not improve the spectrum. Some amide resonances 
experience CSPs thus indicating an interaction between Pim1 and BIM-1. However 
no significant increase in the amide peak count and intensity was observed. This 
implied that the stable Pim1-BIM-1 complex did not significantly perturb the dynamic 
behaviour for most of the Pim1 backbone amides and did not significantly reduce its 
suspected tendency to aggregate. 
 
Another strategy that might improve Pim1 1H, 15N HSQC would be to increase the 
temperature above 25 °C because temperature can also affect the dynamic 
properties of a protein. However, due to the low thermal stability of Pim1 even after 
screening other buffer solution conditions by thermofluorTM this was not possible. 
Despite showing functional activity Pim1 was thus abandoned as a kinase target by 
NMR due to the intractability of assignment. 
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Figure 3.27. apo Pim1 and Pim1-BIM-1 complex HSQC.  
Superimposition of the apo Pim1 1H, 15N HSQC (blue) with the Pim1-BIM-1 complex 
1H, 15N HSQC (red) reveals CSPs induced by BIM-1 interacting with Pim1. slow 
exchange indicative of tight binding after the addition of 1 mM BIM-1. The interaction 
of BIM-1 with Pim1 however does not increase the peak count. The spectra were 
acquired with 0.2 mM 1H, 15N Pim1 at 25°C in 50 mM Hepes pH 7.5, 150 mM NaCl, 
0.5 mM TCEP, 0.02 % Na azide, 10 % 2H2O on a Varian 800 MHZ. The BIM-1 
compound was solubilised in the same buffer conditions. 
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Figure 3.28. Kinase radioactivity assay presented as a silverstain and 
autoradiograph. 
In both the silver stain (upper figure) and autoradiograph (lower figure) lanes 1, 5, 9, 
13 correspond to Kinase incubated with substrate Histone H3 in the presence of 
γ32P-ATP and reaction buffer. Lanes 2, 6, 10, 14 correspond to substrate Histone H3 
in the presence of γ32P-ATP and reaction buffer but no kinase. Lanes 3, 7, 11, 15 
correspond to kinase incubated with γ32P-ATP and reaction buffer but no substrate 
Histone H3. Lanes 4, 8, 12, 16 correspond to kinase incubated with substrate 
Histone H3 and reaction buffer but no γ32P-ATP. Box A highlights the detection of 
TOPK-Invitrogen autophosphorylation with γ32P-ATP. Box B and D highlights the 
detection of Histone H3 phosphorylated with γ32P-ATP, therefore confirming active 
TOPK-Invitrogen and Pim1 respectively. Box C highlights autophosphorylation of 
TOPK-Invitrogen but in the absence of Histone H3. Our E.coli expressed TOPK 
constructs did not exhibit any activity. In summary TOPK-Invitrogen and Pim1 are 
active, TOPK and TOPK10-322 are inactive. Red and yellow arrows denote 
monomeric and dimeric forms of Histone H3 respectively. 
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TOPK and Pim1 are unsuitable targets for NMR   
Despite optimisation of buffer conditions, formation of a stable kinase-inhibitor 
complex and construct truncation, we evaluate that TOPK and Pim1 are not 
amenable targets for NMR because both kinases have a large number of backbone 
amide resonances that broaden out into intermediate exchange. We believe this 
phenomenon is due to their inherent dynamics which cannot be altered based on our 
current optimisation strategies. A secondary issue with Pim1 is its poor thermal 
stability and tendency to precipitat which were emphasised during thermofluorTM 
experiments. Although Pim1 was constitutively active, our TOPK E.coli expressed 
constructs were inactive and was also found to lack binding activity to any ligands 
despite a high throughput ligand screen conducted by the SGC. This would suggest 
that the TOPK nucleotide binding site was inaccessible in bacterially expressed form. 
 
Analysis of CaMK1D, CaMK1G, CSNK1G3 and PAK5 as potential NMR targets 
Due to the poor 1H, 15N HSQC spectra produced by TOPK and Pim1, backbone 
assignments could not be accomplished and subsequent solution structure 
characterisation could not progress further. We therefore continued our analysis of 
kinases by NMR using different kinases. Several cDNA kinase targets were provided 
by the SGC cloned into the pNIC28a-Bsa expression vector that included CaMK1D, 
CaMK1G, CSNK1G3, PAK5, and VRK2. PAK4 was cloned into a pGEX vector. All of 
these kinase targets were transformed into their default expression host cell lines 
and expressed and purified as described in chapter II. The kinase targets which 
yielded soluble amounts of 1H, 15N labelled protein sufficient for a 1H, 15N HSQC 
were CaMK1D, CaMK1G, CSNK1G3 and PAK5, whereas PAK4 and VRK2 failed to 
express and were not pursued further. All the subsequent preliminary kinase 1H, 15N 
HSQC spectra were acquired in 50 mM Na Phosphate pH 7.5, 150 mM NaCl, 0.5 
mM TCEP, 0.02% Na Azide as the default NMR buffer and their results are 
described in the following sections below. These protein kinases were also screened 
in different buffer conditions using the thermofluorTM assay in order to assess their 
thermal stability in different buffer types and pH for potential buffer solution 
optimisation. 
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Evaluation of PAK5 for NMR studies 
 
PAK5 purified to 95% purity and is monomeric by size exclusion folded 
Full length PAK5 is an 80 kDa protein encompassing an N-terminal p21 binding 
domain (PBD), AID and C-terminal kinase catalytic domain. However the PAK5 
construct provided by the SGC only encodes the catalytic domain and we refer to 
this as PAK5 (Figure 3.29, 3.30). PAK5 was expressed and purified to 95% purity 
based on SDS PAGE (Figure 3.31-3.33). Size exclusion purification of PAK5 (Figure 
3.31) suggests that it is monomeric because it elutes as a single peak in a position 
that correlates to a 34 kDa species based on comparison with the elution of protein 
standards.  
 
PAK5 is folded and with an estimated 80 % of the total expected backbone 
amide resonances observable in its 1H, 15N HSQC 
A 1H, 15N HSQC spectrum of PAK5 shown in figure 3.34 illustrates that PAK5 is 
folded due to evidence of amide resonance dispersion. Significantly there are also a 
large number of backbone amide resonances that are visible. Most of these 
resonances show strong to moderate signal intensity but a large subset of amide 
resonances also display very weak intensities thus indicating that the protein 
conformation is dynamic in solution. In addition to this the weak intensities may also 
be due to fast T2 relaxation, a phenomenon associated with large proteins. Initial 
peak count estimates that there are 225 amide resonances with the total number of 
expected backbone amides equal to 280. Therefore the spectrum illustrates 80 % of 
the total expected backbone amide peaks. In the bottom left corner of the spectrum 
where Trp side chain amide Hε resonances reside, only one Trp side chain is readily 
observable whereas the other two exhibit very weak signal intensity and have folded 
over into the top left corner of the spectrum (11.5-10.5 ppm 1H dimension, 105-104 
ppm 15N dimension). They occur in this position of the spectrum because they were 
not acquired within the spectral width of the HSQC in the 15N dimension. 
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Figure 3.29. PAK5 full length and PAK5 KD construct.  
Our PAK5 construct only encodes the kinase catalytic domain from residue 425-719. 
In PAK5 full length the nuclear localisation signal and proline rich region and C-
terminal potential integrin binding domain are shown as red, yellow, and black 
vertical lines respectively. The green box represents the N-terminal p21-binding 
domain (PDB) also known as the Cdc42/Rac which contains the CRIB motif. The 
gray box represents the autoinhibitory domain (AID). 
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       430        440        450        460        470 
    SRVSHE QFRAALQLVV SPGDPREYLA NFIKIGEGST GIVCIATEKH 
       480        490        500        510        520 
TGKQVAVKKM DLRKQQRREL LFNEVVIMRD YHHDNVVDMY SSYLVGDELW 
       530        540        550        560        570 
VVMEFLEGGA LTDIVTHTRM NEEQIATVCL SVLRALSYLH NQGVIHRDIK 
       580        590        600        610        620 
SDSILLTSDG RIKLSDFGFC AQVSKEVPKR KSLVGTPYWM APEVISRLPY 
       630        640        650        660        670 
GTEVDIWSLG IMVIEMIDGE PPYFNEPPLQ AMRRIRDSLP PRVKDLHKVS 
       680        690        700        710        
SVLRGFLDLM LVREPSQRAT AQELLGHPFL KLAGPPSCIV PLMRQYRHH 
 
Predicted pI = 7.7 
 
Figure 3.30. PAK5 primary sequence. 
The primary sequence encoded for our PAK5 construct and its predicted pI are 
shown. 
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Figure 3.31. SDS PAGE of His6-PAK5 Ni
2+ NTA purification.  
Elution fractions were pooled from fraction number 2-9. 
 
 
Figure 3.32. SDS PAGE of PAK5 post His6-tag cleavage. 
PAK5 in the W and Eq fractions were pooled after overnight incubation with TEV 
followed by Ni2+ NTA purification to purify from incomplete His6-tag cleavage (black 
arrow), free His6-tag, and other protein contaminants. 
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Figure 3.33. PAK5 size exclusion elution profile.  
PAK5 is 34 kDa and appears monomeric by size exclusion purification (S75 column) 
because the position it elutes at (165-185 ml) corresponds to a 34 kDa species. The 
correlation between molecular weight and position of elution is based on comparison 
with the elution of protein standards. PAK5 was eluted in 50 mM Na phosphate pH 
7.5, 150 mM NaCl, 0.5 mM TCEP, 0.02 % Na Azide. Fractions highlighted by the red 
box were pooled together. 
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Figure 3.34. PAK5 1H, 15N HSQC. 
Amide resonance dispersion is evident in 1H, 15N HSQC of PAK5 indicating that it is 
folded. A few of the amide resonances display weak intensity possibly due to 
dynamics approaching an intermediate exchange timescale or potentially because of 
fast T2 relaxation due to the large molecular weight of the protein. The spectrum was 
acquired with 0.2 mM 1H, 15N PAK5 at 25°C in 50 mM Na Phosphate pH 7.5, 150 
mM NaCl, 0.5 mM TCEP, 0.02 % Na azide, 10 % 2H2O on a Varian 800 MHZ. 
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PAK5 dynamics suggest a stable conformation 
An analysis of PAK5 B-factors was conducted to probe any correlation between the 
PAK5 B-factors and its 1H, 15N HSQC. Figure 3.35 illustrates the B-factor 
representation of PAK5 revealing that the core of the C-terminal lobe has 
predominantly low B-factors indicative of minimal flexibility. Likewise the N-terminal 
lobe and hinge region show low B-factors. Only a couple of loops and β1 strand 
display intermediate B-factors (20 Å2) in the N-terminal lobe. Not surprisingly the 
most mobile regions of PAK5 are the N-termini and C-termini with both 
demonstrating high B-factors. Globally PAK5 appears relatively rigid suggesting 
limited dynamics. This correlates reasonably well with the PAK5 1H, 15N HSQC 
(Figure 49) because a large number of backbone amide resonances are observable 
with mostly strong to moderate intensity suggesting limited dynamics. Therefore it is 
highly likely these resonances correlate to the rigid portions of PAK5 that show low 
B-factors. A subset of backbone amide resonances broaden out beyond detection 
presumably because they exhibit dynamics on an intermediate exchange time scale. 
We postulate that these resonances are likely to correspond to the mobile loop 
regions described by intermediate and high B-factors.  
 
ThermofluorTM suggests that PAK5 exhibits moderate-high thermal stability in 
buffers that range from pH 6-8 
An evaluation of PAK5 thermal stability in different buffer conditions was necessary 
as a strategy for improving the PAK 1H, 15N HSQC amide peak count. Data from 
thermofluorTM experiments are presented in figure 3.36. It is evident that Tm of PAK5 
did not differ significantly in the buffers tested. The range of Tm for PAK5 falls mainly 
between 55.4-56.2 °C suggesting that it is equally stable in all the tested buffer types 
exhibiting moderate-high stability and that there is no obvious correlation between 
Tm and pH. Only in 50 mM Bis-Tris pH 6.0 was the Tm outside of this narrow range 
with a Tm of 53.4 °C. Thermal melting curves with a Tm that shift by only 1-2 °C are 
not considered significant. Due to the lack of correlation between the buffer 
conditions and pH, optimisation of the PAK5 NMR buffer was difficult to predict. 
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Figure 3.35 apo PAK5 crystal structure and B-factors.  
The apo PAK5 crystal structure illustrates that the catalytic domain adopts the typical 
kinase fold comprised of an N-terminal ATP binding lobe and C-terminal substrate 
binding lobe. The B-factor representation of PAK5 illustrates the dynamic and rigid 
regions of the protein kinase. The N-terminal and C-terminal regions display the 
highest B-factor values thus corresponding to the most mobile parts of PAK5. The 
core regions of both lobes appear rigid as they are described by low B-factors. 
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Figure 3.36. PAK 5 thermofluor pH screen. 
Evaluation of PAK5 thermal stability in different buffer types and pH was conducted 
by thermofluorTM. With the exception of 50 mM Bis-Tris pH 6.0 which had a Tm of 
53.4 °C, the Tm of PAK5 is consistently similar in the all buffer types and pH showing 
a narrow Tm range of 55.4-56.2 °C. PAK5 has a predicted pI of 7.7 but according to 
thermofluorTM, the pI must be higher than pH 8.0 or lower than pH 6.0 because a Tm 
around 55 °C suggests a stable protein far from its pI assuming the results are not 
false positives.  
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PAK5 1H, 15N HSQC amide peak count did not increase at pH 7.0 
Although the PAK5 1H, 15N HSQC showed 80 % of the total expected backbone 
amide peaks further optimisation was necessary to increase this in order to achieve 
a more complete backbone assignment. Furthermore a large subset of peaks 
displayed weak and moderate intensity which is not ideal for backbone assignment. 
Optimisation was attempted by lowering the pH from 7.5 to 7.0 assuming no 
compromise in stability based on the thermofluorTM results. The PAK5 1H, 15N HSQC 
spectrum at pH 7.0 (Figure 3.37) reveals that the signal intensity of some amide 
resonances does increase but was not significant enough for additional amide 
resonances to be observed.  
 
Unfortunately at pH 7.0 there was an increase in PAK5 precipitation compared to  pH 
7.5 during experimental acquisition of the 1H, 15N HSQC at 25 °C. This implies that 
the thermal stability of PAK5 is lower than suggested by thermofluorTM. A 1H, 15N 
TROSY-HSQC of PAK5 (Figure 3.38) illustrates that there is a slight improvement 
over the 1H, 15N HSQC with better line shapes and resolution due to the TROSY 
effect. Further optimisation would require deuteration which might address the lower 
than expected total peak count if amide resonance broadening was due to fast T2 
relaxation associated with its large molecular weight. Resonance intensities should 
also improve with deuteration however further optimisation was not attempted 
because the 1H, 15N HSQC demonstrated by CaMK1D was superior and required 
less optimisation. 
 
 165 
 
 
 
Figure 3.37. PAK5 1H, 15N HSQC at pH 7.0 and pH 7.5.  
An overlay of the PAK5 1H, 15N, HSQC at pH 7.5 (black) and at 7.0 (red) illustrates 
that the spectra are nearly identical. No significant improvements in terms of 
additional peaks were observed at pH 7.0 compared to pH 7.5 but an increase in 
precipitation resulted at pH 7.0. Buffer solution conditions were the same as in 
previous PAK5 spectra. 
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Figure 3.38. PAK5 1H, 15N HSQC and TROSY HSQC at pH 7.0. 
Superimposition of the PAK5 1H, 15N HSQC (black) in its default buffer at pH 7.0 with 
the  PAK5 1H, 15N TROSY-HSQC (blue) in the same buffer at pH 7.0 illustrates an 
improvement in line shape due to the TROSY effect. Notably the signal intensity for a 
few peaks in the TROSY spectrum is reduced and is also due to the TROSY effect. 
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Evaluation CaMK1D for NMR studies 
 
CaMK1D purified to 95 % purity and is monomeric by size exclusion 
Initial expression and purification of 1H, 15N CaMK1D revealed yields of about 10 mg 
L-1 of culture (M9 minimal media) could be obtained and purified to 95 % purity based 
on SDS PAGE whilst size exclusion purification suggests that it purifies as a 
monomeric 37.8 kDa species (Figure 3.41-3.43). Furthermore CaMK1D 
demonstrated activity in our NADH coupled assay when in the presence of 
Ca2+/CaM indicating that CaMK1D was folded and functional. 
 
CaMK1D is folded with an estimated 85 % of the total expected backbone 
amide resonances observable in its 1H, 15N HSQC 
Autoinhibited CaMK1D is comprised of 334 residues (Figure 3.39, 3.40) and the total 
number of expected amide resonances is 322. Our preliminary 1H, 15N HSQC of 
CaMK1D (Figure 3.44) illustrates a spectrum with a large number of observable 
amide resonances. An estimate of the peak count suggests 275 backbone amide 
peaks were visible correlating to an 85 % of the total expected backbone amide 
peaks. Apart from the centre of the spectrum where there is considerable resonance 
overlap the rest of the resonances are well dispersed indicating that the construct is 
folded. Strong signal intensity is associated with the majority of the amide 
resonances implying a stable conformation but some amide resonances with 
intermediate and weak intensities are also apparent suggesting that CaMK1D 
contains dynamic elements. CaMK1D contains five Trp residues and four Trp side 
chain amide Hε resonances are initially observable in the expected bottom left area 
of the spectrum. The remaining unobserved Trp side chain amide Hε resonance was 
only visible at low contour level because it displayed very weak signal intensity. It is 
possible that this particular Trp side chain amide Hε resonance was experiencing 
dynamic exchange that was approaching an intermediate exchange timescale. 
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Figure 3.39. CaMK1D full length and CaMK1D SGC construct. 
The SGC CaMK1D constructs encode the kinase catalytic domain and the regulatory 
AID including the CBD. The C-terminal stretch of residues of unknown function is 
truncated and lacks the remaining 52 residues. 
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1        10         20         30         40        50 
MARENGESSS SWKKQAEDIK KIFEFKETLG TGAFSEVVLA EEKATGKLFA 
        60         70         80         90        100 
VKCIPKKALK GKESSIENEI AVLRKIKHEN IVALEDIYES PNHLYLVMQL 
       110        120        130        140        150 
VSGGELFDRI VEKGFYTEKD ASTLIRQVLD AVYYLHRMGI VHRDLKPENL 
       160        170        180        190        200 
LYYSQDEESK IMISDFGLSK MEGKGDVMST ACGTPGYVAP EVLAQKPYSK 
       210        220        230        240        250 
AVDCWSIGVI AYILLCGYPP FYDENDSKLF EQILKAEYEF DSPYWDDISD 
       260        270        280        290        300 
SAKDFIRNLM EKDPNKRYTC EQAARHPWIA GDTALNKNIH ESVSAQIRKN 
       310        320        330  
FAKSKWRQAF NATAVVRHMR KLHLGSSLDS SNA 
 
Predicted pI = 6.1 
 
Figure 3.40 CaMK1D primary sequence. 
The primary sequence encoded for our CaMK1D construct and its predicted pI are 
shown. Thr 198 (highlighted in red) is phosphorylated by CaMKK for full activation. 
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Figure 3.41. SDS PAGE of His6-CaMK1D Ni
2+ NTA purification. 
Elution fractions were pooled from fraction number 1-12. 
 
 
Figure 3.42. SDS PAGE of CaMK1D post His6-tag cleavage. 
CaMK1D in the FT, Eq, and W fractions were pooled after overnight incubation with 
TEV followed by Ni2+ NTA purification to purify from incomplete His6-tag cleavage, 
free His6-tag, and other protein contaminants. 
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Figure 3.43. SDS PAGE of CaMK1D from size exclusion purification.  
CaMK1D is 37.8 kDa protein that elutes from about 150–180 ml. SDS PAGE of 
these fractions indicates 95 % purity. A higher molecular weight contaminant elutes 
from 130-140ml. CaMK1D was eluted in 50 mM Na phosphate pH 7.5, 150 mM 
NaCl, 0.5 mM TCEP, 0.02 % Na Azide. 
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Figure 3.44. CaMK1D 1H, 15N HSQC.  
The 1H, 15N HSQC of CaMK1D demonstrates amide resonance dispersion indicative 
of a folded protein with a large majority of the resonances displaying strong intensity. 
The spectrum was acquired with 0.2 mM 1H, 15N CaMK1D at 25°C in 50mM Na 
Phosphate pH 7.5, 150mM NaCl, 0.5mM TCEP, 0.02% Na Azide on a Varian 800 
MHZ. 
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CaMK1D dynamics suggests a stable conformation 
We previously inferred from the 1H, 15N HSQC of CaMK1D that the protein was in a 
relatively stable conformation and attempted to examine the CaMK1D B-factors to 
elucidate any potential correlation with the NMR spectrum. Figure 3.45 illustrates the 
B-factor representation of CaMK1D and highlights the dynamic and flexible regions 
of the protein. It is evident that both the N-terminal and C-terminal lobes exhibit high 
and intermediate levels of flexibility. One of the regions showing the highest B-
factors corresponds with the αC helix. This is not surprising because the αC helix is 
a mobile regulatory element in protein kinases and usually adopts a disordered or 
inactive conformation in kinases that are in an inactive state (Huse and Kuriyan 
2002). Another region of high flexibility appears near the base of the C-terminal lobe 
and corresponds to helix αH and the adjacent loop N-terminal to it.  
 
Compared to PAK5, the global structure of CaMK1D appears to be more dynamic 
and flexible in terms of its B-factors even in the presence of the GSK-3 XIII inhibitor. 
This however does not correlate with a poor 1H, 15N HSQC like Pim1, conversely the 
1H, 15N HSQC of apo CaMK1D is superior to PAK5 interms of a higher peak count 
and consistency of peak intensities. This suggests that in solution the CaMK1D 
backbone amide resonance intensities do not correlate with its B-factors. However 
this could suggest that the dynamics of the amide groups is manifested on a slow or 
fast exchange time scale as opposed to intermediate exchange broadening. A 
majority of the resonances are likely to be in a single stable conformation because 
most of the core regions of the N-terminal and C-terminal lobe are defined by low B-
factors. We postulate that stabilising role of the AID has a major influence on the 
dynamics of the resonances and is likely to reduce the number of conformations that 
CaMK1D can sample due to its autoinhibitory role as a pseudosubstrate. 
Furthermore low B-factors describe the AID which reinforces the notion that it is a 
rigid element. It is important to note that the B-factors reflect CaMK1D in complex 
with GSK-3 XIII whereas our 1H, 15N HSQC of CaMK1D is for the apo form therefore 
an accurate correlation between the NMR spectrum and B-factors is not possible. 
 
 174 
 
 
 
Figure 3.45 CaMK1D-GSK3 XIII inhibitor crystal structure and B-factors. 
The crystal structure of CaMK1D in complex with GSK-3 XIII inhibitor (PDB:2JC6) 
exhibits a canonical kinase fold comprised of an N-terminal ATP binding lobe and C-
terminal substrate binding lobe that is followed by a regulatory autoinhibitory domain. 
The activation loop, flexible N-termini and C-termini are not observable in this crystal 
structure due to limited electron density. The B-factor representation of CaMK1D 
illustrates the dynamic and rigid regions of the protein kinase. Notably the majority of 
the AID is very rigid and indicative of a stable pseudosubstrate interaction. 
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ThermofluorTM suggests that CaMK1D exhibits moderate-high thermal stability 
in buffers that range from pH 6-8 and correlates positively with increasing pH 
The thermal stability of CaMK1D was assessed in different buffer conditions using 
thermofluorTM to screen for conditions that might optimise its NMR spectra. Figure 
3.46 shows that the Tm of CaMK1D generally increases with high pH. For example 
the Tm of CaMK1D increases from 48.1-57.1 °C as the pH is shifted from pH 6.0 to 
pH 8.0. Presumably the rational for CaMK1D stability correlating with increasing pH 
is because at high pH we are further away from the predicted CaMK1D pI of 6.1 i.e. 
there is a greater overall surface net charge on CaMK1D thus increasing its solubility 
and stability. Moreover the range of Tm values suggests that CaMK1D has 
moderate-high stability. Notably the Tm of CaMK1D in 50 mM Na phosphate pH 7.0 
and 50 mM HEPES pH 7.5 was 55 and 56 °C respectively suggesting that these 
conditions can potentially produce moderate-high stability at pH that is appropriate 
for NMR. Therefore Na phosphate pH 7.0 and HEPES pH 7.5 were used to generate 
our default CaMK1D NMR buffer which contained 50 mM Na phosphate pH 7.5, 150 
mM NaCl, 0.5 mM TCEP, 0.02% Na Azide.  
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Figure 3.46. CaMK1D thermofluor pH screen. 
Using thermofluorTM the average CaMK1D Tm was determined in different buffer 
solutions. CaMK1D stability appears to correlate positively with increasing pH from 
6.0-80. Consequently CaMK1D appears to be most stable in 50 mM TRIS pH 8.0 
with a Tm of 57.1 °C. 
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CaMK1D 1H, 15N HSQC amide peak count did not increase at pH 7.0 but did 
increase the amide peak intensities 
Our initial 1H, 15N HSQC spectrum of CaMK1D was very promising and was 
therefore selected as the main kinase target for study by NMR. Additional 
optimisation was made by lowering the pH from 7.5 to 7.0 to increase the signal 
intensity of amide resonances and validate if additional resonances could be 
observable. In addition the NaCl concentration was also lowered to 75 mM to 
optimise the sensitivity of the cryoprobe. These buffer changes were made on the 
basis of thermofluorTM data which suggested that CaMK1D had an equivalent Tm in 
pH 7.0 and pH 7.5 and similarly for NaCl at 75 mM and 150 mM. 
 
Lowering the pH to 7.0 resulted in a 1H, 15N HSQC (Figure 3.47) that demonstrated 
resonances with greater signal intensity but additional resonances were not 
apparent. A few resonances exhibit pH dependent chemical shift perturbations. 
Notably a resonance in the top right corner of the spectrum (6.6 ppm 1H dimension, 
103 ppm 15N dimension). Subsequently a 1H, 15N TROSY-HSQC at pH 7.0 was 
acquired for further optimisation and reveals improved line shape and resolution. An 
overlay of this spectrum with the 1H, 15N HSQC spectrum at pH 7.0 shown in figure 
3.48 highlights these differences 
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Figure 3.47. CaMK1D 1H 15N HSQC, pH 7.0, 75 mM NaCl. 
In order to increase the peak count and optimise the sensitivity of the cryoprobe the 
default CaMK1D NMR buffer solution pH and NaCl was lowered from pH 7.5, 150 
mM NaCl (black) to pH 7.0, 75 mM NaCl (blue). The superimposed spectra indicates 
that at pH 7.0 and 75 mM NaCl the resonance intensities are greater due to 
increased protonation of the exchangeable amide groups and sensitivity 
enhancement of the cryoprobe however additional peaks were not evident. Some 
peaks at pH 7.0, 75 mM NaCl (blue) also did not superimpose with the default 
conditions (black) suggesting that these amide resonances where exhibiting pH 
dependent CSPs. 
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Figure 3.48. CaMK1D 1H 15N HSQC and TROSY HSQC, pH 7.0, 75 mM NaCl. 
Under the optimised buffer solution conditions using pH 7.0 and 75 mM NaCl, the 1H, 
15N TROSY-HSQC of CaMK1D (red) was acquired. This spectrum superimposed 
with the 1H 15N HSQC of CaMK1D (blue) acquired in the same optimised buffer 
solution demonstrates improved line shape and resolution of backbone amide 
resonances whilst resonance intensities of the Asn and Gln amides broaden out. 
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Evaluation of CaMK1G for NMR studies 
 
CaMK1G is folded but the majority of expected backbone amide resonances 
are unobservable in its 1H, 15N HSQC 
CaMK1G (Figure 3.49, 3.50) was purified to 90 % purity according to SDS PAGE 
and appeared to be monomeric by size exclusion (Figure 3.51-3.53). In contrast to 
CaMK1D, the 1H, 15N HSQC of CaMK1G (Figure 3.54) is inferior in all aspects. 
Although CaMK1G the spectrum suggests that CaMK1G is folded due to the 
presence of amide resonance dispersion and two dispersed Trp side chain amide Hε 
resonances there are a large number of expected backbone amide resonances 
missing. Theses observations are similar to Pim1 suggesting intermediate exchange 
dynamics and aggregation. The intensity of the few observable resonances ranges 
from moderate to very weak implying dynamic behaviour approaching intermediate 
exchange. Precipitation of the CaMK1G sample was evident after acquiring the 1H, 
15N HSQC spectrum at 25 °C which was likely to have reduced the intensity of the 
few observable resonances. It is somewhat unexpected that the CaMK1G spectrum 
is significantly inferior to CaMK1D considering that they high sequence identity. This 
suggests that the subtle differences in sequence between CaMK1D and CaMK1G 
are enough to significantly alter their intrinsic dynamic behaviour and aggregation 
properties.  
 
Interestingly we note that the CaMK1G construct is slightly truncated at the C-
terminal end of the CBD but hypothetically this should not affect the stability of the 
protein because the majority of the pseudosubstrate interactions are mediated by the 
AID which is N-terminal to the CBD but the 1H, 15N HSQC and low thermal stability of 
CaMK1G (Figure) suggest this is not the case. Instead it would appear that slight 
truncation of the CBD has destabilised the protein significantly which would imply 
that the CBD is implicated in key pseudosubstrate interactions. If this hypothesis is 
correct then the next likely strategy would be construct optimisation to improve the 
stability of CaMK1G and potentially it’s 1H, 15N HSQC spectrum either by truncating 
the regulatory domain further to remove the destabilizing effect or by extending it 
beyond the CBD to increase stabilizing pseudosubstrate interactions. Moreover 
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adjacent to the CBD is the C-terminal extension of CaMK1G which is functionally 
important in the targeting of CaMK1G to membranes. We postulate that some of 
these residues near the CBD may also form further stabilizing interactions across the 
N-terminal lobe but residues further upstream from this point are likely to be 
disordered, dynamic and flexible in the absence of a membrane surface. 
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Figure 3.49. CaMK1G full length and CaMK1G SGC construct.  
Our CaMK1G construct encodes the kinase catalytic domain and the regulatory AID 
which includes the overlapping CBD. The extended C-terminal stretch of residues 
and a small region of the CBD are both truncated. 
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        20         30         40         50         60 
    QTTNIR KTFIFMEVLG SGAFSEVFLV KQRLTGKLFA LKCIKKSPAF 
        70         80         90        100        110 
RDSSLENEIA VLKKIKHENI VTLEDIYEST THYYLVMQLV SGGELFDRIL 
       110        120        130        140        150 
ERGVYTEKDA SLVIQQVLSA VKYLHENGIV HRDLKPENLL YLTPEENSKI 
       160        170        180        190        200 
MITDFGLSKM EQNGIMSTAC GTPGYVAPEV LAQKPYSKAV DCWSIGVITY 
       210        220        230        240        250 
ILLCGYPPFY EETESKLFEK IKEGYYEFES PFWDDISESA KDFICHLLEK 
       260        270        280        290        300 
DPNERYTCEK ALSHPWIDGN TALHRDIYPS VSLQIQKNFA KSKWRQAFNA 
    
AAVVHH 
 
Predicted pI = 5.9 
 
Figure 3.50. CaMK1G primary sequence. 
The primary sequence encoded for our CaMK1G construct and its predicted pI are 
shown. 
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Figure 3.51. SDS PAGE of His6-CaMK1G Ni
2+ NTA purification. 
Elution fractions were pooled from fraction number 3-9. 
 
 
Figure 3.52. SDS PAGE of CaMK1G post His6-tag cleavage. 
CaMK1G in the FT and Eq fractions were pooled after overnight incubation with TEV 
followed by Ni2+ NTA purification to purify from incomplete His6-tag cleavage, free 
His6-tag, and other protein contaminants. 
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Figure 3.53. CaMK1G size exclusion elution profile and SDS PAGE. 
The 35 kDa CaMK1G elutes from about 155–180 ml and produces a monomeric 
peak that corresponds to 90% pure protein on SDS PAGE. Fractions pooled are 
indicated by the red box. 
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Figure 3.54. CaMK1G 1H, 15N HSQC. 
The 1H, 15N HSQC for CaMK1G displays a very low number backbone amide 
resonances suggesting that the majority of the resonances have broadened out due 
to intermediate exchange. The spectrum was acquired in 50 mM Na Phosphate pH 
7.5, 150mM NaCl, 0.5mM TCEP, 0.02% Na Azide at 25°C on a Varian 800 MHZ. 
 
 
 
 
 
 187 
 
CaMK1G dynamics suggests a relatively mobile conformation 
The B-factor values for CaMK1G (Figure 3.55) indicates that the whole protein is 
relatively mobile and dynamic with many loops and secondary structure elements 
across both lobes displaying intermediate B-factor values. In particular high B-factor 
values are also evident in the N-terminus, C-terminus, the regulatory αC helix, αI 
helix, and a loop between β1 and β2. In contrast to the crystal structure of CaMK1D, 
the activation loop of CaMK1G is well defined with the first few residues of the 
activation loop starting from DFG exhibiting low B-factor values. A comparison 
between CaMK1D and CaMK1G of the core regions of the N-terminal and C-terminal 
lobes implies that CaMK1G is more dynamic because its shows more intermediate 
B-factors in these areas. 
 
The region between the lobes comprising the active site cleft also appears more 
dynamic than in CaMK1D suggesting that there is more interlobe conformational 
plasticity associated with CaMK1G in its autoinhibited state than CaMK1D. The 
plasticity of these residues is presumably manifested in the 1H, 15N HSQC with many 
resonances broadening out into intermediate exchange. Furthermore the AID of 
CaMK1G in comparison to CaMK1D appears to be less rigid as it is highlighted by 
intermediate and high B-factors towards the C-terminal end of the first helix of the 
AID. The AID of CaMKIs is typically defined by a helix-loop-helix structure but it is 
evident in the crystal structure of CaMK1G that the latter part of the AID comprising 
the second helix was not determined. This missing region comprises of 14 residues 
corresponding to the sequence KWRQAFNAAAVVHH and we assume that they 
were not defined structurally due to poor electron density indicative of extreme 
flexibility and dynamics. The stability of CaMK1G is therefore expected to be lower 
than CaMK1D due to lower stability and increased mobility of the CaMK1G AID.  
 
We hypothesise that due to the higher intrinsic dynamic behaviour of CaMK1G and 
its less rigid AID, it is possible that CaMK1G is able to sample towards a more 
catalytically competent conformations than CaMK1D. In addition to this the activation 
loop of CaMK1G is well defined in its crystal structure, an observation that is usually 
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associated with an active kinase primed for cataylsis because in active kinases the 
activation loop is often stabilized to enagage in phosphate transfer and substrate 
interactions. In contrast the activation loop of CaMK1D is not well defined suggesting 
that it is adopting a more catalytically incompetent conformation. Although CaMKIs 
require activation loop phosphorylation for maximal activity against most substrates 
the observation of the stabilized CaMK1G activation loop in its autoinhibited state 
suggests that this conformation is primed for activity on a basal level.  
 
It would thus be interesting to compare the activation and catalytic loop of CaMK1G 
with those of constitutively active proteins like Pim1 to examine if CaMK1G is indeed 
sampling a catalytically competent state reflected by its activation loop. However the 
possibility of CaMK1G basal activity independent of Ca2+/CaM is unlikely because 
the AID is still engaged to the substrate binding. This is assuming that the AID 
although partially flexible is still occluding the substrate binding site via the 
pseudosubstrate mechanism.  
 
ThermofluorTM suggests that CaMK1G exhibits low thermal stability in buffers 
that range from pH 6-8 
An evaluation of CaMK1G thermal stability in different buffer conditions was 
conducted using thermofluorTM to explore solution conditions that could improve its 
low amide peak count and intensities. Our results in figure 3.56 show that CaMK1G 
does not exhibit much variation in Tm with buffer type and pH whilst showing no 
obvious correlation between Tm and pH. The differences in Tm between the diffeent 
buffers was only 0.5 °C which is considered insignifcant and indcates a narrow 
range. For example, in 50 mM Na phosphate pH 7.0 and 50 mM HEPES pH 7.5, the 
Tm of CaMK1G was 40.5 and 40.2 respectively °C. Furthermore these Tm values 
are within the low-moderate Tm stability range. This suggests that CaMK1G is 
significantly less stable than CaMK1D in the equivalent buffers and is consistent with 
our hypothesis that the increased flexibility of the CaMK1G and its AID makes 
CaMK1G less stable than CaMK1D. Due its intrinsic intermediate exchange 
dynamics and low stability, CaMK1G was subsequently dropped as an NMR target. 
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Figure 3.55 CaMK1G-inhibitor crystal structure and B-factors. 
The CaMK1G crystal structure in complex with (PDB:2JAM) exhibits a canonical 
kinase fold comprised of an N-terminal ATP binding lobe and C-terminal substrate 
binding lobe that is followed by a regulatory AID. The latter part of the AID was not 
determined. However the activation loop is observable in this crystal structure. The 
CaMK1G B-factors suggest that globally CaMK1G is a relatively dynamic protein. 
The latter part of the AID is described by intermediate and high B-factors indicative 
of increased flexibility. 
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Figure 3.56. CaMK1G thermofluor pH screen. 
The thermal stability of CaMK1G was assessed in different buffers types and pH by 
thermofluorTM. Our results show that the Tm of CaMK1G does not correlate with pH. 
In addition the Tm of CaMK1G is similar in all buffer conditions with a range of Tm 
from 40.0-40.5. °C which suggests low-moderate stability. 
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Evalutation of CSNK1G3 for NMR studies 
  
CSNK1G3 is folded but the majority of amide resonances are not observed in 
the 1H, 15N HSQC spectrum 
CSNK1G3 (Figure 3.57, 3.58) was purified to 95 % purity based on SDS PAGE 
(Figure 3.59-3.61). Purification by size exclusion chromatography suggested that 
CSNK1G3 was a monomer in solution. Analysis of the 1H, 15N HSQC for CSNK1G 
(Figure 3.62) reveals amide resonance dispersion thus confirming that the protein is 
folded. However most of the backbone amide resonances have broadened beyond 
practical detection presumably due to intermediate exchange dynamics and 
aggregation. The few resonances that are observable demonstrate strong, moderate 
and weak intensities suggesting that CSNK1G3 exhibits dynamic behaviour. Our 
CSNK1G3 construct only contains one Trp residue and a single Trp side chain 
amide Hε resonance is seen the bottom left corner of the spectrum. Sample 
precipitation was evident after acquiring the 1H, 15N HSQC at 25 °C indicating low 
stability.  
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Figure 3.57. CSNK1G3 full length and CSNK1G3 SGC constructs. 
Our CSNK1G3 construct encodes the kinase catalytic domain and a small portion of 
the C-terminal domain. 
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        40         50         60         70         80 
    GVLMVG PNFRVGKKIG CGNFGELRLG KNLYTNEYVA IKLEPMKSRA 
        90        100        110        120        130 
PQLHLEYRFY KQLGSGDGIP QVYYFGPCGK YNAMVLELLG PSLEDLFDLC 
       140        150        160        170        180 
DRTFSLKTVL MIAIQLISRM EYVHSKNLIY RDVKPENFLI GRPGNKTQQV 
       190        200        210        220        230 
IHIIDFGLAK EYIDPETKKH IPYREHKSLT GTARYMSINT HLGKEQSRRD 
       240        250        260        270        280 
DLEALGHMFM YFLRGSLPWQ GLKADTLKER YQKIGDTKRA TPIEVLCENF 
       290        300        310        320        330 
PEMATYLRYV RRLDFFEKPD YDYLRKLFTD LFDRKGYMFD YEYDWIGKQL 
       340        350        360 
PTPVGAVQQD PALSSNREAH QHRDKMQQSK NQ 
 
Predicted pI = 9.0 
 
Figure 3.58. CSNK1G3 primary sequence. 
The primary sequence encoded for our CSNK1G3 construct and its predicted pI are 
shown. 
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Figure 3.59. SDS PAGE of His6-CSNK1G3 Ni
2+ NTA purification.  
Elution fractions were pooled from fraction number 3-11. 
 
 
Figure 3.60. SDS PAGE of CSNK1G3 post His6-tag cleavage. 
CSNK1G3 in the FT, Eq, and W fractions were pooled after overnight incubation with 
TEV followed by Ni2+ NTA purification to purify from incomplete His6-tag cleavage, 
free His6-tag, and other protein contaminants. 
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Figure 3.61. CSNK1G3 size exclusion elution profile and SDS PAGE.  
The 38.5 kDa CSNK1G3 elutes from 145–180 ml and produces a monomeric peak 
based on comparison with the elution of protein standards by size exclusion. ractions 
that were pooled are indicated by the red box.  
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Figure 362. CSNK1G3 1H, 15N HSQC. 
The spectrum illustrates that CSNK1G3 has a folded protein backbone but a large 
number of resonances have broadened out into intermediate exchange. The 
spectrum was acquired in 50 mM Na Phosphate pH 7.5, 150mM NaCl, 0.5mM 
TCEP, 0.02% Na Azide at 25°C on  a Varian 800 MHZ. 
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CSNK1G3 dynamics suggests a relatively mobile conformation 
The high B-factors of CSNK1G3 (Figure 3.63) indicate that the CSNK1G3 backbone 
exhibits dynamic behaviour throughout both lobes. This conforms to the dynamic 
behaviour inferred from the CSNK1G3 1H, 15N HSQC spectrum. CSNK1G3 is 
reported to be constitutively active although it can undergo a psuedosubstrate mode 
of inhibition mediated by autophosphorylation of its regulatory C-terminal domain. 
Our CSNK1G construct only encodes the catalytic domain therefore we should 
anticipate a spectrum comparable to Pim1 assuming that CSNK1G3 is constitutively 
active like Pim1. If CSNK1G3 is indeed constitutively active then it is likely to 
dynamically sample multiple catalytically competent conformations. Heterogeneity in 
the phosphorylation state of CSNK1G3 may also have resulted in the poor spectrum 
presumably through modulating the dynamics of CSNK1G3 but the issue of sample 
heterogeneity was not confirmed by mass spec. 
 
ThermofluorTM suggests that CSNK1G3 exhibits low-moderate thermal stability 
in buffers that range from pH 6-8 
In order to improve the amide peak count of CSNK1G3 we decided to optimise its 
buffer solution by analysing its thermal stability in different buffer types using 
thermofluorTM (Figure 3.64). Melting curves produced for CSNK1G3 in the different 
buffer types and pH indicated that the Tm ranged from 40.0-52.0 °C. However there 
is no correlation between Tm and pH. Considering that CaMK1G has a predicted pI 
of 9.0 we might have expected an increasing in Tm with decreasing pH but this is not 
evident. The highest Tm from the buffers tested was produced by 50 mM Na 
phosphate pH 7.0. This is comparable to the Tm for CaMK1D in the same buffer and 
was used as the default buffer for CSNK1G3 including 150 mM NaCl as a default 
stabilizer.  
 
However after acquiring a 1H, 15N HSQC at 25 °C samples recipitation became 
evident suggesting that the Tm of CSNK1G3 is lower than predicted by 
thermofluorTM. Furthermore the CSNK1G3 predicted pI of 9.0 would suggest that at 
lower pH the stability of the protein should increase but this was observed in the 
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thermofluorTM data. We postulate that due to the constitutively active nature of 
CSNK1G3 and the absence of the inhibitory domain the construct is intrinsically 
dynamic and unstable compared to its autoinhibited form. Consequently optimisation 
of the 1H, 15N HSQC for CSNK1G3 and its thermal stability were not progressed 
further and CSNK1G3 was dropped as an NMR target. 
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Figure 3.63 CSNK1G3-inhibitor crystal structure and B-factors. 
The CSNK1G3 crystal structure in complex with (PDB: 2CHL) showing the catalytic 
domain that is comprised of an N-terminal ATP binding lobe and C-terminal 
substrate binding lobe. The activation loop is observable in this crystal structure. The 
CSNK1G3 B-factors illustrate that CSNK1G3 is a relatively dynamic protein, 
particularly at the termini and loops.  
 
 
 200 
 
 
Figure 3.64. CSNK1G3 thermofluor pH screen. 
The stability of CSNK1G3 was characterised in different buffer conditions and found 
to produce a range of Tm but without any correlation between stability and pH. 
Notably theTm of CSNK1G3 in 50mM Na Phosphate pH 7.0 was deduced to be 52.2 
°C. However, under actual NMR experiment conditions the protein precipitated at 25 
°C despite using this buffer type and pH in the default NMR. This suggests that the 
predicted Tm by thermofluor is an overestimate of the actual Tm of CSNK1G3. 
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Expression of CaMK1D and mutants 
 
CaMK1D – an NMR amenable kinase target 
Following our evaluation of six kinases (CaMK1D, CaMK1G, CSNK1G3, PAK5, Pim1 
and TOPK) in terms of their expression, stability, solubility and spectral quality it was 
decided that CaMK1D was the best candidate for study by NMR. The next aim was 
to optimise the expression levels of milligram quantities of 95 % pure and isotopically 
labeled soluble CaMK1D and mutants in order to initiate the backbone assignment of 
CaMK1D and subsequent structural, functional and ligand interaction studies.  
 
Additional CaMK1D mutant constructs (Figure 4.0) were designed by using site 
directed mutagenesis (Stratagene). An activation loop mutant termed 
CaMK1D_T180E was designed by mutating Thr 180 to Glu in order to mimic the 
phosphorylation of Thr 180 in maximally active CaMK1D. CDB mutants 
CaMK1D_W306S and CaMK1D_M319A were also produced to investigate the 
functional importance of these residues in mediating interactions between Ca2+/CaM 
and the CBD. Expression and purification results for CaMK1D and mutants are 
discussed in the following sections. 
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Figure 4.0. CaMK1D contructs for NMR. 
A schematic summarising all of the CaMK1D constructs that were expressed and 
purified.  
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Expression tests of CaMK1D and mutants in LB suggests an optimal post 
induction time of 16 hours 
In order to maximise the yield of soluble protein, the post induction time for CaMK1D 
and the activation loop mutant CaMK1D_T180E were determined in Luria Broth (LB) 
by comparing 8 hours against 16 hours post induction time (Figure 4.1). Analysis of 
the post induction times by SDS PAGE indicates that after 16 hours at 18°C, whole 
cell expression levels of CaMK1D are greater compared to 8 hours post induction. 
The same outcome was demonstrated for CaMK1D_T180E indicating that the 
mutation did not decrease expression levels. Expression tests of the CBD mutants 
CaMK1D_W306S and CaMK1D_M319A in LB confirmed that these constructs could 
also be over expressed after 16 hours induction at 18°C and that the mutations did 
not decrease expression levels. Thus the optimal post induction time for over 
expressing CaMK1D, CaMK1D_T180E and the CBD mutants was judged to be 16 
hours. The default cell line Rosetta (DE3) was used for the expression test of 
CaMK1D and CaMK1D_T180E in LB because the cell line provides an abundance of 
rare codons for E. coli expression. Expression tests of CaMK1D_W306S and 
CaMK1D_M319A in LB were conducted using BL21 (DE3) RIPL codon plus, 
because the expression test for these constructs were conducted after the original 
Rosetta (DE3) cell line had been optimised as described in the following section. 
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Figure 4.1 A. SDS PAGE of CaMK1D and CaMK1D_T180E whole cell 
expression. 
CaMK1D was over expressed  following 8 and 16 hours post induction in LB. The 
position of the His6-tagged CaMK1D band (40.2 kDa) is denoted by the red arrow. B. 
SDS PAGE showing whole cell over expression of CaMK1D_W306S, and 
CaMK1D_M319A. CaMK1D CBD mutants CaMK1D_W306S and CaMK1D_M319A 
were over expressed for 16 hours in LB. The position of the His6-tagged 
CaMK1D_W306S and CaMK1D_M319A bands (both 40.2 kDa) is denoted by the 
red arrow. 
 
SDS PAGE abbreviations: M = marker, Pre = preinduction, 8hr = 8 hour post 
induction, 16hr = 16 hour post induction 
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CaMK1D requires rare codon supplmentation provided by Rosetta (DE3) for 
optimal expression 
The default cell line for CaMK1D expression was Rosetta (DE3). This was based on 
the protocol established by the SGC. Rosetta (DE3) is an E. coli strain designed to 
enhance the expression of eukaryotic proteins which are not optimised for E.coli 
codon usage by encoding rare tRNAs that recognise rare codons sometimes found 
in eukaryotic genes. Analysis of codon usage frequency of CaMK1D using the 
graphical codon usage analyser software (GCUA) revealed for example that codons 
encoding several Leu residues have a low frequency usage in E.coli (Figure 4.2) 
which could potentially decrease the translation efficiency and yield of soluble 
protein. The CaMK1D construct was created by the SGC but was not codon 
optimised for E. coli BL21 (DE3) expression therefore CaMK1D expression in 
Rosetta (DE3) was preferable for the production of unlabelled CaMK1D in LB and 
1H, 15N-labelled CaMK1D in M9 minimal media. Alternatively a synthetic CaMK1D 
codon optimised sequence for E. coli BL21 (DE3) expression could also be 
generated but this was not pursued. M9 minimal media was used for the production 
of isotopically labelled proteins because it was cost effective compared to other 
commercially available media such as bioexpress (Isotec). 
 
Deuteration of CaMK1D is necessary  
Our CaMK1D construct is 37.8 kDa which makes structural analysis by NMR very 
difficult because of increased resonance broadening and overlap associated with 
large proteins (Foster, McElroy et al. 2007). In order to proceed with sequential 
backbone assignment of CaMK1D by NMR it was necessary to incorporate 
deuteration and implement TROSY experiments in order to address these potential 
large molecular weight issues.  
 
Rosetta (DE3) exhibit a prolonged lag phase in media containing 2H2O 
Initial 2H, 15N and 2H, 15N, 13C labelled CaMK1D samples were produced using 
Rosetta (DE3) cells but the transformed cell line was found to exhibit a prolonged lag 
phase of growth particularly in the presence of 2H2O (deuterium oxide). E.coli cells 
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grown in 2H2O containing media experience stress that can result in an increased lag 
phase, reduced biomass and protein synthesis mainly due to the inhibitory effects of 
2H2O on the TCA cycle (Hochuli, Szyperski et al. 2000). In our experience Rosetta 
(DE3) generally exhibits a longer lag phase compared to BL21 (DE3) and in the 
presence of 2H2O the Rosetta (DE3) lag phase is increased further. Therefore cell 
line optimisation was attempted for more efficient production of 2H 15N and 2H, 15N, 
13C labelled CaMK1D samples. 
 
BL21 (DE3) codon plus identified as an optimal cell line for growth and 
expression in deuterated media 
The default SGC CaMK1D expression protocol (SGC) was used as a starting point 
and translated to a small scale expression test that compared CaMK1D expression 
levels in Rosetta (DE3), BL21 (DE3), and BL21 (DE3) RIPL codon plus in M9 
minimal media containing 70 % and 99 % 2H2O content (Figure 77). The BL21 (DE3) 
and BL21 (DE3) RIPL codon plus cultures were tested for expression due to their 
shorter lag phases relative to Rosetta (DE3).  Like Rosetta (DE3), BL21 (DE3) RIPL 
codon plus also encodes rare tRNAs for the recognition of rare eukaryotic codons 
allowing for efficient translation of eukaryotic proteins. In 70 % and 99 % 2H2O, 
Rosetta (DE3) exhibited the longest lag phase in comparison to BL21 (DE3) and 
BL21 (DE3) RIPL codon plus, typically taking an additional 2–4 hours respectively to 
reach approximately an O.D600nM of 0.4. Thus BL21 (DE3) and BL21 (DE3) RIPL 
were better adapted to the 2H2O environment with shorter lag phases of growth.  
 
Whole cell expression levels of CaMK1D in 70 % 2H2O compared to 99 % 
2H2O did 
not show a significant difference between BL21 (DE3) and BL21 (DE3) RIPL codon 
plus cells. This suggested that the cells became adapted to the high 2H2O content 
and maintained their growth and expression. Rosetta (DE3) had greater expression 
level in 70 % 2H2O than 99% 
2H2O. A low level of CaMK1D expression level in 
Rosetta (DE3) in 99 % 2H2O was most likely due to poor induction because the level 
of whole cell protein in the pre and post induction samples appeared the same.  
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A comparison of CaMK1D whole cell expression between the cell lines shows that 
BL21 (DE3) RIPL codon plus (in 70 % and 99 % 2H2O) and Rosetta (DE3) (in 70 % 
2H2O only) exhibit similar levels of over expression whereas over expression in BL21 
(DE3), appears lower than both of these cell lines. This is perhaps expected because 
BL21 (DE3) does not encode rare tRNAs that recognise rare eukaryotic codons thus 
translation is not efficient and can stall if the pool of rare tRNAs is depleted. To 
summarise, the expression of CaMK1D in BL21 (DE3) RIPL codon plus and Rosetta 
(DE3) in 70% 2H2O appeared equivalent by SDS PAGE but Rosetta (DE3) has a 
longer lag phase thus making BL21 (DE3) RIPL codon plus the preferred cell line for 
growth and expression in deuterated M9 minimal media. 
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Figure 4.2. CaMK1D residue 1-150 codon frequency usage in E.coli.  
The analysis is shown for residues 1-150 and is based on the human CaMK1D 
cDNA provided by the SGC. Rare codons are shown in red. 
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Figure 4.2.1. CaMK1D resiue151-300 codon frequency usage in E.coli.  
The analysis is shown for residues 151-300 and is based on the human CaMK1D 
cDNA provided by the SGC. Rare codons are shown in red. 
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Figure 4.2.2. CaMK1D residue 301-334 codon frequency usage in E.coli.  
The analysis is shown for residues 301-334 and is based on the human CaMK1D 
cDNA provided by the SGC. Rare codons are shown in red. Analysis was performed 
using the graphical codon usage analyser (GCUA). The y-axis shows the frequency 
of the codon in E.coli. 
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Figure 4.3. SDS PAGE of CaMK1D expression test in different cell lines and 
2H2O content in M9 media. 
Whole cell expression levels of CaMK1D (indicated by the red arrow) were 
compared in BL21 (DE3), BL21 (DE3) RIPL codon plus, and Rosetta (DE3) cell lines 
in M9 minimal media containing 70 % (v/v) and 99 % (v/v) 2H2O content. 
Consequently BL21 (DE3) RIPL codon plus was found to be the optimal cell line for 
expression of deuterated CaMK1D samples. 
 
 
 
Figure 4.4. SDS PAGE of His6-tagged CaMK1D purified by Ni
2+ NTA affinity 
purification. 
Elution fractions are shown containing His6-tagged CaMK1D  which appears to have 
a molecular weight of about 40 kDa (the migration His6-tagged CaMK1D on SDS 
PAGE is indicated by the red arrow). His6-tagged CaMK1D was eluted using a linear 
imidazole gradient. Contaminating E.coli proteins are also visible. 
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Figure 4.5. SDS PAGE of CaMK1D post His6-tag cleavage. 
Removal of contaminants that co-purify with CaMK1D in the initial Ni2+ NTA affinity 
purification was mediated by cleavage of the His6-tag and dialysis of imidazole 
followed by a second Ni2+ NTA affinity purification step. The red box highlights the 
fractions containing CaMK1D that were purified from the contaminants. 
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Size exclusion chromatography purification of CaMK1D and mutants 
 
CaMK1D purifies as a monomeric protein by size exclusion chromatography 
After the second Ni2+ NTA-affinity purification step, CaMK1D was purified by SEC on  
a S75 26/60 column. The preliminary running buffer used was 50 mM Na phosphate 
pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 0.02 % Na Azide, but for future purifications in 
which samples were used for ligand interaction studies, the buffer was changed to 
50 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM TCEP 0.02 % Na Azide. This was 
necessary in order to compare ligand interaction studies of autoinhibited inactive 
CaMK1D with active CaMK1D•Ca2+/CaM, because Ca2+ is precipated by the 
phosphate component from Na phosphate buffer. The CaMK1D SEC profile (Figure 
56) displayed two resolved peaks with an elution volume from 150-180 ml that 
corresponded to 95% pure CaMK1D as determined by SDS PAGE (Figure 80). 
Based on comparison with the size exclusion elution profile of protein standards the 
position and shape of the CaMK1D peak suggests that CaMK1D is a monomer with 
an apparent molecular weight of 37.8 kDa. A high molecular weight E.coli protein 
contaminant is shown eluted from 120-140 ml (figure) and was well resolved from 
the CaMK1D peak (150-180ml). Analysis of the pre size exclusion CaMK1D sample 
by SDS PAGE reveals that relative to CaMK1D minor amounts of E.coli 
contaminating proteins of high and low molecular weight are still evident but were 
removed from CaMK1D after size exclusion because the CaMK1D size exclusion 
elution fractions appear > 95 % pure. A final determination of the protein estimates 
approximately 25 mg of protein L-1 of culture for unlabelled protein and 20 mg of 
deuterated and isoptocially labelled protein L-1 of culture. 
 
CaMK1D mutants exhibit similar purification results to CaMK1D by size 
exclusion 
CaMK1D_T180E, CaMK1D_W306S and CaMK1D_M319A were found to exhibit 
similar size exclusion elution profiles to CaMK1D. The similarity therefore suggested 
that the mutations did not alter the oligomeric state of the protein or global shape. 
The purity and yields of the mutant constructs was also comparable to that of 
CaMK1D (SDS PAGE data not shown). 
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Figure 4.6. CaMK1D Size exclusion and SDS PAGE  
CaMK1D appears homogenous and 95 % pure after size exclusion purification. 
Elution fractions shown correspond to the fractions under the CaMK1D size 
exclusion peak from approximately 150–180 ml (Figure). PSE = pre size exclusion 
CaMK1D. 
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Expression of CaMK1D C-terminal truncations 
 
CaMK1D1-298 exhibits higher amounts of soluble protein than CaMK1D1-280 
and likewise for T180E C-terminal truncation variants 
In order to characterise active forms of CaMK1D lacking the AID sequence, several 
C-terminal truncations of CaMK1D and CaMK1D_T180E were generated by 
mutagenesis. Based on previous cell line optimisation results with CaMK1D, these 
constructs were expressed in BL21 (DE3) RIPL codon plus. Expression tests were 
conducted to assess the levels of over expressed protein. The whole cell protein, 
soluble and insoluble protein levels were tested because these constructs were not 
previously expressed or purified. Whole cell expression tests revealed that 
CaMK1D1-280, CaMK1D1-298, CaMK1D_T180E_1-280 and CaMK1D_T180E_1-
298 exhibit greater over expression after 16 hours induction at 18°C compared to 4 
and 8 hours (Figure 81).  
 
The levels of soluble protein for CaMK1D1-280 and CaMK1D_T180E_1-280 
appeared to be 50 % soluble and 50 % insoluble (Figure 82). The soluble fractions of 
CaMK1D1-298 and CaMK1D_T180E_1-298 exhibited about 75 % soluble protein 
compared to their respective insoluble fractions. This suggests that at 18 °C, 16 
hours post induction, CaMK1D1-298 and CaMK1D_T180E_1-298 and are more 
stable compared to CaMK1D1-280 and CaMK1D_T180E_1-280. The difference in 
yield of soluble protein is likely due to the stabilizing inhibitory role of the AID 
because the longer constructs CaMK1D1-298 and CaMK1D_T180E_1-298 still 
contain part of the C-terminal AID which can impart some stability on the kinase 
structure. CaMK1D1-280 and CaMK1D_T180E_1-280 completely lack the AID thus 
the interactions of the AID with the substrate binding site and N-terminal ATP binding 
lobe seen in the crystal structure are absent and these shorter constructs are less 
stable and exhibit more tendency to precipitate.  
 
 
 216 
 
 
Figure 4.7. SDS PAGE of CaMK1D and CaMK1D_T180E C-terminal truncation 
mutants expression test.  
Cultures were induced at 18°C for 4, 8, and 16 hours and post expression samples 
were taken for each time point respectively. Expression appears greater at 16 hours 
post induction (red arrow). 
 
 
Figure 4.8. SDS PAGE of CaMK1D and T180E C-terminal truncation insoluble 
and soluble fractions. 
Amounts of insoluble (PF = pellet fraction) and soluble protein (SN = supernatant) 
after 16 hours expression at 18 °C were analysed for CaMK1D1-280, 1-298, 
CaMK1D_T180E_1-280, and CaMK1D_T180E_1-298. The shorter constructs 
CaMK1D1-280 and CaMK1D_T180E_1-280 appear to have only 50% soluble 
protein whereas the longer constructs CaMK1D1-298 and CaMK1D_T180E_1-298 
appear to have 75 % soluble protein. 
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Ni2+ NTA-affinity purification of CaMK1D C-terminal truncations 
 
C-terminal truncated CaMK1D constructs co-elute with minor contaminants by 
Ni2+ NTA affinity 
The C-terminal truncation constructs termed CaMK1D1-280, CaMK1D1-298  and 
their activation loop equivalents CaMK1D_T180E_1-280 and CaMK1D_T180E_1-
298 were all purified via their N-terminal His6-tag in the same manner described for 
CaMK1D using a Ni2+ NTA-affinity column. Only the results for CaMK1D1-280, and 
CaMK1D1-298 are described here because their respective activation loop mutants 
demonstrate similar purification results. Analysis by SDS PAGE of the elution 
fractions from Ni2+ NTA-affinity purification reaveals that both His6-tagged CaMK1D1-
280 and His6-tagged CaMK1D1-298 co-eluted with E.coli contaminant proteins 
(Figure 83, 85). These contaminants were removed using the same method 
described for CaMK1D which involved a second Ni2+ NTA-affinity purification step 
after cleavage of the CaMK1D1-280 and CaMK1D1-280  His6-tag with TEV and 
dialysis for the removal of imidazole.  
 
Cleavage of the N-terminal His6-tag and a second Ni
2+ NTA-affinity purification 
improved the purification of C-terminal truncated CaMK1D constructs  
After incubation with TEV protease we show by SDS PAGE that CaMK1D1-280 
(31.8 kDa) migrates as a slightly lower molecular weight protein relative to its His6-
tagged form (34.2 kDa) thus illustrating successful cleavage of the His6-tag. Likewise 
CaMK1D1-298 (33.8 kDa) migrates as a slightly lower molecular weight protein 
relative to its His6-tagged form (36.2 kDa) after His6-tag cleavage. SDS PAGE was 
also used to identify and confirm the fractions that contained CaMK1D1-280 and 
CaMK1D1-298 following the second Ni2+ NTA-affinity purification step and it was 
evident that CaMK1D1-280 and CaMK1D1-298 do not bind to the Ni2+ NTA column 
and therefore appear in the flow through (FT). The SDS PAGE (Figure 84, 86) also 
shows that CaMK1D1-280 and CaMK1D1-298 that was weakly bound to the column 
was eluted with equilibration (Eq) and wash (W) buffer  whereas the majority of the 
contaminating E.coli proteins bound tightly and did not elute with CaMK1D1-280 and 
CaMK1D1-298 in the Eq and W fractions but eluted in the elution fraction which used 
elution buffer. 
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Figure 4.9. SDS PAGE of His6-tagged CaMK1D1-280 from Ni
2+ NTA affinity 
purification.  
His6-tagged CaMK1D1-280 was eluted with a linear gradient and migrates between 
the 37 and 25kDa molecular weight standards. Fraction number 3-12 were pooled. 
 
Figure 4.10. SDS PAGE of post His6-tag cleavage. 
CaMK1D1-280 was collected in the FT, Eq, and W fractions (highlighted by red box). 
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Figure 4.11. SDS PAGE of His6-tagged CaMK1D1-298 from Ni
2+ NTA affinity 
purification. 
SDS PAGE showing the elution fractions of His6-tagged CaMK1D1-298 (indicated by 
red arrow) using 250 mM imidazole. Although not shown the results for 
CaMK1D_T180E_1-298 are similar to this. 
 
 
Figure 4.12. SDS PAGE of-CaMK1D1-298 post His6-tag cleavage. 
CaMK1D1-298 was collected in the FT, Eq, and W fractions. 
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Size exclusion purification of CaMK1D C-terminal truncations 
 
C-terminal truncated CaMK1D constructs purifiy as monomeric proteins by 
size exclusion chromatography 
Although the majority of the contaminant proteins were removed via the second Ni2+ 
NTA-affinity purification step, the purity of CaMK1D1-280 and CaMK1D1-298 seen 
by SDS PAGE was still < 95 % and aggregation in the samples was not eliminated 
by this technique. Therefore size exclusion purification chromatography was 
necessary in order to remove the remaining contaminants and aggregates that co-
eluted with CaMK1D1-280 and CaMK1D1-298 from the second Ni2+ NTA-affinity 
purification step.  The elution profiles of CaMK1D1-280 and CaMK1D1-298 both 
produce a single peak suggesting that these proteins behave as monomers in 
solution of 31.8 and 33.8 kDa when compared to the elution profile of protein 
standards (Figure 90, 92). The elution volume of the 31.8 kDa CaMK1D1-280 and 
the 33.8 kDa CaMK1D1-298 ranges from approximately 165–195 ml and 145-170 ml 
respectively. Higher molecular weight contaminants and aggregates elute off the size 
exclusion column before both C-terminal truncation mutants as exemplified in their 
respective size exclusion elution profiles. SDS PAGE of the CaMK1D1-280 and 
CaMK1D1-298 size exclusion fractions reveals 90 % and 95 % purity respectively 
(Figure 91, 93). We hypothesise that both constructs exhibit basal constitutive 
activity but evidence of His6-tag phosphorylation similar to Pim1 was not observed.  
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Figure 90. Size exclusion elution profile of CaMK1D1-280 and SDS PAGE. The 
31.8 kDa CaMK1D1-280 elutes from approximately 165–190 ml. 
CaMK1D_T180E_1-280 also elutes from a similar position. CaMK1D1-280 appears 
90 % pure after size exclusion purification. Elution fractions shown correspond to the 
fractions under the CaMK1D1-280 size exclusion peak. PSE = pre size exclusion 
CaMK1D1-280. The T180E variant of this truncation purifies in a similar manner. 
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Figure 92. Size exclusion elution profile of CaMK1D1-298 and SDS PAGE. The 
33.8 kDa CaMK1D1-298 elutes from approximately 145–170 ml. 
CaMK1D_T180E_1-298 also elutes from a similar position. CaMK1D1-298 appears 
95 % pure after size exclusion purification. Elution fractions shown correspond to the 
fractions under the CaMK1D1-298 size exclusion peak. PSE = pre size exclusion 
CaMK1D1-298/CaMK1D_T180E_1-298. 
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CaM Expression 
 
His6-CaM is expressed as a stable and soluble protein at 37C  
Expression and purification of His6CaM was initiated in order to produce the active 
CaMK1D•Ca2+/CaM complex for structural and functional characterisation. In order 
to optimise the yield of soluble stable protein, the expression of CaM afterr different 
post induction times was monitored by SDS PAGE. CaM is a thermal stable protein 
which allowed expression tests in LB to be conducted at a pre and post induction 
temperature of 37 °C. Analysis of the His6-tagged CaM post induction times of 4, 8, 
and 16 hours by SDS PAGE (Figure 94) indicated that over expression of CaM 
increased with time and was greatest after 16 hours. 
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Figure 94. SDS PAGE showing His6-tagged CaM expression test in LB growth 
media. Expression of CaM increases with time, appearing greatest after 16 hours 
post induction. His6-tagged CaM appears to migrate with a molecular weight of 
around 20 kDa. 
 
SDS PAGE abbreviations 
M = marker SN = supernatant, PF = pellet fraction, FT = flow through, Eq = 
equilibration wash, W = wash, E = elution, PHF = pooled his trap fractions, ON = 
overnight, PSE = pre size exclusion, PAE = pre anion exchange. 
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Ni2+ NTA-affinity purification of CaM 
 
CaM co-elutes with minor contaminants by Ni2+ NTA affinity 
In order to initiate binding studies of CaMK1D-Ca2+/CaM, pure CaM protein was 
needed. Therefore His6-tagged CaM was purified in the same manner as described 
previously for all CaMK1D constructs using a Ni2+ NTA-affinity column. Analysis by 
SDS PAGE reveals that His6-tagged CaM also co-elutes with some contaminants 
(figure) but these were removed by further purification steps described below. His6-
tagged CaM was also found in the wash (W) fraction due to saturation of the Ni2+ 
NTA-affinity column with His6-tagged CaM. It is also evident from SDS PAGE (Figure 
95) that the His6-tagged CaM was completely soluble because His6-tagged CaM was 
not present in the insoluble pellet fraction (PF). 
 
Cleavage of the N-terminal His6-tag and a second Ni
2+ NTA-affinity purification 
improved the purification of CaM  
His6-tagged CaM was further purified from the contaminant proteins it co-eluted with 
by removal of the CaM His6-tag and imidazole mediated by TEV protease and 
dialysis respectively. A second Ni2+ NTA-affinity followed these steps and analysis of 
the fractions on SDS PAGE (Figure 96) shows that after incubation with TEV 
protease  CaM (16.8 kDa) migrates as a slightly lower molecular weight protein 
relative to its His6-tagged form (19.4 kDa) thus indicating successful cleavage of the 
His6-tag. SDS PAGE also indicates that CaM appears  in the flow through (FT), 
equilibration (Eq), and wash (W) fractions suggesting that it binds weakly to the 
column whereas the contaminanting proteins bind with greater affinity hence their 
appearence in the elution fraction. 
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Figure 95. SDS PAGE of His6-tagged CaM purified by Ni
2+ NTA affinity 
purification. Elution fractions are shown containing His6-tagged CaM which appears 
to have a molecular weight around 20 kDa. His6-tagged CaM was eluted using a 
linear imidazole gradient. 
 
 
Figure 96. SDS PAGE showing TEV protease mediated removal of the His6-tag 
from His6-CaM. CaM was collected in the FT and Eq fractions.  
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Size exclusion purification of CaM 
 
CaM Size exclusion chromatography purification suggests a monomeric 
protein 
Minor contaminants and imidazole present in the pooled flow through, equilibration, 
and wash fractions of CaM from the second Ni2+ NTA-affinity purification step were 
removed by size exclusion chromatography. The elution profile of CaM produces a 
single peak suggesting that the protein behaves as a monomer in solution (Figure 
97). The peak has a low absorbance at 280nM because CaM does not contain any 
Trp residues and the elution volume of the 16.8 kDa CaM appears to be from 170-
200 ml. High molecular weight contaminants elute before CaM. Analysis of the CaM 
fractions post size exclusion chromatography by SDS PAGE reveals 90 % purity 
(Figure 98). Minor contaminants are evident in the first few fractions and were 
removed by a final purification step involving anion exchange. 
 
Anion exchange purification of CaM 
 
CaM purifies to 95 % purity after anion exchange chromatography 
Analysis of the CaM fractions from anion exchange purification by SDS PAGE 
illustrates 95 % pure protein after the first 7 elution fractions (Figure 99). Activation of 
CaMK1D using Ca2+/CaM in our activity assays confirmed that the purified CaM was 
folded and functional. The first 7 fractions were pooled and purified again by anion 
exchange to remove the minor contaminants. 
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Figure 97. CaM size exclusion elution profile and SDS PAGE. The 16.8 kDa CaM 
purifies as a single peak by size exclusion purification (S75 column). Its elution from 
170–200 ml corresponds to a 16.8 kDa species based on comparison with the 
elution of known protein standards. Size exclusion therefore suggests that CaM is 
monomeric. Minor contaminants are evident in the first few fractions shown by SDS 
PAGE. PSE = pre size exclusion CaM 
 
 
 
 229 
 
 
Figure 99. SDS PAGE of CaM anion exchange (resource Q) purification. CaM 
was purified to 95% purity by pooling the fractions indicated by the red box indicates 
pooled CaM fraction PAE = pre anion exchange CaM. 
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Deuterated CaMK1D and TROSY 
 
2H, 15N CaMK1D is folded after amide 2H exchange for 1H and shows complete 
exchange  
To begin characterisation of the CaMK1D solution structure and subsequent binding 
studies the next aim was to produce a 2H, 15N labelled CaMK1D sample from M9 
minimal media containing 99 % 2H2O in order to acquire a higher resolution 
1H, 15N 
TROSY-HSQC. A preliminary 1H, 15N TROSY-HSQC of 2H, 15N labelled CaMK1D 
post back exchange was acquired to evaluate the spectral improvements and 
feasibility of assigning the CaMK1D backbone using a deuterated sample. Acquiring 
the spectrum also helped to confirm the extent of back exchange because 2H 
labelling introduces 2H at exchangeable amide groups which need to be exchanged 
with 1H in order to detect the 1H amide resonances. Firstly the spectrum shows 
dispersion of backbone amide 1H resonances thus confirming that the protein was 
folded as was implied by the 1D 1H spectrum. Secondly assessment of the amide 1H 
resonance line shape and signal to noise ratio reveals that there was an 
improvement when compared with the 1H, 15N HSQC of the non deuterated 15N 
labelled CaMK1D sample. Thirdly the spectrum illustrates that the extent of amide 2H 
exchange with 1H for backbone and side chain amides was complete because an 
overlay of the 1H, 15N TROSY-HSQC spectra for 2H, 15N CaMK1D and 1H, 15N 
CaMK1D (Figure 101) indicates the same number of peaks (observable amide 1H 
resonances). This suggests that back exchange was complete. Having the same 
number of peaks was important to maximise the number peak that can potentially be 
assigned. Furthermore all backbone triple resonance experiments are correlated to 
the amides seen in the 1H, 15N TROSY-HSQC spectrum therefore allowing the 
assignment of each amide resonance.  
 
In some cases loss of peaks (amide 1H resonance) in a deuterated sample can 
occur when exchange of amide 2H for 1H is not complete because amide 2H 
resonances are not observable in 1H, 15N HSQC experiments but in our case solvent 
exchange process was effectively complete. The complete exchange of amide 2H for 
1H usually requires unfolding and refolding the protein in order to facilitate the 
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exchange of deeply buried and highly stable amides. However, as already described 
this was avoided in our case because the alternative method of buffer exchanging 
into high pH buffer (or low pH for some proteins stable at acidic pH) was found to 
promote exchange effectively. 
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Figure 101. 1H, 15N TROSY-HSQC spectra of a 2H, 15N and 1H, 15N CaMK1D 
sample. Superimposition of the 1H, 15N TROSY-HSQC for 2H, 15N (red) and 1H, 15N 
CaMK1D (black) indicates that deuteration improves the resonance intensity of the 
2H, 15N CaMK1D spectrum. Furthermore, the peak count of both spectra appears 
identical suggesting complete exchange of amide 2H with 1H in deuterated CaMK1D.  
Both spectra were acquired with 0.2 mM in 50 mM Na phosphate pH 7.0, 75 mM 
NaCl, 0.5 mM TCEP, Na Azide 0.02 %, 10 % 2H2O at 25 °C on a Varian 800 MHZ. 
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CaMK1D backbone assignment 
 
Sequential assignment of CaMK1D backbone amide resonances using triple 
resonance experiments 
To initiate the sequential backbone assignment of CaMK1D by NMR, a 2H, 15N, 13C 
labelled CaMK1D sample was produced. TROSY versions of the triple resonance 
experiments HNCO, HN(CA)CO, HN(CO)CA, HNCA, HNCACB, and HN(COCA)CB 
were acquired on a Varian 800MHz equipped with a cryo-probe. Backbone amide 
directed sequential assignments were achieved by establishing the connectivities of 
carbonyl (CO), α (CA) and β (CB) carbon resonances for residues i and i-1 using the 
relevant triple resonance experiments. For a detailed explanation of the triple 
resonance experiments discussed here please refer to chapter II.  
 
Firstly we used the CA resonance information provided by HNCA and HN(CO)CA 
experiments to build connectivities between residues i and i-1. In addition to this CB 
resonance information provided by the HNCACB and HN(COCA)CB was used to 
validate the connectivities between residue i and i-1. Importantly unique CA and CB 
resonances characteristic of a certain residue type were used to help identify residue 
types when possible. For example the CA resonances of Gly residues are unique 
and readily identifiable. Additional validation of connectivities between residue i and 
i-1 was achieved via CO resonance information provided by the HN(CA)CO and 
HNCO. By applying this strategy sequential unambiguous assignments were 
accomplished. For example figures 102 A, B, C, D, illustrates the sequential 
assignment of residues 21-26 corresponding to the sequence KIFEFK in CaMK1D 
based on CA, CB and CO resonance connectivities. 
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Figure 102 A. Sequential backbone assignment of CaMK1D using HNCO and 
HN(CA)CO spectra. Connectivity between residue i and i-1 carbonyl carbons were 
established were using HNCO (brown) and HNCACO spectra (pink). Sequential 
backbone assignments of carbonyl carbon resonances for CaMK1D residues 
KIFEFK (residues 21-26) are shown. 
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Figure 102 B. Sequential backbone assignment of CaMK1D using HN(CO)CA 
and HNCA spectra. Connectivity between residue i and i-1 α carbons were 
established were using HN(CO)CA (blue) and HNCA spectra (red). Sequential 
backbone assignments of α carbon resonances for CaMK1D residues KIFEFK 
(residues 21-26) are shown.  
 
 
Figure 102 C. Sequential backbone assignment of CaMK1D using HN(CO)CA 
and HNCACB spectra. Connectivity between residue i and i-1 α carbons were 
established were using HN(CO)CA (blue) and HNCACB spectra (blue). Sequential 
backbone assignments of α carbon resonances for CaMK1D residues KIFEFK 
(residues 21-26) are shown.  
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Figure 102 D. Sequential backbone assignment of CaMK1D using 
HN(COCA)CB and HNCACB spectra. Connectivity between residue i and i-1 β 
carbons were established were using HN(COCA)CB (purple) and HNCACB spectra 
(orange). Sequential backbone assignments of β carbon resonances for CaMK1D 
residues KIFEFK (residues 21-26) are shown.  
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79% of the CaMK1D backbone was assigned 
The 1H, 15N-TROSY HSQC of the 37.8 kDa deuterated CaMK1D protein in its 
inactive state was acquired as and assigned as shown in figure 103. The backbone 
amide resonances of 255 residues were assigned out of a possible 322, 
representing 79% coverage, including residues from every structural and functional 
element (Figure 104). Of those amino acids assigned, 98% include C’, 100% include 
Cα, and 99% include Cβ chemical shifts. Of all 11 proline residues, 10 were 
assigned, with 80% including C’, 60% including Cα and 40% including Cβ chemical 
shifts. The remaining Pro219 could not be assigned as it is N-terminal to another 
proline. Residues which could not be assigned predominantly due to intermediate 
exchange and resonance broadening  were 1, 6, 9, 34-35, 56, 63-66, 68-70, 74-77, 
82, 84-85, 99-102, 141, 143-144, 146, 164-169, 172, 174, 178-182, 186-187, 199-
200, 212-213, 216, 251-254, 260, 303-305, 317-325 and 327. The unassigned 
residues are mostly found in regions that include for example the activation loop, 
catalytic loop, αC helix, hinge, CBD and C-terminus (Figure 104).  
 
Incomplete assignments in the activation loop and C-terminus also coincided with 
the disorder and high B-factor values seen for these respective regions in the 
CaMK1D PDB: 2JC6 (Figure 58). Resonance assignments in these typically 
exposed and mobile elements were presumably compromised by resonance 
broadening caused by intermediate or slow time scale dynamics. Assignments were 
also complicated by resonance overlap near the centre of the 1H, 15N TROSY-HSQC 
spectrum (Figure 103).  Several residues exhibited a second set of weaker or 
equivalent resonances, including for example Gly103, Gly217 and Asp223 
suggesting additional conformers (Figure, green boxes). Isolated residue 
assignments were made for Glu67, Ala83, His142, Leu145 and Tyr 198 based on 
their unique chemical shifts, intra- and inter-residue correlations in the triple 
resonance spectra, and the CaMK1D structure. 
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Figure 103. 1H, 15N TROSY-HSQC of 2H 15N 13C-labelled CaMK1D. Approximately 
80% of the 37.8kDa CaMK1D backbone was assigned using a deuterated and 
uniformly 15N, 13C-labelled sample (1.2 mM). Assignments are indicated by labelled 
resonances. The densely overlapped region in the centre of the spectrum is 
expanded by the blue box (denoted as box A). The centre of this region is further 
expanded by the red box (denoted as box B). A few resonances demonstrate 
multiple conformations in solution and some of these are highlighted by a green box. 
The spectrum was acquired on a 1.2 mM sample in 50 mM Na Phosphate pH 7.0, 75 
mM NaCl, 0,5mM TCEP, 0.02% Na Azide at 25 °C on a Varian 800 MHZ. 
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Figure 104. CaMK1D backbone assignment coverage. This schematic illustrates 
the extent of the backbone assignment for CaMK1D. Assigned residues in the 
CaMK1D sequence are highlighted in black whilst unassigned are not highlighted. 
The secondary structure cartoon was derived from the CaMK1D PDB: 2JC6. 
Regions of disorder in which the electron density could not be determined in the 
crystal structure are indicated by broken green lines. In total 79 % of the CaMK1D 
backbone was assigned using triple resonance spectra. 
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CaMK1D secondary structure predictions 
 
CaMK1D secondary structure predictions beased on TALOS exhibits 
differences when compared to the crystal structure 
With 79 % of the CaMK1D backbone amides assigned a secondary structure 
prediction was made using TALOS, a program which requires input of the chemical 
shift assignments for the backbone amides to calculate predicted dihedral angles phi 
and psi. Secondary structure elements predicted by TALOS can be shown as a 
probability (Figure 105). A probability described by a positive value predicts α-helix 
whereas a negative value predicts a β-strand and a probability close to 0 predicts 
neither thus suggesting a loop or disordered region (Shen, Delaglio et al. 2009).  
 
A comparison of our CaMK1D secondary structure prediction by TALOS with the 
secondary structure defined by the CaMK1D crystal structure reveals some 
differences that are notable in regions that span both the N-terminal and C-terminal 
lobes. At the N-terminus of the sequence TALOS predicts 3 β-strands (β1, 2, 3) prior 
to the αC helix whereas the crystal structure defines 4 β-strands (β1, 2, 3, 4) and 1 
α-helix (αB) between the first β-strand (β1) and second (β2) strand. TALOS also 
predicts that the start of the αC helix begins immediately after the third β-strand (β3) 
in the TALOS prediction although many assignments were incomplete for the αC 
helix region and therefore predictions for this region are interpreted with caution. The 
crystal structure defines the αC helix as starting after a loop that is C-terminal of β-
strand (β4). The fifth α-helix (αF) in the crystal structure is absent in the TALOs 
prediction and at the C-terminal end the ninth (αJ) and tenth (αK) α-helices of the 
crystal structure are predicted to be smaller by TALOS. In addition to this the last 
helix (αM) in the crystal structure is missing in the TALOS prediction where it is 
instead predicted to be unstructured. Interestingly this last helix (αM) constitutes the 
latter part of the AID that also contains the overlapping CBD. 
 
Another secondary structure prediction method we used for comparison was based 
on ΔCα-ΔCβ which utilises the chemical shift difference method between measured 
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experimental values and random coil values of α and β carbon resonances (Metzler 
1993). A comparison between folded and random coil chemical shifts illustrates that 
α carbon resonances exhibit a propensity to shift up-field in β-strand and β-sheets, 
but shift downfield in α-helices. β carbon resonances exhibit an opposite pattern with 
chemical shifts that have a propensity to shift downfield in β-strand and β-sheets but 
up-field in α-helices. A subtraction between Cα and Cβ shifts will enhance the 
correlation between the Cα, Cβ shifts and secondary structure elements. Our ΔCα-
ΔCβ data predicts the secondary structure of CaMK1D to be relatively similar to our 
TALOS derived secondary structure predictions because the α helix and β strand 
predictions occur in approximately the same positions but the boundaries of 
secondary structure elements predicted by TALOS are more clearly defined. 
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Figure 105. A summary of CaMK1D Secondary structure prediction and 
comparison with the PDB secondary structure. Figure A plots ΔCα-ΔCβ and 
predicts the propensity of the backbone to adopt an α helix (red) if > 0 or β strand 
(blue) if < 0. Figure B represents the propensity for α helix (red) if > 0 and β strand 
(blue) if < 0 as predicted by TALOS and is plotted as a probability. Figure C, is a plot 
of the phi (black) and psi (purple) dihedral angles calculated by TALOS. Figure D 
compares the TALOS derived secondary structure with that of the CaMK1D crystal 
structure and indicates that there are some differences. 
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CaMK1D pH screening 
Assignment of backbone amides could not be extended beyond 79 % coverage due 
to weak or unobservable α and β carbon resonance intensities for the few remaining 
unassigned backbone amides in the spectrum. A lack of connectivities between the 
carbonyl, α and β carbon resonances also suggested that the number of backbone 
amide resonances counted in the spectrum was less than the total expected number.  
These missing backbone amides resonances thus presented a major issue in 
achieving a complete backbone assignment.  
 
CaMK1D exhibits pH dependent CSPs  
In order to improve the intensity and increase the number of peaks (observable 
backbone amide resonances) in the 1H, 15N TROSY-HSQC the pH of the buffer was 
lowered gradually from 7.0 to 6.7, 6.5, and 6.0 (Figure 106) because at lower pH the 
rate of the amide 1H chemically exchanging with the bulk solvent is reduced 
therefore the lifetime of the protonated amide should be prolonged and consequently 
increase the intensity of weak and unobserved peaks. However additional peaks 
were not observed but the intensity of some peaks increased thus improving the 
signal to noise ratio of these resonances. At pH 6.0 CaMK1D also had a tendency to 
precipitate more after acquiring the 1H, 15N TROSY-HSQC at 25 °C most likely 
because CaMK1D has a predicted pI of 6.1.  
 
Furthermore a few notable pH dependent CSPs were observed. Gly 114, Phe 115, 
Tyr 116, Ser 292, Ser 294, and Ala 295 in particular exhibited large chemical shift 
perturbations. Activity assays were also conducted to investigate the pH effect on 
CaMK1D activity. We found that activity decreased with lower pH and postulate that 
it the CaMK1D is likely becoming more unstable at lower pH because the pI is 
predicted to be 6.1. CaMK1D also exhibited a tendency to precipitate during pH 
screening by NMR when below pH 7.0. Although pH screening was conducted with 
the autoinhibited form, most of the peaks that display pH dependent CSPs appear in 
the same position with respect to the spectrum of the activated CaMK1D. 
 
 245 
 
 
 
Figure 106. 1H, 15N TROSY HSQC based screening of optimal pH for CaMK1D. 
The pH of the NMR buffer was lowered from 7.0 to 6.7, 6.5 and 6.0 in order to 
improve the peak intensity and increase the backbone amide peak count in the 1H, 
15N TROSY-HSQC. This was necessary because assignment of backbone amides 
could not be extended beyond 79 % coverage due to peaks that broadened out or 
exhibited weak intensity in the H, 15N TROSY-HSQC. However an increase in peak 
count was not observed but the intensity of some peaks increased. pH dependent 
CSPs were also evident. Spectra were acquired with 0.4 mM 2H, 15N CaMK1D in 50 
mM HEPES pH 7.5, 6.7, 6.5, and 6.0, 150 mM NaCl, 0.5 mM TCEP, 0.02 % Na 
Azide at 25 °C on a Varian 800 MHZ. 
 
The pH dependent chemical shift perturbations of some residues is due to 
their proximity to His residues 
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A histogram of the pH dependent CSPs reveals that there are four main regions 
significantly perturbed (Figure 107). The first region is near E112, K113, G114, F115, 
Y116. These residues span the C-terminal end of helix αD and the adjacent 
connecting loop that is between the αD and αE helices. The histogram also shows 
that Gly 114 exhibits the largest CSP out of all the significant CSPs (> 1 S.D). The 
second region occurs around H136, which is located towards the C-terminal end of 
the αE helix. A single CSP occurs in the third region that constitutes the activation 
loop and this is attributed to V177. The fourth region spans part of the RD where 
S294 is significantly perturbed. 
 
In order to understand the basis of the pH dependent CSPs we mapped the CSPs 
onto our apo autoinhibited model of CaMK1D generated by structural alignment with 
rat CaMK1A and substation of their respective RDs (Figure 108 A,B). Mapping 
illustrates that E112, K113, G114, F115, and Y116 are in close proximity to the side 
chain of H290. Likewise S294 is also positioned close to the H290 side chain. L135 
and H136 are shown to be near the side chains of H78 and H142. V177 was not 
observed in the crystal structure because the activation loop was not determined but 
we postulate that V177 must be spatially close to at least one of three His side 
chains that reside near the active site cleft because this is the conformational space 
that the activation loop will typically occupy in protein kinases. The three His side 
chains located near the active site are H78, H136, and H142 as seen from the 
structure. Notably H142 is part of the catalytic loop which interacts closely with the 
activation loop in protein kinases.  
 
We propose that these CSPs occur when the pH is lowered because the His side 
chain imidazole group has more tendency to become protonated and become 
positively charged (+1) and therefore the local chemical and electronic environment 
of His changes due this charge. Consequently the chemical shift of nearby residues 
is altered due to the positively charged His side chain imidazole group. Some of 
these nearby residues experienced larger CSPs (i.e. Gly 114) because they were 
closer in proximity to effects of the charge. The pKa of the imidazole group in an 
isolated His is 6.8, although the His residues in CaMK1D are not isolated we 
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presume that some of them will have a side chain pKa that is very similar to an 
isolated His. H290 for example induces large changes in the chemical shift of G114 
when small changes in pH are made from pH 7.0. This would suggest that the pKa of 
H290 is around 6.8 because when the pH is close to the pKa then small changes in 
pH will cause large changes in the population of protonated and deprotonated forms 
of the His side chain imidazole group. 
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Figure 107. Histogram of pH dependent CSPs along the CaMK1D backbone. 
The average CSPs is shown indicated by the gray line. CSPs that are >1 or 2 S.D 
are indicated by the yellow and red line respectively. 
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Figure 108 A. CaMK1D pH dependent CSP mapping.  A cartoon representation of 
the apo autoinhibited CaMK1D model structure with residues colored according to 
the extent of CSP due to a change in the buffer pH from 7.0 to 6.0. 
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Figure 108 B. CaMK1D pH dependent CSP mapping A 180° rotated view of the 
previous figure illustrating a cartoon representation of the apo autoinhibited CaMK1D 
model structure with residues colored according to the extent of CSP due to a 
change in the buffer pH from 7.0 to 6.0. 
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CaMK1D crystal structure  
 
CaMK1D-GSK-3 XIII co-crystallised as a dimer and is structurally similar to rat 
CaMK1A 
Firist human CaMKI isoform structure Our collaborators the SGC (knapp et al) have 
co-crystallised the CaMK1D construct with the ATP competitive inhibitor Glycogen 
synthase kinase-3 (GSK-3) XIII inhibitor ((5-Methyl-1H-pyrazol-3-yl)-(2-
phenylquinazolin-4-yl) amine) and thus determined its structure by X-ray 
crystallography at a resolution of 2.3 angstroms. The structure revealed that 
CaMK1D crystallised as a dimer (figure 113). The tertiary structure of CaMK1D 
adopts a canonical kinase bilobal fold consisting of a small N-terminal β sheet ATP 
binding lobe and a large C-terminal α helical substrate binding lobe that includes a 
regulatory AID and CBD. The GSK-3 XIII inhibitor is shown bound to the ATP binding 
site of the inactive CaMK1D. Functional elements such as the hinge, p-loop, catalytic 
loop and regulatory αC helix are well resolved in the structure. The AID is shown 
consisting of 2 helices (denoted as αR1 helix and αR2 helix) connected by a short 
loop with the N-terminal portion of the AID comprised of αR1 helix folding over the 
substrate binding site whilst making multiple contacts that are mediated by a 
pseudosubstrate mechanism.  
 
The αR2 helix which comprises the C-terminal portion of the AID and the overlapping 
CBD makes contact with the small N-terminal lobe but residues downstream from 
Thr 313 are not evident in the structure presumably due to disorder giving rise to 
weak electron density. In addition to this, a segment of the N-termini, a loop between 
β4 strand and αC helix, and the activation loop are also missing from the CaMK1D 
crystal structure. It is apparent from the structure that dimerisation of CaMK1D 
appears to be mediated by the N-terminal β1 strand which forms a dimer interface. 
Interestingly our CaMK1D secondary structure prediction based on TALOS lacks the 
β1 strand and αB helix suggesting that these secondary structure elements defined 
in the CaMK1D crystal structure are artefacts of dimerisation driven by 
crystallisation. Moreover we did observe any evidence of dimerisation by NMR or 
size exclusion chromatography.  
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Figure 113. Crystal structure of the CaMK1D-GSK-3 XIII inhibitor complex 
dimer. CaMK1D was co-crystallised with a GSK-3 XIII inhibitor by the SGC (Knapp 
et al) and subsequent structure determination at 2.3 angstroms revealed that the 
CaMK1D-GSK-3 XIII inhibitor complex (PDB: 2JC6) crystallised as a dimer via an N-
terminal β strand that forms a dimer interface (highlighted by the red box). The 
CaMK1D structure reveals a canonical bilobal kinase fold (cyan and red) and a C-
terminal regulatory AID (blue) that interacts with the C-terminal substrate binding site 
and the small N-terminal lobe. Interactions between the AID and substrate binding 
site are driven by a pseudosubstrate mechanism which inhibits the kinase. Other 
functional elements which are highlighted in the structure include the regulatory C 
helix (gray), the hinge, catalytic loop, and p-loop (all shown in yellow). Notably the 
activation loop (residues 164-185) was not determined due to weak electron density. 
The ATP competitive inhibitor GSK-3 XIII was shown to bind to the ATP binding site. 
CaMK1D (10mg/ml) was mixed with 3-fold excess of GSK-3 XIII inhibitor and 
crystals were obtained by the SGC at 4 °C in sitting drops using the vapour diffusion 
method by mixing 75 nl of the concentrated protein (10 mg/ml in 25 mM HEPES pH 
7.5, 150 mM NaCl) with 75 nl of the well solution (0.1 M citrate pH 5.6, 20 % 
isopropanol, 20% PEG 4K). 
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CaMK1D hybrid NMR/crystal structure model 
 
Refinement of the CaMK1D crystal structure and modelling of missing loops 
using TALOS data 
The previously described CaMK1D crystal structure contained 4 regions of disorder 
that resulted in missing electron density. These regions correlated to residues 1-10 
(N-termini), 59-63 (loop between β4 strand and αC helix), 164-185 (activation loop), 
and 314-333 (C-termini). Furthermore our comparison of the secondary structure 
defined by the crystal structure and TALOS data highlighted some discrepancies and 
that some secondary structure elements in the crystal structure maybe due to 
crystallisation artefacts. We thus decided to refine the crystal structure as a 
monomer and model the disordered regions by using  and  dihedral angle 
restraints predicted by TALOS which utilises chemical shift data from our CaMK1D 
backbone resonance assignments.  
 
The refined CaMK1D models were subsequently generated by CNS and 5 of these 
models were superimposed (figure 114) to reveal that residues at the N-termini and 
C-termini exhibited a large degree of flexibility and dynamics which was not 
surprising because they are part of the flexible and disordered termini. Sequence 
analysis based on Ca2+/CaM and rat CaMK1A CBD binding studies (Matsushita and 
Nairn 1998) indicates that the CaMK1D CBD spans from residue 303-320 but in the 
crystal structure the electron density of residues beyond Thr 313 were not 
determined presumably due to disorder and dynamics causing weak electron 
density. In our model residues 314-320 which comprise the remainder of the CBD 
appear as flexible random coil thus reinforcing the idea that this part of the CBD is 
unstructured and dynamic. Similarly the activation loop also exhibits a considerable 
degree of flexibility and dynamics but samples a smaller conformational space. 
Residues 59-63 which comprise part of a small loop displayed minimal mobility in the 
model. 
 
 
 255 
 
 
 
Figure 114. CaMK1D crystal structure and NMR hybrid model. The crystal 
structure of CaMK1D and its missing loops was refined and modelled as a monomer 
using  and  dihedral angle restraints predicted by TALOS using chemical shifts 
from our backbone resonance assignments. Five resulting structures were then 
generated from CNS and superimposed via the Cα carbons of the CaMK1D structure 
(gray) using molmol. Modelling of the disordered loops are highlighted and include 
the N-termini (yellow), C-termini (blue), the loop between β4 strand and αC helix 
(cyan), and the activation loop (red). These disordered loops exhibit flexibility and 
dynamics. 
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Characterisation of the CaMK1D-Ca2+/CaM complex by NMR, ITC, and 
thermofluorTM 
 
CaMK1D-Ca2+/CaM complex by NMR suggests that Ca2+/CaM binds tightly to 
the CBD  
Most members of the CaMK family are regulated by a C-terminal AID and require 
Ca2+/CaM binding to the CBD to relieve autoinhibition but the mechanism of 
activation is not fully understood (Hook and Means 2001; Soderling and Stull 2001; 
Swulius and Waxham 2008). Hence we decided to investigate the interaction 
between CaMK1D and Ca2+/CaM from the perspective of CaMK1D by using NMR in 
order to gain insight into the solution structure of the complex, mechanism of 
activation, and binding mode. This involved titrating unlabelled Ca2+/CaM into 15N 
labelled CaMK1D with subsequent conformational changes in CaMK1D monitored 
via 1H, 15N HSQC TROSY experiments. However, large protein complexes are 
associated with slow and aniostropic tumbling in solution that causes an increase in 
T2 relaxation due to enhanced 1H-1H dipolar relaxation and 1H-1H scalar coupling. 
Formation of the CaMK1D-Ca2+/CaM complex results in a combined molecular 
weight of 54.6 kDa, therefore deuterated 15N labelled CaMK1D and deuterated CaM 
were used in order to suppress 1H-1H dipolar relaxation and 1H-1H scalar 
contributions to 1H lineshape broadening. Furthermore deuteration decreases the 
amide 1H transverse relaxation rate due to the fact that 2H has a lower gyromagnetic 
ratio compared to 1H (Sattler and Fesik 1996; Gardner and Kay 1998; Foster, 
McElroy et al. 2007).  
 
Titrations were also made in increments of 0.25, 0.5, 1.0, 1.5 and 2.0 equivalents of 
Ca2+/CaM (Figure 116) in order to validate saturation of CaMK1D and to follow the 
CSPs which were revealed display line shape reduction and slow exchange 
phenomena thus suggesting an intermediate and high affinity interaction. At 2.0 
equivalents of Ca2+/CaM, CaMK1D is saturated, peak intensity is reduced and many 
broaden out completely whilst. Presumbably because new peaks occur clustered 
around the centre whilst others broaden out this suggests a large complex formation 
and anisotropic tumbling in solution. 
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 Previous reports estimate the dissociation constant of rat CaMK1A and Ca2+/CaM 
by Trp fluorescence to be about 30 nM (Clapperton, Martin et al. 2002). The tracking 
of peaks that display CSPs on a slow exchange time scale is a lot more difficult 
compared to fast exchange and requires reassignment of the complex. Thus the 
majority of the additional peaks observed in the CaMK1D-Ca2+/CaM spectrum 
cannot be identified without reassignment of the complex. Furthermore due to the 
significant overlap of peaks seen in the centre of the CaMK1D-Ca2+/CaM spectrum 
this further complicates the tracking and identification of peaks experiencing CSPs. 
Mapping of these peak intensity changes to the structure indicates that they correlate 
predominantly to the AID and the overlapping CBD (figure 116). The large peak 
intensity reduction for peaks spanning this region even at 0.25 eq of Ca2+/CaM  
suggests that these residues are directly involved in the interaction with Ca2+/CaM.  
 
Peak intensity reductions were also evident at the base of the C-terminal lobe 
suggesting weak interactions with Ca2+/CaM upon disengagement of the RD as 
illustrated by our SAXS CaMK1D-Ca2+/CaM complex model (figure 111). The other 
notable region displaying peak broadening was the p-loop which has been shown to 
make contact with the AID via the overlapping CBD (αR2 helix) in the crystal 
structure of CaMK1D. Peak intensity reduction within and around the vicinity of the p-
loop suggests that Ca2+/CaM binding spans the entire CBD (αR2 helix) and part of 
the p-loop. Further evidence in support of this has been demonstrated by the recent 
DAPK-Ca2+/CaM structure which indicates that Ca2+/CaM binding spans near this 
region and slightly alters the interaction between the CDB and p-loop (de Diego, 
Kuper et al. 2010).  
 
No CSP or significant line broadening was observed for Trp 306 side chain εH 
A key residue implicated in the CaMK1D-Ca2+/CaM interaction is reported to be Trp 
306 (Goldberg, Nairn et al. 1996; Matsushita and Nairn 1998; Clapperton, Martin et 
al. 2002). In the bottom left corner of the spectrum we observe 5 peaks that 
corresponds to 5 Trp side chain amide εH but none of these undergo any significant 
CSPs or line shape broadening in our spectrum. We thus postulate that these 5 
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peaks that are observed do not correspond to each of the 5 individual Trp side chain 
amides εH including Trp 306 suggesting that some of the other Trp side chain 
amides εH maybe existing in more than 1 conformation and that we cannot observe 
the Trp 306 side chain amide εH because it is intermediate exchange. Alternatively 
the side chain of Trp 306 in CaMK1D may not be implicated in the interaction as is 
believed but we think this is an unlikely scenario.  
 
Additional peaks in the CaMK1D-Ca2+/CaM 1H 15N TROSY-HSQC suggests 
random coil and/or increased helical content 
The appearance of additional peaks in the centre of the spectrum and apparent 
reduction in backbone amide resonance dispersion in the first increment of the 1H, 
15N TROSY HSQC (data not shown) initially suggested that there was an unfolding 
mechanism occurring but based on the crystal structures of CaMK AID peptide-
Ca2+/CaM (Clapperton, Martin et al. 2002; de Diego, Kuper et al. 2010) and DAPK-
Ca2+/CaM complex an unfolding mechanism does not correlate with these structures. 
In contrast our SAXS model of the CaMK1D-Ca2+/CaM complex suggests that there 
is unfolding in the RD upon disengagement, perhaps facilitating its release from the 
substrate binding site. 
  
Limited CSPs are seen in the functional elements upon Ca2+/CaM binding 
A protein kinase that switches from an inactive to active state is also often 
associated with rearrangement of the p-loop, αC helix, catalytic lysine, catalytic loop 
and stabilization of the activation loop. These changes are concomitant with 
formation of the R-spine and completion of the C-spine upon ATP binding which 
reflects an active and catalytically competent state (Taylor and Kornev 2010). All 
these events bring about the orientation of key catalytic residues into a catalytically 
competent configuration for ATP binding and phosphoryl transfer (Adams 2001). In 
our CaMK1D-Ca2+/CaM 1H, 15N TROSY HSQC the peaks that correlate to the 
backbone amides of residues within key functional elements such as the activation 
loop, catalytic loop, hinge, catalytic lysine (Lys 52 in CaMK1D), and regulatory αC 
helix exhibit peak intensity reduction above the mean suggesting small 
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conformational changes. This suggests that binding of Ca2+/CaM reconfigures the 
conformation of these elements into a catalytically competent state. For the 
appearance of new peaks in slow exchange at saturation only reassignment of the 
complex would likely confirm their chemical shift.  
 
A loop preceding the AID and substrate binding site only has small peak 
intensity redcution 
Other regions that we postulate to be implicated in the CaMK1D-Ca2+/CaM 
interaction include the loop that precedes the AID and the substrate binding site 
however these do not exhibit significantly large peak intensity reduction, leaving 
ambigiuity in the state of the complex that is observed in solution. We expect 
structural changes in this loop region on the basis of our proposed SAXS CaMK1D-
Ca2+/CaM complex model (figure 111) because the swing out motion of the AID 
bound to Ca2+/CaM via the CBD causes rearrangement of the AID and bound 
Ca2+/CaM to occupy a position near the base of the CaMK1D C-terminal lobe 
resulting in the opening of the substrate binding site. This conformational change 
would require rearrangement of the AID and the loop preceding the AID but if the 
pivot point of the AID αR1 helix is closer to the N-terminal end of the αR1 helix then 
perhaps small changes and thus smaller peak intensity reductions occur or perhaps 
there chemical environment and dynamic is not significantly altered in autoinhibited 
and disengaged states. The latter scenario could explain the lack of CSPs and peak 
intensity reduction associated with residues from the loop.  
 
Ca2+ is required for CaM to interact with CaMK1D 
CaM contains 4 E-F hand motifs with each CaM molecule known to bind a total of 4 
Ca2+ ions. Therefore CaM with respect to Ca2+ has a binding stoichiometry of 1:4. It 
has been reported that CaMK1D and Ca2+/CaM can interact even at 
substoichiometric concentrations of Ca2+ and postulated that CaM can interact 
weakly with CaMK members independent of Ca2+ (Hook and Means 2001). We 
decided to investigate the interaction of CaM with CaMK1D in the absence of Ca2+ 
and at substoichiometric concentrations of Ca2+ to characterise its binding mode in 
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comparison to Ca2+ saturated CaM. Consequently our data demonstrates that CaM 
cannot interact in the absence of CaM even weakly when up to 2 equivalents of CaM 
was added due to the absence of CSPs and additional peaks (figure 117). However 
an interaction between CaMK1D and CaM at a substiochimetric concentration of 1:2 
(CaM to Ca2+) was evident due to the appearance of additional peaks. At a 
stoichiometry of 1:4, 1:8, and 1:16 (CaM to Ca2+) the spectra of the CaMK1D-
Ca2+/CaM complex 1H, 15N TROSY HSQC appeared to resemble the saturated form 
of the CaMK1D-Ca2+/CaM complex (Figure 118, 119) with evidence of additional 
peaks in slow exchange indicative of tight binding as previously observed. Overlay of 
the spectra at different concentrations of Ca2+ also indicates that the binding affinity 
appears to be tight even at a substiochimetric concentration of 1:2 (CaM to Ca2+) 
because the peaks in slow exchange superimpose well and increase in peak 
intensity when the Ca2+ concentration was increased (Figure 118). 
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Figure 115. CaMK1D-Ca2+/CaM interaction shown by 1H, 15N TROSY HSQC.  The 
interaction between apo deuterated 15N CaMK1D and deuterated Ca2+/CaM was 
monitored by 1H, 15N TROSY HSQC. The superimposed spectra indicates that the 
addition of Ca2+/CaM to apo CaMK1D (black spectrum) produces a reduction in peak 
intensity whilst new peak appear indicating slow exchange timescale of binding 
suggesting that conformational changes are occurring in the backbone upon a high 
affinity interaction between CaMK1D and Ca2+/CaM.. Spectra were acquired with 0.2 
mM of 2H, 15N CaMK1D in 50 mM HEPES pH 7.0, 150 mM NaCl, 0.5 mM TCEP, 
CaCl2, 0.02 % Na Azide on a Varian 800 MHz at 25 °C. 
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Figure 116. A histogram of CaMK1D amide peak intensity reduction induced by 
Ca2+/CaM.  The mean and and S.D are shown for titration of 0.25, 0.5 and 1,0 eq of 
Ca2+/CaM in gray, black, and red respectively. 
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Figure 116A. Peak intensity reduction mapping upon binding 0.25eq 
Ca2+/CaM. Peak intensity reductions occur around the RD, predominantly the near 
CBD where Ca2+/CaM is known to bind. The base of the C-lobe is shown to illustrate 
long range peak intensity reduction suggesting Ca2+/CaM may disengage the Rd 
and interact weakly with this region. 
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Figure 116B. Peak intensity reduction mapping upon binding 0.25eq 
Ca2+/CaM. A 180° view of the previous figure 
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Figure 116B. Peak intensity reduction mapping upon binding 0.5eq Ca2+/CaM. 
Peak intensity reductions occur around the RD, predominantly near the CBD where 
Ca2+/CaM is known to bind. The base of the C-lobe is shown to illustrate long range 
peak intensity reduction suggesting Ca2+/CaM may disengage the Rd and interact 
weakly with this region. 
 
 
 266 
 
 
Figure 116B. Peak intensity reduction mapping upon binding 0.5eq Ca2+/CaM. 
A 180° view of the previous figure 
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Figure 116C. Peak intensity reduction mapping upon binding 1eq Ca2+/CaM. 
Peak intensity reductions occur around the RD, predominantly the near CBD where 
Ca2+/CaM is known to bind. The base of the C-lobe is shown to illustrate long range 
peak intensity reduction suggesting Ca2+/CaM may disengage the Rd and interact 
weakly with this region. 
. 
 
 268 
 
 
Figure 116D. Peak intensity reduction mapping upon binding 1eq Ca2+/CaM. A 
180° view of the previous figure.  
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Figure 117. 1H, 15N TROSY HSQC of CaMK1D and CaM. A titration of CaMK1D 
with two equivalents of CaM in the absence of Ca2+ indicates that there is no 
interaction because no CSPs were evident. Spectra were acquired with 0.185 mM of 
2H, 15N CaMK1D in 50 mM HEPES pH 7.0, 150 mM NaCl, 0.5 mM TCEP, CaCl2, 
0.02 % Na Azide on a Varian 800 MHz at 25 °C. 
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Figure 118. 1H, 15N TROSY HSQC of CaMK1D and CaM titration with Ca2+. 
CaMK1D in the presence of two equivalents of CaM (black) was titrated with 
increasing concentrations of Ca2+. Upon addition of 740 uM Ca2+ additional peaks 
appear in slow exchange indicative of tight binding affinity. With each increasing 
addition of Ca2+ the intensity of the additional peaks in slow exchange increases 
further suggesting an increase in affinity. Spectra were acquired with 0.185 mM of 
2H, 15N CaMK1D in 50 mM HEPES pH 7.0, 150 mM NaCl, 0.5 mM TCEP, CaCl2, 
0.02 % Na Azide on a Varian 800 MHz at 25 °C. 
 
 
 
 271 
 
 
 
Figure 119. CaMK1D and Ca2+/CaM endpoint titration with 5920 uM Ca2+ by 1H, 
15N TROSY HSQC. For simplification of the previous spectra this spectra only 
illustrates CaMK1D in the presence of two equivalents of CaM (black) being titrated 
with 5920 uM of Ca2+.   
 
 
 
 
 
 
 272 
 
ITC confirms the high affinity interaction between CaMK1D and Ca2+/CaM 
We previously inferred from our 1H, 15N TROSY HSQC spectra showing the titration 
of deuterated Ca2+/CaM with deuterated 15N CaM1D (figure 115) that there was a 
high binding affinity between the proteins due to evidence of CSPs in slow 
exchange.  Isothermal titration calorimetry (ITC) was therefore used to determine the 
binding affinity between CaMK1D and Ca2+/CaM (figure) and we found an average 
dissociation constant (Kd) of 28.5 nM (deduced from 2 separate ITC experiments 
which produced Kd values of 38+12.9 nM and 19+7.7 nM respectively). These 
results reinforce the high affinity interaction suggested by our NMR data. Our 
determined Kd value for the CaMK1D interaction with Ca
2+/CaM was comparable 
with the reported Kd value for the interaction between rat CaMK1A and Ca
2+/CaM 
determined by Trp fluorescence (Clapperton, Martin et al. 2002). Likewise Knapp et 
al report similar binding affinities for CaMK proteins by ITC (Knapp 2010).    
 
The CaMK1D and Ca2+/CaM interaction is enthapically driven and forms a 1:1 
complex 
The heat change associated with the interaction between Ca2+/CaM (ligand) and 
CaMK1D (macromolecule) shown in figure, indicates an exothermic reaction in the 
system and corresponds to a ΔH (enthalpy change) of -5431+171.5 cal mol-1, whilst 
the associated ΔS (entropy change) was 15.7 cal mol-1 K-1. The thermodynamic 
parameter ΔH reflects the strength of non-covalent interactions between Ca2+/CaM 
and CaMK1D relative to those existing with the solvent whereas ΔS reflects entropic 
contributions from changes in solvation entropy and changes in conformational 
entropy. Both ΔH and ΔS are determinants of ΔG (free energy of binding) which is 
also related to the association constant (Ka) because ΔG = -RTlnKa = ΔH-TΔS. 
Therefore our ΔH and ΔS values produce a large negative ΔG indicating that the 
binding of Ca2+/CaM to CaMK1D is tight and a spontaneous process. Furthermore 
the interaction appears to be enthalpically driven is because the ΔH value was 
negative and of greater magnitude than the ΔS contribution. The stoichiometry of the 
Ca2+/CaM and CaMK1D interaction was expected to be 1:1 based evidence of rat 
CaMK1A and other members of the CaMK family () interacting with Ca2+/CaM. Our 
ITC data produced an N value (stoichiometry) of 0.95+0.0187 (figure) which 
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approximates to a 1:1 stoichiometry between CaMK1D and Ca2+/CaM. The data for 
these thermodynamic parameters represents the results from one of two ITC 
experiments and was comparable to results produced from the second experiment 
(data for the repeated experiment not shown).  
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Figure 121. Characterisation of the CaMK1D and Ca2+/CaM interaction by ITC.  
The figure shows the raw exothermic heat changes associated with each injection 
(upper panel) and the binding isotherm which illustrates the integrated binding 
enthalpy changes (lower panel). The Kd determined for this experiment and a repeat 
experiment was 38 nM and 19 nM respectively thus giving an average Kd of 28.5 nM. 
The large negative ΔH and small positive ΔS values contribute to a negative and 
thus favourable ΔG of binding indicative of a spontaneous and high affinity 
interaction. For this particular ITC experiment, the protein concentrations used were 
12 µM CaMK1D (macromolecule) and 120 µM Ca2+/CaM (ligand). All CaMK1D and 
Ca2+/CaM experiments were conducted in 50 mM Hepes pH 7.5, 150 mM NaCl, 0.5 
mM TCEP, 5 mM CaCl2 at 25 °C. 
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The CBD mutant CaMK1D_W306S exhibits weak binding affinity with Ca2+/CaM 
A key CaMK1D residue that is postulated to be important in mediating the tight 
binding interaction between CaMK1D and Ca2+/CaM is Trp 306. This residue is 
located in the CBD and its side chain is solvent exposed in the rat CaMK1A structure 
(Goldberg, Nairn et al. 1996). It is postulated that this Trp side chain ( Trp 303 in rat 
CaMK1A) can initiate the interaction with Ca2+/CaM by binding into a hydrophobic 
pocket within one of the Ca2+/CaM globular domains (Clapperton, Martin et al. 2002). 
Studies by Matsushita et al have demonstrated that mutation of rat CaMK1A Trp 303 
to a Ser increased the Kd for the rat CaMK1A interaction with Ca
2+/CaM to about 100 
µM. Analysis of the CaMK1D structure however indicates that Trp 306 is not solvent 
exposed but instead appears to be buried unlike in rat CaMK1A where its Trp 303 is 
solvent exposed (Figure 122). Assuming Trp 306 in CaMK1D is indeed solvent 
exposed then the CBD conformation in the CaMK1D crystal structure is not 
representative of its native conformation in solution but is likely an artefact of 
crystallisation or due to the presence of GSK-3 XIII. We predict that mutation of 
CaMK1D Trp 306 will reduce the binding affinity with Ca2+/CaM without significantly 
affecting the global backbone conformation i.e. not because of unfolding but because 
of a localised side chain mutation.  
 
Alternatively we also hypothesise that if Trp 306 is indeed buried then a non 
conservative mutation to a Ser will cause drastic changes to the hydrophobic interior 
of the protein and cause significant backbone conformational changes whereas a 
more conservative mutation to a Phe would result in subtle changes to the backbone 
conformation. To address these hypothesises we produced a CBD mutant termed 
CaMK1D_W306S and first used ITC in order to determine the Kd and associated 
thermodynamics for its interaction with Ca2+/CaM. Production of a more conservative 
mutant, CaMK1D_W_306F was also attempted but could not be produced 
successfully due to expression issues. Our CaMK1D_W306S ITC data (figure 123) 
indicates that the binding isotherm was very shallow and that the Kd and 
thermodynamic parameters could not be determined quantatively. The shallow 
binding isotherm suggests that there was insufficient heat change associated with 
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each injection because either or both the affinity of the interaction was too weak or 
the CaMK1D_W306S concentration in the sample cell was too low.   
 
Based on results demonstrated by the rat CaMK1A Trp mutant we predicted the Kd 
for CaMK1D_W306S binding to Ca2+/CaM to be around 100 µM and therefore 
required a high CaMK1D_W306S concentration in order to produce a sufficient heat 
change and a reasonable c value (c = NKa[M]T) for a sigmoidal binding isotherm. 
Despite using 250 µM CaMK1D_W306S and 2.5 mM Ca2+/CaM to produce a c value 
of 2.5, the heat change was insufficient and thus below the detection limits of the ITC 
instrument.  The range of Kd that can be determined by the ITC instrument is from 
estimated to be from 0.01-100 µM thus implying that the Kd for the binding interaction 
between CaMK1D_W306S and Ca2+/CaM was at least greater than 100 µM.  
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Figure 122. Human CaMK1D and rat CaMK1A structural alignment. A Structural 
alignment of CaMK1D (light blue) and rat CaMK1A (purple) was conducted to 
examine potential differences in structure. It is apparent from the alignment that 
structural differences arise in the CBD region defined by the αR2 helix. Specifically 
highlighted is the conformation of CaMK1D Trp 306, which is buried whereas rat 
CaMK1A Trp 303 is exposed to solvent. These residues are implicated in mediating 
interactions with Ca2+/CaM. Given that CaMK1D Trp 306 appears to be buried 
implies that it might have a different binding mode to Ca2+/CaM or it is the result of a 
crystallisation artefact and is a non-native conformation. This structural alignment 
was created using Pymol and produced a RMS value of 0.835 indicative of a 
conserved fold. 
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Figure 123. Characterisation of the CaMK1D_W306S and Ca2+/CaM interaction 
by ITC. The shape of the binding isotherm for the titration of Ca2+/CaM with 
CaMK1D_W306S appears very shallow indicating that the binding affinity is very 
weak beyond the Kd sensitivity limits of 0.01 – 100 uM. Therefore we can deduce 
from the binding isotherm that the Kd is greater than 100 uM . For this particular ITC 
experiment, the protein concentrations used were 250 µM CaMK1D (macromolecule) 
and 2500 µM Ca2+/CaM (ligand). All CaMK1D and Ca2+/CaM experiments were 
conducted in 50 mM Hepes pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 10 mM CaCl2 at 
25 °C. 
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CaMK1D_W306S is folded and suggests that W306 is in intermediate exchange 
Structural alignment of CaMK1D and rat CaMK1A revealed an RMSD of 0.835 
indicating a highly conserved fold. However a notable structural difference occurs in 
the CBD region in which the relative orientation of Trp 306 is different. In CaMK1D it 
appears buried but in rat CaMK1A it is solvent exposed. To confirm that if Trp 306 
was solvent exposed or buried we acquired a HQSC TROSY (figure 124) and 
anticipated that the protein would still be folded suggesting that Trp306 is not buried. 
Consequently the data indicated the protein to be folded. This confirmed that the 
side chain is not buried but curiously five Trp side chain amides still appear 
indicating that Trp306 in CaMK1D is in intermediate exchange and does not 
correspond to anyone of these five Trp. DNA sequencing was validated to confirm 
that the mutation was present. This finding reinforces the weak binding (> 100 uM) 
kd observed by ITC for the CaMK1D_W306S interaction with Ca2+/CaM. 
CaMK1D_W306S and Ca2+/CaM by ITC were due to the mutation of Trp 306 to Ser 
and not because of the protein unfolding.  
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Figure 124. A comparison of the CaMK1D_W306S backbone structure with 
CaMK1D. The TROSY HSQC spectrum of CaMK1DW306S (blue) was 
superimposed with the TROSY HSQC spectrum of CaMK1D and shows that 
CaMK1D_W306S was still folded and 5 Trp side chain Hε are still apparent. 
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Figure 124. Histogram showing the CS difference between the backbone of 
CaMK1D and CaMK1D_W306S. Residues with the most pronounced CSPs (> 2 or 
1S.D) are indicated by the yellow and red line. The mean CSP is indicated by the 
gray line. 
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ThermofluorTM suggests the CaMK1D-Ca2+/CaM complex has a lower stability 
compared to apo CaMK1D 
Our previous NMR and ITC data on the CaMK1D-Ca2+/CaM complex suggested that 
the interaction between CaMK1D and Ca2+/CaM was tight binding. Therefore we 
decided to characterise the thermal stability of the complex presuming that a tight 
binding complex with a Kd of 38 nM would result in an increase in the thermal 
stability compared to CaMK1D. However thermofluorTM results (Figure 125) indicate 
that this was not the case because the complex exhibited a Tm of 49.3 °C whereas 
the Tm of CaMK1D was 51.2 °C. This indicates a slight decrease in Tm upon 
CaMK1D-Ca2+/CaM complex formation and suggests that there is destabilization 
when Ca2+/CaM binds and disengages the AID. Notably the Tm of apo CaMK1D is 
also slightly lower than its Tm of reported in its default NMR buffer 
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Figure 125. Thermal stability of CaMK1D and CaMK1D-Ca2+/CaM. ThermofluorTM 
was used to compare the stability of apo CaMK1D and the CaMK1D-Ca2+/CaM 
complex. Our results indicate that the complex has a lower stability with respect to 
apo CaMK1D. The ΔTm between apo CaMK1D and the complex was estimated to 
be 1.9 °C. We postulate that the complex has lower stability due to the removal of 
stabilizing interactions imparted by the pseudosubstrate AID upon Ca2+/CaM binding.  
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SAXS solution structures of CaMK1D, Ca2+/CaM, and CaMK1D-Ca2+/CaM 
complex 
 
SAXS model of CaMK1D is monomeric and adopts a bilobal shape 
In order to further understand the mechanism of CaMK1D activation by Ca2+/CaM 
we attempted to determine the global solution structure of the CaMK1D-Ca2+/CaM 
complex, CaMK1D and Ca2+/CaM by small angle x-ray scattering (SAXS). Solution 
structure determination of the individual proteins using SAXS was necessary to 
compare global conformational changes that might occur upon complex formation 
and guide the construction of a SAXS derived complex. All data collected were free 
of aggregation as indicated by the scattering curves and Rg values from the guinier 
plots which did not show significant deviation from the linear region suggesting 
negligible particle interference and aggregation (see table for SAXS statistics). 
Therefore we began with characterising the SAXS model of CaMK1D. Figure109 
reveals that the CaMK1D SAXS model appears to be bilobal. Superimposition of the 
CaMK1D crystal structure in momomeric form with the SAX model indicates that only 
one CaMK1D protein can fit within the SAX envelope and it closely resembles the 
bilobal fold of the crystal structure. The SAXS model of CaMK1D therefore indicates 
that CaMK1D is a monomer in solution and validates the suggestion that CaMK1D 
elutes as a 37.8 kDa monomer by size exclusion. Furthermore it reinforces the 
notion that the CaMK1D dimer evident in the crystal structure is indeed an artefact of 
crystallisation.  Most of the core secondary structural elements from both of the lobes 
are enclosed within the envelope except for a small loop within the N-terminal lobe 
which protrudes the SAXS envelope slightly. Overall the CaMK1D crystal structure 
closely resembles the CaMK1D SAXS solution structure.  
 
SAXS model of Ca2+/CaM is monomeric and adopts a dumbbell shape 
Structure determination of Ca2+/CaM by SAXS (figure 110) reveals that the SAXS 
model of Ca2+/CaM adopts a dumbbell shaped conformation in solution. 
Consequently superimposition of the Ca2+/CaM crystal structure with the SAX model 
illustrates that they conform.  Only one Ca2+/CaM protein can fit into the SAX model 
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of Ca2+/CaM which confirms that Ca2+/CaM is monomeric in solution. However the 
SAX envelope does not completely envelope the Ca2+/CaM crystal structure. In 
comparison to the CaMK1D SAXS structure there are more secondary structure 
elements in Ca2+/CaM that protrude the SAX envelope. Notably these include α 
helices from the E-F hand motif. 
 
SAXS model of the CaMK1D-Ca2+/CaM complex adopts an elongated shape 
Activation of CaMK1D requires binding of Ca2+/CaM to the C-terminal CBD of 
CaMK1D but the exact binding mode and conformation of the active complex is not 
fully understood. To address this we first determined the SAXS model of the 
CaMK1D-Ca2+/CaM complex then constructed the complex by combining SAXS 
models with the crystal structures of CaMK1D and Ca2+/CaM. Our SAXS model of 
the CaMK1D-Ca2+/CaM complex is shown to adopt an elongated conformation 
(Figure 111) thus indicating a global conformational change when compared to the 
SAXS models of CaMK1D and Ca2+/CaM. Subsequently the SAXS model of the 
complex was used to guide the construction of the final complex. by manually fitting 
a modified crystal structure of CaMK1D lacking the AID-CBD and Ca2+/CaM in 
complex with the .  
 
This structure of CaMK1D is termed CaMK1D1-288 due to removal of the C-terminal 
Δ289-313 segment that includes the AID and CBD. With CaMK1D1-288 we 
constructed the final complex using the crystal structure of Ca2+/CaM in complex with 
an AID-CBD peptide. Manual fitting of the two crystal structures to the SAXS 
complex envelope reveals a model whereby Ca2+/CaM-AID-CBD is positioned at the 
base of the CaMK1D C-terminal substrate binding lobe. This model proposes the 
active conformation of a CaMK protein when in complex with Ca2+/CaM. Interestingly 
this binding mode is different from the DAPK-Ca2+/CaM crystal structure which 
demonstrates Ca2+/CaM bound to the AID-CBD but not disengaged from the 
substrate binding site (de Diego, Kuper et al. 2010). It is also evident in our final 
model that both proteins bind to each other in a one to one stoichiometry which 
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conforms to our ITC data and both proteins are almost completely enclosed within 
the SAXS envelope. 
 Rg (nM) Dmax (nM) NSD Chi value 
CaMK1D 2.42 7.3 1.713 1.189 
Ca2+/CaM 2.14 6.4 1.487 2.210 
CaMK1D-Ca2+/CaM 3.04 10.2 1.567 1.360 
 
Table 4. SAXS statistics 
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Figure 109A. SAXS scattering curves and the P(r) distribution plot for CaMK1D, 
Ca2+/CaM, and the CaMK1D-Ca2+/CaM complex.  The scattering curves indicate 
that samples are not affected by aggregation or interparticle interference when q 
approaches 0. Furthermore all scattering curves superimpose well with their crysol 
and dammif derived scattering curves suggesting that the solution and crystal 
structure conformations are similar. The P(r) distribution plot indicates the Dmax 
values of each sample and as expected the complex has the largest Dmax. 
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Figure 109B. Guinier plots of CaMK1D, Ca2+/CaM, and the CaMK1D-Ca2+/CaM 
complex.  The guinier plots for all samples appear linear in the regions shown 
indicating that the samples are free of aggregration and interparticle interference 
aswell as producing reasonable estimates of the Rg values for each protein. 
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Figure 109C. CaMK1D SAXS envelope model fitted with the CaMK1D crystal 
structure. The CaMK1D SAXS envelope is shown as a surface representation and 
reveals a bilobal shaped conformation. The small N-terminal lobe (N-lobe) and large 
C-terminal lobe (C-lobe) of the CaMK1D (cyan) crystal structure (PDB: 2JC6) fits 
favourably within the SAXS envelope. This indicates that the SAXS CaMK1D 
solution conformation closely resembles the crystal structure conformation. The 
SAXS model of CaMK1D also implies that in solution CaMK1D exists as a monomer 
rather than the crystallised strand exchanged dimer. Similarly the RD of rat CaMK1A 
modelled into our CaMK1D structure by structural alignment also conforms to the 
SAXS envelope. 
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Figure 110. Ca2+/CaM SAXS envelope model fitted with the Ca2+/CaM crystal 
structure. The SAXS envelop of Ca2+/CaM is shown as a surface representation 
and reveals a dumbbell shaped conformation that is similar to the Ca2+/CaM (yellow) 
crystal structure (3CLN). Fitting of the Ca2+/CaM crystal structure into the SAXS 
envelope demonstrates that both the globular domains and the flexible linker are 
accommodated into the envelope. Not all of the local secondary structure elements 
of Ca2+/CaM are completely enclosed within the SAXS envelope but their domain 
orientations conform to the SAXS envelope and indicate that in solution Ca2+/CaM 
exists as a monomer in an extended dumbbell conformation. 
 
 293 
 
 
 
 
 
 
 
 
 294 
 
Figure 111. CaMK1D-Ca2+/CaM complex reconstructed from SAXS and crystal 
structures.  The SAXS envelope model of the complex is illustrated as a surface 
representation and adopts an elongated shape. The CaMK1D-Ca2+/CaM complex 
was reconstructed using a modified version of the CaMK1D crystal structure (2JC6) 
in which the co-ordinates for a portion of the regulatory AID-CDB segment Δ289-313 
which presumably is rearranged was deleted for simplification. The crystal structure 
of CaMK1D1-288 kinase domain (blue) was fitted into the top portion of the envelope 
whilst the crystal structure of Ca2+/CaM (yellow) bound to the peptide sequence of 
the AID-CBD (red) (1MXE) was fitted into the lower portion of the envelope. The 
front, back, top and base perspectives show that the majority of the secondary 
structure elements and loops fit within the SAXS envelope. The dotted line is a 
simplified extrapolation of the AID loop to the loop of the AID-CBD peptide. The AID-
CBD peptide sequence is taken from the rat homolog of CaMK1A and corresponds 
to: IKKNFAKSKWKQAFNATAVVRHMRK (residues 294 -318) (Clapperton, Martin et 
al. 2002).  
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Figure 112. CaMK1D-Ca2+/CaM complex reconstructed from SAXS and crystal 
structures. Model of the CaMK1D-Ca2+/CaM complex calculated using the SAXS 
envelope and fitting of the crystal structures of CaMK1D1-288 and Ca
2+/CaM-AID-
CBD as described and shown in another perspective similar to those shown in figure. 
The CaMK1D1-288 (blue) and Ca2+/CaM-AID-CBD crystal structures (yellow and 
red) was fitted into the top and lower portions of the SAXS envelope, respectively.  
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CaMK1D and small molecule ligand interactions by NMR 
 
Apo autoinhibited CaMK1D binds to ATP with low affinity 
The crystal structure of rat CaMK1A determined by Goldberg and co-workers first 
revealed that the canonical kinase bilobal fold was autoinhibited by the AID via a 
pseudosubstrate mechanism that occluded the substrate binding site and disrupted 
the conformation of the N-terminal ATP binding lobe (Goldberg, Nairn et al. 1996). 
However the possibility of ATP binding cannot be ruled out because of the open 
conformation adopted by rat CaMK1A which results in solvent exposure of the active 
site cleft (Goldberg, Nairn et al. 1996). Structural alignment of CaMK1D with rat 
CaMK1A indicates that the active site cleft of autoinhibited CaMK1D also adopts a 
similar conformation. We postulated that although CaMK1D is autoinhibited it could 
still bind ATP but with reduced affinity compared to active CaMK1D-Ca2+/CaM. 
Furthermore the fact that CaMK1D was co-crystallised with GSK-3 XIII in the active 
site cleft indicated that the site was accessible and solvent exposed.  
 
We used an NMR based approach to study the interaction of AMPPNP (a non-
hydrolysable ATP analog) with CaMK1D by monitoring the CSPs of peaks in the 1H, 
15N TROSY HSQC to infer residues that interact directly or indirectly with AMPPNP. 
Our results (Figure 126) indicate that titration of CaMK1D with increasing 
concentrations of AMPPNP caused a number of peaks to become progressively 
perturbed in a fast exchange which suggests that the affinity of the interaction is 
within the weak-moderate affinity range. Due to the nature of fast exchange, peaks 
which experience this NMR timescale can be tracked and their chemical shift change 
can be determined. In order to estimate the binding affinity, titrations were conducted 
until saturation with the ligand in excess to determine the endpoint where there are 
no longer any observed chemical shift changes. Consequently the Kd for the binding 
interaction can be estimated from a binding curve by plotting the normalised 
chemical shift changes of a residue against the increasing ligand concentrations. 
Using this method our Kd estimate for CaMK1D binding to AMPPNP was 
1.306+0.093 mM, indicative of very weak binding (figure 129). 
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A histogram of the CSPs induced by AMPPNP (figure 127) binding reveals the 
residues which undergo the most significant perturbations span predominantly 
across the N-terminal ATP binding lobe. These residues correlate closely in 
sequence to three distinct functional regions. Both Val 38 and Ala 40 are located 
near in sequence to the p-loop which interacts with the phosphate groups of 
nucleotides i.e. ATP and ADP, whereas Val 51 and Ile 54 are close to Lys 52, a 
highly conserved Lys that interacts with the nucleotide and is essential for catalysis 
of the phosphoryl transfer reaction. Glu 89, Ser 90, Leu 94, and Tyr 95 are all 
located N-terminal of the hinge, a loop region (residues 100-104) which is implicated 
in hydrogen bonding to the adenine ring of nucleotides. Binding of AMPPNP 
presumably causes the hinge to convey long range conformational changes to Glu 
89, Ser 90, Leu 94, and Tyr 95. A few residues located outside of the N-terminal lobe 
also exhibit significant CSPs and include Lys 14, Ile 19, Glu 112, and Leu 150. 
Analysis of these CSPs mapped onto the CaMK1D structure (figure 128) indicates 
that Lys 14, Ile 19, and Glu 112 are perturbed indirectly via conformational changes 
induced by AMPPNP binding. Glu 112 in particular appears to be a long range 
downstream effect of the hinge. Leu 150 appears close in space to the active site 
cleft where AMPPNP binds. 
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Figure 126. CaMK1D titration with AMPPNP. The superimposed 1H, 15N TROSY 
HSQC spectra shows the progressive CSPs that occurred when increasing 
concentrations of AMPPNP was titrated into CaMK1D. A few notable CSPs are 
highlighted. Titration experiments were performed using 170 uM 2H, 15N CaMK1D, in 
50 mM HEPES pH 7.0, 150 mM NaCl, 0.5 mM TCEP, 0.02 % Na Azide, 10 % 2H2O, 
at 25 °C 
 
 
,  
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Figure 127. Histogram of the CaMK1D CSPs induced by AMPPNP. The 
histogram shows the residues which undergo CSPs due to AMPPNP binding. 
Residues with the most pronounced CSPs (> 2 or 1S.D) are indicated by the yellow 
and red line. The mean CSP is indicated by the gray line. 
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Figure 128 A. CaMK1D CSPs induced by AMPPNP.  A cartoon of our CaMK1D 
autoinhibited model structure with CSPs induced by AMPPNP mapped on. As 
indicated by the gradient scale, backbone residues are coloured according to the 
magnitude of the normalised chemical shift changes that occurred upon titrating in 
AMPPNP.  
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Figure 128 B. CaMK1D CSPs induced by AMPPNP. A 180° rotated view of the 
previous figure illustrating a cartoon of the CaMK1D crystal structure with CSPs 
induced by AMPPNP mapped on with levels of perturbation corresponding to the 
gradient scale indicated. 
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Figure 129. CaMK1D binds to AMPPNP with a Kd of 1.3 mM. The magnitude of 
normalised chemical shift change (y axis) for various perturbed CaMK1D residues 
are plotted against increasing AMPPNP concentration (x axis) to produce binding 
curves. Kd estimates were deduced from the binding curves and averaged to 
produce a weak Kd value of 1.306±0.093 mM. 
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CaMK1D in the presence of AMPPNP binds Mg2+ with a low affinity 
Most kinase proteins including CaMK1D require Mg2+ in complex with ATP for kinase 
activity. In order to characterise the binding of AMPPNP-Mg2+ to CaMK1D we titrated 
MgCl2 into CaMK1D saturated with AMPPNP and used the same 
1H, 15N TROSY 
HSQC approach in our AMPPNP and CaMK1D interaction to monitor the CSPs. Our 
results illustrate (figure 130) that Mg2+ interacts with CaMK1D-AMPPNP to form 
CaMK1D-AMPPNP-Mg2+ due to evidence of CSPs. These perturbed peaks 
displayed progressive CSPs characteristic of fast exchange phenomena which 
allowed a binding curve to be plotted as previously described for our CaMK1D and 
AMPPNP interaction. From our binding curve (figure 133) we estimate the Kd for 
CaMK1D and AMPPNP-Mg2+ interaction to be 0.611±0.133 mM. This approximately 
a two-fold increase in affinity compared to the CaMK1D interaction with AMPPNP. 
 
A comparison of the CSPs from the titration of MgCl2 into CaMK1D-AMPPNP with 
those from the titration of AMPPNP into CaMK1D reveals a common set of peaks 
that are perturbed in both experiments. Some of the CaMK1D-AMPPNP CSPs 
induced by Mg2+ appear to move in an opposite direction to the CSPs induced by 
AMPPNP. This suggests that Mg2+ modulates the binding interaction of AMPPNP 
bound to CaMK1D by binding to AMPPNP to form the AMPPNP-Mg2+ complex. The 
Mg2+ induced CaMK1D-AMPPNP CSPs which move in an opposite direction to the 
CaMK1D CSPs induced by AMPPNP suggests that these residues in CaMK1D-
AMPPNP undergo a conformational change that is similar to its conformation prior to 
AMPPNP binding to CaMK1D (i.e. a similar chemical environment) because the 
peaks move back towards the position from which they originally started from .  
 
Peaks that display this behaviour correlate to residues Ala 40 Lys 52, Ile 54, 89E, 
Ser 90, 150 Leu, and Gly 173. Titration of MgCl2 also caused additional peaks to 
undergo CSPs suggesting that the AMPPNP-Mg2+ complex forms additional 
interactions with CaMK1D which is expected because Mg2+ is known to coordinate 
further interactions between ATP and the activation loop (adams) Additional 
perturbed peaks include those assigned as Thr 31, Glu 79, Gly 105, Glu 112 and 
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Phe 115. Thr 31 and Gly 105 are located within the p-loop and hinge respectively 
indicating that Mg2+ via AMPPNP-Mg2+ mediates further interactions with these 
functional elements. Titration experiments were also conducted using up to 10 mM 
MgCl2 in the absence of AMPPNP (data not shown) to investigate any AMPPNP 
independent Mg2+binding sites. Consequently no CSPs were evident indicating that 
MgCl2 does not interact with CaMK1D in the absence of AMPPNP.  
 
Minimal CaMK1D CSPs due to buffer differences 
All of our titration experiments by NMR were conducted in 50 mM HEPES buffer pH 
7.0 instead of 50 mM Na Phosphate pH 7.0 because the intention was to repeat the 
same titration experiments on the active CaMK1D-Ca2+/CaM complex which was not 
compatible with Na phosphate due to the need for Ca2+ which reacts with phosphate 
and precipitates. An overlay of the CaMK1D 1H, 15N TROSY HSQC spectra in both 
respective buffers indicated minimal CSPs.  
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Figure 130. CaMK1D-AMPPNP titration with MgCl2. The superimposed 
1H, 15N 
TROSY HSQC spectra shows the progressive CSPs that occurred when increasing 
concentrations of MgCl2 was titrated into CaMK1D saturated with 10 mM AMPPNP. 
A few notable CSPs are highlighted. Titration experiments were performed using 180 
uM 2H, 15N CaMK1D, in 50 mM HEPES pH 7.0, 150 mM NaCl, 0.5 mM TCEP, 0.02 
% Na Azide, 10 % 2H2O, on a Varian 800 MHz at 25 °C 
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Figure 131. Histogram of CSPs for CaMK1D-AMPPNP induced by Mg2+. The 
histogram shows the residues which undergo CSPs due to Mg2+ binding to 
CaMK1D-AMPPNP. Residues with the most pronounced CSPs (> 2 or 1S.D) are 
indicated by the yellow and red line. The mean CSP is indicated by the gray line. 
 307 
 
 
 
 
Figure 132 A. CaMK1D-AMPPNP CSPs induced by MgCl2. A cartoon 
representation of the CaMK1D crystal structure with CSPs induced by Mg2+ mapped 
on. As indicated by the gradient scale, backbone residues are coloured according to 
the magnitude of the normalised chemical shift changes that occurred upon titrating 
in MgCl2.  
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Figure 132 B. CaMK1D-AMPPNP CSPs induced by MgCl2. A 180° rotated view of 
the previous figure illustrating a cartoon of the CaMK1D crystal structure with CSPs 
induced by Mg2+ mapped on.  
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Figure 133. CaMK1D binds AMPPNP-MgCl2 with a Kd of 0.611 mM. The 
magnitude of normalised chemical shift change (y axis) for various perturbed 
CaMK1D residues are plotted against increasing MgCl2 concentration (x axis) to 
produce binding curves. Kd estimates were deduced from the binding curves and 
averaged to produce a weak Kd value of 0.611±0.133 mM for the interaction between 
CaMK1D and AMPPNP-Mg2+. 
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CaMK1D binds several kinase inhibitors by thermofluorTM 
In addition to providing information about the thermal stability of proteins, 
thermofluorTM can also indicate binding to ligands because often ligand binding 
results in an increase in the thermal stability of a protein depending on its affinity. In 
collaboration with the SGC, CaMK1D was screened against a library of kinase 
inhibitors using thermofluorTM and several hits were discovered as shown in table 5. 
The data indicates that the active site cleft is accessible to various ATP analog 
inhibitors. Inhibitors that produced larger changes in Tm suggested tighter binding. 
 
5 % DMSO lowers the thermal stability of CaMK1D and causes a few CSPs 
Most of the inhibitors (table) that were suggested to bind to CaMK1D by 
thermofluorTM required dimethlysulfoxide (DMSO) for solubility. Therefore prior to 
characterisation of such ligands by NMR we decided to deduce an optimal DMSO % 
(v/v) for CaMK1D stability and established this to be 5.0 % by thermofluorTM. Our 
results indicated a 5.0 °C decrease in the Tm of CaMK1D when in the presence of 
5.0 % DMSO (Figure 134). At 10.0 % DMSO, sigmoidal melting curves could not be 
obtained due to precipitation of CaMK1D (data not shown). CaMK1D stability in the 
presence of 5.0 % DMSO was further characterised by NMR in which CSPs were 
monitored by titrating into CaMK1D 0, 1.0, 2.5, and 5.0 % DMSO (figure 135). 
Results from this titration experiment indicate that CaMK1D is still folded in 5.0 % 
DMSO. Small progressive CSPs in fast exchange were also evident. Tracking these 
CSPs allowed us to account for the CSPs induced by 5.0 % DMSO when conducting 
titrations with DMSO soluble inhibitors by NMR in our CaMK1D. Mapping of the 
DMSO interaction sites on CaMK1D suggests that DMSO binds to two main patches 
one of which is located near Thr 28 and Ala 33 near the C-terminal portion of the R2 
helix of the AID/CBD and at the base of the C-terminal lobe (figure 138). We 
postulate that at 10.0 % DMSO or above, there is disruption and destabilisation of 
the local structure of these two patches caused by DMSO binding. Destabilisation of 
the AID/CBD αR2 helix in particular will impact the overall stability of CaMK1D 
because this helix contributes towards stabilizing contacts with the CaMK1D catalytic 
domain. 
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Figure 134. CaMK1D thermal melting curves in the presence of 5 % DMSO. The 
thermal stability of CaMK1D was assessed by thermofluorTM in the presence of 5 % 
DMSO and found to decrease by 5.0 °C. 
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Compound Description Compound 
Screen: Tm Shift 
(C) 
Staurosporine 11 
 Syk Inhibitor II 5.3 
SB 218078 4.6 
IKK Inhibitor  VII 4.3 
K252c; Staurosporine Aglycone 4.2 
JAK Inhibitor I 4.2 
K252a 3.8 
GSK inhibitor XIII 3.5 
IKK Inhibitor VI 3.4 
Cdk4 Inhibitor 3.4 
Quercetin 3.3 
Cdk1/2 Inhibitor III 3.2 
 
Table 5. Compounds that bind to CaMK1D. Our collaborators the SGC conducted 
a high throughput screen of known kinase inhibitors against CaMK1D by 
thermofluorTM and discovered several interacting compounds. Changes in the Tm of 
CaMK1D induced by each compound are listed to illustrate their effect on CaMK1D 
stability. 
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Figure 135. CaMK1D titration with DMSO. Increasing concentrations of DMSO 
from 0-5 % (v/v) was titrated into CaMK1D and CSPs were monitored by 1H, 15N 
TROSY HSQC. A few peaks display progressive perturbations in fast exchange. At 
DMSO concentrations beyond 5 %, CaMK1D precipitation accelerated greatly and 
compromised the quality of the spectrum. Spectra were acquired on a Varian 800 
MHz at 25 °C using 180 µM 2H, 15N CaMK1D, in 50 mM HEPES pH 7.0, 150 mM 
NaCl, 0.5 mM TCEP, 0.02 % Na Azide with 1, 2.5, and % 5 DMSO titrated in. 
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Figure 136. Histogram of CaMK1D CSPs induced by 5 % DMSO. The average 
peak intensity reducion is shown indicated by the gray line. Those that are >1 or 2 
S.D are indicated by the yellow and red line respectively. 
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Figure 137 A. CaMK1D CSPs induced by DMSO. A cartoon representation of the 
CaMK1D crystal structure with CSPs induced by DMSO mapped on. As indicated by 
the gradient scale, backbone residues are coloured according to the magnitude of 
the normalised chemical shift changes that occurred upon titrating in DMSO from 0-5 
% (v/v). 
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Figure 137 A. CaMK1D CSPs induced by DMSO. A cartoon representation of the 
CaMK1D crystal structure with CSPs induced by DMSO mapped on. As indicated by 
the gradient scale, backbone residues are coloured according to the magnitude of 
the normalised chemical shift changes that occurred upon titrating in DMSO from 0-5 
% (v/v). 
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GSK-3 XIII inhibitor binds into the CaMK1D active site cleft and interacts with 
the AID/CBD 
The binding mechanism of the ATP analog GSK-3 XIII to CaMK1D was elucidated 
by comparing X-ray crystallography and solution state NMR data, revealing the local 
and unprecedented long range interactions. Most protein kinases are successfully 
co-crystallised in the presence of an inhibitor because the apo form is often dynamic 
and samples multiple conformations (Vogtherr, Saxena et al. 2006)Federov 2007). 
Likewise the structure of CaMK1D was determined by the SGC as a CaMK1D-GSK-
3 XIII inhibitor complex. This ligand was discovered in a HTS using thermofluorTM 
(table 4). The complex reveals that the ATP competitive inhibitor binds to the active 
site cleft of autoinhibited CaMK1D and makes several contacts (Figure 139). Two 
notable hydrogen bonds are evident between the GSK-3 XIII inhibitor and Leu 29 
and Val 101.  A hydrogen bond interaction between the inhibitor and Leu 29 is 
mediated via a water molecule. Other residues shown in close proximity to GSK-3 
XII include Val 37, Ala 50, Lys 52, Val 82, Met 98, Gln 99, Leu 100, Val 101, Gly 104, 
Leu 151, Ser 164, Trp 306, and Phe 310. Side chains of Trp 306 and Phe 310 
appear buried and directed towards GSK-3 XIII suggesting that there is an 
interaction between them that further stabilizes this region of the AID/CBD. This is in 
contrast to the apo rat CaMK1A where the equivalent Trp side chain is solvent 
exposed (Goldberg, Nairn et al. 1996). We therefore believe that the buried 
orientation of the Trp 306 side chain suggests an allosteric mode of inhibition 
because stabilization of the AID/CBD and the enforced burial of the Trp 306 side 
chain will prevent activation by Ca2+/CaM. Our ITC data confirmed the importance of 
this solvent exposed side chain in mediating the CaMK1D interaction with Ca2+/CaM. 
In our NMR studies these residues are resolved thus facilitating our analysis of the 
conformational changes involved which we discuss in the subsequent section. 
 
CaMK1D binds to GSK-3 XIII inhibitor with a high affinity and shows 
pronounced CSPs around the active site cleft 
Although the CaMK1D-GSK-3 XIII co-crystal structure provides insight into the 
binding mode of GSK-3 XIII and residue contacts within the active site cleft, 
information about potential long range conformational changes beyond the binding 
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site are not readily apparent due to the lack of an apo CaMK1D crystal structure for 
comparison and potential artefacts from enforced lattice contacts in a crystal 
structure. We therefore examined by NMR the conformational changes of CaMK1D 
in solution which were induced by GSK-3 XIII binding to gain mechanistic insight into 
its mode of inhibition and potential allosteric sites that modulate the activity of the 
CaMK1D.  
 
For this study of possible inhibitor-induced conformational changes we titrated from 
0-1.5 equivalents of GSK-3 XIII inhibitor into CaMK1D and monitored CSPs by 1H, 
15N TROSY HSQC (figure 140). Spectra collected at each titration point were 
overlaid, revealing CSPs in slow exchange and therefore indicative of a tight binding 
interaction (data not shown). Some assigned peaks which exhibit CSPs and 
intermediate exchange broadening are highlighted in figure 140, which illustrates 
only the apo CaMK1D and titration endpoint spectra superimposed for simplification. 
The perturbed amide peaks included those of the activation loop residues Gly 173 
and Gly 175, which were found to exhibit slow and intermediate exchange, 
respectively. Thus the CSPs of Gly 173 and Gly 175 suggests that this region of the 
activation loop maybe in close proximity to GSK-3 XIII or indirectly experience a 
conformational change that is conveyed through the active site cleft. Due to the 
phenomenon of slow exchange the final positions of some peaks in the endpoint 
spectra had to be predicted.  It was not possible to assign the CaMK1D-GSK-3 XIII 
complex due to time and financial constraints as well as the limited quality of the 
spectra collected during the titration.  
 
A histogram of the peak intensity reduction induced by GSK-3 XIII (figure 141) 
indicates a spread of residues from both lobes. Some of these residues occur within 
or near ATP interacting functional elements such as the P-loop, the catalytic Lys 52, 
and the hinge. Mapping of the intensity reduction onto the structure (figure 142) 
reveals that the large reductions occur around the active site cleft but interesting also 
the RD which is not surprising because this is seen in the crystal structure 
(figure139).  
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A few residues in the histogram with large intensity reduction that appear far in 
sequence from the ATP interacting functional elements include Asn 80, Ile 87, Asn 
149, Leu 150, and Leu 214 but mapping of these perturbed residues onto the 
CaMK1D structure indicates all residues except Leu 214 are in close promixity to the 
active site cleft (figure142). Leu 214 is buried within the core of the C-terminal lobe 
but is in close proximity to Pro 147 which is C-terminal of the catalytic loop by one 
residue. Since the catalytic loop also forms part of the active site cleft think that a 
long range conformational change induced by GSK-3 XIII is conveyed through to Leu 
214 via the catalytic loop and Pro 147.  
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Figure 139. CaMK1D and GSK-3 XIII inhibitor co-crystal interactions. The upper 
and lower (rotated 180° with respect to upper figure) cartoon figures illustrate the co-
crystal structure of CaMK1D with GSK-3 XIII inhibitor bound inside the active site 
cleft. The expanded active site cleft highlights the CaMK1D residues that are within 
the vicinity of the GSK-3 XIII inhibitor. Hydrogen bonds (defined as polar contacts 
between 2.6-3.5 Å in pymol) are shown between CaMK1D and GSK-3 XIII as yellow 
dashed lines whilst orange spheres denoted water molecules.  
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Figure 140. CaMK1D titration with GSK-3 XIII inhibitor in 5 % DMSO. Overlay of 
the 1H, 15N TROSY HSQC spectra for apo CaMK1D (black) and the titration endpoint 
of CaMK1D with 1.5 equivalents of GSK-3 XIII inhibitor (blue) reveals peaks that 
display CSPs and intermediate exchange broadening thus indicating an interaction 
between CaMK1D with the inhibitor. Titration of CaMK1D with 0.1, 0.25, 0.5, 0.75, 
and 1.5 equivalents of GSK-3 XIII inhibitor displayed CSPs in slow exchange 
indicative of a tight binding affinity (spectra not shown). All spectra were acquired at 
25 °C on a Varian 800 MHZ spectrometer using 180 µM 2H, 15N CaMK1D, in 50 mM 
HEPES pH 7.0, 150 mM NaCl, 0.5 mM TCEP, 0.02 % Na Azide, 5 % DMSO. The 
GSK-3 XIII inhibitor was prepared in an identical buffer. 
 
 
 322 
 
 
Figure 141. Histogram of CaMK1D amide peak intensity reduction induced by 
GSK-3 XIII. The average peak intensity reducion is shown indicated by the gray line. 
Those that are >1 or 2 S.D are indicated by the yellow and red line respectively. 
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Figure 142 A. CaMK1D CSPs induced by GSK-3 XIII. A cartoon representation of 
the CaMK1D crystal structure with peak intensity reduction induced by GSK-3 XIII 
mapped on. 
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Figure 142 B. CaMK1D CSPs induced by GSK-3 XIII. A 180° rotated view of the 
previous figure illustrating a cartoon of the CaMK1D crystal structure with peak 
intensity reduction induced by GSK-3 XIII mapped on.  
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Chapter IV Discussions and Conclusions 
Protein kinases by NMR 
Our preliminary analysis of six different kinase proteins by NMR has shown that only 
two out of the six targets were feasibly tractable to backbone structural studies by 
NMR without needing extensive optimisation. CaMK1D and PAK5 were the two 
kinases that produced 1H, 15N HSQC spectra feasible for structural studies. In 
contrast TOPK, Pim1, CSNK1G3, and CaMK1G were not tractable to backbone 
structural studies predominantly because the majority of their backbone amide 
resonances broadened out on an intermediate exchange time scale. We deduce that 
the main reason for this phenomenon is because of the inherently dynamic nature of 
kinases which was reflected by their 1H, 15N HSQC spectra and B-factors. This is not 
surprising because it is well established that kinases are dynamic entities that 
sample an ensemble of conformations permitted by their conformational plasticity 
(Vogtherr, Saxena et al. 2006) Kuryian 2002).  
 
Stability, heterogeneity and post translational modifications were additional issues 
that hindered our study of kinases. Extensive efforts were made to optimise stability 
by screening different buffer solution conditions because we suspected that an 
increase in kinase stabilibilty might correlate with improved NMR spectra via 
changes in the dynamic properties of the kinase. However, our results showed that 
altering the buffer solution conditions had no significant impact on improving the 
amide peak count even though an increase in stability was apparent by 
thermofluorTM in the presence of NaCl as a stabilizer, but these were often small 
changes typically 2-4 °C. The main notable changes in NMR spectra due to buffer 
optimisation were increases in peak intensities and pH dependent CSPs. We thus 
conclude that increasing the Tm of a kinase via changes in buffer conditions does 
not correlate with an improvement in NMR spectra. Our results emphasise the 
difficulty in working with kinases particularly by NMR. Hence only a small number of 
kinases have reportedly been assigned and studied using NMR (Langer, Vogtherr et 
al. 2004; Vogtherr, Saxena et al. 2005; Gelev, Aktas et al. 2006; Vogtherr, Saxena et 
al. 2006; Vajpai, Strauss et al. 2008; Masterson, Shi et al. 2009). 
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The importance of the AID for CaMK1D stability 
Both CaMK1D and PAK5 produced 1H, 15N HSQC spectra which were evaluated to 
be feasible for structural analysis but we decided to pursue CaMK1D as our main 
target because its NMR spectrum was superior to PAK5 in terms of peak count and 
intensity. Furthermore during acquisition of 1H, 15N HSQC spectra, CaMK1D 
displayed fewer tendencies to precipitate at 25 °C compared to PAK5 suggesting 
that CaMK1D is more stable. There appeared to be a correlation between protein 
stability and spectral quality. For example the stability of PAK5 and CaMK1D was 
deduced to be relatively high compared to the other kinases based on thermofluorTM 
data. CaMK1D in particular exhibited the highest long term stability at 25 °C during 
acquisition of NMR experiments. In contrast thermofluorTM data suggested that the 
stability of Pim1, CaMK1G and CSNK1G3 was relatively low with no correlation 
between Tm and buffer pH. Given that these samples also demonstrated an 
increase in precipitation 25 °C during acquisition of NMR experiment is consistent 
with the notion suggested by thermofluorTM that these proteins are relatively 
unstable. The stability of TOPK was neither relatively low nor high but was 
considered to have moderate stabiity whilst its 1H, 15N HSQC was superior to Pim1, 
CaMK1G and CSNK1G3 but inferior to CaMK1D and PAK5.  
 
We examined the B-factors associated with the kinases to infer a correlation with the 
dynamics suggested by their 1H 15N HSQC spectra. Generally high B-factors were 
found to correlate with increased dynamics in their spectra often on an intermediate 
exchange timescale. Another important observation was the difference in stability 
and dynamics of kinases possessing a regulatory domain and those that were purely 
catalytic domains. CaMK1D for example contains a relatively rigid AID whereas Pim1 
is comprisesd of a catalytic domain only. We believe that the reason CaMK1D 
produces a high peak count in its spectra with a relatively large subset of consistent 
and intense peaks is because of its AID which is able to mediate pseudosubstrate 
contacts and reduce conformational sampling concomitant with a reduction in 
conformational dynamics.  
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Conversly Pim1 is constitively active and permitted to sample multiple conformations 
which we believe correlates to substantial intermediate exchange dynamics. 
However PAK5 and CaMK1G are execeptions to this because our PAK5 construct 
for example constitutes the catalytic domain only yet it has an intrinsically stable 
conformation with stable dynamics. Whereas CaMK1G which we would predict to be 
similarly well behaved for NMR like CaMK1D is instead contrastingly different 
exhibiting intermediate exchange dynamics deduced from its NMR specrum. Despite 
possessing an AID CaMK1G B-factors imply that its conformation is relatively 
dynamic whilst its stability is low. To summarise these points we believe that based 
on our results it is effectively very difficult to predict how a kinase and its intrinsic 
dynamics and stability affects its 1H, 15H HSQC spectrum. Although the presence of 
a stabilizing AID as exempliefied by CaMK1D suggests that reduced mobility and 
thus limited sampling of conformations can produce NMR spectra with well dispersed 
strong amide peak intensites and a high peak count. We have seen that the extent of 
kinase dynamic behaviour and the NMR time scales on which they occur varies 
widely with each kinase. 
 
Kinase backbone assignments 
Having found a kinase tractable to structural studies by NMR in CaMK1D we have 
managed to assign 79 % of the backbone amide resonances for apo autoinhibited 
CaMK1D. The extent of our backbone assignment is comparable to the backbone 
assignments that have been demonstrated with other kinases. For example PKA in 
complex with AMPPNP-Mg2+ and Abl in complex with Imatinib have been assigned 
for 80 % and 96 %, of their backbone amides respectively (Vajpai, Strauss et al. 
2008; Masterson, Shi et al. 2009). In comparison to other apo kinases, our backbone 
assignment coverage for apo CaMK1D is also comparable to PKR which had in total 
75 % of its backbone assigned and an improvement on the backbone assignments 
reported for PKA and p38MAPK (Langer, Vogtherr et al. 2004; Vogtherr, Saxena et 
al. 2005; Gelev, Aktas et al. 2006). It is interesting to note from these few examples 
that a more complete backbone assignment can be accomplished for kinases in 
complex with ligand rather than in apo form due to the fact that kinases are dynamic 
proteins. Therefore a ligand can stabilize and trap a kinase in a particular 
conformation whereas an apo kinase can sample an ensemble of conformations. 
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This is also analogous to kinases that are tackled by protein crystallography which 
often require a ligand in order the kinase to become receptive to conditions that 
promote crystallisation. 
 
The key regions which were unassigned in CaMK1D correlate predominantly to 
loops that include the catalytic and activation loops. In the CaMK1D crystal structure 
the catalytic loop is well defined but the activation loop is disordered. This is often 
the case if the activation loop is in an unstable conformation usually in the absence 
of activation loop phosphorylation. Curiously the crystal structure of CaMK1G 
displays an ordered activation which is in contrast to CaMK1D even though they 
share high sequence homology. Other unassigned regions correlate to functionally 
mobile elements such as the αC helix, the hinge, and a portion of the CBD. Apart 
from the CBD these elements are well defined in the CaMK1D crystal structure. 
Analysis of the CaMK1D B-factors reveals that the αC helix is relatively dynamic and 
in our spectrum we presume that this correlates to dynamics on an intermediate 
exchange timescale. 
 
Assignments could not be acquired for the unassigned regions predominantly 
because the amide resonances were very weak in intensity or completely broadened 
out. Some sequential assignments could not be established due to CB resonance 
broadening. Therefore in order to increase our backbone assignment coverage we 
attempted to optimise the CaMK1D spectrum by lowering the pH but this had 
negligible effect in terms of producing new peaks and increasing the intensity of 
weak resonances. We conclude that these regions must be inherently dynamic on an 
intermediate exchange timescale. Lowering the pH did however induce pH 
dependent CSPs and when these were mapped to the CaMK1D structure there was 
a localise patch of pH sensitive residues near the N-terminal start of the AID. We 
therefore speculate whether there is a potential pH dependent effect on the 
disengagement of the AID. For future studies aiming to optimise the peak count we 
propose the use of a ligand such as AMPPNP to stabilize the active site cleft 
elements such as the catalytic and activation loops, hinge, and the αC helix. This has 
been demonstrated by Masteron et al with 80 % of the PKA backbone amides 
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assigned. A significant improvement on the previous backbone assignment of PKA 
which was only had 55 % of its total backbone amide resonances assigned (Langer, 
Vogtherr et al. 2004; Masterson, Shi et al. 2009). 
 
Refinement of CaMK1D crystal structure using NMR 
A TALOS based structure prediction was performed using our backbone 
assignments and compared with the secondary structure defined by the CaMk1D 
crystal structure. Some differences were revealed in this comparison, notably at the 
N-terminus β1 strand is absent in our prediction because this secondary structure 
element is a crystallisation artefact that acts as a dimerisation interface possibly via 
strand exchange. We had no evidence with size exclusion chromatography, NMR, or 
SAXS to suggest that the CaMK1D crystal structure dimer occurred in solution. 
Another noteworthy difference was evident in the CBD which is defined as a helix 
(αR2 helix) in the crystal structure however in our NMR data this was predicted as 
random coil. We postulate that this region becomes structured when Ca2+/CaM binds 
to it. Secondary structural differences were also evident in the length of helices 
within the C-terminal substrate binding lobe. TALOS predicted these helices to be 
shorter. These highlighted structural differences were subsequently decided 
combined to create a hybrid CaMK1D model by using our dihedral angles restraints 
derived from TALOS to refine the crystal structure. Furthermore we included dihedral 
angle restraints from assignments that spanned disordered regions in the crystal 
such as the activation loop, N-termini, and C-termini. As a result of this our final 
model illustrates a refined crystal structure with missing loops including the activation 
loop modelled in. The activation model also reflects the dynamics and disordered 
nature of the loops.  
 
CaMK1D-Ca2+/CaM complex model and insight into mechanism of activation 
CaMK proteins are dependent on Ca2+/CaM for activation and it is known that the 
binding interaction occurs around the CBD. The binding mode of Ca2+/CaM and the 
CBD has been characterised through studies using CBD peptides which revealed 
that Ca2+/CaM essentially wraps around the CBD and involves Trp and Met  being 
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buried into two hydrophobic pockets within Ca2+/CaM (Clapperton, Martin et al. 
2002). Structural characterisation of full CaMK protein with Ca2+/CaM have not been 
desmonstrated only until recently with the DAPK- Ca2+/CaM complex (de Diego, 
Kuper et al. 2010). We were also interested in characterising the complex and 
attempted co-crystallisation screening of CaMK1D- Ca2+/CaM complex but had no 
success.  
 
Another technique we used to complement our complex data was SAXS. Our final 
CaMK1D-Ca2+/CaM complex model illustrates an elongated conformation with 
Ca2+/CaM positioned at the base of the CaMK1D C-terminal substrate binding lobe. 
This model is in contrast to the crystal structure of the DAPK- Ca2+/CaM complex (de 
Diego, Kuper et al. 2010). Based on our model we suggest an activation mechanism 
that can be described in a three step process. Firstly CaMK1D binds to Ca2+/CaM 
and forming a tight interaction around the CBD. In this position Ca2+/CaM is docked 
against CaMK1D as illustrated by the DAPK-Ca2+/CaM complex (de Diego, Kuper et 
al. 2010).  
 
The second step involves disengagement of the AID and CBD from the substrate 
binding site and N-terminal lobe. We postulate that this is coupled to a swing out 
mechanism with a pivot point acting near the beginning of AID which is defined by 
about seven residues in a loop enabling flexibility of the AID once disengaged. A 
third and final step to form an active complex with the substrate binding site exposed 
would involve docking of the Ca2+/CaM-AID-CBD to the base of C-terminal lobe. This 
final step according to SAXS data represents the active complex as opposed to the 
structure of DAPK-Ca2+ which still has the substrate binding site occluded. Finally we 
propose that the three step cycle repeats and is dynamic with the Ca2+/CaM-AID-
CBD engaging and disengaging from the the substrate binding site until Ca2+/CaM 
dissociates. Based on this model and current knowledge about other CaMKI 
regulatory mechanism we have devised a schematic that summaries the 
conformational and functional states of CaMK1D (figure 143). 
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Figure 143. A schematic of CaMK1D regulation. A summary of the different 
conformational and functional states that CaMK1D undergoes. CaMK1D can exists 
in main states described as autoinhibited CaMK1D, autoinhibited CaMK1D-
Ca2+/CaM, active CaMK1D-Ca2+/CaM, autoinhibited CaMK1D_T180*, autoinhibited 
CaMK1D_T180*-Ca2+/CaM, maximally active CaMK1D_T180*-Ca2+/CaM, 
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To help us further elucidate the mechanism of CaMK1D activation we used CSPs 
and peak intensity changes from our CaMK1D interactions with Ca2+/CaM by NMR 
to infer conformational changes but the evidence is not clear. Firstly we observe a 
tight interaction due to evidence of slow exchange coupled with an increase in peaks 
near the centre of the spectrum. Initially we proposed an unfolding mechanism 
because of this observation. Furthermore when the CaMK1D titrations with 
Ca2+/CaM were performed by NMR we noticed in the first increment in a 1H, 15N 
HSQC TROSY suggest unfolded due to an apparent reduction in resonance 
dispersions in the 1H dimension in the amide region. However an unfolding 
mechanism is not consistent with Ca2+/CaM-CBD peptide studies and the DAPK- 
Ca2+/CaM complex (Clapperton, Martin et al. 2002; de Diego, Kuper et al. 2010). 
Therefore we suspect that there is an increase in helical content upon and perhaps 
random coil structure from the activation loop which gives rise to the increased peak 
overlap in the centre of the CaMK1D-Ca2+/CaM 1H, 15N HSQC spectrum. 
 
Mapping of the CSPs based purely on whether resonances broadened out or 
exhibited slow exchange were found to localise predominantly on the AID, CBD, a 
region near the p-loop, our putative Ca2+/CaM docking site base of the C-terminal 
lobe and a couple of the residues that comprise the first loop of the AID (figure 116). 
CSPs corresponding to this loop however are not dramatic which we would expect 
for a swing out mechanism. It is possible that the pivot point is not within the loop but 
at the N-terminal end of the αR1 helix of the AID. In order to validate this mechanism 
we would ideally reassign the CaMK1D-Ca2+/CaM because many peaks undergo 
CSPs on a slow exchange timescale but this could be difficult to accomplish due to 
the increase in resonance overlap in the centre the spectrum. 
 
In addition to this mechanism of activation regarding the accessibility of the substrate 
binding site we examined the functional elements involved in catalysis i.e. the 
catalytic Lys 52, p-loop, αC helix, catalytic loop, activation loop, and hinge. We had 
assignments that spanned some of these elements. Upon Ca2+/CaM binding the 
CaMK1D spectrum did not appear to exhibit significant CSPs associated with 
resonances that correlated to these elements. We conclude that Ca2+/CaM did not 
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induce any local conformational changes to the active site cleft functional elements. 
This would suggest that the main role of Ca2+/CaM is to open up the substrate 
binding site. It is suspected that rearrangement of the active site cleft is induced by 
activation loop phosphorylation analogous to PKA.  
 
Ca2+/CaM and CBD binding mode 
The CaMK1D crystal structure exhibited an interesting structural difference when 
compared to the rat CaMK1A crystal structure. This key difference was highlight in 
the CBD and concerned the orientation of Trp 306 in CaMK1D which appeared to 
adopt a buried orientation as opposed to the solvent exposed Trp 303 in rat CaMK1A 
(Goldberg, Nairn et al. 1996). Both Trp residues are equivalent and throughout the 
CaMKI family it is conserved. The implications of this residue have been shown to be 
critical for Ca2+/CaM binding and its binding mode has been studied in peptide 
models (Matsushita and Nairn 1998; Clapperton, Martin et al. 2002). Consequently 
our mutatgenesis studies on this residue show that the residue is not buried because 
on the basis of our backbone solution structure of CaMK1D_W306S the protein 
exhibits a fold similar to CaMK1D suggesting that the side chain is not buried. ITC 
experiments also confirmed the importantance of Trp 306 in mediating a high affinity 
interaction. In CaMK1D the affinity with Ca2+/CaM was 28.5 nM whereas in 
CaMK1D_W306S the affinity was reduced significantly something > 100 µM. We 
could not accurately determine the affinity for CaMK1D_W306S because this affinity 
was at the detection limits of the ITC instrument. A second contact point for 
Ca2+/CaM is also postulated in CaMK1D Met 319 but our proposed experiment was 
not possible due to time constraints. 
 
Ligand binding 
Our ligand binding studies by NMR and thermofluor have shown that autoinhibited 
CaMK1D has an accessible active site cleft. Binding to the inhibitor GSK-3 XIII 
suggested two modes of inhibition firstly via competitive inhibition in the active site 
cleft and secondly via allosteric modulation of the CBD and Trp 306 side chain into a 
non productive binding mode with Ca2+/CaM. Furthemore our AMPPNP-Mg2+ binding 
studies have illustrated that autoinhibited CaMK1D has a very weak binding affinity. 
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This suggests that another activation mechanism is necessary for increased 
nucleotide affinity in the active complex. 
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Appendix 
 
Recipes 
M9 Minimal media recipe per L 
 
Nutrient mix 14ml, per L 
2ml 1M MgSO4 
0.5ml metal mix 
100ul 1M CaCl2 
400ul 3mM FeCl2 
10ml 20% (w/v) Glucose (2g), (for 13C labelling use 13C-glucose, for perduteration 
use deuterated glucose) 
1ml 20mg/ml Thiamine 
1g 15NH4Cl  
Sterilise through 0.22uM filter. 
 
M9 10X buffer salts 1L stock 
60g Na2HPO4 
30g KH2PO4 
5g NaCl 
pH 7.2 
Sterilise through a 0.22 uM filter, and autoclave if not made up in 2H2O, use 100ml 
per L of minimal media 
 
Metal mix 100ml stock 
Dissolve the metals in the following order: 
0.115g ZnSO4 7H2O (4mM) 
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0.0169g of MnSO4 5H2O (1mM) 
0.029g of H3BO3 (4.7mM) 
0.0175g of CuSO4 (0.7mM) 
Sterilise through 0.22uM filter 
 
M9 Minimal Media 
100 ml 10X M9 buffer salts pH7.2 
14 ml metal mix 
Make up the M9 minimal media to a final volume of 1L with mQH2O or 2H2O for 
expression of deutrated proteins if inoculated with resuspended cell pellet. 
Alternatively adjust the volume of mQH2O or
 2H2O to account for the volume of pre-
culture inoculate. For perdueterated protein nutrient mix and M9 buffer salts in 100 % 
2H2O 
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Chemical shift list 
Backbone assignment Chemical shift list 
 
#Atom   Residue 
#shift  Seq     Residue Atom    Atom    Shift/  Error/  Ambiguity 
#assign code    Label   Name    Type    ppm     ppm     Code 
#--------------------------------------------------------------- 
# 
 
1        2      Met     C       C       175.779 0.000   1 
2        2      Met     CA      C       55.139  0.000   1 
3        2      Met     CB      C       32.266  0.000   1 
4        3      Ala     C       C       177.349 0.000   1 
5        3      Ala     CA      C       52.042  0.000   1 
6        3      Ala     CB      C       18.480  0.000   1 
7        3      Ala     H       H       8.354   0.000   1 
8        3      Ala     N       N       126.137 0.000   1 
9        4      Arg     C       C       176.064 0.000   1 
10       4      Arg     CA      C       55.406  0.000   1 
11       4      Arg     CB      C       30.176  0.000   1 
12       4      Arg     H       H       8.232   0.000   1 
13       4      Arg     N       N       120.940 0.000   1 
14       5      Glu     C       C       175.329 0.000   1 
15       5      Glu     CA      C       55.974  0.000   1 
16       5      Glu     CB      C       29.820  0.000   1 
17       5      Glu     H       H       8.407   0.000   1 
18       5      Glu     N       N       122.895 0.000   1 
19       6      Asn     C       C       179.348 0.000   1 
20       6      Asn     CA      C       54.457  0.000   1 
21       6      Asn     CB      C       40.284  0.000   1 
22       6      Asn     H       H       8.003   0.000   1 
23       6      Asn     N       N       124.987 0.000   1 
24       7      Gly     C       C       174.627 0.000   1 
25       8      Glu     C       C       176.969 0.000   1 
26       8      Glu     CA      C       56.194  0.000   1 
27       8      Glu     CB      C       29.489  0.000   1 
28       8      Glu     H       H       8.435   0.000   1 
29       8      Glu     N       N       121.165 0.000   1 
30       9      Ser     C       C       175.059 0.000   1 
31       9      Ser     CA      C       58.001  0.000   1 
32       9      Ser     CB      C       63.411  0.000   1 
33       9      Ser     H       H       8.387   0.000   1 
34       9      Ser     N       N       117.251 0.000   1 
35       10     Ser     CA      C       58.413  0.000   1 
36       11     Ser     C       C       174.821 0.000   1 
37       11     Ser     CA      C       58.232  0.000   1 
38       11     Ser     CB      C       63.034  0.000   1 
39       11     Ser     H       H       8.199   0.000   1 
40       11     Ser     N       N       117.563 0.000   1 
41       12     Ser     C       C       174.428 0.000   1 
42       12     Ser     CA      C       58.488  0.000   1 
43       12     Ser     CB      C       63.060  0.000   1 
44       12     Ser     H       H       8.120   0.000   1 
45       12     Ser     N       N       117.491 0.000   1 
46       13     Trp     C       C       175.387 0.000   1 
47       13     Trp     CA      C       56.037  0.000   1 
48       13     Trp     CB      C       28.643  0.000   1 
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49       13     Trp     H       H       7.476   0.000   1 
50       13     Trp     N       N       120.607 0.000   1 
51       14     Lys     C       C       175.457 0.000   1 
52       14     Lys     CA      C       54.952  0.000   1 
53       14     Lys     CB      C       32.153  0.000   1 
54       14     Lys     H       H       7.349   0.000   1 
55       14     Lys     N       N       121.091 0.000   1 
56       15     Lys     C       C       175.958 0.000   1 
57       15     Lys     CA      C       55.932  0.000   1 
58       15     Lys     CB      C       33.074  0.000   1 
59       15     Lys     H       H       8.122   0.000   1 
60       15     Lys     N       N       125.057 0.000   1 
61       16     Gln     C       C       176.107 0.000   1 
62       16     Gln     CA      C       54.709  0.000   1 
63       16     Gln     CB      C       29.030  0.000   1 
64       16     Gln     H       H       8.516   0.000   1 
65       16     Gln     N       N       121.575 0.000   1 
66       17     Ala     C       C       175.622 0.000   1 
67       17     Ala     CA      C       50.663  0.000   1 
68       17     Ala     CB      C       20.012  0.000   1 
69       17     Ala     H       H       8.615   0.000   1 
70       17     Ala     N       N       126.136 0.000   1 
71       18     Glu     C       C       176.558 0.000   1 
72       18     Glu     CA      C       58.007  0.000   1 
73       18     Glu     CB      C       29.134  0.000   1 
74       18     Glu     H       H       8.493   0.000   1 
75       18     Glu     N       N       122.678 0.000   1 
76       19     Asp     C       C       177.837 0.000   1 
77       19     Asp     CA      C       52.745  0.000   1 
78       19     Asp     CB      C       41.537  0.000   1 
79       19     Asp     H       H       7.750   0.000   1 
80       19     Asp     N       N       115.905 0.000   1 
81       20     Ile     C       C       176.191 0.000   1 
82       20     Ile     CA      C       59.835  0.000   1 
83       20     Ile     CB      C       38.303  0.000   1 
84       20     Ile     H       H       9.256   0.000   1 
85       20     Ile     N       N       129.928 0.000   1 
86       21     Lys     C       C       177.579 0.000   1 
87       21     Lys     CA      C       56.827  0.000   1 
88       21     Lys     CB      C       29.817  0.000   1 
89       21     Lys     H       H       8.016   0.000   1 
90       21     Lys     N       N       121.551 0.000   1 
91       22     Lys     C       C       176.828 0.000   1 
92       22     Lys     CA      C       56.715  0.000   1 
93       22     Lys     CB      C       31.716  0.000   1 
94       22     Lys     H       H       7.404   0.000   1 
95       22     Lys     N       N       115.869 0.000   1 
96       23     Ile     C       C       176.227 0.000   1 
97       23     Ile     CA      C       60.787  0.000   1 
98       23     Ile     CB      C       38.127  0.000   1 
99       23     Ile     H       H       7.294   0.000   1 
100      23     Ile     N       N       117.589 0.000   1 
101      24     Phe     C       C       173.681 0.000   1 
102      24     Phe     CA      C       56.059  0.000   1 
103      24     Phe     CB      C       43.051  0.000   1 
104      24     Phe     H       H       7.983   0.000   1 
105      24     Phe     N       N       118.392 0.000   1 
106      25     Glu     C       C       176.320 0.000   1 
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107      25     Glu     CA      C       53.996  0.000   1 
108      25     Glu     CB      C       30.774  0.000   1 
109      25     Glu     H       H       9.067   0.000   1 
110      25     Glu     N       N       120.078 0.000   1 
111      26     Phe     C       C       176.041 0.000   1 
112      26     Phe     CA      C       55.787  0.000   1 
113      26     Phe     CB      C       36.617  0.000   1 
114      26     Phe     H       H       9.015   0.000   1 
115      26     Phe     N       N       128.879 0.000   1 
116      27     Lys     C       C       175.781 0.000   1 
117      27     Lys     CA      C       55.752  0.000   1 
118      27     Lys     CB      C       31.458  0.000   1 
119      27     Lys     H       H       9.116   0.000   1 
120      27     Lys     N       N       124.959 0.000   1 
121      28     Glu     C       C       175.030 0.000   1 
122      28     Glu     CA      C       55.722  0.000   1 
123      28     Glu     CB      C       30.953  0.000   1 
124      28     Glu     H       H       7.767   0.000   1 
125      28     Glu     N       N       117.485 0.000   1 
126      29     Thr     C       C       174.244 0.000   1 
127      29     Thr     CA      C       63.646  0.000   1 
128      29     Thr     CB      C       68.674  0.000   1 
129      29     Thr     H       H       8.788   0.000   1 
130      29     Thr     N       N       119.300 0.000   1 
131      30     Leu     C       C       177.504 0.000   1 
132      30     Leu     CA      C       54.690  0.000   1 
133      30     Leu     CB      C       41.800  0.000   1 
134      30     Leu     H       H       9.215   0.000   1 
135      30     Leu     N       N       128.565 0.000   1 
136      31     Gly     C       C       171.962 0.000   1 
137      31     Gly     CA      C       45.106  0.000   1 
138      31     Gly     H       H       7.922   0.000   1 
139      31     Gly     N       N       107.977 0.000   1 
140      32     Thr     C       C       173.973 0.000   1 
141      32     Thr     CA      C       60.944  0.000   1 
142      32     Thr     CB      C       70.526  0.000   1 
143      32     Thr     H       H       8.280   0.000   1 
144      32     Thr     N       N       114.339 0.000   1 
145      33     Gly     C       C       173.519 0.000   1 
146      33     Gly     CA      C       43.813  0.000   1 
147      33     Gly     H       H       8.249   0.000   1 
148      33     Gly     N       N       112.484 0.000   1 
149      34     Ala     CA      C       53.864  0.000   1 
150      34     Ala     CB      C       17.976  0.000   1 
151      34     Ala     H       H       8.453   0.000   1 
152      34     Ala     N       N       123.970 0.000   1 
153      36     Ser     C       C       173.217 0.000   1 
154      36     Ser     CA      C       57.262  0.000   1 
155      36     Ser     CB      C       65.398  0.000   1 
156      37     Glu     C       C       174.418 0.000   1 
157      37     Glu     CA      C       55.090  0.000   1 
158      37     Glu     CB      C       31.827  0.000   1 
159      37     Glu     H       H       8.030   0.000   1 
160      37     Glu     N       N       119.898 0.000   1 
161      38     Val     C       C       175.249 0.000   1 
162      38     Val     CA      C       60.568  0.000   1 
163      38     Val     CB      C       32.185  0.000   1 
164      38     Val     H       H       8.768   0.000   1 
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165      38     Val     N       N       124.815 0.000   1 
166      39     Val     C       C       174.208 0.000   1 
167      39     Val     CA      C       58.829  0.000   1 
168      39     Val     CB      C       34.185  0.000   1 
169      39     Val     H       H       8.990   0.000   1 
170      39     Val     N       N       124.114 0.000   1 
171      40     Leu     C       C       174.749 0.000   1 
172      40     Leu     CA      C       54.737  0.000   1 
173      40     Leu     CB      C       41.905  0.000   1 
174      40     Leu     H       H       8.648   0.000   1 
175      40     Leu     N       N       126.710 0.000   1 
176      41     Ala     C       C       174.282 0.000   1 
177      41     Ala     CA      C       49.729  0.000   1 
178      41     Ala     CB      C       23.833  0.000   1 
179      41     Ala     H       H       9.200   0.000   1 
180      41     Ala     N       N       129.836 0.000   1 
181      42     Glu     C       C       176.328 0.000   1 
182      42     Glu     CA      C       53.233  0.000   1 
183      42     Glu     CB      C       33.137  0.000   1 
184      42     Glu     H       H       8.910   0.000   1 
185      42     Glu     N       N       121.906 0.000   1 
186      43     Glu     C       C       176.584 0.000   1 
187      43     Glu     CA      C       55.924  0.000   1 
188      43     Glu     CB      C       29.345  0.000   1 
189      43     Glu     H       H       9.766   0.000   1 
190      43     Glu     N       N       131.272 0.000   1 
191      44     Lys     C       C       178.955 0.000   1 
192      44     Lys     CA      C       59.929  0.000   1 
193      44     Lys     CB      C       30.658  0.000   1 
194      44     Lys     H       H       8.296   0.000   1 
195      44     Lys     N       N       132.543 0.000   1 
196      45     Ala     C       C       178.436 0.000   1 
197      45     Ala     CA      C       53.928  0.000   1 
198      45     Ala     CB      C       18.981  0.000   1 
199      45     Ala     H       H       8.842   0.000   1 
200      45     Ala     N       N       117.053 0.000   1 
201      46     Thr     C       C       176.212 0.000   1 
202      46     Thr     CA      C       60.893  0.000   1 
203      46     Thr     CB      C       71.135  0.000   1 
204      46     Thr     H       H       7.006   0.000   1 
205      46     Thr     N       N       102.381 0.000   1 
206      47     Gly     C       C       173.750 0.000   1 
207      47     Gly     CA      C       44.965  0.000   1 
208      47     Gly     H       H       8.705   0.000   1 
209      47     Gly     N       N       112.957 0.000   1 
210      48     Lys     C       C       174.789 0.000   1 
211      48     Lys     CA      C       56.742  0.000   1 
212      48     Lys     CB      C       33.069  0.000   1 
213      48     Lys     H       H       8.038   0.000   1 
214      48     Lys     N       N       121.845 0.000   1 
215      49     Leu     C       C       176.150 0.000   1 
216      49     Leu     CA      C       53.140  0.000   1 
217      49     Leu     CB      C       43.199  0.000   1 
218      49     Leu     H       H       7.688   0.000   1 
219      49     Leu     N       N       120.914 0.000   1 
220      50     Phe     C       C       173.401 0.000   1 
221      50     Phe     CA      C       57.154  0.000   1 
222      50     Phe     CB      C       44.217  0.000   1 
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223      50     Phe     H       H       9.091   0.000   1 
224      50     Phe     N       N       118.364 0.000   1 
225      51     Ala     C       C       175.863 0.000   1 
226      51     Ala     CA      C       50.138  0.000   1 
227      51     Ala     CB      C       19.374  0.000   1 
228      51     Ala     H       H       8.312   0.000   1 
229      51     Ala     N       N       123.700 0.000   1 
230      52     Val     C       C       174.900 0.000   1 
231      52     Val     CA      C       60.235  0.000   1 
232      52     Val     CB      C       32.518  0.000   1 
233      52     Val     H       H       9.154   0.000   1 
234      52     Val     N       N       123.133 0.000   1 
235      53     Lys     C       C       174.826 0.000   1 
236      53     Lys     CA      C       54.956  0.000   1 
237      53     Lys     CB      C       32.980  0.000   1 
238      53     Lys     H       H       9.375   0.000   1 
239      53     Lys     N       N       130.181 0.000   1 
240      54     Cys     C       C       174.733 0.000   1 
241      54     Cys     CA      C       56.790  0.000   1 
242      54     Cys     CB      C       28.050  0.000   1 
243      54     Cys     H       H       9.267   0.000   1 
244      54     Cys     N       N       127.319 0.000   1 
245      55     Ile     C       C       173.512 0.000   1 
246      55     Ile     CA      C       57.640  0.000   1 
247      55     Ile     CB      C       40.691  0.000   1 
248      55     Ile     H       H       9.172   0.000   1 
249      55     Ile     N       N       127.443 0.000   1 
250      57     Lys     C       C       179.533 0.000   1 
251      57     Lys     CA      C       59.371  0.000   1 
252      57     Lys     CB      C       31.430  0.000   1 
253      58     Lys     C       C       177.433 0.000   1 
254      58     Lys     CA      C       58.231  0.000   1 
255      58     Lys     CB      C       31.170  0.000   1 
256      58     Lys     H       H       8.460   0.000   1 
257      58     Lys     N       N       119.283 0.000   1 
258      59     Ala     C       C       177.529 0.000   1 
259      59     Ala     CA      C       52.520  0.000   1 
260      59     Ala     CB      C       18.170  0.000   1 
261      59     Ala     H       H       7.367   0.000   1 
262      59     Ala     N       N       120.285 0.000   1 
263      60     Leu     C       C       176.487 0.000   1 
264      60     Leu     CA      C       53.644  0.000   1 
265      60     Leu     CB      C       41.043  0.000   1 
266      60     Leu     H       H       7.332   0.000   1 
267      60     Leu     N       N       116.792 0.000   1 
268      61     Lys     C       C       177.665 0.000   1 
269      61     Lys     CA      C       57.129  0.000   1 
270      61     Lys     CB      C       31.378  0.000   1 
271      61     Lys     H       H       7.122   0.000   1 
272      61     Lys     N       N       120.233 0.000   1 
273      62     Gly     C       C       174.516 0.000   1 
274      62     Gly     CA      C       45.005  0.000   1 
275      62     Gly     H       H       8.786   0.000   1 
276      62     Gly     N       N       114.605 0.000   1 
277      63     Lys     CA      C       56.879  0.000   1 
278      63     Lys     CB      C       32.759  0.000   1 
279      63     Lys     H       H       7.743   0.000   1 
280      63     Lys     N       N       126.300 0.000   1 
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281      67     Ile     CA      C       61.152  0.000   1 
282      67     Ile     CB      C       37.729  0.000   1 
283      68     Glu     CA      C       59.063  0.000   1 
284      68     Glu     CB      C       28.935  0.000   1 
285      68     Glu     H       H       7.814   0.000   1 
286      68     Glu     N       N       120.631 0.000   1 
287      71     Ile     CA      C       61.177  0.000   1 
288      72     Ala     C       C       179.396 0.000   1 
289      72     Ala     CA      C       54.424  0.000   1 
290      72     Ala     CB      C       16.646  0.000   1 
291      72     Ala     H       H       7.945   0.000   1 
292      72     Ala     N       N       122.971 0.000   1 
293      73     Val     C       C       177.515 0.000   1 
294      73     Val     CA      C       59.143  0.000   1 
295      73     Val     CB      C       31.221  0.000   1 
296      73     Val     H       H       6.866   0.000   1 
297      73     Val     N       N       115.034 0.000   1 
298      74     Leu     C       C       177.404 0.000   1 
299      74     Leu     CA      C       57.315  0.000   1 
300      74     Leu     CB      C       42.915  0.000   1 
301      74     Leu     H       H       7.912   0.000   1 
302      74     Leu     N       N       119.064 0.000   1 
303      78     Lys     C       C       172.981 0.000   1 
304      79     His     C       C       175.213 0.000   1 
305      79     His     CA      C       57.293  0.000   1 
306      79     His     CB      C       33.729  0.000   1 
307      79     His     H       H       8.988   0.000   1 
308      79     His     N       N       126.128 0.000   1 
309      80     Glu     C       C       176.612 0.000   1 
310      80     Glu     CA      C       58.396  0.000   1 
311      80     Glu     CB      C       29.403  0.000   1 
312      80     Glu     H       H       7.911   0.000   1 
313      80     Glu     N       N       126.583 0.000   1 
314      81     Asn     C       C       173.722 0.000   1 
315      81     Asn     CA      C       53.852  0.000   1 
316      81     Asn     CB      C       39.861  0.000   1 
317      81     Asn     H       H       11.519  0.000   1 
318      81     Asn     N       N       119.225 0.000   1 
319      82     Ile     C       C       175.414 0.000   1 
320      82     Ile     CA      C       61.089  0.000   1 
321      82     Ile     CB      C       40.500  0.000   1 
322      82     Ile     H       H       7.709   0.000   1 
323      82     Ile     N       N       118.802 0.000   1 
324      83     Val     CA      C       61.793  0.000   1 
325      83     Val     CB      C       31.827  0.000   1 
326      84     Ala     CA      C       52.577  0.000   1 
327      84     Ala     CB      C       18.304  0.000   1 
328      84     Ala     H       H       8.185   0.000   1 
329      84     Ala     N       N       125.802 0.000   1 
330      86     Glu     C       C       176.760 0.000   1 
331      86     Glu     CA      C       57.025  0.000   1 
332      86     Glu     CB      C       29.678  0.000   1 
333      87     Asp     C       C       173.982 0.000   1 
334      87     Asp     CA      C       53.239  0.000   1 
335      87     Asp     CB      C       45.639  0.000   1 
336      87     Asp     H       H       8.015   0.000   1 
337      87     Asp     N       N       116.869 0.000   1 
338      88     Ile     C       C       174.198 0.000   1 
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339      88     Ile     CA      C       60.390  0.000   1 
340      88     Ile     CB      C       40.637  0.000   1 
341      88     Ile     H       H       8.603   0.000   1 
342      88     Ile     N       N       118.345 0.000   1 
343      89     Tyr     C       C       174.601 0.000   1 
344      89     Tyr     CA      C       55.774  0.000   1 
345      89     Tyr     CB      C       43.116  0.000   1 
346      89     Tyr     H       H       9.104   0.000   1 
347      89     Tyr     N       N       123.689 0.000   1 
348      90     Glu     C       C       174.217 0.000   1 
349      90     Glu     CA      C       54.737  0.000   1 
350      90     Glu     CB      C       32.554  0.000   1 
351      90     Glu     H       H       9.217   0.000   1 
352      90     Glu     N       N       121.630 0.000   1 
353      91     Ser     C       C       173.767 0.000   1 
354      91     Ser     CA      C       56.171  0.000   1 
355      91     Ser     CB      C       64.901  0.000   1 
356      91     Ser     H       H       9.468   0.000   1 
357      91     Ser     N       N       127.001 0.000   1 
358      92     Pro     C       C       177.431 0.000   1 
359      93     Asn     C       C       175.503 0.000   1 
360      93     Asn     CA      C       52.700  0.000   1 
361      93     Asn     CB      C       40.695  0.000   1 
362      93     Asn     H       H       8.201   0.000   1 
363      93     Asn     N       N       108.322 0.000   1 
364      94     His     C       C       172.268 0.000   1 
365      94     His     CA      C       57.243  0.000   1 
366      94     His     CB      C       34.299  0.000   1 
367      94     His     H       H       8.079   0.000   1 
368      94     His     N       N       121.586 0.000   1 
369      95     Leu     C       C       174.316 0.000   1 
370      95     Leu     CA      C       53.417  0.000   1 
371      95     Leu     CB      C       45.029  0.000   1 
372      95     Leu     H       H       8.869   0.000   1 
373      95     Leu     N       N       120.928 0.000   1 
374      96     Tyr     C       C       174.787 0.000   1 
375      96     Tyr     CA      C       56.024  0.000   1 
376      96     Tyr     CB      C       39.002  0.000   1 
377      96     Tyr     H       H       9.277   0.000   1 
378      96     Tyr     N       N       120.338 0.000   1 
379      97     Leu     C       C       174.719 0.000   1 
380      97     Leu     CA      C       53.788  0.000   1 
381      97     Leu     CB      C       40.718  0.000   1 
382      97     Leu     H       H       9.192   0.000   1 
383      97     Leu     N       N       124.497 0.000   1 
384      98     Val     C       C       173.931 0.000   1 
385      98     Val     CA      C       62.554  0.000   1 
386      98     Val     CB      C       30.064  0.000   1 
387      98     Val     H       H       8.767   0.000   1 
388      98     Val     N       N       126.159 0.000   1 
389      99     Met     C       C       173.767 0.000   1 
390      99     Met     CA      C       53.217  0.000   1 
391      99     Met     CB      C       33.769  0.000   1 
392      99     Met     H       H       9.446   0.000   1 
393      99     Met     N       N       127.409 0.000   1 
394      103    Ser     C       C       175.019 0.000   1 
395      103    Ser     CA      C       57.956  0.000   1 
396      103    Ser     CB      C       64.269  0.000   1 
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397      104    Gly     C       C       173.835 0.000   1 
398      104    Gly     CA      C       45.776  0.000   1 
399      104    Gly     H       H       7.608   0.000   1 
400      104    Gly     N       N       109.868 0.000   1 
401      105    Gly     C       C       172.396 0.000   1 
402      105    Gly     CA      C       43.363  0.000   1 
403      105    Gly     H       H       8.189   0.000   1 
404      105    Gly     N       N       109.460 0.000   1 
405      106    Glu     C       C       177.924 0.000   1 
406      106    Glu     CA      C       56.213  0.000   1 
407      106    Glu     CB      C       30.070  0.000   1 
408      106    Glu     H       H       8.561   0.000   1 
409      106    Glu     N       N       117.915 0.000   1 
410      107    Leu     C       C       178.455 0.000   1 
411      107    Leu     CA      C       58.335  0.000   1 
412      107    Leu     CB      C       41.428  0.000   1 
413      107    Leu     H       H       8.070   0.000   1 
414      107    Leu     N       N       123.450 0.000   1 
415      108    Phe     C       C       178.128 0.000   1 
416      108    Phe     CA      C       58.005  0.000   1 
417      108    Phe     CB      C       36.321  0.000   1 
418      108    Phe     H       H       8.798   0.000   1 
419      108    Phe     N       N       114.970 0.000   1 
420      109    Asp     C       C       178.048 0.000   1 
421      109    Asp     CA      C       57.147  0.000   1 
422      109    Asp     CB      C       39.975  0.000   1 
423      109    Asp     H       H       7.169   0.000   1 
424      109    Asp     N       N       117.784 0.000   1 
425      110    Arg     C       C       179.444 0.000   1 
426      110    Arg     CA      C       56.734  0.000   1 
427      110    Arg     CB      C       28.339  0.000   1 
428      110    Arg     H       H       7.432   0.000   1 
429      110    Arg     N       N       118.027 0.000   1 
430      111    Ile     C       C       178.533 0.000   1 
431      111    Ile     CA      C       64.852  0.000   1 
432      111    Ile     CB      C       36.809  0.000   1 
433      111    Ile     H       H       7.744   0.000   1 
434      111    Ile     N       N       118.789 0.000   1 
435      112    Val     CA      C       66.352  0.000   1 
436      112    Val     CB      C       30.813  0.000   1 
437      113    Glu     CA      C       56.710  0.000   1 
438      113    Glu     CB      C       29.561  0.000   1 
439      113    Glu     H       H       7.503   0.000   1 
440      113    Glu     N       N       117.157 0.000   1 
441      114    Lys     C       C       177.056 0.000   1 
442      114    Lys     CA      C       58.247  0.000   1 
443      114    Lys     CB      C       33.057  0.000   1 
444      114    Lys     H       H       7.387   0.000   1 
445      114    Lys     N       N       120.316 0.000   1 
446      115    Gly     C       C       172.530 0.000   1 
447      115    Gly     CA      C       45.133  0.000   1 
448      115    Gly     H       H       6.844   0.000   1 
449      115    Gly     N       N       104.228 0.000   1 
450      116    Phe     C       C       173.693 0.000   1 
451      116    Phe     CA      C       56.835  0.000   1 
452      116    Phe     CB      C       40.750  0.000   1 
453      116    Phe     H       H       6.977   0.000   1 
454      116    Phe     N       N       120.808 0.000   1 
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455      117    Tyr     C       C       172.305 0.000   1 
456      117    Tyr     CA      C       57.269  0.000   1 
457      117    Tyr     CB      C       41.784  0.000   1 
458      117    Tyr     H       H       8.055   0.000   1 
459      117    Tyr     N       N       129.204 0.000   1 
460      118    Thr     C       C       174.685 0.000   1 
461      118    Thr     CA      C       58.544  0.000   1 
462      118    Thr     CB      C       73.374  0.000   1 
463      118    Thr     H       H       8.533   0.000   1 
464      118    Thr     N       N       118.063 0.000   1 
465      119    Glu     C       C       178.429 0.000   1 
466      119    Glu     CA      C       59.437  0.000   1 
467      119    Glu     CB      C       30.037  0.000   1 
468      119    Glu     H       H       9.711   0.000   1 
469      119    Glu     N       N       119.972 0.000   1 
470      120    Lys     C       C       179.175 0.000   1 
471      120    Lys     CA      C       58.832  0.000   1 
472      120    Lys     CB      C       30.523  0.000   1 
473      120    Lys     H       H       7.962   0.000   1 
474      120    Lys     N       N       119.326 0.000   1 
475      121    Asp     C       C       178.751 0.000   1 
476      121    Asp     CA      C       57.385  0.000   1 
477      121    Asp     CB      C       40.753  0.000   1 
478      121    Asp     H       H       7.471   0.000   1 
479      121    Asp     N       N       121.375 0.000   1 
480      122    Ala     C       C       178.454 0.000   1 
481      122    Ala     CA      C       55.305  0.000   1 
482      122    Ala     CB      C       17.891  0.000   1 
483      122    Ala     H       H       7.363   0.000   1 
484      122    Ala     N       N       123.728 0.000   1 
485      123    Ser     C       C       176.160 0.000   1 
486      123    Ser     CA      C       60.179  0.000   1 
487      123    Ser     CB      C       60.859  0.000   1 
488      123    Ser     H       H       8.471   0.000   1 
489      123    Ser     N       N       113.858 0.000   1 
490      124    Thr     C       C       177.286 0.000   1 
491      124    Thr     CA      C       66.096  0.000   1 
492      124    Thr     CB      C       68.483  0.000   1 
493      124    Thr     H       H       7.825   0.000   1 
494      124    Thr     N       N       116.940 0.000   1 
495      125    Leu     C       C       178.635 0.000   1 
496      125    Leu     CA      C       58.075  0.000   1 
497      125    Leu     CB      C       41.617  0.000   1 
498      125    Leu     H       H       7.457   0.000   1 
499      125    Leu     N       N       123.300 0.000   1 
500      126    Ile     C       C       177.594 0.000   1 
501      126    Ile     CA      C       61.351  0.000   1 
502      126    Ile     CB      C       34.016  0.000   1 
503      126    Ile     H       H       8.394   0.000   1 
504      126    Ile     N       N       119.052 0.000   1 
505      127    Arg     C       C       178.597 0.000   1 
506      127    Arg     CA      C       60.180  0.000   1 
507      127    Arg     CB      C       28.985  0.000   1 
508      127    Arg     H       H       9.112   0.000   1 
509      127    Arg     N       N       122.190 0.000   1 
510      128    Gln     C       C       177.578 0.000   1 
511      128    Gln     CA      C       58.832  0.000   1 
512      128    Gln     CB      C       30.301  0.000   1 
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513      128    Gln     H       H       7.026   0.000   1 
514      128    Gln     N       N       117.457 0.000   1 
515      129    Val     C       C       177.629 0.000   1 
516      129    Val     CA      C       66.569  0.000   1 
517      129    Val     CB      C       30.675  0.000   1 
518      129    Val     H       H       7.490   0.000   1 
519      129    Val     N       N       118.829 0.000   1 
520      130    Leu     C       C       178.445 0.000   1 
521      130    Leu     CA      C       57.608  0.000   1 
522      130    Leu     CB      C       41.994  0.000   1 
523      130    Leu     H       H       9.101   0.000   1 
524      130    Leu     N       N       118.384 0.000   1 
525      131    Asp     C       C       178.583 0.000   1 
526      131    Asp     CA      C       57.467  0.000   1 
527      131    Asp     CB      C       41.373  0.000   1 
528      131    Asp     H       H       7.859   0.000   1 
529      131    Asp     N       N       120.032 0.000   1 
530      132    Ala     C       C       178.634 0.000   1 
531      132    Ala     CA      C       54.081  0.000   1 
532      132    Ala     CB      C       18.740  0.000   1 
533      132    Ala     H       H       7.754   0.000   1 
534      132    Ala     N       N       121.891 0.000   1 
535      133    Val     C       C       176.413 0.000   1 
536      133    Val     CA      C       65.917  0.000   1 
537      133    Val     CB      C       29.402  0.000   1 
538      133    Val     H       H       8.658   0.000   1 
539      133    Val     N       N       117.882 0.000   1 
540      134    Tyr     C       C       177.573 0.000   1 
541      134    Tyr     CA      C       58.999  0.000   1 
542      134    Tyr     CB      C       37.202  0.000   1 
543      134    Tyr     H       H       8.895   0.000   1 
544      134    Tyr     N       N       122.253 0.000   1 
545      135    Tyr     C       C       177.276 0.000   1 
546      135    Tyr     CA      C       61.365  0.000   1 
547      135    Tyr     CB      C       37.078  0.000   1 
548      135    Tyr     H       H       7.484   0.000   1 
549      135    Tyr     N       N       119.700 0.000   1 
550      136    Leu     C       C       179.489 0.000   1 
551      136    Leu     CA      C       57.777  0.000   1 
552      136    Leu     CB      C       39.142  0.000   1 
553      136    Leu     H       H       7.785   0.000   1 
554      136    Leu     N       N       119.954 0.000   1 
555      137    His     C       C       181.194 0.000   1 
556      137    His     CA      C       57.810  0.000   1 
557      137    His     CB      C       30.768  0.000   1 
558      137    His     H       H       9.407   0.000   1 
559      137    His     N       N       121.229 0.000   1 
560      138    Arg     C       C       178.444 0.000   1 
561      138    Arg     CA      C       58.874  0.000   1 
562      138    Arg     CB      C       28.935  0.000   1 
563      138    Arg     H       H       8.611   0.000   1 
564      138    Arg     N       N       122.507 0.000   1 
565      139    Met     C       C       176.078 0.000   1 
566      139    Met     CA      C       54.574  0.000   1 
567      139    Met     CB      C       31.880  0.000   1 
568      139    Met     H       H       7.494   0.000   1 
569      139    Met     N       N       117.318 0.000   1 
570      140    Gly     C       C       173.779 0.000   1 
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571      140    Gly     CA      C       45.365  0.000   1 
572      140    Gly     H       H       7.888   0.000   1 
573      140    Gly     N       N       108.330 0.000   1 
574      141    Ile     C       C       173.316 0.000   1 
575      141    Ile     CA      C       59.830  0.000   1 
576      141    Ile     CB      C       38.579  0.000   1 
577      141    Ile     H       H       8.218   0.000   1 
578      141    Ile     N       N       124.395 0.000   1 
579      142    Val     C       C       177.955 0.000   1 
580      142    Val     CA      C       61.636  0.000   1 
581      142    Val     CB      C       30.718  0.000   1 
582      143    His     C       C       179.558 0.000   1 
583      143    His     CA      C       59.492  0.000   1 
584      143    His     CB      C       31.272  0.000   1 
585      143    His     H       H       8.178   0.000   1 
586      143    His     N       N       125.529 0.000   1 
587      145    Asp     C       C       175.437 0.000   1 
588      145    Asp     CA      C       52.859  0.000   1 
589      145    Asp     CB      C       42.609  0.000   1 
590      146    Leu     C       C       175.209 0.000   1 
591      146    Leu     CA      C       55.833  0.000   1 
592      146    Leu     CB      C       40.770  0.000   1 
593      146    Leu     H       H       8.476   0.000   1 
594      146    Leu     N       N       123.702 0.000   1 
595      148    Pro     C       C       176.963 0.000   1 
596      149    Glu     C       C       176.262 0.000   1 
597      149    Glu     CA      C       58.635  0.000   1 
598      149    Glu     CB      C       28.193  0.000   1 
599      149    Glu     H       H       9.586   0.000   1 
600      149    Glu     N       N       114.802 0.000   1 
601      150    Asn     C       C       173.285 0.000   1 
602      150    Asn     CA      C       51.914  0.000   1 
603      150    Asn     CB      C       38.440  0.000   1 
604      150    Asn     H       H       7.338   0.000   1 
605      150    Asn     N       N       114.986 0.000   1 
606      151    Leu     C       C       173.585 0.000   1 
607      151    Leu     CA      C       53.144  0.000   1 
608      151    Leu     CB      C       40.649  0.000   1 
609      151    Leu     H       H       7.289   0.000   1 
610      151    Leu     N       N       121.731 0.000   1 
611      152    Leu     C       C       177.043 0.000   1 
612      152    Leu     CA      C       51.915  0.000   1 
613      152    Leu     CB      C       45.572  0.000   1 
614      152    Leu     H       H       8.286   0.000   1 
615      152    Leu     N       N       121.399 0.000   1 
616      153    Tyr     C       C       176.174 0.000   1 
617      153    Tyr     CA      C       58.998  0.000   1 
618      153    Tyr     CB      C       38.171  0.000   1 
619      153    Tyr     H       H       8.822   0.000   1 
620      153    Tyr     N       N       120.307 0.000   1 
621      154    Tyr     C       C       175.634 0.000   1 
622      154    Tyr     CA      C       60.611  0.000   1 
623      154    Tyr     CB      C       39.038  0.000   1 
624      154    Tyr     H       H       7.954   0.000   1 
625      154    Tyr     N       N       121.624 0.000   1 
626      155    Ser     C       C       173.921 0.000   1 
627      155    Ser     CA      C       56.033  0.000   1 
628      155    Ser     CB      C       66.171  0.000   1 
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629      155    Ser     H       H       9.348   0.000   1 
630      155    Ser     N       N       113.812 0.000   1 
631      156    Gln     C       C       175.302 0.000   1 
632      156    Gln     CA      C       56.321  0.000   1 
633      156    Gln     CB      C       27.802  0.000   1 
634      156    Gln     H       H       8.621   0.000   1 
635      156    Gln     N       N       118.015 0.000   1 
636      157    Asp     C       C       177.625 0.000   1 
637      157    Asp     CA      C       54.510  0.000   1 
638      157    Asp     CB      C       41.188  0.000   1 
639      157    Asp     H       H       7.862   0.000   1 
640      157    Asp     N       N       119.548 0.000   1 
641      158    Glu     C       C       177.863 0.000   1 
642      158    Glu     CA      C       58.693  0.000   1 
643      158    Glu     CB      C       28.872  0.000   1 
644      158    Glu     H       H       8.947   0.000   1 
645      158    Glu     N       N       125.785 0.000   1 
646      159    Glu     C       C       175.745 0.000   1 
647      159    Glu     CA      C       55.190  0.000   1 
648      159    Glu     CB      C       27.817  0.000   1 
649      159    Glu     H       H       8.625   0.000   1 
650      159    Glu     N       N       117.492 0.000   1 
651      160    Ser     C       C       175.366 0.000   1 
652      160    Ser     CA      C       58.151  0.000   1 
653      160    Ser     CB      C       64.403  0.000   1 
654      160    Ser     H       H       7.236   0.000   1 
655      160    Ser     N       N       113.430 0.000   1 
656      161    Lys     C       C       175.787 0.000   1 
657      161    Lys     CA      C       55.818  0.000   1 
658      161    Lys     CB      C       32.820  0.000   1 
659      161    Lys     H       H       8.485   0.000   1 
660      161    Lys     N       N       126.337 0.000   1 
661      162    Ile     C       C       172.713 0.000   1 
662      162    Ile     CA      C       56.289  0.000   1 
663      162    Ile     CB      C       40.379  0.000   1 
664      162    Ile     H       H       8.271   0.000   1 
665      162    Ile     N       N       122.157 0.000   1 
666      163    Met     C       C       175.759 0.000   1 
667      163    Met     CA      C       52.316  0.000   1 
668      163    Met     CB      C       34.877  0.000   1 
669      163    Met     H       H       8.765   0.000   1 
670      163    Met     N       N       120.235 0.000   1 
671      164    Ile     C       C       176.519 0.000   1 
672      164    Ile     CA      C       61.638  0.000   1 
673      164    Ile     CB      C       37.431  0.000   1 
674      164    Ile     H       H       8.713   0.000   1 
675      164    Ile     N       N       121.189 0.000   1 
676      170    Ser     C       C       179.850 0.000   1 
677      170    Ser     CA      C       61.571  0.000   1 
678      171    Lys     C       C       176.796 0.000   1 
679      171    Lys     CA      C       57.744  0.000   1 
680      171    Lys     CB      C       29.442  0.000   1 
681      171    Lys     H       H       8.052   0.000   1 
682      171    Lys     N       N       115.940 0.000   1 
683      172    Met     C       C       177.342 0.000   1 
684      172    Met     CA      C       55.889  0.000   1 
685      172    Met     CB      C       32.443  0.000   1 
686      172    Met     H       H       7.491   0.000   1 
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687      172    Met     N       N       117.066 0.000   1 
688      173    Glu     C       C       174.534 0.000   1 
689      173    Glu     CA      C       57.757  0.000   1 
690      173    Glu     CB      C       28.147  0.000   1 
691      174    Gly     C       C       173.746 0.000   1 
692      174    Gly     CA      C       44.691  0.000   1 
693      174    Gly     H       H       8.212   0.000   1 
694      174    Gly     N       N       110.802 0.000   1 
695      175    Lys     C       C       177.081 0.000   1 
696      175    Lys     CA      C       55.858  0.000   1 
697      175    Lys     CB      C       31.977  0.000   1 
698      176    Gly     C       C       173.769 0.000   1 
699      176    Gly     CA      C       44.942  0.000   1 
700      176    Gly     H       H       8.407   0.000   1 
701      176    Gly     N       N       110.252 0.000   1 
702      177    Asp     C       C       176.356 0.000   1 
703      177    Asp     CA      C       53.825  0.000   1 
704      177    Asp     CB      C       40.734  0.000   1 
705      177    Asp     H       H       8.137   0.000   1 
706      177    Asp     N       N       120.890 0.000   1 
707      178    Val     CA      C       62.032  0.000   1 
708      178    Val     CB      C       31.934  0.000   1 
709      178    Val     H       H       8.054   0.000   1 
710      178    Val     N       N       120.212 0.000   1 
711      183    Cys     C       C       177.119 0.000   1 
712      184    Gly     C       C       174.289 0.000   1 
713      184    Gly     CA      C       44.916  0.000   1 
714      184    Gly     H       H       8.592   0.000   1 
715      184    Gly     N       N       109.781 0.000   1 
716      185    Thr     C       C       174.732 0.000   1 
717      185    Thr     CA      C       57.751  0.000   1 
718      185    Thr     CB      C       65.427  0.000   1 
719      185    Thr     H       H       8.792   0.000   1 
720      185    Thr     N       N       118.044 0.000   1 
721      188    Tyr     C       C       175.311 0.000   1 
722      188    Tyr     CA      C       56.872  0.000   1 
723      188    Tyr     CB      C       38.574  0.000   1 
724      189    Val     C       C       173.428 0.000   1 
725      189    Val     CA      C       61.249  0.000   1 
726      189    Val     CB      C       32.116  0.000   1 
727      189    Val     H       H       7.436   0.000   1 
728      189    Val     N       N       121.202 0.000   1 
729      190    Ala     C       C       175.899 0.000   1 
730      190    Ala     CA      C       49.095  0.000   1 
731      190    Ala     CB      C       17.539  0.000   1 
732      190    Ala     H       H       7.597   0.000   1 
733      190    Ala     N       N       125.163 0.000   1 
734      191    Pro     C       C       178.193 0.000   1 
735      191    Pro     CA      C       64.524  0.000   1 
736      191    Pro     CB      C       30.560  0.000   1 
737      192    Glu     C       C       177.131 0.000   1 
738      192    Glu     CA      C       58.496  0.000   1 
739      192    Glu     CB      C       25.544  0.000   1 
740      192    Glu     H       H       9.808   0.000   1 
741      192    Glu     N       N       115.450 0.000   1 
742      193    Val     C       C       180.729 0.000   1 
743      193    Val     CA      C       64.434  0.000   1 
744      193    Val     CB      C       30.233  0.000   1 
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745      193    Val     H       H       6.906   0.000   1 
746      193    Val     N       N       120.984 0.000   1 
747      194    Leu     C       C       178.388 0.000   1 
748      194    Leu     CA      C       56.758  0.000   1 
749      194    Leu     CB      C       39.166  0.000   1 
750      194    Leu     H       H       6.843   0.000   1 
751      194    Leu     N       N       121.679 0.000   1 
752      195    Ala     C       C       175.713 0.000   1 
753      195    Ala     CA      C       51.543  0.000   1 
754      195    Ala     CB      C       17.945  0.000   1 
755      195    Ala     H       H       7.745   0.000   1 
756      195    Ala     N       N       119.203 0.000   1 
757      196    Gln     C       C       175.297 0.000   1 
758      196    Gln     CA      C       56.362  0.000   1 
759      196    Gln     CB      C       24.729  0.000   1 
760      196    Gln     H       H       7.699   0.000   1 
761      196    Gln     N       N       112.920 0.000   1 
762      197    Lys     C       C       173.996 0.000   1 
763      197    Lys     CA      C       53.227  0.000   1 
764      197    Lys     CB      C       30.689  0.000   1 
765      197    Lys     H       H       7.859   0.000   1 
766      197    Lys     N       N       119.474 0.000   1 
767      198    Pro     C       C       176.455 0.000   1 
768      198    Pro     CA      C       62.574  0.000   1 
769      198    Pro     CB      C       30.945  0.000   1 
770      199    Tyr     C       C       174.228 0.000   1 
771      199    Tyr     CA      C       56.803  0.000   1 
772      199    Tyr     CB      C       39.190  0.000   1 
773      199    Tyr     H       H       7.880   0.000   1 
774      199    Tyr     N       N       119.098 0.000   1 
775      201    Lys     C       C       175.744 0.000   1 
776      201    Lys     CA      C       58.835  0.000   1 
777      201    Lys     CB      C       30.474  0.000   1 
778      202    Ala     C       C       182.667 0.000   1 
779      202    Ala     CA      C       54.293  0.000   1 
780      202    Ala     CB      C       18.427  0.000   1 
781      202    Ala     H       H       7.905   0.000   1 
782      202    Ala     N       N       120.871 0.000   1 
783      203    Val     C       C       178.558 0.000   1 
784      203    Val     CA      C       65.139  0.000   1 
785      203    Val     CB      C       33.249  0.000   1 
786      203    Val     H       H       8.370   0.000   1 
787      203    Val     N       N       118.324 0.000   1 
788      204    Asp     C       C       178.123 0.000   1 
789      204    Asp     CA      C       56.485  0.000   1 
790      204    Asp     CB      C       40.652  0.000   1 
791      204    Asp     H       H       7.772   0.000   1 
792      204    Asp     N       N       121.553 0.000   1 
793      205    Cys     C       C       175.757 0.000   1 
794      205    Cys     CA      C       63.295  0.000   1 
795      205    Cys     CB      C       26.545  0.000   1 
796      205    Cys     H       H       7.209   0.000   1 
797      205    Cys     N       N       119.245 0.000   1 
798      206    Trp     C       C       177.429 0.000   1 
799      206    Trp     CA      C       60.538  0.000   1 
800      206    Trp     CB      C       27.528  0.000   1 
801      206    Trp     H       H       7.359   0.000   1 
802      206    Trp     N       N       119.734 0.000   1 
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803      207    Ser     C       C       175.971 0.000   1 
804      207    Ser     CA      C       62.962  0.000   1 
805      207    Ser     CB      C       66.611  0.000   1 
806      207    Ser     H       H       7.857   0.000   1 
807      207    Ser     N       N       113.580 0.000   1 
808      208    Ile     C       C       176.808 0.000   1 
809      208    Ile     CA      C       65.913  0.000   1 
810      208    Ile     CB      C       36.749  0.000   1 
811      208    Ile     H       H       7.951   0.000   1 
812      208    Ile     N       N       120.456 0.000   1 
813      209    Gly     C       C       173.185 0.000   1 
814      209    Gly     CA      C       48.149  0.000   1 
815      209    Gly     H       H       7.648   0.000   1 
816      209    Gly     N       N       108.906 0.000   1 
817      210    Val     C       C       178.236 0.000   1 
818      210    Val     CA      C       65.920  0.000   1 
819      210    Val     CB      C       30.711  0.000   1 
820      210    Val     H       H       7.635   0.000   1 
821      210    Val     N       N       121.960 0.000   1 
822      211    Ile     C       C       177.042 0.000   1 
823      211    Ile     CA      C       65.794  0.000   1 
824      211    Ile     CB      C       37.123  0.000   1 
825      211    Ile     H       H       8.098   0.000   1 
826      211    Ile     N       N       118.814 0.000   1 
827      212    Ala     C       C       176.959 0.000   1 
828      212    Ala     CA      C       55.693  0.000   1 
829      212    Ala     CB      C       17.088  0.000   1 
830      212    Ala     H       H       8.631   0.000   1 
831      212    Ala     N       N       121.680 0.000   1 
832      214    Ile     C       C       179.222 0.000   1 
833      214    Ile     CA      C       64.857  0.000   1 
834      214    Ile     CB      C       40.066  0.000   1 
835      215    Leu     C       C       177.874 0.000   1 
836      215    Leu     CA      C       56.553  0.000   1 
837      215    Leu     CB      C       40.373  0.000   1 
838      215    Leu     H       H       8.727   0.000   1 
839      215    Leu     N       N       118.699 0.000   1 
840      216    Leu     C       C       175.259 0.000   1 
841      216    Leu     CA      C       53.797  0.000   1 
842      216    Leu     CB      C       41.651  0.000   1 
843      216    Leu     H       H       7.100   0.000   1 
844      216    Leu     N       N       115.379 0.000   1 
845      217    Cys     C       C       174.223 0.000   1 
846      218    Gly     C       C       170.480 0.000   1 
847      218    Gly     CA      C       45.960  0.000   1 
848      218    Gly     H       H       9.433   0.000   1 
849      218    Gly     N       N       115.601 0.000   1 
850      219    Tyr     C       C       170.653 0.000   1 
851      219    Tyr     CA      C       53.452  0.000   1 
852      219    Tyr     CB      C       37.968  0.000   1 
853      219    Tyr     H       H       7.796   0.000   1 
854      219    Tyr     N       N       116.754 0.000   1 
855      221    Pro     C       C       175.372 0.000   1 
856      221    Pro     CA      C       63.986  0.000   1 
857      222    Phe     C       C       174.961 0.000   1 
858      222    Phe     CA      C       54.713  0.000   1 
859      222    Phe     CB      C       40.199  0.000   1 
860      222    Phe     H       H       6.937   0.000   1 
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861      222    Phe     N       N       114.085 0.000   1 
862      223    Tyr     C       C       173.129 0.000   1 
863      223    Tyr     CA      C       60.245  0.000   1 
864      223    Tyr     CB      C       39.909  0.000   1 
865      223    Tyr     H       H       8.857   0.000   1 
866      223    Tyr     N       N       123.049 0.000   1 
867      224    Asp     C       C       173.822 0.000   1 
868      224    Asp     CA      C       54.233  0.000   1 
869      224    Asp     CB      C       44.693  0.000   1 
870      224    Asp     H       H       6.656   0.000   1 
871      224    Asp     N       N       126.639 0.000   1 
872      225    Glu     C       C       175.682 0.000   1 
873      225    Glu     CA      C       57.639  0.000   1 
874      225    Glu     CB      C       28.884  0.000   1 
875      225    Glu     H       H       8.485   0.000   1 
876      225    Glu     N       N       124.081 0.000   1 
877      226    Asn     C       C       175.104 0.000   1 
878      226    Asn     CA      C       51.894  0.000   1 
879      226    Asn     CB      C       39.157  0.000   1 
880      226    Asn     H       H       9.566   0.000   1 
881      226    Asn     N       N       120.783 0.000   1 
882      227    Asp     C       C       177.346 0.000   1 
883      227    Asp     CA      C       57.247  0.000   1 
884      227    Asp     CB      C       39.800  0.000   1 
885      227    Asp     H       H       8.675   0.000   1 
886      227    Asp     N       N       126.762 0.000   1 
887      228    Ser     C       C       176.961 0.000   1 
888      228    Ser     CA      C       61.373  0.000   1 
889      228    Ser     H       H       8.053   0.000   1 
890      228    Ser     N       N       115.330 0.000   1 
891      229    Lys     C       C       178.856 0.000   1 
892      229    Lys     CA      C       57.771  0.000   1 
893      229    Lys     CB      C       30.739  0.000   1 
894      229    Lys     H       H       7.555   0.000   1 
895      229    Lys     N       N       123.326 0.000   1 
896      230    Leu     C       C       177.709 0.000   1 
897      230    Leu     CA      C       57.688  0.000   1 
898      230    Leu     CB      C       40.312  0.000   1 
899      230    Leu     H       H       7.969   0.000   1 
900      230    Leu     N       N       122.527 0.000   1 
901      231    Phe     C       C       177.039 0.000   1 
902      231    Phe     CA      C       60.062  0.000   1 
903      231    Phe     CB      C       37.658  0.000   1 
904      231    Phe     H       H       8.029   0.000   1 
905      231    Phe     N       N       117.573 0.000   1 
906      232    Glu     C       C       178.649 0.000   1 
907      232    Glu     CA      C       58.901  0.000   1 
908      232    Glu     CB      C       28.949  0.000   1 
909      232    Glu     H       H       7.430   0.000   1 
910      232    Glu     N       N       116.634 0.000   1 
911      233    Gln     C       C       178.791 0.000   1 
912      233    Gln     CA      C       58.705  0.000   1 
913      233    Gln     CB      C       28.281  0.000   1 
914      233    Gln     H       H       7.898   0.000   1 
915      233    Gln     N       N       118.991 0.000   1 
916      234    Ile     C       C       177.835 0.000   1 
917      234    Ile     CA      C       65.001  0.000   1 
918      234    Ile     CB      C       36.758  0.000   1 
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919      234    Ile     H       H       7.725   0.000   1 
920      234    Ile     N       N       121.068 0.000   1 
921      235    Leu     C       C       179.350 0.000   1 
922      235    Leu     CA      C       57.422  0.000   1 
923      235    Leu     CB      C       41.206  0.000   1 
924      235    Leu     H       H       7.750   0.000   1 
925      235    Leu     N       N       117.348 0.000   1 
926      236    Lys     C       C       176.383 0.000   1 
927      236    Lys     CA      C       56.750  0.000   1 
928      236    Lys     CB      C       32.292  0.000   1 
929      236    Lys     H       H       7.314   0.000   1 
930      236    Lys     N       N       114.898 0.000   1 
931      237    Ala     C       C       175.089 0.000   1 
932      237    Ala     CA      C       53.020  0.000   1 
933      237    Ala     CB      C       17.305  0.000   1 
934      237    Ala     H       H       8.186   0.000   1 
935      237    Ala     N       N       122.729 0.000   1 
936      238    Glu     C       C       174.300 0.000   1 
937      238    Glu     CA      C       55.478  0.000   1 
938      238    Glu     CB      C       29.422  0.000   1 
939      238    Glu     H       H       8.274   0.000   1 
940      238    Glu     N       N       119.830 0.000   1 
941      239    Tyr     C       C       172.674 0.000   1 
942      239    Tyr     CA      C       55.042  0.000   1 
943      239    Tyr     CB      C       38.776  0.000   1 
944      239    Tyr     H       H       7.298   0.000   1 
945      239    Tyr     N       N       120.378 0.000   1 
946      240    Glu     C       C       174.168 0.000   1 
947      240    Glu     CA      C       53.212  0.000   1 
948      240    Glu     CB      C       33.152  0.000   1 
949      240    Glu     H       H       8.311   0.000   1 
950      240    Glu     N       N       118.288 0.000   1 
951      241    Phe     C       C       175.003 0.000   1 
952      241    Phe     CA      C       54.280  0.000   1 
953      241    Phe     CB      C       35.239  0.000   1 
954      241    Phe     H       H       8.733   0.000   1 
955      241    Phe     N       N       123.750 0.000   1 
956      242    Asp     C       C       176.562 0.000   1 
957      242    Asp     CA      C       55.240  0.000   1 
958      242    Asp     CB      C       40.627  0.000   1 
959      242    Asp     H       H       7.542   0.000   1 
960      242    Asp     N       N       119.104 0.000   1 
961      243    Ser     C       C       174.338 0.000   1 
962      243    Ser     CA      C       57.115  0.000   1 
963      243    Ser     CB      C       62.706  0.000   1 
964      243    Ser     H       H       8.917   0.000   1 
965      243    Ser     N       N       119.678 0.000   1 
966      244    Pro     C       C       177.630 0.000   1 
967      244    Pro     CA      C       62.818  0.000   1 
968      244    Pro     CB      C       33.450  0.000   1 
969      245    Tyr     C       C       177.588 0.000   1 
970      245    Tyr     CA      C       59.447  0.000   1 
971      245    Tyr     CB      C       37.488  0.000   1 
972      245    Tyr     H       H       6.561   0.000   1 
973      245    Tyr     N       N       124.546 0.000   1 
974      246    Trp     C       C       177.520 0.000   1 
975      246    Trp     CA      C       57.422  0.000   1 
976      246    Trp     CB      C       28.662  0.000   1 
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977      246    Trp     H       H       8.372   0.000   1 
978      246    Trp     N       N       114.680 0.000   1 
979      247    Asp     C       C       177.350 0.000   1 
980      247    Asp     CA      C       57.320  0.000   1 
981      247    Asp     CB      C       38.671  0.000   1 
982      247    Asp     H       H       7.757   0.000   1 
983      247    Asp     N       N       124.020 0.000   1 
984      248    Asp     C       C       175.526 0.000   1 
985      248    Asp     CA      C       53.658  0.000   1 
986      248    Asp     CB      C       40.607  0.000   1 
987      248    Asp     H       H       8.568   0.000   1 
988      248    Asp     N       N       116.625 0.000   1 
989      249    Ile     C       C       176.487 0.000   1 
990      249    Ile     CA      C       57.277  0.000   1 
991      249    Ile     CB      C       35.404  0.000   1 
992      249    Ile     H       H       7.007   0.000   1 
993      249    Ile     N       N       122.412 0.000   1 
994      250    Ser     C       C       174.813 0.000   1 
995      250    Ser     CA      C       59.357  0.000   1 
996      250    Ser     CB      C       63.102  0.000   1 
997      250    Ser     H       H       10.543  0.000   1 
998      250    Ser     N       N       126.978 0.000   1 
999      251    Asp     C       C       179.538 0.000   1 
1000     251    Asp     CA      C       56.630  0.000   1 
1001     251    Asp     CB      C       39.310  0.000   1 
1002     251    Asp     H       H       8.605   0.000   1 
1003     251    Asp     N       N       120.309 0.000   1 
1004     255    Asp     C       C       177.531 0.000   1 
1005     255    Asp     CA      C       57.374  0.000   1 
1006     255    Asp     CB      C       42.955  0.000   1 
1007     256    Phe     C       C       176.029 0.000   1 
1008     256    Phe     CA      C       61.653  0.000   1 
1009     256    Phe     CB      C       37.713  0.000   1 
1010     256    Phe     H       H       8.070   0.000   1 
1011     256    Phe     N       N       121.599 0.000   1 
1012     257    Ile     C       C       178.294 0.000   1 
1013     257    Ile     CA      C       65.400  0.000   1 
1014     257    Ile     CB      C       37.147  0.000   1 
1015     257    Ile     H       H       7.706   0.000   1 
1016     257    Ile     N       N       116.817 0.000   1 
1017     258    Arg     C       C       178.006 0.000   1 
1018     258    Arg     CA      C       58.380  0.000   1 
1019     258    Arg     CB      C       29.354  0.000   1 
1020     258    Arg     H       H       8.514   0.000   1 
1021     258    Arg     N       N       119.338 0.000   1 
1022     259    Asn     C       C       175.211 0.000   1 
1023     259    Asn     CA      C       55.073  0.000   1 
1024     259    Asn     CB      C       37.890  0.000   1 
1025     259    Asn     H       H       6.962   0.000   1 
1026     259    Asn     N       N       113.435 0.000   1 
1027     260    Leu     C       C       177.936 0.000   1 
1028     260    Leu     CA      C       56.248  0.000   1 
1029     260    Leu     CB      C       41.398  0.000   1 
1030     260    Leu     H       H       6.912   0.000   1 
1031     260    Leu     N       N       121.249 0.000   1 
1032     261    Met     C       C       175.499 0.000   1 
1033     261    Met     CA      C       54.891  0.000   1 
1034     261    Met     CB      C       28.794  0.000   1 
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1035     262    Glu     C       C       176.417 0.000   1 
1036     262    Glu     CA      C       52.391  0.000   1 
1037     262    Glu     CB      C       30.493  0.000   1 
1038     262    Glu     H       H       7.036   0.000   1 
1039     262    Glu     N       N       122.527 0.000   1 
1040     263    Lys     C       C       174.955 0.000   1 
1041     263    Lys     CA      C       59.798  0.000   1 
1042     263    Lys     CB      C       31.975  0.000   1 
1043     263    Lys     H       H       9.257   0.000   1 
1044     263    Lys     N       N       131.328 0.000   1 
1045     264    Asp     C       C       176.199 0.000   1 
1046     264    Asp     CA      C       50.745  0.000   1 
1047     264    Asp     CB      C       40.823  0.000   1 
1048     264    Asp     H       H       9.619   0.000   1 
1049     264    Asp     N       N       121.545 0.000   1 
1050     265    Pro     C       C       177.091 0.000   1 
1051     265    Pro     CA      C       64.197  0.000   1 
1052     265    Pro     CB      C       31.045  0.000   1 
1053     266    Asn     C       C       176.051 0.000   1 
1054     266    Asn     CA      C       54.638  0.000   1 
1055     266    Asn     CB      C       38.074  0.000   1 
1056     266    Asn     H       H       8.481   0.000   1 
1057     266    Asn     N       N       115.620 0.000   1 
1058     267    Lys     C       C       176.121 0.000   1 
1059     267    Lys     CA      C       55.928  0.000   1 
1060     267    Lys     CB      C       33.557  0.000   1 
1061     267    Lys     H       H       7.409   0.000   1 
1062     267    Lys     N       N       119.134 0.000   1 
1063     268    Arg     C       C       175.702 0.000   1 
1064     268    Arg     CA      C       55.970  0.000   1 
1065     268    Arg     CB      C       30.737  0.000   1 
1066     268    Arg     H       H       7.338   0.000   1 
1067     268    Arg     N       N       123.110 0.000   1 
1068     269    Tyr     C       C       177.782 0.000   1 
1069     269    Tyr     CA      C       55.414  0.000   1 
1070     269    Tyr     CB      C       36.677  0.000   1 
1071     269    Tyr     H       H       8.415   0.000   1 
1072     269    Tyr     N       N       127.747 0.000   1 
1073     270    Thr     C       C       176.827 0.000   1 
1074     270    Thr     CA      C       60.177  0.000   1 
1075     270    Thr     CB      C       71.107  0.000   1 
1076     270    Thr     H       H       8.161   0.000   1 
1077     270    Thr     N       N       110.487 0.000   1 
1078     271    Cys     C       C       176.258 0.000   1 
1079     271    Cys     CA      C       64.461  0.000   1 
1080     271    Cys     CB      C       26.014  0.000   1 
1081     271    Cys     H       H       9.142   0.000   1 
1082     271    Cys     N       N       119.024 0.000   1 
1083     272    Glu     C       C       178.432 0.000   1 
1084     272    Glu     CA      C       58.785  0.000   1 
1085     272    Glu     CB      C       28.477  0.000   1 
1086     272    Glu     H       H       8.267   0.000   1 
1087     272    Glu     N       N       118.160 0.000   1 
1088     273    Gln     C       C       179.448 0.000   1 
1089     273    Gln     CA      C       57.740  0.000   1 
1090     273    Gln     CB      C       28.247  0.000   1 
1091     273    Gln     H       H       7.131   0.000   1 
1092     273    Gln     N       N       117.472 0.000   1 
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1093     274    Ala     C       C       178.375 0.000   1 
1094     274    Ala     CA      C       54.889  0.000   1 
1095     274    Ala     CB      C       18.762  0.000   1 
1096     274    Ala     H       H       8.471   0.000   1 
1097     274    Ala     N       N       122.386 0.000   1 
1098     275    Ala     C       C       177.505 0.000   1 
1099     275    Ala     CA      C       53.332  0.000   1 
1100     275    Ala     CB      C       17.477  0.000   1 
1101     275    Ala     H       H       8.141   0.000   1 
1102     275    Ala     N       N       116.622 0.000   1 
1103     276    Arg     C       C       176.080 0.000   1 
1104     276    Arg     CA      C       54.544  0.000   1 
1105     276    Arg     CB      C       30.235  0.000   1 
1106     276    Arg     H       H       6.936   0.000   1 
1107     276    Arg     N       N       112.798 0.000   1 
1108     277    His     C       C       175.376 0.000   1 
1109     277    His     CA      C       55.438  0.000   1 
1110     277    His     CB      C       32.603  0.000   1 
1111     277    His     H       H       7.724   0.000   1 
1112     277    His     N       N       126.359 0.000   1 
1113     278    Pro     C       C       176.938 0.000   1 
1114     278    Pro     CA      C       64.955  0.000   1 
1115     279    Trp     C       C       178.489 0.000   1 
1116     279    Trp     CA      C       61.932  0.000   1 
1117     279    Trp     CB      C       27.699  0.000   1 
1118     279    Trp     H       H       11.225  0.000   1 
1119     279    Trp     N       N       123.062 0.000   1 
1120     280    Ile     C       C       177.273 0.000   1 
1121     280    Ile     CA      C       58.526  0.000   1 
1122     280    Ile     CB      C       35.813  0.000   1 
1123     280    Ile     H       H       7.628   0.000   1 
1124     280    Ile     N       N       116.368 0.000   1 
1125     281    Ala     C       C       178.052 0.000   1 
1126     281    Ala     CA      C       52.527  0.000   1 
1127     281    Ala     CB      C       19.457  0.000   1 
1128     281    Ala     H       H       8.411   0.000   1 
1129     281    Ala     N       N       120.826 0.000   1 
1130     282    Gly     C       C       175.413 0.000   1 
1131     282    Gly     CA      C       44.607  0.000   1 
1132     282    Gly     H       H       7.976   0.000   1 
1133     282    Gly     N       N       109.977 0.000   1 
1134     283    Asp     C       C       176.585 0.000   1 
1135     283    Asp     CA      C       53.233  0.000   1 
1136     283    Asp     CB      C       40.802  0.000   1 
1137     283    Asp     H       H       8.469   0.000   1 
1138     283    Asp     N       N       122.272 0.000   1 
1139     284    Thr     C       C       175.608 0.000   1 
1140     284    Thr     CA      C       61.851  0.000   1 
1141     284    Thr     CB      C       68.641  0.000   1 
1142     284    Thr     H       H       7.093   0.000   1 
1143     284    Thr     N       N       107.887 0.000   1 
1144     285    Ala     C       C       178.170 0.000   1 
1145     285    Ala     CA      C       52.486  0.000   1 
1146     285    Ala     CB      C       16.904  0.000   1 
1147     285    Ala     H       H       8.136   0.000   1 
1148     285    Ala     N       N       123.486 0.000   1 
1149     286    Leu     C       C       173.854 0.000   1 
1150     286    Leu     CA      C       54.173  0.000   1 
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1151     286    Leu     CB      C       41.443  0.000   1 
1152     286    Leu     H       H       6.993   0.000   1 
1153     286    Leu     N       N       123.494 0.000   1 
1154     287    Asn     C       C       174.895 0.000   1 
1155     287    Asn     CA      C       50.991  0.000   1 
1156     287    Asn     CB      C       39.323  0.000   1 
1157     287    Asn     H       H       8.017   0.000   1 
1158     287    Asn     N       N       115.080 0.000   1 
1159     288    Lys     C       C       176.812 0.000   1 
1160     288    Lys     CA      C       54.899  0.000   1 
1161     288    Lys     CB      C       32.987  0.000   1 
1162     288    Lys     H       H       7.310   0.000   1 
1163     288    Lys     N       N       121.129 0.000   1 
1164     289    Asn     C       C       176.454 0.000   1 
1165     289    Asn     CA      C       53.196  0.000   1 
1166     289    Asn     CB      C       36.714  0.000   1 
1167     289    Asn     H       H       9.025   0.000   1 
1168     289    Asn     N       N       123.539 0.000   1 
1169     290    Ile     C       C       175.264 0.000   1 
1170     290    Ile     CA      C       61.102  0.000   1 
1171     290    Ile     CB      C       37.298  0.000   1 
1172     290    Ile     H       H       9.304   0.000   1 
1173     290    Ile     N       N       126.705 0.000   1 
1174     291    His     C       C       177.522 0.000   1 
1175     291    His     CA      C       61.707  0.000   1 
1176     291    His     CB      C       32.058  0.000   1 
1177     291    His     H       H       8.064   0.000   1 
1178     291    His     N       N       120.296 0.000   1 
1179     292    Glu     C       C       178.439 0.000   1 
1180     292    Glu     CA      C       60.308  0.000   1 
1181     292    Glu     CB      C       28.412  0.000   1 
1182     292    Glu     H       H       9.010   0.000   1 
1183     292    Glu     N       N       120.299 0.000   1 
1184     293    Ser     C       C       177.041 0.000   1 
1185     293    Ser     CA      C       60.309  0.000   1 
1186     293    Ser     CB      C       62.941  0.000   1 
1187     293    Ser     H       H       8.272   0.000   1 
1188     293    Ser     N       N       112.288 0.000   1 
1189     294    Val     C       C       178.552 0.000   1 
1190     294    Val     CA      C       66.375  0.000   1 
1191     294    Val     CB      C       31.377  0.000   1 
1192     294    Val     H       H       7.531   0.000   1 
1193     294    Val     N       N       117.726 0.000   1 
1194     295    Ser     C       C       175.932 0.000   1 
1195     295    Ser     CA      C       61.563  0.000   1 
1196     295    Ser     CB      C       62.336  0.000   1 
1197     295    Ser     H       H       8.501   0.000   1 
1198     295    Ser     N       N       112.978 0.000   1 
1199     296    Ala     C       C       181.242 0.000   1 
1200     296    Ala     CA      C       54.745  0.000   1 
1201     296    Ala     CB      C       17.531  0.000   1 
1202     296    Ala     H       H       7.159   0.000   1 
1203     296    Ala     N       N       124.171 0.000   1 
1204     297    Gln     C       C       179.273 0.000   1 
1205     297    Gln     CA      C       57.508  0.000   1 
1206     297    Gln     CB      C       26.357  0.000   1 
1207     297    Gln     H       H       7.884   0.000   1 
1208     297    Gln     N       N       117.173 0.000   1 
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1209     298    Ile     C       C       178.866 0.000   1 
1210     298    Ile     CA      C       65.006  0.000   1 
1211     298    Ile     CB      C       36.774  0.000   1 
1212     298    Ile     H       H       8.885   0.000   1 
1213     298    Ile     N       N       124.588 0.000   1 
1214     299    Arg     C       C       178.171 0.000   1 
1215     299    Arg     CA      C       58.785  0.000   1 
1216     299    Arg     CB      C       29.466  0.000   1 
1217     299    Arg     H       H       7.905   0.000   1 
1218     299    Arg     N       N       116.951 0.000   1 
1219     300    Lys     C       C       177.864 0.000   1 
1220     300    Lys     CA      C       57.560  0.000   1 
1221     300    Lys     CB      C       33.181  0.000   1 
1222     300    Lys     H       H       7.199   0.000   1 
1223     300    Lys     N       N       116.395 0.000   1 
1224     301    Asn     C       C       174.694 0.000   1 
1225     301    Asn     CA      C       55.248  0.000   1 
1226     301    Asn     CB      C       40.697  0.000   1 
1227     301    Asn     H       H       8.094   0.000   1 
1228     301    Asn     N       N       114.786 0.000   1 
1229     302    Phe     C       C       175.039 0.000   1 
1230     302    Phe     CA      C       56.525  0.000   1 
1231     302    Phe     CB      C       38.628  0.000   1 
1232     302    Phe     H       H       8.395   0.000   1 
1233     302    Phe     N       N       119.653 0.000   1 
1234     303    Ala     C       C       177.895 0.000   1 
1235     303    Ala     CA      C       52.787  0.000   1 
1236     303    Ala     CB      C       18.590  0.000   1 
1237     303    Ala     H       H       7.782   0.000   1 
1238     303    Ala     N       N       123.728 0.000   1 
1239     306    Lys     C       C       176.713 0.000   1 
1240     306    Lys     CA      C       56.597  0.000   1 
1241     306    Lys     CB      C       31.483  0.000   1 
1242     307    Trp     C       C       176.490 0.000   1 
1243     307    Trp     CA      C       56.696  0.000   1 
1244     307    Trp     CB      C       28.873  0.000   1 
1245     307    Trp     H       H       7.900   0.000   1 
1246     307    Trp     N       N       121.222 0.000   1 
1247     308    Arg     C       C       176.176 0.000   1 
1248     308    Arg     CA      C       55.994  0.000   1 
1249     308    Arg     CB      C       29.814  0.000   1 
1250     308    Arg     H       H       7.953   0.000   1 
1251     308    Arg     N       N       122.213 0.000   1 
1252     309    Gln     C       C       175.732 0.000   1 
1253     309    Gln     CA      C       55.584  0.000   1 
1254     309    Gln     CB      C       28.716  0.000   1 
1255     309    Gln     H       H       8.143   0.000   1 
1256     309    Gln     N       N       121.209 0.000   1 
1257     310    Ala     C       C       177.394 0.000   1 
1258     310    Ala     CA      C       52.110  0.000   1 
1259     310    Ala     CB      C       18.558  0.000   1 
1260     310    Ala     H       H       8.153   0.000   1 
1261     310    Ala     N       N       124.791 0.000   1 
1262     311    Phe     C       C       175.329 0.000   1 
1263     311    Phe     CA      C       57.401  0.000   1 
1264     311    Phe     CB      C       38.890  0.000   1 
1265     311    Phe     H       H       8.070   0.000   1 
1266     311    Phe     N       N       119.399 0.000   1 
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1267     312    Asn     C       C       174.513 0.000   1 
1268     312    Asn     CA      C       52.582  0.000   1 
1269     312    Asn     CB      C       38.437  0.000   1 
1270     312    Asn     H       H       8.186   0.000   1 
1271     312    Asn     N       N       120.978 0.000   1 
1272     313    Ala     C       C       177.747 0.000   1 
1273     313    Ala     CA      C       52.358  0.000   1 
1274     313    Ala     CB      C       18.657  0.000   1 
1275     313    Ala     H       H       8.117   0.000   1 
1276     313    Ala     N       N       125.059 0.000   1 
1277     314    Thr     C       C       174.137 0.000   1 
1278     314    Thr     CA      C       61.527  0.000   1 
1279     314    Thr     CB      C       69.160  0.000   1 
1280     314    Thr     H       H       7.971   0.000   1 
1281     314    Thr     N       N       113.203 0.000   1 
1282     315    Ala     C       C       177.310 0.000   1 
1283     315    Ala     CA      C       51.934  0.000   1 
1284     315    Ala     CB      C       18.670  0.000   1 
1285     315    Ala     H       H       8.062   0.000   1 
1286     315    Ala     N       N       126.949 0.000   1 
1287     316    Val     C       C       175.362 0.000   1 
1288     316    Val     CA      C       61.982  0.000   1 
1289     316    Val     CB      C       31.826  0.000   1 
1290     316    Val     H       H       8.053   0.000   1 
1291     316    Val     N       N       120.902 0.000   1 
1292     317    Val     C       C       180.921 0.000   1 
1293     317    Val     CA      C       63.072  0.000   1 
1294     317    Val     CB      C       32.601  0.000   1 
1295     317    Val     H       H       7.635   0.000   1 
1296     317    Val     N       N       128.406 0.000   1 
1297     326    Gly     C       C       174.244 0.000   1 
1298     326    Gly     CA      C       44.814  0.000   1 
1299     327    Ser     C       C       174.785 0.000   1 
1300     327    Ser     CA      C       57.912  0.000   1 
1301     327    Ser     CB      C       63.274  0.000   1 
1302     327    Ser     H       H       8.151   0.000   1 
1303     327    Ser     N       N       116.144 0.000   1 
1304     328    Ser     C       C       174.611 0.000   1 
1305     328    Ser     CA      C       58.213  0.000   1 
1306     328    Ser     CB      C       63.514  0.000   1 
1307     329    Leu     C       C       177.259 0.000   1 
1308     329    Leu     CA      C       54.938  0.000   1 
1309     329    Leu     CB      C       41.218  0.000   1 
1310     329    Leu     H       H       8.195   0.000   1 
1311     329    Leu     N       N       124.036 0.000   1 
1312     330    Asp     C       C       176.432 0.000   1 
1313     330    Asp     CA      C       54.023  0.000   1 
1314     330    Asp     CB      C       40.611  0.000   1 
1315     330    Asp     H       H       8.230   0.000   1 
1316     330    Asp     N       N       121.436 0.000   1 
1317     331    Ser     C       C       174.864 0.000   1 
1318     331    Ser     CA      C       58.190  0.000   1 
1319     331    Ser     CB      C       63.398  0.000   1 
1320     331    Ser     H       H       8.185   0.000   1 
1321     331    Ser     N       N       117.014 0.000   1 
1322     332    Ser     C       C       174.350 0.000   1 
1323     332    Ser     CA      C       58.630  0.000   1 
1324     332    Ser     CB      C       63.234  0.000   1 
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1325     332    Ser     H       H       8.317   0.000   1 
1326     332    Ser     N       N       118.136 0.000   1 
1327     333    Asn     C       C       173.764 0.000   1 
1328     333    Asn     CA      C       52.824  0.000   1 
1329     333    Asn     CB      C       38.717  0.000   1 
1330     333    Asn     H       H       8.242   0.000   1 
1331     333    Asn     N       N       121.197 0.000   1 
1332     334    Ala     C       C       182.491 0.000   1 
1333     334    Ala     CA      C       53.472  0.000   1 
1334     334    Ala     CB      C       19.314  0.000   1 
1335     334    Ala     H       H       7.745   0.000   1 
1336     334    Ala     N       N       129.850 0.000   1 
 
stop_ 
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